SIMPLE_CHEMICAL,frequency
ultraviolet,35
germicidal,17
FDA,152
Enfuvirtide,1
sulfur dioxide,8
nitrogen dioxide,11
carbon monoxide,20
Steroids,2
steroids,79
carbon dioxide,54
nucleotide,868
B-group,1
[severe acute respiratory syndrome]),1
base/day,1
(E)-peptide,1
SIN842,1
SIN849,1
SIN850,1
SIN852,1
high-density,1
1â5,18
nucleic acid,409
2.7-Ã ,2
magnesium ions,4
reactive sites required,1
1-methyladenine,1
3-methylcytosine,1
PLA,11
carbon monoxide [D(L)CO],1
[pred]),1
lactic acid,38
LAB,49
LAB species,1
LNA,3
LNA-modified,5
dual-labelled,1
conjugated with,11
microspheres,17
streptavidin,4
corona virus,11
IFN-Î³,227
163-,1
IFN-Î±/Î² and,1
IFN-Î±/Î²,3
electron,805
glucose,123
E,80
1â3,10
3-methyladenine,13
agarose,81
double-stranded,192
TF3,10
tannic acid,10
TF2B,3
Puer,1
caffeine,12
EGCg,1
epicatechin,2
theophylline,8
catechin,17
epicatechin gallate,2
ECg,1
epigallocatechin,2
I-A(d,1
hydrogen,98
sub-G1,5
7-AAD,2
wide-spectrum anti-CoV,1
Phosphatidylserine,1
tunicamycin,54
liposomes,56
phosphatidylserine (PS),4
5â² terminal,6
3â² terminal,5
2â²-O-methyl nucleotide,3
droplets,178
water,401
sodium tetraborate,1
"XL""B",1
calcium chloride,3
think-model,1
reactive oxygen species,111
nitric oxide,127
Chloroquine,63
chloroquine,246
"F483,",1
MSN,8
[severe acute respiratory syndrome] and,1
31(st,5
14(th,1
bed,31
2002â2003,48
18S rRNA),2
PMOs,18
alcohol,101
16S,4
PEI,13
clay minerals,3
clay,9
Mte,2
avid,2
IFN-Î³ +,3
IFN-Î³ +874 AA,1
catechins,7
EGCG,38
dispersions,1
chloroquine Chloroquine,1
cholesterol-rich microdomains,6
sodium-dependent phosphate transporter,1
fluticasone propionate,7
salmeterol,3
corticosteroids,222
FP,20
FPS,6
fluticasone,6
technologyâa,1
N-glycan,15
11-dihydroxymeliacarpin,1
"[2,3]",2
"[2,4]",1
SP600125,28
5 1/2,1
corticosteroid use,11
cholesterol,314
FcÎµRI-aggregation,1
calcium,118
corona,7
ribavirin,427
lopinavir,36
ritonavir,33
LPV/r,23
IVIG,92
ROS,172
phytol,10
methotrexate,7
18-Î²-glycyrrhetinic acid,2
PLx,1
isoguanosine,1
isocytidine,1
T487S and,1
5â²,22
polyamine,21
NDP,4
oxygen,410
indium tin oxide (ITO),3
abasic lesions,1
fluorophore,1
quencher,2
lipid,112
ethanol,97
Long-Term,16
âsevereâ amniotic fluid inflammation,1
2-nucleotide,1
OME,55
Cs for,1
intra-strand nucleotide,1
estrogens,6
estrogen,17
17Î±-ethinylestradiol,1
â1 PRF,86
HDL,40
Gln-44,1
AOM,211
amoxicillin,46
penicillin,26
clavulanic acid,2
PB2,14
"NS, NP)",1
NH(4)Cl,26
TNF-Î±,20
NADPH,12
nicotinamide adenine dinucleotide phosphate (,3
NADPH oxidase-activating,2
semi-synthetic outbreaks,1
ribonucleotide,7
PMO,30
L-arginine,4
D-arginine,2
splice-correction,4
6-aminohexanoic acid,2
nucleic acid mass tagâpeptide nucleic acid,2
PNA,26
E sites,1
CGS,4
MG-132,7
ALLN,2
muramyl dipeptide,5
alum,26
ribosome factory of,1
reactive thiolate on,1
disulfide bond,24
reactive thiolate is an additional receptor-dependent step,1
banaba,3
corosolic acid,2
methanol extract,11
ellagitannin Lagerstroemin,1
banaba water,1
gallotannins,1
PGG,13
gallotannin,1
Lagerstroemin,1
73.27,1
lipopolysaccharide,118
LPS,101
fucose ligand,1
2d coronaviruses,2
myeloperoxidase,25
MPO,21
[1-3],1
Flav100F,1
Flav200R,1
bile duct,2
dose(50,1
prostaglandin E2,24
NS398,2
Aspirin,6
methanol,31
[2],14
[3],10
bestatin,15
poly(ethylene imine),1
PEG-PEI copolymers,2
PEG,11
2'OMe ESOs with,1
NG,5
colloidal gold,5
copolymers,2
2'OMe ESOs,1
CT,16
i.m,26
Biojector 2000 or by,1
repeated-dose,5
eicosanoid,6
hydrogen peroxide,51
acetic acid,6
5.8S,1
arsenite (As)-induced,1
BFA,97
DDT,3
conjugated,30
cisplatin,17
etoposide,2
doxorubicin,14
paclitaxel,5
chemoradiotherapy,1
jejunal mucosal scrapings at 12 and,1
doi:10.1007/s00705-008-0118-6,1
IL-4,30
NAI resistance,2
nebulised heparin in acute lung,1
heparin,43
nebulised heparin to,2
nebulised heparin was,1
"nebulised heparin,",1
nebulised heparin.,1
CX3CR1(+/GFP,1
nucleoside analogues,29
bilayers,14
OAG,2
cyclosporin,5
methylprednisolone,60
cyclophosphamide,33
HCY,1
PEP,51
convoluted membranes,24
WTA,1
bortezomib,40
CRT/E7,4
high-density single nucleotide,1
P.O. routes,1
"NAB,",1
PEG vs.,1
1.7Â±0.5,1
contemporaneous-,1
NF-ÎºB-Dependent,1
IFNÎ±/Î²,2
"â¼100,000",1
Membranes,12
Corticosteroids for community-acquired pneumonia,1
[25%â75%,1
CPP,9
Ahx,1
conjugated PMO,1
metals-induced,1
cadmium,18
mercuric (Hg) chloride,1
salts for 3 or,1
interferon gamma,2
sulfadiazine,12
fatty acid,54
Avicel,3
carboxymethyl-cellulose,1
Liposomal,7
chemotherapies,3
vinorelbine,2
ActD,4
Food,113
bile and,1
bile related to,1
sodium,72
Sodium,4
sodium channel proteins,1
sodium channel related information,1
OTA,19
cationic liposomes,5
broad-spectrum immune,1
ICLC,3
ODNs,21
449â461,1
0â18,8
2[0â3],2
3[3â4.7],1
â¼3000,1
1890â1921,1
CoVMpro-octapeptide,1
RTâPCR,6
fatty acids,53
carbon,45
bile salts,2
cytochalasin D,6
1aâmembrane,2
Tannic acid,1
tannic acid-responsive element is,1
10(1,7
10(3,17
10(5,13
struvite urolithiasis,1
struvite,4
PI,152
glycerol,12
antimalarial agents,2
AGE,16
DOP,3
Falls,1
Ozone,6
reactive oxidant scavenging in WT mice,1
ozone,18
sulfated peptide hormones derived,1
S228G,1
SUD(core,2
ADP-ribose,45
G-quadruplexes,46
amino-acids,1
reactive center loop,1
disulfide bond-dependent proteins,1
disulfide bonds,25
plasma-free,4
excipients,2
corticosteroid,26
NO,162
prednisolone,31
hexamethylene amiloride (HMA),2
amiloride,23
dodecylphosphatidylcholine micelles,1
[(3)H]-T-incorporation,1
leflunomide,2
biotin,18
nitric oxide synthase,27
carbobenzoxy-valinyl-phenylalaninal,1
zVF,3
PD150606,3
cycloheximide,36
PIN1,1
n-3,2
PUFA,3
eicosapentaenoic acid,3
docosahexaenoic acid,3
menhaden fish oil/corn oil,1
jasmonic acid,3
cytokinins,2
IbMADS1-transformed potatoes,1
Flavonoids,16
extravascular-lipid-deposit,1
lipid-deposition,1
1995â2006,1
26â31,1
SIRAS-derived,1
lysosomotrophic,1
ammonium chloride,39
"[3,4]",2
rofecoxib,2
Corticosteroids,10
Particulate Air,1
clonidine,4
"29,455",1
NPA specimens,4
NPA,40
phospholipid membranes A tryptophan-rich octapeptide,1
dimyristoyl phosphatidylcholine liposomes,1
spin-labelled lipids,1
adenosine triphosphate,5
Glycyrrhizin,42
cortisone,9
CFR,18
purines,5
pyrimidines,3
U0126,18
[1.6â4.9 yrs,1
[OR] 5.28,1
1.32â3.33,1
polynucleotides,3
Frankfurt/Germany (strain Frankfurt-1,1
ACT,10
ATP,153
apigenin,12
ara C,1
Î¼M oligomycin,1
sialic acid,236
host-generated,1
PCN,2
[ERCP]),1
polyethylene glycol (PEG),8
KCl,5
Tween,6
CINAHL,19
exposureâthat,1
~25,1
interassay,3
IU (P =,1
"reactive âbiodefense,",1
Acridine Derivatives with Known Anti-Prion Activities,1
acridine derivatives,1
chlorpromazine,28
CPZ,9
quinacrine,1
Ursodeoxycholic acid,1
UDCA,3
"bile,",3
Con A-induced,5
LDR,4
clodronate,2
Achromobacter xylosoxidans,1
GM1-ganglioside,2
prostitutes/highly,1
GDP,53
MDI/spacer,7
glycosaminoglycan,10
MPP,13
â¼2000 10-mers,1
Airway Proteases Enhances,1
SMS,21
economy-wide,1
[Formula:,65
fluconazole by,1
azole antifungals,1
fluconazole,6
1 Ã 10(1,1
hydroxyproline,8
ORION-VIRCAT,4
hydrolyse peptide bonds in proteins,1
E protein,35
RSP,2
Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A,1
aurintricarboxylic acid,21
amantadine hydrochloride,2
edeine,1
sulphur oxides,1
LTB,4
LLO-containing liposomes,1
P-2,4
M-6,1
cationic lipid,1
exchanges,3
Triton X-100,29
sucrose,110
para-acrosomal,1
hydroxytamoxifen,1
esfenvalerate,4
UK-12,5
urate deposits,1
hydrogen bonding,2
actinomycin D,11
selenocysteine,1
Facemasks in Reducing,1
E and,5
endoglycosidase H,9
aluminium,2
Disulfide Bonds in Glycoprotein E2,1
Amantadine,7
Ribavirin,93
adamantanes,15
rimantadine,22
amantadine,29
NAIs,4
reactive cocktails of,1
CR2-Crry,1
IPTG,21
DEAE sepharose FF,1
endotoxin,43
streptozotocin,1
STZ,1
diadenosine tetraphosphate hydrolase,2
nucleotide Ap(4)A,1
aldehyde,25
aldehydes,7
glutaraldehyde,15
nonionic detergents,2
BA,30
1Ã10(0)â¼1Ã10(2,1
1Ã10(5)â¼1Ã10(6,1
1Ã10(2,1
BioT,1
zanamivir,37
descriptor-variability,1
broad-spectrum,87
stemâloop,1
20(th,11
11(th,3
NDMA,1
dATP,7
AMP,19
second-line,16
fixed-dose,6
43.7%(677/1548,1
heme-associated iron,1
glutamic acid,17
PPE,340
20â25 PPE,1
5-fluoro,1
Zinc,12
S-adenosyl-L-methionine (AdoMet)-dependent (guanine-N7)-methyltransferase,1
micromolar,24
CQ,65
amodiaquine,11
4-aminoquinoline,1
non-4-aminoquinoline,1
artemisinin,12
1999â2006,1
Electron,9
EDTA,18
LY294002,10
PD98059,10
Schiff,13
Andrographolide Derivatives as Î±-Glucosidase Inhibitors Andrographolide derivatives,1
andrographolide,12
andrographolide derivatives,1
5-fluorouracil,14
sialic acid-dependent,4
18â68,2
13d,1
22a,1
Imiquimod,2
CRT/E7 DNA,2
imiquimod,15
CSF/plasma,1
HPLC-DAD,3
liquiritin,8
glycyrrhizin (2),1
flavones,9
flavonols,7
Compounds 1,1
CI 1.2 - 1.9,1
vitamin D,82
25-hydroxyvitamin,1
25-hydroxyvitamin D,1
glycyrrhizin,139
Lipid,22
PGF,1
2000â2005,3
isoflavone,3
gemfibrozil,3
GGOs,15
dynasore,7
EIPA,7
cytochalasin-D,1
cholesterol-independent,1
DEAE-cellulose,7
Affi-gel blue,8
SP-Sepharose,6
FPLC,7
disulfide bond is,2
anti-escape,1
E2 aa115â119,1
10(4,23
Inv extends inverse folding capabilities to RNA pseudoknot structures.,1
early-October 2009,1
30(th,3
163/402,1
confusions,1
saline,144
G-CSF,22
Lycorine,21
lycorine,68
vitamin D-binding protein,1
Vitamin D-binding,1
Vitamin D,30
vitamin D-binding,1
1 Ã SYBR greenI,1
H2DCFDA,1
fluoroquinolones,33
intra-molecular interactions,2
Bortezomib,11
CIP,7
FACS,1
peracetic acid,5
F1-,2
E H244,1
prM.,2
broad-spectrum inhibitors,12
(123 mg/L and 112 mg/L vs. 40,1
e1000863,1
overstimulates,1
DENs,1
"1, 3,",1
CD200(tr,1
Amiloride,2
amiloride-resistant,1
cation,29
oseltamivir-zanamivir,1
OZ,5
FI,1
doi:10.1007/s12014-010-9058-8),1
Zn(2+,34
Zinc Ionophores Block the,1
zinc-ionophores like pyrithione,1
MgEDTA,1
E form,1
time-dependent,26
corticosteroid administration in severe acute respiratory,1
thionin,1
methadone,5
vidarabine,2
scavenger species,1
partial-duplex,4
70-nt,2
5-nitroindole,1
Light,1
Calcium,8
[Ca(2+)]cyto,2
thapsigargin,4
dampness-related agents,1
CIs,26
12â18,5
nucleid acid,1
lisinopril,2
unsaturated fatty acids,9
dimethylamiloride,1
DMA,5
cytochalasin B,7
nucleos(t)ide,13
[OR],54
IHR(2005,9
IFN-Î³ producing,1
luciferin,1
palmitate,8
monosaccharides,17
oligosaccharides,27
anti-nematode,1
41Â±14 (range 18â83,1
steroid,5
MDA,33
pan-Microbial,1
viralâlike particles,1
SARS-coronavirus/polyethylenimine nanoparticles,1
broad-spectrum antiviral arbidol,1
phospholipids,34
phospholipid,22
tryptophan derivatives or membrane peptides,1
25.2Â±38.2,1
high-dose,50
reactive glia,3
chloride,22
lipid droplets,7
"1, 3, 7",1
Cephalosporins,1
LDL- cholesterol,1
"Fusobacteria (1,4%",1
Corynebacterium,4
H [Shannon entropy],1
purine/pyrimidine,1
amino/keto,1
vitamin C,29
Immumax,7
elemental zinc 7.5,1
glutathione,38
Reactive oxygen species,7
"thiol antioxidants,",1
GSH,33
thiols,3
single-dose,19
OTC,11
1-5,3
[1.15â4.28],1
[2.15â9.15],1
[1.32â11.11],1
[1.49â20.39],1
7/896,1
Luminal,1
Lead,3
double-barreled,1
nitric oxide release,1
5â² guanosine cap,1
N-7,3
5â² cap,6
Exhaled,7
EBC,11
exhaled,75
1 EBC,1
antioxidant,33
bronchodialatory,1
eudesmenolides,1
flavanoids,1
DMXAA,11
"5,6-dimethylxanthenone-4-acetic acid",2
apo,8
strand-strand,1
AF-liposomes,3
cyclodextrins,9
CyDs,2
pDNA,4
liposomal membrane,1
calcein,5
prostaglandin,15
PGE) 2,1
statins,35
rosuvastatin,4
FITC-dextran,3
sugar,100
intravenous immunoglobulin,3
â¼0.01,1
peptide/lipid,2
broad-spectrum antiviral,64
LBM,4
CY,5
thymoglobulin,2
CYA,1
NST may,1
thiol,2
NHS-PEG-MAL,1
conjugated cargo,1
beta-lactam antibiotic,2
Imipenem,1
beta-lactam antibiotic drugs) to,1
â1 RF,1
PCV-2a/motif 2b,1
PCV-2b/motif 2a,1
[1],46
[3] government,1
DG,16
w/v,7
CA-074Me,8
lipid peroxidation,7
SOD,18
GSH-Px,2
TAOC,1
radical-induced lipid peroxidation,1
NA sequencing and/or NA inhibition,1
Î²(2)-AR,1
PHP,1
Lithium Chloride,4
Lithium chloride,9
LiCl,67
MTT,27
propidium iodide staining,5
lithium salts,1
galactose,35
Drug Administration,88
Lysosomotropic agents,1
LA,14
Ammonium chloride,7
NH(4)Cl),1
NH4Cl,5
19(th,2
N7) molecular type,1
trivalent 2009-2010,1
4â55,1
azithromycin,64
mg/kg/dose,1
flavonoids,128
methylene chloride fraction,1
nanomolar,17
sesquiterpenes,7
eugenol,2
farnesol,1
Î²-caryophyllene oxide,1
SsTroA,5
Zn(2+)/Mn(2+,1
PFCs,4
NIPPV,14
DAD,21
658Ã10(3,1
insect-produced,1
Sinefungin,2
S-adenosylmethionine,7
0.26â0.73,1
vitamins,32
NCT01133782,1
[1.02â1.18],1
[1.05â1.14]),1
-2b,2
BEV,49
1Â·43 (1Â·29â1Â·57,1
bat-inflicted wounds,1
PECLA,2
heparin sulfate,4
nanoparticulated,1
nanoparticulated vaccine,1
aminobisphosphonate pamidronate,3
"carbohydrates,",2
lipids,21
3â²-proximal region,2
NTPs,4
dTTP,2
GTP,26
dGTP,3
NTP and,1
ForceâDistance,1
MS2,20
(C+G)(12)%,1
doi:10.1007/s00068-010-0067-0),1
1 base,1
iron oxide nanoparticles,1
iron oxide,3
USPIO,7
SPIO,1
Prussian blue,1
iron,42
IL-1Î²,58
single-stranded (ss)RNAs,1
broad-spectrum pathogen,3
cytidine residue,1
liposomal Î²-galactosidase,1
Estrogen,3
colistin,21
tigecycline,5
meropenem catalysis,1
doxycycline,31
cations,32
[AOR] 2.42,1
Sphingomyelin,1
sphingomyelin,9
SM is acquired,1
ceramide,8
CERT-dependent,1
[AOR],5
sulfur mustard,1
"Sulfur mustard ""bis (2-chlroethyl) sulphide",1
genetics/biology,1
1.4â30.9,1
fluorescent dye,4
isothiocyanate (,1
ZipTipÎ¼-C18 columns,1
s/n,1
prophylacticaly,1
Colchicine,1
colchicine,6
BP,48
PEEP,10
Mycophenolic Acid,1
GMP,16
diphosphate,3
mycophenolic acid,18
MPA,13
IL-12p70,4
FluâA,1
CD4(+,87
20-40,2
"2,6",1
inorganic nanoparticles,3
size-defined,1
non-peptidic dendrimers,1
3-MA,12
Rapamycin,8
Lipopolysaccharide,6
Ribose,1
ribose 2â²-O-methylation,1
sialic acids,90
cytosine,12
sibs/half-sib kittens,1
eIF2Î±-mediated,1
B12,6
intranasal administration about,1
Membranes Positive-stranded,1
PEGylation,3
IHP estimates,1
IHP,1
bj@pnl.gov Supplementary,1
alkaline,7
nucleic acids,19
methylprednisolone acetate,2
MPSL,10
Long-Term Prophylaxis of Vaccinia Virus,1
S-adenosyl-L-methionine (SAM)-dependent methyltransferases (,1
ribose 2â²-O,6
methyl donor SAM,1
m7GpppA-RNA,2
PI cattle,4
Agarose,4
Quercetin 7-rhamnoside,1
quercetin 7-rhamnoside,2
NAC,42
pyrrolidine dithiocarbamate,5
PDTC,20
vitamin E,29
trolox,2
interdisulfide,1
thiol-based redox locus for antigen,1
CTLA-4/Ig,3
cyclosporine A,15
pre-rRNA,6
2â²-O-ribose,4
fibrillarin 2,1
â¼30,16
broad-spectrum peptidomimetic inhibitors,1
"tetromycin derivatives, tetromycins 1â4",1
tetromycin B (5),1
2D NMR spectroscopy,1
bleomycin lung,1
nickel resin,2
adenosine phosphoramidites,1
compounds,9
1 tagIndel,1
Luteolin,13
luteolin,39
LOC,1
Lactococci,1
Lactobacillus,23
lactobacilli,4
clodronate liposomes,7
dUTP,11
E2-210Q,1
E2-210L,1
40S ribosomes,1
5â² untranslated,3
uric acid,12
Urate,1
niclosamide,67
Amiodarone,7
"2-butyl-3-(3â²,5â²-diiodo-4âÎ±-diethylaminoethoxybenzoyl)-benzofuran]",1
nonhepatotoxic,1
bile acid,6
mono-N-desethylamiodarone,1
etanercept,11
xylopine,1
pyridinium fragment,1
broad-spectrum technologies like high-throughput,1
Vitamins,1
Polyketides,1
nitro-,1
hydroxy-substituted salicylaldehydes,1
salicylaldehyde derivatives (X =,1
OH,53
3-hydroxybenzaldehyde by,1
salicylaldehyde,1
H-bond,2
doi:10.1007/s00894-011-1044-1,1
broad-spectrum antivirals,24
fatty-acid,1
PF-429242,1
neurofibrillary tangles,1
hydrogen bond acceptors,2
Nitric Oxide,21
nitric oxide (iNO),1
topical steroids,3
cartridge,1
phenylboronic acid cartridge,1
tannins,20
reveratrol,1
viniferin,1
ampelopsin,1
hydrocyanic acid,1
delphinidin,1
cyanidin,1
kaempferol,12
myricetin,24
quercetin,119
triterpenes,3
epifriedelanol,1
diuretic,3
infectionâa,1
2266,2
9-O-acetylated Sias,1
HE esterase,1
bioflavonoid,2
FFURA,2
Naringin,1
Hesperetin,3
Quercetin,25
daidzein,2
naringin,3
hesperetin,13
bioflavonoids,1
fisetin,2
flavonol,3
dipolar,2
glycyrrhetinic acid monoglucuronide,1
GAMG,20
glycyrrhetinic acid,12
Î³c chain,1
CAL,21
electrolyte,58
calcium oxide,1
dsRNA-encircling ring structure [i.e. nsp(7+,1
16S rDNA,2
2004â2005,4
[OR] 8.99,1
8.3â15.7,1
CI 1.0â1.4,1
HSI2000S [Wahl Instruments,1
citrate synthase gene,1
"1, 2 or 3 in",1
KRG,14
NCT01478009,2
MCA,5
Resveratrol,16
resveratrol,59
Optic-Nerve,1
luxol,1
Ethanol,6
adenosine-stimulated ion,1
adenosine,32
cAMP-activated chloride channel,1
adenosine-stimulated chloride transport,1
ethanol-suppression,1
cAMP analogs,1
CFTR-mediated chloride,1
cyclosporin A,37
FK506,12
disulfide linkages,5
D665,1
Chlorine Gas Intoxication,1
Chlorine,4
chlorine gas are reported,1
bronchodilators,15
â0.61,1
polar air masses were,1
hemin,2
anesthetics,6
BSA,14
MPEG 5K,1
~8 Ã ,1
Phosphatidylinositol 4-Kinase IIIÎ²,1
1.24â12.07,1
ribonucleotide 4-mer,1
heparin (100 Î¼g/mL,1
[ICT]),1
[RR] 7.4,1
nucleoside analogs,21
[OR] 1.95,1
10(2,15
topical antiseptics,1
VGC,1
apyrase,1
O2,23
"2,6-linked sialic acids",1
C-bound benzene rings,1
C-bound benzene rings [ring centroidâcentroid,2
anthracycline,4
idarubicin,2
DGFW,3
GFW,1
Shenfu,2
Sia,35
lipopolysaccharide (LPS)-induced,10
budesonide/formoterol,4
salbutamol,7
AED,1
High-dose intravenous immunoglobulin (,1
NVB,6
NBV 111,1
rOv-ASP-1,20
trichothecene mycotoxin deoxynivalenol,1
DON,19
Z-VAD-FMK,4
acridine orange/ethidium bromide staining,1
anisomycin,5
ricin,4
dextran-,1
iron oxides,2
DM-USPIO,3
Prussian blue-stained specimens,1
(â)-catechin gallate,1
(â)-gallocatechin gallate,3
gallate,3
aglycon,4
teicoplanin,19
virucidal,108
interferon-Î³,23
PepMapper,2
FEV(1,7
SPB +1580 T,1
Eicosanoids,1
prostaglandins,10
leukotrienes,6
leukotriene,2
doi:10.1007/s00134-011-2341-y,1
Act,37
fibrates,3
thiazolidinediones,4
Surflex_Score,2
D_Score,2
"113,228",1
FRET,34
Dynasore,1
Prostaglandin E2,3
fishhook-like,1
vitamin A,17
GCV,4
Clarithromycin,4
polyinosinic-polycytidylic acid,5
Propionibacterium acnes,3
unsaturated fatty acid,4
molybdopterin,2
ODN,19
mat_peptide,1
warm-blood hosts,1
IgY,32
MAP30,6
polyethyelene glycol BACKGROUND:,1
polyethylene glycol (PEG)ylated proteins,1
di-,5
low-release,1
co-extracted inhibitors,1
Jasmonic Acid,1
LaCl(3)-Induced Baicalin,1
Lanthanum,1
La-induced,1
LaCl(3,1
baicalin,21
[(18)F]-FDG,8
Rituxan,1
Remicade,1
Herceptin,1
Humira,1
Avastin,1
Simvastatin,3
statin,11
simvastatin,8
Cyclosporin A,8
CsA,82
CyP,6
arachidonic acid,15
epoxide LTA4,1
K565A,1
LTA4,1
tripeptide,1
K565,1
indigo,5
indirubin,14
liposomes (LP),1
liposomes containing,1
MHC-I.,1
photosensitizers,2
Con A,13
LCA,4
CI [1.02â2.67],1
CI [1.05â3.66],1
mannose,42
aminothiophenecarboxylic acid,1
C003,6
C052,5
C003/C052,4
BTV-induced,2
virostatic agents,1
corticosteroid (ICS),1
âCommunity Acquired Pneumoniaâ(CAP,1
airway-tree,1
NEBs,1
bleomycin,20
ORT,10
ZeihlâNeelsen,1
furazolidone,5
N7 segments,1
stacks,1
non-substrate strand,1
ISSR,2
progoitrin,6
epiprogoitrin,5
uridine,25
guanosine,14
hypoxanthine,2
milrinone,2
20 pathogens accounted,1
PMO):,1
Pip5e-PMO,1
18Ã-glycyrrhetinic acid,1
vitexin,3
apigenin-7-O-glucoside,1
DQ0000496,1
NSTEMI 40,1
STEMI 25,1
charcoal,11
Charcoal,1
soughts,1
curcumin,45
retinoic acid,7
106â130,1
Reactive,2
Nanoparticle,2
CVT-E002,16
FGA,4
nitrogen,4
phosphorus,15
"sulfur, metal resistance",1
pain-killer,1
double-stranded small,1
insect-,1
inâhospital,1
lipopolysaccharide endotoxin,1
lipopolysaccharides (,2
TNF-Î± serum,1
NA Flu,1
C14B1,2
RVP,26
"[IFN-Î³,",1
[IL6],1
low-dose rapamycin (,1
Rapa,5
âdiversity,1
ARBs],1
ARB,36
OroA,8
NS segments,1
bacterial-derived,1
[HR] 4.6,1
aluminium hydroxide-based,1
Alum,17
RIG-I.,10
1.22â2.18,1
0.25â0.69,1
[myeloperoxidase (,1
[cathepsin D,1
"[defensin,",1
[bactericidal/permeability-increasing protein,1
Fusarium graminearum virus 1-DK21,1
polyamines,15
fascicle-like bundles,1
high-performance,9
fluconazole stress,1
cereal yellow dwarf virus (CYDV),1
sodium sulfite,3
5â44,1
Sodium taurocholate cotransporting polypeptide,1
sodium taurocholate cotransporting polypeptide,7
NTCP,25
Niclosamide,8
Proton,3
salicylanilide niclosamide,1
(PFU)/mL,2
glycosphingolipid,1
holotoxin,2
sialic acid receptors,8
hydroxynaphthol blue dye,3
hydroxynaphthol blue,3
HNB,9
"28,035 nucleotides",1
S-adenosyl methionine (AdoMet)-dependent 2â²O,1
Sublingual,7
Sublingual (s.l.,1
Nicotinic acetylcholine receptor,1
Free fatty acids,1
oleate,1
FFA,16
anion-exchange,7
MTEs,3
citric acid,10
aphidicolin,3
HCI,8
low-molecular weight compounds,2
event(s,3
asbestos,7
Asbestos,3
H+,5
Isotope,6
pentose,7
1 of 196 without acute respiratory,1
cytoplasmic-expression,1
TPA,13
saponin,21
mutations/year,1
PHE,20
colloidal gold-labeled,3
aluminum,15
Exhaled Air,3
L (CatB,3
lycorine lipid nano-emulsion,1
M-LYC-OA-LNEs,4
LNEs,4
lycorine-oleic acid ionic complex,1
lipid nano-emulsions,1
LYC-OA-LNEs,1
pIC,3
1.2-1.3,1
C23,3
leptomycin B,2
jasmonate,1
nanoparticle-entrapped,2
PLGA,24
Potassium Channel Activator Which,1
"phosphatidylinositol-4,5-bisphosphate",1
PIP2,1
KIOM 198,1
âantigenic subversionâ,1
polyinosinic acidâpolycytidylic acid,1
glycogen,10
disulfide bond remodeling in,1
disulfide isomerases/ reductases,1
DTNB,1
salubrinal,5
Ovid,10
phenanthroquinolizidine alkaloids 1â24,1
"compounds 1, 2",1
Ningnanmycin,1
phenanthroquinolizidine alkaloids,4
hydroxy,2
CWE,16
lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-Î±,1
polyphenols,11
2006â2009,1
cytosine-phosphate-guanosine,1
CpG-A,5
[OR] 1.03,2
nucleotide insert,1
metformin,22
viralâbacterial,3
ribose sugars,1
thiazide diuretics,5
CCBs,2
beta-blockers (3.2%,1
[AOR] 1.49,1
beta-blockers,2
thiazide,3
Mizoribine Monophosphate Is an Inhibitor of,1
Mizoribine monophosphate,1
MZP,7
IMPDH,7
guanine nucleotide,8
Mizoribine,4
mizoribine monophosphate inhibits,1
382-amino acids,1
BrdU,10
cis genetic elements of adenoâassociated virus,1
Chlorpromazine,2
oleic acid,7
Laurdan,1
FLIM,1
Glycyrrhizic acid,18
glycyrrhizic acid,40
Ã 4.0,1
acetonitrile,7
0.5mM ammonium acetate buffer in,1
10.27 Î¼g/ml respectively,1
individualâs,16
L 5â²-UTR,2
nucleoside triphosphate (NTP),2
Nasal nitric oxide,1
nasal nitric oxide,1
hexamethylene amiloride,4
triazine derivative represented new M2 inhibitory chemotypes that,1
triazine derivative,1
sodium taurocholate cotransporting peptide,1
phospholipid bilayer,5
nanodiscs,1
9.5,2
sufentanil,3
midazolam,9
TIVA,2
sufentanil-midazolam,6
Î¼g/mL sufentanil,1
pH.,18
carbohydrate moieties,5
amine acidotropic drug,1
Curcumin,12
Hemin,5
NF-ÎºB,10
VOIs,2
VOI,1
SUVs,2
ethyl acetate,2
n-BuOH extracts,1
thiazolyl blue tetrazolium bromide,1
pimpinellin,2
sodium chloride,6
TSS,2
magnesium,16
XCE2-,2
Glucocorticosteroids,1
a2NTD,7
scavenger,8
scavengers,2
Bioaerosol,5
Phosphate Displacement Enveloped virus,1
(15)N,3
Nucleoside,1
nucleoside,66
sugar-modified T7,1
"Ethyl 4-(5-bromo-1H-indol-3-yl)-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexaÂ­hydroÂ­quinoline-3-carboxylÂ­ate",1
[110].,1
membranous compartments,1
polyethylenimine,2
amifostine,1
NaÃ¯ve Bayes,1
vaccinologyâ¡,1
Inhaled corticosteroid use,1
ORS,17
antidiarrhoeal agents,1
racecadotril,2
diosmectite,6
Carboxyethylpyrrole,1
IPM,2
ion-pair complex,1
Vincristine,1
VCR,4
VCR-oleic acid ion-pair complex,1
VCR-OA,1
VCR-OA-SME,5
sustained-release,4
Hematoxylin,4
toluidine blue,1
saikosaponin-d,2
Ssd,5
CHA,5
1.0Â±1.1 transfusions,1
P=0.007,5
countriesâ,2
Alginic Acid-Coated Chitosan Nanoparticles Loaded,1
alginic acid-coated chitosan nanoparticles,1
A.C.NPs,9
chitosan nanoparticles,1
C.NPs,1
alginic acid,2
berberine alkaloids,1
BAs,8
broad-spectrum antibacterial,4
berberine,15
coptisine,1
jatrorrhizine,1
palmatine,1
sodium nitroprusside,3
salicylic acid,1
methyl jasmonate (MeJA) treatment,2
"141,111",1
CI 3.3â14.2,1
dual-agonist,2
"bile, saliva",2
nCoV.,2
picomolar,7
peracetic acid-based airborne disinfectants,1
Spearman-KÃ¤rber CPE,1
airborne peracetic acid containing disinfectants were recovered at 60 and,1
ipilimumab,4
â¥,1
"sialic acid (SA)Î±2,6-Gal receptors",1
bioflavone,1
anti-asthma,1
Rosiglitazone,5
rosiglitazone,13
triglyceride,18
ursodeoxycholic acid,1
tacrolimus,15
NIM811,4
E Genes,2
E genes,4
Intrathecal Humoral Immunity to Encephalitic RNA Viruses,1
single-stranded,4
14/204 (6.9%,1
19/409 (3.3%,1
curcumin-loaded polyvinylpyrrolidone nanoparticles,2
CURN,6
curcumin water,1
CURH,4
Chloroquine diphosphate,2
chloroquine diphosphate,2
acyclovir,33
prednisone,15
interferon-based,8
107-SWWSFNPE-114,1
aromatic residue retention,1
2011â2012 Season,2
"1,033/1,983",1
disulfide,8
salt,34
iron-uptake,1
protective/therapeutic vaccines,1
iodide,3
Macugen,1
CI 77.1â98.8,1
JS-2004-02,1
"Cl,",2
"K, Ca, Ti, V,",1
Cr,20
Mn,9
"Fe,",1
Pb,17
Cl,5
IPS,35
Ferroquine,3
SSR97193,1
ellagic acid,8
punicalagin,2
carbon nanotubes,19
nCRT,1
rCRT/18-197,1
rCRT/18-412,1
phytoalexin,2
1/Log(R(0,1
Lactobacillus acidophilus-Induced Interferon Beta Signaling,1
Lactobacillus acidophilus,4
BMS-354825,1
imatinib,18
dasatinib,10
STAT1-targeted,1
hypochlorite/hypochlorous acid,1
HOCl,10
SH-groups,1
aluminosilicate mineral,1
L* and,1
flavanol compounds,1
theaflavins,6
Sodium New Houttuyfonate Alone,1
Oxacillin,1
houttuyfonate,4
houttuynin,2
oxacillin,3
cephalothin,1
vancomycin,22
levofloxacin,22
minocycline,8
netilmicin,3
Âµg/mL,1
FIC,10
16S rRNA,24
oxazolone,1
i.p,24
Fiftyâfive,1
Ethyl Acetate,1
Ethyl acetate,1
EtOAc,2
chloroform extracts,3
MeOH,1
487.40 Î¼g/mL,1
chrysin,6
low-dose baicalein with,1
10-Âµl intranasal,1
100-Âµl intraperitoneal virus,1
mannitol,7
MtlR.,1
Nick,1
anti-microbial,13
interleukin-2,2
29âNovember 2,1
Sections,2
D (,2
intranasal instillation or intravenous injection,1
NN-DNJ,1
BIT225,2
saturated fatty acid-induced,1
albumin-associated lipids,1
CHP,2
HCCL,1
20/219,1
ABT-263,3
ABT-199,1
ABT-737,1
3-deaza-adenosine,1
LFD,13
NA RT-LAMP,1
FOB,9
tree-in-bud infiltrates (36.5,1
Pidotimod,6
pidotimod,8
zymosan (IL-8),1
TNF-Î± Acts,1
"1-(2-pyridyl)-3-(2-hydroxyphenyl)imidazo[1,5-a]pyridine (3a)",1
animal-based foods,4
intra-molecular,2
CPIs,6
S29 proteins,1
S29,1
Palivizumab,7
RBV,29
5-FU,21
microtubule organizing center.,1
Anionic Liposomes,1
anionic liposomes,1
chitosan/DNA,1
CS/DNA,3
nasal mucosal surface,1
Fungus Penicillium marneffei,1
Penicillium marneffei,4
marneffei,6
qde-2(KO,1
clindamycin,26
FL,19
rhamnosus GG mono-association,1
LGG,8
chebulagic acid,2
glycosaminoglycans,10
punicalagin (,1
GAGs,6
FEV1,32
rVpr,3
Lactobacillus rhamnosus CRL1505,1
Lr05,7
Lr06,6
nickel,6
folic acid,5
carboxyfluorescein succinimidyl ester (,1
CFSE,3
Sialic Acid,14
Case-Based,1
4â8,4
fluorescent-tagged antibody or,1
polycytidylic acid,14
18-nucleotide,2
Co-mordidity,1
D-GalN,1
antibody-(mAb-,1
out-of-pocket,8
fatty acids covalently,1
17-octadecynoic acid,1
17-ODYA,1
2-bromopalmitic acid,1
2BP,3
eicosanoid-derived,1
fungus Podospora anserina,1
CD13(KO,2
Matrine,2
quinolizidine alkaloid derived from,1
dexamethasone,56
DEX,18
Azithromycin,16
amnii,3
"1,411,214 decoys",1
2Ã10(11,1
bafilomycin,12
ribose,4
Concanamycin A,1
Wortmannin,2
Plasmid-DNA,1
SNO,1
SNO sites,4
Cholesterol,46
SAON,17
tert-butyl hydroquinone,1
TBHQ,6
rapamycin,47
salubrinal â,1
Ku-0063794,1
rapalogues,1
Fingerprint,3
resazurin,7
CND3514,1
antiemetics,1
ondansetron,1
antidiarrheal agents (racecadotril),1
Lactobacillus rhamnosus GG,3
Lactobacillus reuteri,2
superfine rigid nanoparticles and,1
nanocarriers,1
glargine insulin,1
Lantus,1
dichlorofluorescein,1
DCF,1
apolipoprotein J,1
Sertraline,2
sertraline,3
YPFS,20
Celecoxib,1
Mesalazine,1
Eritoran,1
Manganese,2
Mn),1
manganese can,1
manganese causes,1
N-acetylcysteine,13
Mn interferes with polymerase fidelity,1
manganese.,1
IPA3,1
sodium â¤130,1
technetium tricarbonyl.,1
carbonyl,7
technetium carbonyl radiolabeling of,1
DG SANCO,2
Spironolactone,1
spironolactone,8
F4/80+CD11c+CD206+,1
apamin,2
intrathecal antibody,5
[aHR],2
eudesmanolides,1
sesquiterpenoids,1
sesquiterpene acids,1
flavone glycosides,2
flavonoid C-glycosides,1
isoflavone glycoside,1
sterols,1
oxygenated monoterpenes,1
sesquiterpene hydrocarbons,1
oxygenated sesquiterpenes,1
antihyperlipidemic,1
cineole,1
Cineole,4
Corticosteroid Administration,1
FVFG,4
corticosteroid administration group,1
Droplets,2
amOR,2
ci 1.6,1
1-70,1
CI 1.2-3.4,1
1-4,3
CI 3.0,1
beta-lactam,2
MPR,8
3MA,1
CI 1.4-2.4,1
"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide",3
Trimellitic Anhydride-Induced Th2,1
trimellitic anhydride- (TMA-)induced contact hypersensitivity (CHS),1
NPM-9,2
dpp4):,1
read-overlap graph,1
Halistanol Sulfate,1
Halistanol Sulfate C,1
n-butanol,6
halistanol sulfate (1),1
halistanol sulfate C (2),1
compounds 1 (SI =,1
compounds 1 and,3
Compounds 1280 Japanese encephalitis virus,1
Compounds,3
cilnidipine,3
NS Segment Expression Exchange of,1
NS segment of type A,1
[regulatory sites in,1
ISIS zoo network,1
ISIS zoos,1
ISIS,1
1â4,2
cyclosporine,25
Cs and,1
Cs binding,1
Amine,1
amine functionalized,1
guar gum,1
mono-ammonium salt,1
Drug-loaded microparticles,1
sodium tripolyphosphate,3
guar gum alkyl amine (,1
"2,4,6-trinitrobenzene sulfonic acid-induced rat colitis",1
malondialdehyde,13
amine derivative of guar gum,1
monoammonium salt,1
3â²-end nucleotide,1
12:844-861,1
WCX,1
2554.6 Da,1
sialic acid receptor determinants,1
2004â2006,1
penta nucleotide frequencies,1
PCC,1
Al,2
Multi-omic network,1
proton,21
carboxyfluorescein,1
protons,16
Imatinib,2
Imatinib Mesylate,1
Imatinib mesylate,2
CBr,3
reactive nitrogen species,2
RNS,4
quercetin-related flavonoids,1
quercitrin,11
isoquercitrin,5
quercetin 3-O-Î²-(2â³-galloyl)-rhamnopyranoside,1
QGR,5
quercetin 3-O-Î²-(2â³-galloyl)-glucopyranoside,1
QGG,6
gallic acid,20
"2,2-diphenyl-1-picrylhydrazyl",4
superoxide,13
peroxynitrite,11
flavonoids QGR,1
25(OH)D,14
[HR],8
aspirin,31
corticosteroid regimen,1
isopropyl Î²-D-1-thiogalactopyranoside,1
potassium,24
terpenoid,1
methyl jasmonate (MeJA),1
flavonol glycosyltransferases,1
lignan glycosyltransferases,1
SRTAW04,3
cation-pi,1
D-glucose,5
CPA,5
Cl),2
Co,1
mycophenolate mofetil,11
AmphoB,3
AmBisome,2
"50,240",2
antifungal,2
antifungal agents,4
nystatin,9
Non-cytotoxic,1
polyphenol,6
AT+AA,1
4.23pfu/mL,1
Zinc Oxide,1
"Zn (2500 ppm, Zn(high)",1
zinc oxide,9
WMD,1
BAI,6
36/206,1
NP-KAg vaccine,1
chloroquine chemoprophylaxis,1
atovaquone/proguanil,1
G4s,24
dipeptide,2
Imino sugar glucosidase inhibitors,1
imino sugars,4
titanium dioxide nanoparticles in,1
psoralens,3
PUVA,3
photosensitizing dyes,1
porphyrins,1
phenothiaziniums,1
antifragile,1
18S rRNA,2
excretions,5
free radical scavenging,1
FcÎ³RIIC-13Gln,1
Nano-ZnO,1
spiro[indoline-pyranodioxine] derivatives,1
"2,2-dimethyl-1,3-dioxane-4,6-dione",1
doi:10.1007/s11033-014-3019-7,1
SARIs,7
carboxymethylaminomethyl,1
cmnm,1
ammonium,11
mnm(5)s(2)U,1
cypoviral positive-stranded,1
mupirocin,5
Ï6,3
bentonite,3
clays,2
2-5A,6
"T223N, R229K",1
208/1564 samples,1
vitamin D.,3
IU/day,2
vitamin D serum,3
citrate synthase,1
coenzyme,1
TCA,21
rAAV-N796 24,1
1 Ã 10(7,1
non-antitumor compounds,1
hIgG/hIgÎ»,2
troglitazone,1
MLD,2
energy-,2
Zn atoms,1
de-,6
Cuprizone,4
CHX,16
quinine,4
artemether,2
artesunate,13
superoxide anions,2
NO and,1
SOCS3-siRNA,1
methacholine,16
wax,3
Fatty Acid,3
cerulenin,1
fatty acid synthase,3
TOFA,3
C75,4
end-product,1
Palmitate,1
etomoxir,3
trimetazidine,1
NP-KAg partially cleared the,1
Fe(2+,2
EDD,2
dP/dt,1
LPS/GalN,2
LDL,19
phorbol-12-myristate-13-acetate (PMA)-stimulated THP-1 cells,1
PMA,17
acetyl LDL.,1
NiV-associated ALI,1
Penicillium,3
[OR 1.11 (1.03 to 1.20)],1
[OR 1.58 (1.28 to 1.96)],1
[OR 1.10,1
[OR 1.25,1
IFNÎ²-1b sc,1
IFNÎ²-1a sc formulations,1
Flexibile fiberoptic bronchoscopic lobar lavage,1
side-chain,9
ribonucleoside 5â²-monophosphates,1
N-dimethylamino)acetamide hydrochloride,1
PJ34,1
lipophilic bis(amide) 3e,1
methoxypyridine 5c,1
High-dose,4
Zn concentrations,1
forskolin-induced chloride,1
prednisone/prednisolone,1
ipratropium bromide),1
corticosteroid responsiveness,1
CSFs,1
peroxidized eicosanoids,1
VRC,8
intragastric gavage of 10,1
20 mg/kg weight,1
Luxol,1
mid-dose glycyrrhizin promoted,1
sc/ip,1
2â3-fold,1
okadaic acid,11
ICA,12
breathcloud,1
[P <,1
high-dose steroid,3
ethanol extracts,2
adenosine monophosphate,7
cAMP,10
isoproterenol was 15.5,1
propranolol,4
isoproterenol,1
Tanshinone IIA,1
glucocorticoid,11
TIIA,6
EXD,1
2â²,3
3â²-cyclic phosphate,2
3â²-cyclic phosphates,1
methionine,3
Arbidol,6
T-705,21
Favipiravir,12
Ribavirin [100 mg/(kgÃd)],1
[150 mg/(kgÃd)],1
T-705 at 1 h,1
[300 mg/(kgÃd)],1
copolymer P3,1
intravenous fluids,8
lactic acidosis,2
bicarbonate infusion,1
nucleic acid extracts,2
rivastigmine,1
galanthamine,6
donepezil,1
tacrine,1
E palmitoylation,2
E protein-containing vesicles,1
E association,1
diplacone,3
1978â1996,1
sialic acid-containing,3
MDGs,2
[Piglets â,1
Natalizumab,2
ADP-ribose derivatives,1
"2,4-dichlorophenoxyacetic acid",1
"2,4-D",2
6-benzylaminopurine,1
BAP,1
conjugated cargoes,1
cell-impermeable compounds,1
CÃ´te dâIvoire,1
intravenous immunoglobulins,11
Vitamin D(3,3
vitamin D(3,5
sodium houttuyfonate,2
octasilver salt,1
pHs,9
salts,8
MBCs,12
PLP(190â209,1
CSEs,1
1971â2010,1
PAMAM,5
dendriplexes,5
N/P,1
metered-dose inhalers,1
pMDIs,3
HFA,1
Tyr/Trp fluorescence,1
plakortide E,2
Plakortide E,1
tannin ellagic acid,1
sulforhodamine B,1
Î¼g/mL,6
Glycyrrhizic Acid,5
18-beta-glycyrrhetic acid,1
non-nucleoside,7
bile and organ samples,1
SB203580,22
HK-PK and,1
2008â2011,3
ammonia chloride,1
FluTrackers,1
pravastatin,6
agarose-agarose,1
2012â2013 Winter,1
ILI/influenza,2
thienopyridines,1
losartan,18
cinanserin,5
lactated Ringerâs,1
Primaxin,2
CLP,6
IFITM3-Dependent,1
polyinosinic-polycytidylic acid [Poly(I:,1
N-based,6
FLU,6
FLU 002,1
FLU 002- NCT01056354,1
FLU 003- NCT01056185,1
formamide,5
n-3 fatty acid desaturase,1
20-carbon n-6 substrates,1
n-6 polyunsaturated fatty acids,1
PUFAs,5
n-3 PUFAs,2
Lipofectamine2000(TM,1
DHA,9
DPA,3
Polycytidylic Acid,1
CI 1Â·37â6Â·22,1
[95%,4
IFN Î³,2
CI=0.96â,1
IFN-Î³ +874 TT,1
Factorless IRES-Dependent,1
1-methyl-4-phenylpyridinium,1
MPP(+))-induced,1
doi:10.1186/1471-2105,2
doi:10.1186/1471-2334-14-424,1
dextran sodium sulphate,1
NCDO 2118,1
9.00-12.00,1
ACV,6
valacyclovir,2
intravenous immunoglobulin (,1
CPMs,3
1990â2012,1
SDPP,3
PEDV-shedding,1
lipotechoic acid,1
doi:10.1186/1471-2334-14-434,1
Kimchi,1
1961â1985,1
evidence/likelihood,1
glycyrrhizic,1
glutamate-enhanced,1
sgmRNA 7,2
FTY720,16
fingolimod,4
WeCoF,1
Nitric oxide,17
sodium/potassium,1
saturated fatty acids C16:0,1
C18:0,1
cholesterol (3.29 g 100 g(â1,1
esters,5
Cu,13
Fe,4
"Zn,",1
"Ni,",1
Glucose,6
carbonyl] benzoic acid,1
ABTS radical,1
expoxy-silanized,1
BOP,1
alcohols,4
1-alkoxy-1H-benzo- (,1
BOP undergoes reactions with,1
peptide-coupling agents can react with alcohols.,1
(31)P{(1)H,1
phosphonium,1
tosylate derivatives of alcohols,1
acyclic nucleoside-like compounds,1
pyrrolidine enamines,1
Pd catalysis,1
inter-chain disulfide bond of,1
IgG1Î»,3
inter-chain disulfide,1
piperacillin,5
tazobactam,3
Piperacillin-tazobactam,1
piperacillin-tazobactam,2
tazobactam pulmonary,1
tazobactam pulmonary penetration ratio,1
Docetaxel,3
DOC,6
Tri-iodothyronine,1
3â²-UTR,5
icariin,14
sodium trimetaphosphateâsodium tripolyphosphate,1
Icariin,4
(ER)-based,2
Hystopaque,1
CLEM,6
SIF network,1
indole alkaloids in I. indigotica,1
aminoglycosides,8
11(5Â·8,1
1Â·37â6Â·24,1
ABG,2
N-glycan Cryptic Antigens,1
NA of,1
substrate-induced,1
Cholesterol-Independent,1
cholesterol synthesis/transport,1
broad-spectrum mediators,1
broad-spectrum influenza,1
nucleotide ATP,1
Nerve-evoked EFS contractions,1
atropine,4
"Î±,Î²-methylene ATP",1
Bethanechol,1
28S,3
Sialic acids,21
NAI,12
Cl-free,1
isoproterenol perfusion (Î0Cl(-) + Iso,1
forskolin/IBMX,1
carbachol,3
histamine,35
thymidine phosphorylase (,1
FRC,1
ultra-low-dose,1
sub-mSv,1
NIC,5
nucleotide triphosphates,2
[OR] 6.03,1
15â44,3
EDTA vacutainers,1
exo-hASCs,2
FcÎ³RI,1
FcÎ³RIII,2
chlorphenamine,4
phenylephrine,6
antihistamine,12
NCT01389518,1
NS protein NS1â²,1
NTD,13
Fungus Pseudogymnoascus destructans,1
fungus Pseudogymnoascus destructans,1
anti-microbial peptide,1
cation-specific,1
Cap,6
PPARÎ±/Î³/Î´,5
antidiabetic agents because,1
Cpd#1,2
Oxygen Species,1
oligomycin-insensitive oxygen consumption,1
adenine nucleotide,4
mito-TEMPO,1
aluminium hydroxide,3
polyriboinosinic acid,1
doi:10.1186/s12879-014-0583-3,1
MP4 strain,1
NH(4)Cl (inhibitor of acidification),1
vinblastine,2
nonhuman/sporadic,1
oxygen â¥28,1
2 ng/kg LPS,1
Guanosine Monophosphate,1
guanosine monophosphate,1
cGMP,15
doi:10.1186/s12916-014-0127-0),1
IMV,21
IMV failure were,1
venovenous ECMO,2
NPPV,6
OFSC,1
immuno-modulators,1
"[1.212, 2.323])",1
Put,2
doi:10.1186/s12865-014-0038-z,1
Zn),2
Zn oxide,1
LH1,1
LH2,1
doi:10.1186/1471-2334-14,2
Instagram,6
HDL3,1
ICLs,2
flap,1
FAN1-DNA,1
PPP,3
XKB,14
fungus Xylaria sp.,1
doi:10.1186/s12879-014-0635-8),1
Oxygen,21
steroids (OR 3.4,1
3â²-non-coding regions,1
Lipid Metabolism Hepatitis C Virus,1
lipoviroparticle,1
meat/poultry/fish,1
todayâs market,1
novel/pre-licensure,1
PED,68
hsa-miR-4474-5p,1
protein-nucleic acid,1
TUViD-VM]),1
TUViD-VM,2
PMO oligonucleotides,1
conjugated cationic cell penetrating peptides,1
"Crown Ethers** Crown ethers are small, cyclic polyethers that",1
protein-crown ether,1
18-crown-6,1
apoproteins,3
"917,798",1
saponin glycoside glycyrrhizin,1
Glycyrrhetinic acid,4
18Î² glycyrrhetinic acid,1
phenolics,12
G isomer,1
doi:10.1186/s12879-014-0690-1,1
doi:10.1186/s13028-014-0091-x,1
APH,3
2011-Jun 2012,1
immunomodulators in the,1
anthraquinones,8
triterpenoids,3
iridoids,7
salidroside,1
chlorogenic acid,21
forsythoside E,1
cryptochlorogenic acid,3
amygdalin,1
sweroside,1
hyperin,1
rutin,21
forsythoside A,1
phillyrin,1
rhein,6
LOQ,2
aluminum salts,4
colloids,2
polyelectrolyte,1
aluminum-based formulations,1
A779,17
NFâÎºB,1
ion-exchange,12
VRC 206,1
bactericidal agents against,1
doi:10.1186/s12879-014-0721-y,1
[PI]:,2
Nelfinavir,5
NFV,8
ribosomal frame-shifts,1
Acetone Extract,1
cottonseed oil,1
Gossypol,2
acetone,17
dSTORM,3
CI 1.15-1.41,1
5-azacytidine,5
[n=166 (67.2%,1
74.8Â±4.8,1
8.4Â±4.4 vs,1
doi:10.1186/s13054-015-0764-5,1
Anti-VEGF,3
zanamivir (2Â·5,1
0Â·25,1
non-nucleic acid,2
Maleic Anhydride-Modified Human,1
maleic anhydride (ML)-modified,1
Flavone,1
VAF,1
F17,1
40S subunits,1
40S,2
48S,6
ADP,6
FCR,2
FCR of,1
doi:10.1186/s12917-015-0372-2,1
sulfated glycans,2
hostâs blood,1
FMP,1
PPIs,32
nasal Nitric Oxide,1
FL constituents,1
neohesperidin,1
liquiritigenin,1
isorhamnetin,4
isoliquiritigenin,4
doi:10.1186/s12879-015-0863-6,1
L1371I,1
sublingually,1
2.0â4.4,1
MG132,56
QAC,5
QAC surfactant,1
21â120,1
fluorescent dyes,3
FM178558,1
doi:10.1186/s13063-015-0645-x,1
BX795,2
EDC,4
âopen,1
ESWL,1
vermicides,1
p<0.000001,1
NCT00435110,1
bile ducts,3
gluten,1
CPS-CQ,1
mefloquine,8
MQ,2
doi:10.1186/s12936-015-0626-2,1
PPAA,1
paeonol,2
20 Î¼g/mL PGG,1
Organic Carbamates in,1
carbamate,1
prodrugs,10
carbamate moiety,1
carbamates,2
pigment biopolymers,1
cis-,4
land-remediation,1
Cationic nanoparticles directly,1
cationic polyamidoamine dendrimer,1
anionic PAMAM nanoparticles,1
cationic nanoparticles can,1
lactic acid dehydrogenase-,1
lactate,15
NADH,5
doi:10.1186/s12879-015-0896-x,1
septicemium,1
L segment gene,1
aristolochic acids,2
NCT00973895,1
PIP,7
monophosphate species,1
islandâs,1
FFN,8
Astragalin,2
astragalin,7
kaempferol-3-O-glucoside,2
1â20 Î¼M.,1
spermidine,3
PD173074,1
ISF,1
doi:10.1186/s12917-015-0354-4,1
broad-spectrum lead compound,1
16R,7
1 log(10,1
adenosine diphosphate ribose,2
3-AB,1
doi:10.1186/s12889-015-1750-1,1
hsa-miR-6743-5p,1
H7N9-M2e peptide,1
PG,8
D3-11,1
N/C,3
doi:10.1186/s12879-015-0938-4,1
low-molecular-weight hydrophobic,1
FGL-2,1
Treg-immune-suppression-assays,1
FGL2-regulation,1
doi:10.1186/s13054-015-0852-6,1
donorâs,4
doi:10.1186/s12889-015-1811-5,1
ethics-sensitive,1
Dieckol,5
Interferon-Î³ Stimulated HaCaT Human Keratinocytes Macrophage-derived chemokine,1
dieckol,3
[4.0â17.1],1
teamsâ,1
Omeprazole,1
Esomeprazole,1
CDC influenza-like illness (ILI),1
inorganic nanomaterials,1
silver nanoparticles,5
Micrococcus luteus,1
1(Ã)-O-galloyl pedunculagin,1
quercetin-3-O-glucuronide,1
nickel compound,1
acetohydroxamate,1
orotic acid,1
"3-amino-1,2,4-triazole could slightly",1
galangin,5
dihydromyricetin,7
myricitrin,5
SB225002,1
27/687,1
broad-spectrum antiviral agents,12
ultrapurified,1
Gentamicin,3
P=0.080,1
incretin hormones,2
Phosphatidic Acid,1
phosphatidylcholine-,1
phosphatidic acid,1
oxidants,2
prostaglandin E(2,8
Ion,23
interferon-free,2
boceprevir,2
telaprevir,2
NB-DNJ,8
Epigallocatechin gallate,1
nobiletin,1
DRAG mice,3
ALA,9
antiamoeba cellular,1
sialic acids type I lactosamine,1
salvianolic acid B,2
hydroxysafflor yellow A,1
syringin,1
Lineweaver-Burk,2
SaB,3
warfarin,1
multivitamin,1
omega-3,1
glucosamine,14
vitamin,16
omega-3 fatty acids,1
G clusters,1
heparan sulfate,22
doi:10.1186/s13756-015-0061-8),1
from19,1
Zanamivir,2
aptamer-recognized,2
FeL,10
allopurinol,6
Meglumine antimoniate,1
dual-labeled,3
brefeldin-A,4
P276,3
Sodium Suppresses Digestive Efficiency via,1
fats,4
Low Systemic IFN-Î³,1
Anti-D immunoglobulin,1
silymarin,3
acetyl CoA carboxylase,1
Fatty acid synthase,1
carnitine palmitoyl transferase 1,1
arachidonic acid (AA),3
Fluocinolone Acetonide Intravitreal Implant for,1
fluocinolone acetonide,1
FA,37
Bausch,1
2.1-mg FA intravitreal implant in patients with,1
2.1-mg FA implant surgically,1
0.59-mg,2
2.1-mg implant),2
FA intravitreal implant significantly,1
5/2,1
vitamin D-,1
hydroxychloroquine,58
antimalarial quinolines are,1
quinoline-based,1
Chelex-100,1
doi:10.1186/s12889-015-1910-3,1
Enterococci,1
Firmicutes,1
doi:10.1186/s12917-015-0419-4,1
oxygen species,4
MPT,3
doi:10.1186/s12879-015-0987-8),1
Statins,8
2â²-5â²-linked oligoadenylate polyribonucleotides (2-5As,1
dNTPs,3
nshomron@post.tau.ac.il Supplementary,1
Berenil,1
serine-borate,1
IABP,10
BNO 1016,4
water buffalo,1
LeTx,6
doi:10.1186/s13054-015-0983-9,1
CRL1005 poloxamer,1
benzalkonium chloride,9
phosphonate nucleotide analogues,1
"diethyl 2-(4,5-dimethoxycarbonyl-1H-1,2,3-triazol-1-yl)alkylphosphonates",1
dimethyl acetylenedicarboxylate,1
dihydrazides,1
"phosphonate analogues of acyclic nucleosides having nucleobases replaced with substituted 1,2,3-triazoles.",1
doi:10.1007/s00706-013-1137-x,1
CFD,60
NA cassettes,1
toilet,19
tetracycline,22
macrolide,27
beta-lactam resistance genes,1
drugâdrug,1
crofelemer,1
Rosuvastatin Statins,1
acetyl-L-carnitine,1
cilostazol,1
prednisolone 1 mg/kg,1
rosuvastatin-induced lung,1
ganglioside,5
sialic acid 9-O-acetylation,1
acetyl,8
acetyl-coenzyme A,1
CMP-activated sialic acid,1
bactericidal agents,1
clarithromycin,15
ceftriaxone,16
intravenous ceftriaxone,1
macrolides,28
lipopolysaccharide binding protein (,3
pi,3
3â²-to-5â²,3
adenosine triphosphate (ATP)-dependent,1
lamivudine (LMV)-resistant,1
rtM204I,2
gadolinium,2
T1249,4
peptidyl,2
Zinc Oxides,1
equimolar,3
(FDA)-approved,7
doi:10.1186/s40203-015-0011-4,1
doi:10.1186/s40064-015-1207-0,1
PRE,3
[large (L) and small (S)],1
NGS,12
aminoacid,1
CI 1.16â4.48,1
doi:10.1186/s13028-015-0134-y,1
T20âs,1
enfuvirtide,18
[OR] 2.16,1
43.16Â± 2.47,1
BIE,4
141st,1
1.7â60.7,1
doi:10.1186/s12862-015-0456-4,1
broad-spectrum host-oriented therapies,1
Amodiaquine,4
cowsâ blood,1
virusâbacterium,1
magnolol,2
honokiol,7
Polyphenols like flavonoids,1
dye-leakage,1
doi:10.1186/s12916-015-0450-0),1
single-stranded DNAs,1
2c,7
http://cran.r-project.org/web/packages/metaMix,1
1.3â4.5,1
CNIC,7
OR=5.18,1
TNF-Î± Nanoparticles,1
cholesteryl pullulan,1
TNF/CHP nanoparticles,5
CCA,3
beta-agonist,1
doi:10.1186/s12881-015-0229-3,1
"phosphatidylinositol 3,4,5-trisphosphate",1
quercetin glycosides,1
sucrose phosphorylase,1
fructose,7
UDP-glucose,2
UDP-galactose,2
UDP-rhamnose,1
hyperoside,4
quercetin 3-O-galactoside,1
1.12 g/L quercitrin,1
quercetin 3-O-rhamnoside,1
flavonols like kaempferol,1
morin,1
flavonol glycosides hyperoside,1
Lactic acid,6
probiotic agents,1
LAB engineered,1
povidone iodine,6
PVP-I,9
PVP-I against enveloped viruses,1
Chlorogenic Acid,1
CGA,6
intra-molecular interaction,1
broad-spectrum antibiotics,7
15N and,2
FCM,9
potassium ions,4
grandisol,2
creatinine,37
grandisol (135 Î¼g/mouse,1
grandisol 135 Î¼g/mouse,1
membranous,1
7.35 log(10,1
chlipid,1
cream,3
chlipid-siRNA nanocomplexes,1
phosphatidylinositol 4-phosphate,6
[OR] 2.47,1
Probes,7
ITS2,6
doi:10.1007/s13337-015-0248-x,1
intra-helical,1
gluten-free,7
35.2â61.3,1
ergosterol,16
mevalonic acid,1
triterpenoid saponin glycyrrhizic acid,1
HMGR,1
[1/77]),1
[3/141],1
[15/134],1
[23/58]),2
[1/20]),1
FRET peptide,1
"[TSS(1â4,",1
MYCI,6
doi:10.1186/s12917-015-0575-6,1
(18)F-fluorodeoxyglucose [18F-fluorodeoxyglucose ((18)F-FDG)],1
radiocontrast,1
2009â2013 Acute respiratory infections,1
OADs,2
meglitinide,1
sulfonylurea,1
electrophorethic,1
2011â2014,2
SeeplexTM RV,1
IVB,3
ECMO,10
doi:10.1186/s13054-015-1083-6,1
Lactobacillus reuteri:,1
sodium dodecyl sulfate polyacrylamide,3
-triphosphates,1
80A,1
NAP disulfide leaching from the,1
polymerâcrystal,1
orthorhombic crystal,1
water-rich,1
RSNO,2
NO release catheters can,1
methyl,5
Jorqui described public,1
doi:10.1186/s12879-015-1189-0,1
13C6,3
anti-GP,1
doi:10.1186/s12890-015-0122-z,1
ethynyl nucleotides and cycloaddition of azide fluorophores,1
Lb,2
viridans group,2
8a,15
cadmium chloride,2
HMG A,1
mcm(5)s(2)U,1
mcm(5)U,1
ncm(5)U,1
sulphur,1
Fat,6
low-dose' corticosteroid is supposed,1
ciclesonide,9
inhalational steroid,1
MPSS,1
2009â2014,6
864â989],1
8.5â10.3,1
[2.03â5.02],1
Flupep,1
L segments of,1
nucleotide sequencesâ,1
Sugar,6
Ethanol Extract,2
LJEE,5
Sugar Moieties,1
broad-spectrum virus,2
broad-spectrum virus-neutralizing agents,1
alkaloids,44
AA1,4
hippeastrine,1
AA2,1
virusâpositive,1
costâeffective,2
DTT,22
NIC),1
NIC designation,1
doi:10.1186/s13643-015-0131-2,1
âhidden populationâ.,1
MRV,3
chloroform,9
Antibiotic,5
carboxyfluorescein succinimidyl ester (CFSE)-labeled myelin-specific CD4 T cells,1
Fed-CL,1
doi:10.1186/s12917-015-0595-2,1
broad-spectrum RNA mutagens,1
purine,18
pyrimidine biosynthesis inhibitors.,1
nucleosides,18
NS protein of,1
Polyethylene glycol-mediated,1
water-insoluble polyelectrolyte-based,1
doi:10.1186/s12879-015-1271-7,1
doi:10.1186/s12879-015-1250-z,1
carbon dioxide expired (VCO(2),1
long-course,5
Vancomycin,4
cefepime,6
linezolid,18
long-course antibacterial,1
4C2h,1
DOI 10,1
DOI 11,1
DOI 12,1
DOI 22,1
8.3,1
NCT02190799,1
VER-155008,1
CI [4.0â6.7],1
4-1BB,2
doi:10.1186/s12879-015-1081-y,1
polyvinyl chloride,4
PVC,3
copper alloy,3
copper alloys,2
copper,57
(SAM)P,1
N7,7
nucleotide triphosphatase,1
phytoconstituents,1
doi:10.1007/s13337-015-0276-6,1
Psoralen,1
psoralen,5
rye,1
Flt3-L,1
NC8,1
WCFS1,1
WCFS1-pSIP411,1
Harbor,1
NO (,2
[UI] 1.1â3.3,1
immunoinformatics-driven,3
electro-aerodynamic,3
electro-aerodynamically,1
glatiramer acetate,3
GA,1
PVP-I: 4%,1
PVP-I surgical scrub,1
PVP-I gargle/mouthwash,2
CI 19.9â24.2,1
waterless antiseptics (,1
broad-spectrum antibiotic,2
Triptolide,2
triptolide,6
Leptotrichia,1
chocolate cyst,1
2010/11â2012/13,1
isoquinoline alkaloids,8
BRT,1
water body,1
IPC,57
Diff-Quik,1
Enrofloxacin,2
metronidazole,1
ampicillin,17
amoxicillin/clavulanic acid,2
cefoxitin,5
chloramphenicol,5
enrofloxacin,7
10âyear,2
enteral viruses,1
[1.013-1.128],1
CRRT,10
12.744 [1.418-114.565,1
[1.626-64.666,1
CI [22.6â24.0],1
z-VAD-fmk,3
Naso/oropharyngeal swabs,1
IVIg,4
naphthalene diimide derivatives,1
Tobacco-derived antibodies,1
DPP4-Fc,1
GalNAc,6
nicotinamide adenine dinucleotide,6
doi:10.1186/s12917-015-0624-1,1
Prostaglandin E(2,1
Cyclooxygenase-2-derived prostaglandin E(2,1
Triton X-100 at 4 Â°C,1
seminolipid,1
MBCD,1
phospholipids in,1
sphingolipid,10
hygromycin,1
Guanidinium hydrochloride,1
XOD,2
MNPs,5
ENR,9
ciprofloxacin,19
difloxacin,1
sarafloxacin,1
pefloxacin,1
norfloxacin,7
cocktails,4
1.9â11.6,1
tanshinones Tanshinones,1
tanshinones,5
tanshinone,2
cryptotanshinone,2
CPT,2
TNI,1
microemulsions,1
cyclodextrin,5
flavonol quercetin,3
quercetin aglycone,3
non-esterified fatty acids,1
triglycerides,16
ferric,1
thiobarbituric acid reactive species,2
F2-isoprostanes,2
doi:10.1186/s13054-015-1157-5,1
ester,10
âcytokine,1
BIPAP,1
E ratio 1:1,1
end-expiratory,4
25.2Â±2.1,1
ventilator-induce lung,1
sodium chlorite,1
FSS-RNA,1
N-methyl peptides,1
7AAD,1
terpenoids,14
wild-type-virus-,1
M1âM8,1
IDV,17
9-O-acetylated sialic acids,5
doi:10.1007/s13205-015-0352-z,1
human/wildlife,2
NPH,1
NPH-qPCR and,1
doi:10.1186/s12879-016-1373-x,1
chaotropic agents,2
domain-swapped oligomers,2
heme,7
"Days 1, 2",1
[OR 5.27 (95%,1
intranasal routes,3
nonâpandemic,1
F4(+,3
antioxidant SOD,1
w/w ethanol,1
w/w 2-propanol,1
urea,10
FCS,16
Carbohydrate binding agents,1
itaconic acid,4
cis-aconitic acid,1
tricarboxylic acid,4
Itaconic acid,1
glyoxylate,2
lipopolysaccharides,8
DPP-4,5
salicylate,1
Reactive Oxygen Species Assay Kit,1
non-Markovian-ness,1
outbreakâs,2
doi:10.1007/s11606-015-3493-1,1
cGAMP,14
fenofibrate,9
Fenofibrate,1
Filovirdae,1
docetaxel,2
carboplatin,2
annexin-V,1
propidium iodide,4
doi:10.1186/s12885-016-2197-1,1
NP-RNA binding,1
origin-to-destination,1
PGDP,2
doi:10.1186/s12889-016-2867-6,1
Myricetin,7
lipids against,1
Lattices,1
[SARS-HCP: 35 (21~68,1
SARS-HCP [12.24%,1
SARS-non-HCP [24.50%,1
SARS-HCP [p =,1
0~52,1
[11,1
PCM,1
(ORF)1a,1
DQA,2
CsCl,15
Î³-radiation,1
ethylamine,2
formaldehyde,4
organic acid portions,1
NAPSC,5
phosphate buffer saline (,1
1-3,1
adenosine diphosphate (ADP)-ribose,1
Chiralpak IC column,1
NPLC,1
high-dose interleukin (IL)-2,1
AOM patients,1
sunlight,16
diaminopropionic acid,1
heterobifunctional polyethylene glycol chains (abbreviated as DAPEG),1
"71,865 body",1
"27,680",1
P<0.005,1
CBJ113,3
DBP genes,1
S377â588-Fc,3
broad-spectrum empirical antimicrobials,1
uridine phosphates,1
lysine hydrochloride,2
Vitamins A,3
choline,6
MCFA,10
1â27 PC,1
choline chloride,2
producer-organized,1
[Ca(2+)](cyto)-mediated,1
2â-5â-linked oligomers,1
sepharose,1
Sepharose beads,2
phosphates,3
2-amino-6-mercapto-7-methylpurine ribonucleoside,1
methylthioguanosine,1
MESG,1
purine base,1
2-amino-6-mercapto-7-methylpurine,1
purine nucleoside phosphorylase (phosphorylase),1
pyrophosphate kit,1
cyclosporin A.,3
doi:10.1186/s12916-016-0566-x,1
1g samples,1
IDTE,4
Hydrogen,4
CPT-cGMP Is A New Ligand,1
neurotransmitters,9
CPT-cGMP,4
ribose 2'-hydroxy,1
13289â13294,1
5'-GGUCA,1
microalbumin,1
N-acetylneuraminic acid,9
6â²-sialyllactose,3
gangliosides,10
uncharged hydrophilic residues,1
liposome,4
NAL,2
HAL,6
2010â2014,5
wortmannin,7
erythromycin,20
Mid-nasal swabs,1
GFC,4
outbreak-size,1
doi:10.1186/s12964-016-0132-3,1
42â48,1
nucleobase,1
broad-spectrum anti-infectives,1
Cisatracurium â¤,1
F(abâ²)(2,3
Epi,5
CI 14.4â17.1,1
endothelium-dependent,1
Lipid peroxidation,1
Dembo-PCR,4
Acids Absolute,1
dRPA,1
Retinoic acid,3
"1,2,3âTriazolylbenzylâaminophosphonates A",1
3g,1
Xâray,1
compounds 4b and,1
polylactic-co-glycolic acid,1
PLGA-NP,1
step-wise,3
NOX2-siRNA or,1
diphenyleneiodonium chloride,1
bile acid malabsorption in dogs with,1
Bile acid,2
bile acid malabsorption,1
Sirt1-PGC-1Î±-PPARÎ±,1
S/N,7
SEDs,6
S/D,3
DES,7
Tri-n-butyl phosphate/1,1
Triton X-45 at 31Â°C,1
1 AA,1
organic dyes,1
analyte,7
GO-Ag,3
adults/elderlies,2
Non-hydrolyzable Diubiquitin Probes,1
polyethyleneimine,2
Lactic acid bacteria (LAB),3
GW9662,3
Diadenosine Tetraphosphate,1
Ap(4)A,2
nucleotide diadenosine tetraphosphate,1
Tryptophan,1
2.3.4.4 clade,2
doi:10.1186/s12911-016-0290-7,1
TPCK,12
VetMAXâ¢ Triplex,1
25â30 Î¼g,1
vasopressors,3
doi:10.1186/s13054-016-1303-8),1
Prefusion,1
chlorhexidine,9
Drug Administration-approved,4
Teicoplanin derivatives,1
dalbavancin,2
oritavancin,2
telavancin,1
MarchâMay,1
Berberine,4
n-butyl alcohol extract,1
acetylcholine-,1
ACH-,1
nifedipine,3
"pyrazole 3,",1
âpumping outâ,1
[95% CI 50â71],1
time-dependently,2
Stattic,1
eEBLL-1,4
LODs,2
Q411,1
OPHS,1
doi:10.1186/s12889-016-3056-3,1
reactive antibodies against,3
IRRs,2
Far-Northwestern,1
domain-swapped dimers,1
1990s,4
1977â1990,1
opener NS1619,1
tetraethylammonium,1
TEA,2
paxilline,1
SIBA,4
doi:10.1007/s00253-016-7491-y,1
reactive antibodies in,1
cap,11
palivizumab,26
2013â2014 Dromedaries,1
lysophosphatidic acid (LPA)-related signal,1
LPA,16
sildenafil,1
superoxide anion,10
Periplocoside E,1
BBMVs,1
Sodium dodecyl sulfonate-polyacrylamide,1
periplocosides,1
p-PD,6
melanin,3
L-glucose,1
sotrastaurin,1
Go6976,1
ruboxistaurin,1
rottlerin,1
PKC-Î´,3
chitosan,34
N-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride,3
HTCC,7
hydrophobically-modified,1
HTCC polymers,1
probiotic formulations in,1
VOC,7
carbon oxide,1
Allium sativum L.,1
TAM,20
HPDs,3
Zika-endemic,1
hAFCs,3
10(â3,5
CVs,14
Farmersâ,1
MLN-4760,4
IFN-Î³ + 874 A,2
IFN-Î³ + 874,1
IFN-Î³ + 874 T,3
CD4+FOXP3,1
Isoniazid-Mediated,1
CC-3052,2
isoniazid,4
INH,4
Nâ terminal,1
129.0 +,1
Tanreqing,1
Tanreqing injection,1
bloodâborne,1
carbon nanoparticle,1
Carbonaceous nanoparticles,1
5â² near,1
OH social network,1
OH network,1
NCEs,3
Acid,5
DA,22
2.2-16.9(o)C,1
panCoV,4
mPSCs,6
Cryo-Electron,5
vaccine/s,1
delta inulin,24
Faecalibacterium prausnitzii,2
deoxynivalenol,1
WBI,1
RO,6
clodronate-encapsulated liposomes,2
dMAb,3
FRCoV.,1
carbapenems,8
CRA,5
bla(OXA-58-like)-positive CRA,2
doi:10.1186/s12879-016-1670-4,1
CI 1.16â1.57,1
CI 1.13â2.4,1
doi:10.1186/s40064-016-2745-9,1
N-acetyl-L-cysteine,1
sodium citrate,4
NALC,4
33.9â38.6 with,1
18Î²-glycyrrhetinic acid,2
3â²âuntranslated regions,1
journalistsâ,3
278/345(78Â·5,1
QuilA,3
twoâstage,1
Sialic acid tissue,1
"NS, avianâlike swine PA",1
2Â·6,3
6â59,4
-0.17 - +0.33ÂºC,1
-0.02 - +,1
-0.22 - -0.10ÂºC,1
intra-,2
exposure-days,2
CSSD,1
LGI,1
LGI network,2
hydrogen deuterium,1
doi:10.1186/s13054-016-1325-2,1
imidazodiazepine,1
phenothiazine,1
quinoline,6
triphenylmethane,1
acridone,1
squalene aspiration,1
squalene oil-in-water,1
protein/squalene oil-in-water,1
Who,5
Gc-driven,1
TOC,19
anion,18
FA9,2
Retinoic Acid Response Element (,1
(2),1
retinoic acid-dependent,1
lipopolysaccharide (LPS)-induced acute lung,5
squalene,3
1400âfold in N;,1
doi:10.1186/s40064-016-2957-z,1
Long-Term Follow-Up,1
privateâcan,1
lipid nanoparticles,1
LNP,4
broad-spectrum universal influenza vaccines,1
20(4,1
nonâparametric,1
[1â8 yoa,1
Alkaloids,7
matrine,1
sophoridine,1
oxymatrine,12
Be Worried,1
A779 [antagonist of Ang (1-7)],1
nonpolar lipids,1
chloroform-methanol-water (10:10:3),1
cellulose,10
Clomiphene,3
clomiphene,5
enclomiphene,1
zuclomiphene,1
clomiphene isomers accumulate,1
JAK1/JAK2,3
Nano-carriers,1
side-effects,2
SUA,1
"[0.0,0.12]",1
"[0.03,9.0]",1
doi:10.1186/s12879-016-1787-5,1
BME,6
DIZE,7
15mg/kg/d,1
Met-RANTES,3
doi:10.1186/s12974-016-0665-9,1
Â¥136 120,1
"quinoxaline 1,4-di-N-oxides (QdNOs)",1
cyadox,3
mequindox,3
quinocetone,5
"antimycoplasma,",1
rifampicin,8
Fractional Inhibitory Concentration Index (FIC),1
(RNAi)âa natural,1
vertebratesâcan,1
single-stranded nucleic acids,2
2-methacryloyloxyethyl phosphorylcholine,1
micro-particles,1
measles-mumps-rubella,1
reactive,6
nucleic acid aptamers,1
PHEV-CC14,1
Choline,3
corticosteroid binding globulin were,1
TOE,1
YTSNETTDVTS(175â185,1
practitionerâs network,1
carbapenem resistance (1986â2015),1
carbapenem,17
IDL,2
IDL tail,3
sanglifehrin A,2
"broad-spectrum,",1
doi:10.1186/s12879-016-1849-8),1
24/289 [8.3,1
TSs,2
1996â2014,1
2012âJanuary,1
phenolic acids,15
quinones,8
saponins,13
Xb130,1
Cloxacillin,1
cloxacillin,3
5â² guanosine nucleoside cap,1
DHPs,12
aldehyde-epoxide,1
PED-positive,3
OctoberâDecember,1
expatriatesâ,1
"27,615 nucleotides",1
CI 1.03â3.31 for 1 unit,1
RU,11
chloroquine plasma,1
Nanoparticle Displaying DENV-E Proteins,1
lactic-co-glycolic acid,2
N-Desmethylclozapine,1
Fluoxetine,1
Salmeterol,1
N-desmethylclozapine,1
fluoxetine hydrochloride,1
salmeterol xinafoate,2
IC(50)s,8
high-nanomolar,1
liposome-based,6
[Xpert MTB/RIF] confirmed,1
[IQR] 19â66,1
doi:10.1186/s12879-016-1934-z,1
Suramin,1
A-438079,1
doi:10.1186/s12974-016-0748-7,1
CIT,10
cis regulatory lncRNAs,1
Dexamethasone Exosomes,1
Drug Administrationâapproved,1
.-,2
N-formyl-methionyl-leucyl-phenylalanine (fMLF)-,1
phorbol myristate acetate (PMA)-induced O(2,1
"Î±2,6-linked sialic acids",1
AG2-2-IV,1
daratumumab,1
INN,1
commercial-scale,1
1 g mAb/kg,1
Glycyrrhetinic Acid,1
dipotassium glycyrrhizate,1
disodium succinoyl glycyrrhetinate (GR-SU),1
stearyl glycyrrhetinate,1
glycyrrhetinyl stearate,1
gentamicin,13
Inosine pranobex is,1
Inosine pranobex,1
inosine pranobex,8
Inosine pranobex was,1
doi:10.1186/s12879-016-1965-5,1
nucleoside phosphonates,4
tenofovir,5
methylene,1
"1,2-ethylidene linkers",1
"O,",1
O-diethyl (2-aminoethoxy)methylphosphonate,1
Dimethyloxaloylglycine,1
dimethyloxaloylglycine,1
DMOG,5
doi:10.1186/s12879-016-2003-3,1
I529T,3
doi:10.1186/s13054-016-1517-9,1
MK886,3
TAPI-2,3
Ã 10(6)/ml,1
ASMq,11
"CTX group),low-dose",1
medium-dose ASMq,1
high-dose ASMq,1
CTX,3
fluorogenic peptide,3
doi:10.1186/s13195-016-0217-7,1
peptide-membrane,1
electron spin,1
FPs,25
phosphatidylethanolamine membranes,1
anionic membranes,1
Artemisinin,2
SM934,7
zidovudine,5
didanosine,1
stavudine,1
abacavir sulphate,1
entecavir,2
celgosivir,1
castanospermine,13
ouabain,15
omeprazole,1
esomeprazole,1
Gleevec,1
Tasigna,1
17-DMAG,7
BGB324,2
NS),12
NS,9
NS and TW.,1
NS and TW,1
"NS,",2
quinolones,8
doi:10.1186/s12889-016-3881-4,1
CaKoV.,1
NA genes,7
Thiazolidinedione,1
thiazolidinedione,1
TZDs,5
lobeglitazone,4
Fe levels,3
Fe as,1
Fe is,1
doi:10.1186/s12889-016-3893-0,1
Contact,1
4â5,4
15â30-day,1
2â5,10
standard-dose,10
Lactobacillus plantarum Avian influenza virus,1
NC8-pSIP409-NP-M1-DCpep,1
FG loops,2
anatase/rutile,1
LAM,1
Eugenol (phenylpropene used,1
Triethylene glycol),1
Isopropanol,1
"n-Alkyl Dimethyl Benzyl Amonium Chlorides,",1
n-Alkyl Dimethyl Ethylbenzyl Ammonium Chloride,1
Eugenol,2
Antiviral Agents,3
Foxp3(+,12
284â1875 pmol/L,1
NMA,11
sodium chloride salt,1
doi:10.1007/s11418-016-1041-x,1
E encoding-genes,1
sample-to-detection,1
BCMs,3
76/178,1
doi:10.1186/s13756-016-0149-9,1
doi:10.1186/s12879-016-2118-6,1
CMA,2
Mevastatin,1
vegetables,8
broad-spectrum antimicrobial,4
cetylpyridinium chloride,2
glycerin,1
xanthan gum,1
doi:10.1186/s12879-016-2177-8),1
CDs,5
LED fluorescent smear,1
LED fluorescence,1
"polyethylene glycol, organic flocculation with",1
glass wool filtration,1
polyethylene glycol,7
Feed,4
sodium hypochlorite sanitizing solution,1
cis elements of,2
nonsteroidal anti-inflammatory drugs or small interfering RNAs,1
N-nitro-l-methyl-arginine ester,1
nonsteroidal anti-inflammatory drugs,4
NSAIDs,30
indomethacin,19
COX-2-specific,1
NS-398,1
celecoxib,7
Levodopa,1
levodopa,2
LEV,3
hematoxylin,10
OIT,5
FAs,6
FA mice,1
FA mouse colon,3
FA mouse plasma,1
doi:10.1186/s13045-016-0383-x,1
FRT,1
SERMs,2
CADs,7
carboxymethyl cellulose microneedle,1
phosphate buffered saline-immunized,1
2H,21
2H enzymes,1
reactive phosphate moiety,1
â2.06,1
P/S,1
Doxycycline,8
tetracycline derivative,1
DOX,17
mitochondrial-specific ROS,1
intravenous prednisolone,1
MVV,1
45.9â92.5,1
High-dose steroid,2
high-dose steroids,4
LTR-IV,2
D-,1
anti-TNFÎ±,2
Rv3615c-Mtb10.4-Rv2660c,1
Intravenous vitamin C,2
parenteral vitamin C,1
vitamin C intravenously,1
BPA,6
doi:10.1186/s12936-017-1709-z,1
doi:10.1186/s12910-017-0169-x,1
titanium dioxide,3
ultraviolet light,5
Polyprenyl Immunostimulant Treatment of,1
Polyprenyl Immunostimulant,3
doi:10.1186/s12879-017-2225-z,1
Food-,1
adalimumab,2
5â²end,1
IRAV,2
endonuclease-mediated,1
Î´,3
N-acetylcysteine (1,1
magnesium (2 studies,1
PBNA,4
tanespimycin,1
Nitric oxide-generating compound,1
GSNO,7
S-nitrosoglutathione,1
NO-generating,2
29th May 2014,1
thymine,7
fucosylated sialosides,1
vitamins A,6
Vitamin A,6
low-dose,14
3â-terminal,2
0.92â0.95,1
Interferon Lambda: Modulating Immunity in Infectious Diseases Interferon lambdas (IFN-Î»s,1
LysoTracker,1
[(125)I]apelin-13 binding with nanomolar affinity,1
antiplatelets,1
liposome patch,2
anions,6
monophosphate prodrug,2
adenosine nucleoside,2
hexylresorcinol,4
carrageenan lozenges,1
anesthetics amylmetacresol,1
"2,4-dichlorobenzyl alcohol (DCBA)",2
Lemon [#7],1
trimethoprime,1
sulphamethoxazole @ 40 mg/kg body weight,1
metronidazole @ 10 mg/kg body weight,1
hydrochloric acid,4
W/D,3
OH-proline,2
acid aspiration acute lung,1
intracerebroventricular (ICV),1
NA injection,1
camptothecin,6
formulations,1
emodin,86
rheum emodin,1
astragaloside,3
condensed nuclei,1
BX-795,12
3.125-25 Î¼mol/L,1
non-steroidal anti-inflammatory drug,2
NSAID,6
cysteinyl leukotrienes,4
cysLTs,3
Indomethacin,4
cysLT,1
18(th,1
HDM,1
18391005,1
Lysophosphatidic Acid,1
Lysophosphatidic acid,1
PTX,5
PKCÎ´-DN,1
1 (1%,1
15â24,3
benzo-heterocyclic amine,2
guanine nucleotides,1
sitagliptin,2
Onconase,3
health-care-,1
CVP,4
HCO3,1
2000â2013,1
heparin columns,1
Nanoparticle Hybridization,1
mRT-LAMP-IRNH,2
doi:10.1186/s13028-017-0285,1
USG,1
364/1967,1
N-methyl-glucamine antimoniate,3
countriesÂ´,1
LTR-G-quadruplex interacting protein,1
"57,363",1
[13 vs. 6 days,1
Lf derivatives,1
cytidine,12
Artesunate,2
anti-tubercular,4
antihistamines,22
Deoxycholate,1
deoxycholate,4
fungus were further used in,1
Retinoic Acid-Induced P19 Neuronal,1
Minnesota/Iowa,1
spatialâtemporal,1
NA inhibitors,4
Feed additives,2
phosphoric acid,2
fumaric acid,1
INF,4
1.93â27.79,1
Phosphate Buffered,1
Saline,1
ectoenzyme,8
HDP,4
FebruaryâMarch 2015,2
dimethyl sulfate (DMS) experiments,1
(Cy3)tRNA(Lys,1
reversed-phase high-performance liquid chromatography,1
podophyllotoxin,2
amentoflavone,2
levofloxacin capsule,1
Levofloxacin ST,1
intranasal (i.n.),1
buprenorphine,16
drug-lipid,2
cholesterol-triglyceride,3
dextrose,2
intravenous acetate Ringerâs,1
acetated Ringerâs,2
Intravenous (IV),1
fucose,15
glyans,1
apilimod,11
self-incorporation,1
antidiarrhoeal,1
Diosmectite,3
anti-diarrhoeal,1
adenosine deaminases,1
quinazolinone,2
P=0.005,1
[OR (95%,1
Antiviral Agents Against Dengue,1
5 quinoline alkaloids,1
"20 aurones,",1
chalcones,3
Emodin,26
"3-methyl-1, 6,",1
jasmonic acid methyl ester,1
ADPr,9
aspartate,9
ADPr and,1
pyrophosphate,2
O-acetyl-ADP-ribose,1
Nitazoxanide,17
tizoxanide,3
Fusobacterium,13
doi:10.1186/s12917-017-1035-2,1
total-body,2
C15,2
doi:10.1186/s12931-017-0567,1
Sunitinib,1
mmu-miR-17-5p,1
hydrolyzed ingredients for management,1
panhypoproteinemic,1
FF,4
FF%,1
[200-200] versus 200 FF [102.75â200],1
[36.1â98.9],1
[200-200] versus,1
[8.13â100],1
doi:10.1186/s12879-017-2434-5,1
Taraweeh,1
BMC Bioinformatics 17:304,1
BMC Bioinformatics 17:397,1
BMC Bioinformatics 17:457,1
Hydrogen sulfide,2
H(2)S,9
gentamicin-induced,1
CpG-ODN,15
L allele in,1
PQ,8
L allele may,1
F683A),1
0â9,1
"NS, NPS,",2
"NS, TTW",1
NS and,1
DNS,2
Colistin,3
spilled-over,1
spiramycin,2
tetracyclines,14
penicillins,3
vitamin A.,2
12 phenanthrenes,1
Orchidaceae,1
"phenanthrenes 1, 2, 3, 4, 6, 9",1
"phenanthrenes 2, 3, 4, 6, 7 10",1
"Compounds 1, 3, 4, 6",1
"compounds 2, 3, 4 6",1
diphenanthrenes,1
LPC,3
distillers grains,5
naphtalene diimide G-quadruplex,1
indocyanine green,1
half-dose,1
AXB,3
"27,649 nucleotides long",1
doi:10.1186/s12889-017-4374-9,1
triamcinolone acetonide,4
triterpenoid saponins,6
polyacetylenes,3
lignans,3
saikosaponins,6
enthalpy,7
1 base pair,1
CIL,4
"[RR], 1.6;",1
0.8â1.2,1
miRâ127â5p,7
PDMP,12
chloroquine analogs,6
Myricitrin,3
H/R,1
17-AAG,3
aciclovir,2
steroid-free,1
doi:10.1186/s13054-017-1731-0,1
methanol extracts,2
PMO conjugate,1
PMO SSO,1
âpre-emergentâ,1
temporalâspatial,1
surfactin,27
intravascularly Ad5-Fluc-infected Rag2,1
eukaryome,1
pyrazolopyridine KDU731,1
DH2/2016 Isolated,1
R667,1
CYT387,2
lipoteichoic acid,5
Fortyâthree,1
ascorbic acid,9
pyridylaminated chitotriose,1
chitotetraose,1
N-acetyllactosamine,1
cholesterol-rich,2
cholesterol-poor fluid lipid,1
ICF,2
treosulfan,1
fludarabine,5
thiotepa,3
toltrazuril,21
toltrazuril (,2
toltrazuril resistance against,1
doi:10.1186/s13028-017,1
P024,1
aromatic acids,1
AQ,5
norepinephrine,7
vasopressin +,1
D Jakubczyk,1
tobramycin A. Kuzovlev,1
P103,1
amikacin,14
P105,1
enoxaparin,3
P123,2
Dexamethasone,7
IABCS):,1
low-dose atrial natriuretic peptide,1
P144,1
levosimendan,2
FernÃ¡ndez,1
Laribi,2
crystalloids,1
Plasma-Lyte,1
crystalloid fluid,3
Citrate,1
Barettin,1
Calcium gluconate,1
veno-venous,2
CVVHD,1
education-programme,1
cuff-leak,1
Cho,3
end-tidal CO2,1
edi-derived,1
opioids,5
Lactate,2
veno-venous extracorporeal membrane,1
vv-ECMO,1
Bicarbonate dialysis removes carbon dioxide,1
nitric oxide â,1
vitamin d,1
Omega-3 fatty acids,1
amiodarone,25
L-carnitine,2
valproic acid,2
levetiracetam,2
hypertonic saline,12
P369 - Impact,1
sevoflurane,11
Dexmedetomidine,1
dexmedetomidine,6
K. Zaza,1
P407,1
P418,1
Bor,1
"K. Shuker, M. Faulds",1
K Shuker,1
sulfone derivatives of p-methylaminophenol:,1
sulfonyl derivatives of p-methylaminophenol were,1
sulfinic acids,2
tris,1
sulfonyl-p-(methylamino)phenol derivatives,1
p-methyl quinoneimine with,1
ECEC,1
Hydrocortisone,1
intravenous hydrocortisone,1
megestrol acetate administration,1
NS1/126-225,2
Dextran Sulfate Sodium-Induced Acute Colitis,1
HMF,5
polysaccharides,2
dextran sulfate sodium-,1
MDRD,1
IFN-Î²/Î»,1
phenol,10
Apigenin,2
"210,054 IU/mL",1
doi:10.1007/s00705-017-3361-x,1
[cHR],1
1.5â14.0,1
7.3â68.5,1
Theaflavins (TFs),1
benzotropolone,1
anti-mutagenicity,1
16S rRNA V4,1
Micrococcus,1
IFNÎ»,7
sulphuric acid,1
SG-AL,1
Sulfuric acid biosynthesis enzymes were,1
CA2,1
EB/AO,1
has-miR-195,1
N-glycolylneuraminic acid,14
Neu5Gc,33
NA in,2
meat-based diets,1
compounds 4a-o,1
Compounds 7b,1
sunitinib,4
7e-loaded PLGA,1
doi:10.1186/s12879-017-2614-3,1
11H10,1
SAR114,2
sodium arsenite,5
VIP,1
sodium selenite,3
Pateamine A,1
fumarate,2
teriflunomide,1
mitoxantrone,3
natalizumab,2
ofatumumab,1
ocrelizumab,2
alemtuzumab,10
daclizumab,1
Nanoparticle orientationally displayed antigen,1
NA levels,1
polar bonds,1
Carbon,3
"guanidine nucleotide exchange factor,",1
forskolin,7
L10,1
gallic acid equivalents,1
GAE,3
Âµg/mg quercitin,1
2-diphenyl-1-picrylhydrazyl,1
DPPH,5
anti-oxidant,10
corona viruses,5
Polyethylenimine,2
naphthopyrones,1
nanoshells,2
doi:10.1186/s40168-017-0317-z,1
emergency/Intensive,1
20 (9.0%,1
baicalin superfine,1
Low-substituted Hydroxypropyl Cellulose,1
monophosphoramidate prodrug of,2
high-density lipoprotein-cholesterol,1
VLDL-C,1
low-density lipoprotein-cholesterol,1
LDL-C,4
Friedewald formula,1
HDL-C,1
NBV,12
delta inulin microparticles,3
E-64,6
PMSF,2
AEBSF,6
doi:10.1186/s12879-017-2643-y,1
Mesalamine,1
mesalamine,4
mesalamine against,1
C)-induced IFN-Î²,2
retinoic acid-induced gene I (,1
2â5 Î¼M,1
10â30 Î¼M,1
NK2A-derived peptide,1
dORF3-5,1
A47,1
IPKM,1
PLE,1
phosphatidylinositol,7
tulathromycin,4
tiamulin,1
5â² and,2
Solute,1
acid-fast,2
CpG7909,2
NPU,2
FTLR2,4
ContextâSome Loose,1
mannosides,1
N-glycan core pentasaccharide,1
OAA,3
disulfide -linked tetrameric protein,1
C40,1
PR-619,2
mono-treatment,1
LPSs,2
Sias,12
"7,9-",1
9-O-acetyl,3
Chanteraines,1
cefotaxime,2
doi:10.1186/s13028-017-0326-8),1
AChEI,2
CPH,2
C5a-induced,1
FLU A/B,2
"FLU A/B (1,074,",1
intragastric application of,1
L-isoleucine,3
Cetylpyridinium Chloride,1
CPC,2
CI 3.80â1931.18,1
doi:10.1186/s40659-017-0135-6,1
error-burdened,1
keto,1
Pyrimidine Biosynthesis Inhibitors That,1
"3-(1H-indol-3-yl)-2,3-dihydro-4H-furo[3,2-c]chromen-4-one derivatives",1
edge-fused polycyclic moieties,1
dicoumarol,1
7-Methylguanosine 5â²-triphosphate,1
m7GTP,2
ligandâindependent peptide,1
macrophageâtargeted nanoparticles,1
dihydroberberine,2
NFâÎºB in NCIâH460 cells,1
IFITMs-HIV,1
EPF,7
HFD,9
Xintrabodies Restricts,1
crosslinkers engineered,1
crosslinker,1
glycyrrhetinic acid monoglucuronide Glycyrrhetinic acid monoglucuronide,1
glucuronic acid,3
flavonoids glycyrrhiza,1
2.66-fold,1
front-line,12
DMAb,7
reactive antibodies protects,1
24-hour fluid recall,1
intravenous fluid,10
intravenous fluid requirement,1
heteroaryldihydropyrimidines,1
Sodium dodecyl sulfate polyacrylamide,2
w/w,12
JanuaryâJuly 2015,1
water vapor condensation,1
pXXGST-3,1
P=0.801,1
P=0.035,1
diphyllin,9
diphyllin dose-dependently,1
PEG-PLGA,2
diphyllin nanoparticles,3
high-dose intravenous administration,1
manidipine,3
cardiotonic steroids (CTS),1
retinoic acid-induced skin irritation,1
all-trans retinoic acid,2
retinoid,1
ground-glass opacity (GGO),4
myricetin derivatives,3
"1,3,4-thiadiazole derivatives were",1
myricetin analogues,2
"3d, 3f, 3i, 3m",1
"3d, 3e, 3f, 3i and",1
"compounds 3d, 3f, 3i and",1
JC-1,1
Deciphers,1
phenazine,1
phenazine derivative 14,1
[(18)F]FDG,5
Tamoxifen,2
alendronate,1
extracorporeal shock and,1
hyperbaric oxygen for,1
Carbopol,5
Etanercept,3
alloSCT,1
glucocorticosteroids,3
133âresidue transmembrane,1
intramuscular G1b,1
sham-challenge,1
valve-type,3
valve-type respirators,2
decitabine,4
DAC,5
high-salt,3
eukaryoviruses,3
LL-HA1/L/AcmA,4
organic anion transporting,1
OATP1B3-mediated,3
FLAG-OATP1B1,1
SCH,1
133.95 Â±,1
epoxomicin,3
carfilzomib,2
OATP1B3-mediated [(3)H]CCK-8,1
OATP-mediated DDIs,1
[ExoN(-)] in,1
ExoN(-,11
Nanoparticle Concentration,1
CT + CC,1
FAO,6
CD4(+)FoxP3(+,2
anthraquinone,7
29th,1
doi:10.1186/s41256-017-0034-y,1
[OR]=5.0,1
CI 3.0-8.0,1
CI 1.4-3.0,1
broad-spectrum compounds,1
10.1186/s12931-017-0672,1
fed-state gastrointestinal fluids,1
casei rLpPG(F)-T7g10-eGFP-6D-COE,1
Allopurinol,1
L infantum blood DNA,1
low-dose lipopolysaccharide,2
doi:10.1186/s41256-016-0014-7,1
IMP,5
far-red fluorophores,1
condensed foci to increasingly decondensed genomes,1
remethylation,1
Broad-spectrum antiviral agents,1
nitrite,4
[1.2â6.8],1
[0.1â0.6],1
10.1186/s12879-017-2823-9,1
intensifications,1
carbon material,1
18F-fluorodeoxyglucose,1
FDG,3
CEs,11
Lactobacillus casei,6
hydrogen peroxide disinfectant to,2
propylene glycol solution,1
Ensure,1
PHEM,3
toolâs,1
Re6,1
Re6 vaccine,1
Polyamines,5
10.1186/s12879-017,1
electron-deficient (16-electron) half-sandwich precious metal complexes,1
ruthenium,1
osmium,1
"iridium ([Os/Ru(Î·(6)-p-cymene)(1,2-dicarba-closo-dodecarborane-1,2-dithiolato)] (1/2)",1
"[Ir(Î·(5)-pentamethylcyclopentadiene)(1,2-dicarba-closo-dodecarborane-1,2-dithiolato)] (3)",1
"[Ir(Î·(5)-pentamethylcyclopentadiene)(benzene-1,2-dithiolato)] (6)",1
iridium complexes 3 and,1
ISO 22609,1
10.1186/s12879-017-2858-y,1
Genomeâwide,1
10.1186/s12890-017-0546-8),1
Toxicodynamics of Tetrachloroethylene Using,1
trichloroacetate,1
10âday decitabine,2
Decitabine,1
corticosteroid therapy from June 2005,1
CRâpositive,1
10.1186/s12879-017-2855-1,1
10.1186/s12913-017,1
ATB,2
Ltd,1
nasogastric feeding),2
exhaled VOC,2
mevalonate,6
10.1186/s12879-017-2852-4,1
dNTP,6
â¤28,2
10(4.0,1
ICA kit,2
Indirubin,4
CQR,6
PMVs,2
Scorpion-derived Peptide,1
scorpion-derived AMP,1
glycerophospholipids,4
lysophospholipids,5
fatty acid Î²-oxidation,2
Nisseiken PED,1
VC,14
whey,7
VC (1.7,1
PBB,2
1248 common proteins,1
F. necrophorum (2/29),1
2010â2011,1
candidate-miRNAs,1
Ins,1
epigallocatechin-3-gallate,3
GTE,10
sodium benzoate,1
DLS,1
non-TBD samples,1
microtubule severing,1
doi:10.1186/s12879-017-2934-3,1
Rocaglamide,1
16S rRNA marker gene,1
10.1186/s40168-017-0395-y,1
CMP-N-acetylneuraminic acid hydroxylase,1
Neu5Gc-containing foods,1
nondeuterostomes,2
FastViromeExplorer,4
27â47,1
205.34 Kbp,1
"80,283 (",1
Gemcitabine,3
gemcitabine,11
uridine mono-phosphate,1
UMP,2
5â²-gag-pol-env-3â²,1
harringtonine,1
~ 7,1
IDâTag(TM,1
water-extractable polysaccharides,1
binâReza,1
quasiâexperimental,1
1996â2008,2
0.9958â1.0766,1
influenzaâpositive,1
HPIV2=54,1
lipopolysaccharide (LPS)-induced septic shock,1
n-butanol extract,1
11Â·76,1
"44.6/100,000",1
blinatumomab,1
BW,18
131/349,1
matrixâabsorption,1
Bile culture,1
bile cultures,1
73.0Â±6.3,1
sodium fluorescein,2
1.25â5 Î¼g/ml,1
colloidal bismuth subcitrate,4
lopinavir-ritonavir,3
lopinavir/ritonavir,58
doi:10.1186/s13063-017-2427-0,1
nicotine,15
nicotine replacement,1
NRT,7
NRT (r =,2
FAR below 10,1
pyrropus,1
W/O/W,1
Drug Administration-approved antivirals or vaccines,1
N92A,2
oligosaccharide,8
kifunensine,2
FRAP,7
alpha motif,1
phospholipid scramblase,1
cubic B-spline,1
PED virus,3
doi:10.1186/s41073-017-0028-9,1
2.65â56.18,1
10.1186/s12879-018-2982-3,1
broad-spectrum agents,2
DAP IVs,1
Intracellular nucleic acid,1
GMP-AMP (,2
cGAMP) synthase (,1
SeMet,7
selenium,13
selenomethionine,1
OTA-induced,3
HBP,3
nicotinamide,1
vitamin B2,2
thioacetamide,1
Nicotinamide (NA),1
VB2,2
TAA + NA group,1
NA at a,1
TAA + VB2,1
TAA + VC,1
NA + VB + VC,1
low-density lipoprotein,2
nitic oxide,1
"NA,",1
"NA, VB2",1
6-Thioguanine,2
6-thioguanine,7
batch-wise,1
LDT,17
ICDâ10,1
7.5â15.1,1
Adenosine,3
purine nucleoside,2
10.1186/s12889-018-5172-8),1
â¤ 136,1
vildagliptin,2
MUP,1
sodium dodecyl sulphate-polyacrylamide,3
testosterone,7
ventromedial nucleus,1
A35,11
phosphatidic acids,1
diacylglycerols,1
hydroperoxide,1
choline plasmalogens,1
triacylglycerols,1
sphingomyelins,1
tea,9
IgM-enriched immunoglobulins,1
linagliptin,2
Linagliptin,3
AR14,1
digoxin,7
0.93â0.96,1
E298-409,3
E301-404,1
2015/Colombia (FLR),1
FLR,1
E298-409-specific antibodies,1
Lactobacilli,7
LPS-,2
ethyl acetate fraction,2
LPS intranasal,1
100â300 mg/kg,1
kaempferol (100 Î¼g/ml,1
dithiothreitol,14
emulsions,2
10.1186/s13071-018-2697-8),1
10.1186/s12879-018-3040-x,1
Adenine,1
adenine (A),2
NTG,1
5â²-triphosphate ribonucleosides,1
MCPP,7
75.3%â85.7,1
SUC,10
infliximab,7
RU486,5
1.0â2.0],1
1.6â26],1
1.5â38.4],1
1.9â82],1
10.1007/s00705-018-3706-0,1
adenosine tri-phosphate,1
biocidal reactive oxygen species,1
âalways online.â,1
virucidal (>99.999,1
caffeoylquinic acids derivatives,1
quercertin diclycosides,1
quercertin derivatives,1
flavonol glycosides,1
Intravenous Immunoglobulin,1
Corticosteroid Therapies: Association with,1
high-dose intravenous methylprednisolone,1
IVMP,5
intravenously-infused,1
PVD201,1
IFNÎ3 circulating,1
ISRCTN99586989,1
toremifene,5
toremifene citrate,1
Zinc DeficiencyâLike,1
Zinc deficiencyâlike,1
BARB,2
TDB,1
curdlan,2
parenteral vaccines,3
cocktail antisense oligonucleotides (AOs),1
cytidine deaminases,3
deoxycytidine (dC),1
deoxyuridine (dU),1
antigen-conjugated fluorescent beads,1
FRÎ±,3
systemâs,1
Non-Steroidal Anti-inflammatory Drugs (NSAID),1
[1].,2
exopolysaccharide,2
FTIR,7
PODD,6
biliverdin,2
3-indolepropionic acid,1
reactive oxygen scavenging,1
lysophosphatidycholine,1
enterolactone,1
hexahydrohippurate,1
Tacrolimus,4
Cyclosporine,3
single-aisle,3
nucleotide analogs,1
Nucleosides,1
nucleotide analogs acting as inhibitors of RNA chain,1
favipiravir,30
Nucleoside analogs,3
G-tetrads,3
SMS 232,1
Nanoparticle Nucleic Acid,1
NP-mediated,1
"sialic acid Î±2,6-Gal receptors",1
"1,4-dioxane",9
lactide-co-glycolide,1
tricalcium phosphate,1
PLGA/TCP,3
Dimethyl formamide (DMF),1
DMF,2
1â40 ppm,1
PHEMS,1
glycosides,11
nucleotide diphosphate (NDP)-sugars,1
trans-glycosylation,1
NDP-sugars,1
sugars,13
aglycons,3
cytidine deamination,1
palivizumab immunoglobulin,1
cafeteria,2
10.1186/s12879-018-3093-x,1
FARP,13
paraquat,4
anti-C5aâbased,1
Biliverdin reductase-A,1
biliverdin reductase-A,1
eNOS-generated NO,1
magnesium pyrophosphate,5
C07,1
LTA,1
morpholine rings,2
uncharged nucleic acid analogs,1
beta-lactam antibacterials,1
"macrolides (0.74,",1
[OR] 6.6 [95%,1
silvestrol,22
Ellagic Acid,2
TCMs,3
BI-D1870,3
PD0325901,3
Nucleos(t)ide,2
Firmicutes (P =,1
ABGs,1
L* binds the,1
2â-5â oligoadenylates,1
L* efficiently,1
L* can functionally substitute for the,1
poly-ADP-ribose,2
tq-PCR,1
Jak1/STAT3,1
adamantane analogs,1
adamantane derivatives,1
rimantadine molecules,1
rimantadine analogs,1
ESG,1
antibody-conjugated graphene oxide,1
fluorescein isothiocyanate,2
NCFM,2
NCFM-derived mutantsâNCK2025,1
Lactobacillus acidophilus mucosal vaccine,1
nitazoxanide,25
CFC,2
Polysialic acid,1
polysialic acid,4
student/postdoc,1
2-Benzoylamino-N-phenyl-benzamide derivatives,1
"2-phenyl-3,1-(4H)-benzoxazin-4-one 3",1
transaminases,1
bile ducts of,1
"3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-induced",1
bile ductular injured mice,1
glycerophospholipid,2
radicicol,4
Leishmanicidal,1
Quercetin Derivatives,1
quercetin derivatives,3
pKa,3
catechol hydroxyl,1
hydroxyl,22
glucantime,2
"quercetin acetate derivatives (2, 3",1
sodium taurocholate cotransporting polypeptide Sodium taurocholate cotransporting polypeptide,1
glabridin,8
licorice-derived isoflavane,1
taurocholate,1
acetyl-l-carnitine,3
n=3168,1
hinokiflavone,1
Silymarin,1
bioflavonoid hinokiflavone,1
NP-SH,1
IFITM3-rs12252 CC,1
10.1186/s13601-018-0205-z,1
Al-,1
E and 3a proteins,1
super-important nodes,1
NA in serum,2
NA in target,1
NHR-helical trimers,1
glycyrrhetinic acids,2
pentacyclic triterpenoid compounds oleanolic acid,1
oleanolic acids,1
5-diphenyltetrazolium bromide,1
113/217,1
28/217,1
reactive oxygen radical,1
"11,098,243",1
"191,114 (95%",1
disulfide bonds involving residue Cys171,1
NA of A/Hamburg/4/2009 (,1
Keggin polyoxometalate,1
PT-1,2
N36 peptide,1
Oxymatrine,3
Ultraviolet,7
juglanin,5
UVB,3
"indoleamine-2,3-dioxgenase-1",1
218/1238 [18%,1
Virucidal,3
Povidone-Iodine Gargle/Mouthwash,1
povidone-iodine,5
PVP-I) 7,1
EN14476,1
PVP-I 7,2
[0.3 g/l bovine serum albumin,1
Povidone-Iodine,1
Chlorhexidine Gluconate,1
PVP-I),1
chlorhexidine gluconate,6
virucidal [,1
PVP-I 7.5,2
CHG,3
PVP-I (1.57â2.57),1
CHG 4,1
creatine phosphokinase,5
H3N2r [,1
immiscible polymers,1
10.1186/s12889-018-5626-z,1
Corticosteroid,7
Inhaled corticosteroids (ICS),1
fluticasone propionate (FP),1
Quinoline Derivatives against Dengue Virus Serotype 2 Dengue virus,1
quinoline derivatives,2
exopolymers,1
[21.2â41.2],1
10.1007/s00705-018-3794-x,1
papyriflavonol A,1
kazinol J,1
10.1186/s12931-018-0784-1,1
Chitosan,7
Non-Aqueous Hydrophilic Solid-Phase,1
tanshinone IIA,1
ferruginol,1
FMT,6
10.1186/s12931-018-0782-3,1
alisporivir,6
broad-spectrum anti-Flaviviridae,1
H genes (n=6),1
É,1
Triclosan,3
triclocarban,2
broad-spectrum antimicrobials,2
triclosan,13
fluorophores,6
Saracatinib,1
saracatinib,4
IB-H120,1
IB-VAR2-vaccinated flock,1
NTD(231â501,1
Ursolic Acid,2
ursolic acid,15
Ursolic acid,1
D-Mannitol,1
thiopyranothiazoles,1
thiazolidine derivatives,1
Thiazolidine,1
heterosystem,1
tablet,4
mononucleotide,1
dinucleotides,1
Trimethoprim/sulfamethoxazole,1
First-Line,1
ADR,3
arbortus,1
rifampin,5
streptomycin,9
Bioactivities,2
Forskolin,1
10.1186/s12913-018-3326-0,1
FOCRT,1
20 mg/kg toltrazuril,1
10.1186/s13071-018-2976-4,1
Ceftazidime,1
Ampicillin,1
Clavulanic Acid,1
Ceftriaxone,4
70.81,1
CI [6.0â7.1],1
CI [1.8â2.7],1
CI [7.8â10.0],1
CI [7.5â9.6],1
DFAs,1
LoDs,2
10(2) TCID(50,1
FISH,1
xylometazoline hydrochloride,1
Xylometazoline hydrochloride,1
HCl,3
xylometazoline HCl,5
20.2â29.8,1
PtdOH,4
10.1186/s12961-018-0327-8),1
aluminum oxide-coated glass (ACG),1
VDP,1
aluminum oxide,1
Al-oxide,1
Î±-5-pentylphosphonic acid,1
TCHO,1
low-density lipoprotein cholesterol/high density lipoprotein cholesterol,1
LDL-C/HDL-C,1
56/1203,1
10.1186/s12879-018-3223-5,1
10.1186/s12889-018-5709-x,1
Firmicutes (2.7%,1
Mg,4
N-peptide monomers,1
mid-dose,2
Vitamin C,5
RVN,14
LE/L cholesterol,2
"HR2-based fusion inhibitor), biologicals (convalescent plasma",1
Intrathecal B Cells,1
inflammatory-(OIND,1
androgens,2
progesterone,10
CI 3.94â33.04,1
"3C.3a,",1
DDE,1
eucalyptus,1
clove oils,1
allergen components,2
0.32/dose,1
CMO,2
antiprogestin,5
Oil,7
CPD,7
look-alike,2
10.1186/s13071-018-2996-0,1
"3,2â²-dimethyl 4-aminobiphenyl",1
DMAB,1
GNPs,8
LAIs,5
IFN-Î±2b,5
UPE,1
Alcohol,7
nitrosamine ketone (NNK),1
NNK,3
myelinated fibre,1
opiates,2
buprenorphine implants,1
Xylitol,2
âbirch sugarâ,1
toothpaste,1
xylitol,1
xylitol syrup,1
[OR]: 1.12; 95,1
DDP-4,2
174/1313,1
Ï (2)(1,3
P=0.072,1
dromedariesâapart,1
broad-spectrum vaccine,1
dibenzazepine,1
DBZ,2
nonâMERSâCoV,1
vasopressors for 41 (39%,1
[6 (8%,1
10.1186/s13613-018-0429-z,1
A78,2
C24,2
Polyphenols,3
OMWW,6
colistin 2,1
OHSA,5
Act 85,1
beta-lactams,1
epigallocatechin gallate,8
puerarin,3
intranasal route,3
10.1007/s00401-018-1885-0,1
nasal route in 1,2
AZT,19
NRTIs,3
NNRTIs,6
azidothymidine,2
diarylpyridine (DAPA)-2e,1
Cyclohexapeptide,1
solid-phase peptide,2
solid-phase cyclohexapeptide synthesis using the on-resin and,1
HPLC-UV,1
R-goitrin,3
glucosinolates in 37 samples,1
glucosinolates,4
glucosinolate,2
Primaquine,1
mono-ethyl fumarate (1a),1
acids 3a,1
"1-[bis(Dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate",1
p-fluoro,1
"m-substituted derivatives 4a,",1
levofloxacin 500,1
ciprofloxacin eye,1
acetaminophen,12
G2/M.,2
tannin-containing forage in ruminant diets,1
cordyceps,1
cordyceps fungi,5
cordyceps fungus based on,1
fungus of Chinese cordyceps,1
Frafraha communities,1
S1-ACE2 complex,2
NA to,1
PEEP10,3
H2O PEEP,1
27.7â36.7,1
direct-acting antiviral agents,1
DAAs,3
inositol requiring enzyme 1 Î±,1
10.1186/s12889-018-5931-6,1
Iron,3
Ochratoxin-A,1
ochratoxin-A,1
quercetagetin,2
PPNDS,2
2â²-C-methylcytidine (2CMC,1
10.1186/s12936-018-2444-9,1
protonophores,1
CCCP,1
carbonyl cyanide m-chlorophenyl hydrazone),1
FCCP,1
carbonyl cyanide-p-trifluoromethoxyphenylhydrazone,1
"Na,",11
HDIs,1
uracil,4
5-halouracils,1
major-groove triplex formation,1
Acids (PNAs),2
TÂ·AâU base,1
5-methyl,1
halogen atoms (F,1
N3 nitrogen atom,1
halouracils,2
bromouracils,1
L protein contains,1
âdaâ layers,1
naringenin,8
RP-,1
ethyl acetate:formic acid,1
12.434x + 443.49,1
10.08x + 216.85,1
Gallic acid,1
7.01 Î¼g/mg,1
CFDA,3
saikosaponin,2
torilidis fructus ethanol,1
Torilidis fructus,1
torilidis,1
lipopolysaccharide (LPS)-induced nitric oxide,1
salicylic acid (SA)âdependent HRâlike cell,1
âbeing,1
retina 1,1
10.1007/s00335-018-9750-y,1
archazolid,7
acidifies intracellular compartments,1
hypochlorous acid,2
chloride ions,3
sodium channel inhibitors did,1
4-aminobenzoic hydrazide,1
JOL967,1
28(th,3
2.44E5,1
10.1186/s12879-018-3358-4,1
Flagellin-SAPN,1
IBV-Flagellin-SAPN,1
SBM,4
BEL,5
HSBM,2
LSBM,3
N-free,2
HSBM pigs,1
"BW, 0.129 (",1
Diar1,1
insulin-to-glucose,1
10.1186/s40794-018-0071-7,1
endotoxins,9
agaroseâacrylamide,1
keratan sulfate,2
GoldView nucleic acid dye,1
NbMS10-Fc,1
broad-spectrum host-targeted antiviral,1
diarylheptanoids,3
(2)D-LC,1
chromone,2
calycosin,1
formononetin,6
cimicifugoside,1
sec-O-glucosylhamaudol,1
Loperamide,1
pimozide,6
STF-62247,4
loperamide,5
pimozide-,1
Amentoflavone,1
anti-diabetes,1
Microemulsion,1
microemulsion,4
D101 resin,1
[methyl-(3)H] thymidine,2
CFPE,2
10.1007/s11033-018-4204-x,1
https://github.com/woolfson-group/isocket,1
homocysteine,3
memantine,5
taxane-based,3
2.357â66.298,1
infections/liver injuries,1
phosphatidate phosphate,1
phosphatidate,1
diacylglycerol,1
medium-chain fatty acids,3
hexanoic,1
octanoic,1
decanoic acid,1
MCFA rice hull,4
anti-histamines,1
Sulfur Dioxide Background:,1
season-standardized,1
sulphated polysaccharides,1
Deoxypodophyllotoxin,1
dehydroabietic acid derivative,1
Heparin,5
heparin-related sulphated carbohydrates,1
selenium nanoparticles,1
Selenium nanoparticles,1
SeNPs,2
Se@RBV nanoparticles,1
virusesâAnything,1
ammonium sulfate,10
(IDSA)/American,1
GLIMP,2
epitope-overlapped,1
MDAs,1
cephalosporins,8
10.1007/s12250-018,3
1 Ã 10(5) TCID(50,1
115/775,1
10.1186/s12879-018-3429-6,1
Montelukast,5
EDN,2
budesonide,7
montelukast,10
montelukast 4,2
beta2-agonist,1
Alprostadil,4
Oleic Acid,1
alprostadil,4
MFCs,2
TRL,3
demonstration.â Solutions,1
enterococci,7
Macrolide,1
Levofloxacin,6
corticosteroids (CST),1
DXC,1
LFX),1
LFX,4
fluorescein isothiocyanate (FITC)-dextran,2
10.1186/s12913-018-3583-y,1
developmentâ,1
anti-PD-1,4
fungus contained on,1
fungus exhibited different,1
10.1186/s12964-018-0283-5,1
[OR] 3.71,1
2015/2016,7
urine sodium,1
Kaplan-Meier,2
ZIKV-induced intracellular,1
niclosamide chemotype attenuate obesity related changes,1
Niclosamide Ethanolamine (,1
Niclosamide Piperazine (NPP),1
niclosamide derivatives,1
N-substituted phenylbenzamide derivatives of,1
niclosamide salicylanilide chemotype,1
IN A,1
antitumorigenic agents,1
ssDNA viruses,1
10.1186/s12879-018-3446-5,1
10.1186/s12879-018-3425-x,1
nucleic acid (LNA)-based,1
mOTNRT-PCR,1
Fatty Acids,1
Drug Administration (FDA)-approved drug,2
daunorubicin,2
rifapentine,2
sitafloxacin,4
intravenous antiviral agents,1
CWs,1
FICT,3
europium nanoparticles,1
BRB,7
EPAC-specific inhibitors,2
ESIs,1
foscarnet,3
sub-cytotoxic,1
LysRS,1
Ni-affinity,1
micellar nanoparticles conjugated,1
lipopolysaccharide (LPS)âinjected,1
[1.01â1.22]),1
GEs,1
TLR-Ls,2
Catechins,2
CMDA,3
galloyl moiety anchors,1
galloylated catechins,1
XCA,1
"1,3-Dipolar cycloaddition of N-methyl C-(diethoxyphosphoryl) nitrone to N3-substituted 6-bromo-2-vinyl-3H-quinazolin-4-ones",1
quinazolinones,2
isoxazolidine cycloadducts,1
trans-11e,1
trans-11,1
Aminobenzosuberone,1
"7-amino-5,7,8,9-tetrahydrobenzocyclohepten-6-one",1
aminobenzosuberone,1
Aconitine Alkaloids,1
aconitine alkaloids,4
aconitine cardiotoxicity,1
MERS-S,1
LV,40
96â97,1
CI 1.2â36.0,1
fatty acid binding proteins,1
10.1186/s13071-018-3179-8),1
CI 568,1
723.5,1
intra-molecular fidelity-modulating,1
10.1186/s12992-018,1
"110,000â165,000",1
17/370,1
9-O-acetylated sialic acid,10
vincristine,2
Tc-bovine plasma,1
negative-stain electron,1
10.1186/s12931-018-0922-9,1
LJM17-based vaccines,1
hydroxyurea (HU)-dependent fork restart,1
0.84â22.79,1
76â95,1
acylated steroidal glycosides,2
steroidal glycoside acyltransferase,1
17Î²-hydroxyl steroids,1
steroid 17Î²-glucosides,1
steroidal glycosides,1
Etacrynic Acid A,1
etacrynic acid derivatives,1
2-Oxo-5-aryl-3-hydrazone Pyrrolidine Derivatives Some novel,1
pyrrolidine compound 1b,1
"2,3-dioxo-5-aryl pyrrolidine 2b",1
hydrazone derivatives,1
hydrazine salts,1
elemental,9
guanidinium moieties,1
dendrimer,3
guanidinium,1
pochonin D,3
pochonin D treatment,1
"27,599 nucleotides",1
"61,895",1
10.1186/s12874-018-0586-7,1
Gallic Acid,1
"3,4,5-trihydroxybenzoic acid",1
mM.,9
(-)-Î²-pinene,2
Veliparib,1
ABT-888,2
pyrrolidinedithiocarbamic,2
UA,7
CAPD,2
pleconaril,1
NO-metoprolol,1
Glu276,1
cycloartenol triterpene saponins,1
ethyl acetate soluble,1
electron-attracting trifluoromethoxy substituent at position-5 of,1
Benzopyrano-Coumarin Derivatives,1
4-hydroxycoumarin dimers 1â15,1
"compounds 7,",1
4-hydroxycoumarin moieties,1
2-nitrophenyl derivatives (compounds 7,1
carbonyl oxygen atoms,1
compounds 7,1
4-hydroxy-coumarin moieties are,1
adenosine 5â²-monophosphate,1
3â² terminal adenosine,1
homoharringtonine,7
28/680,2
Jie-Geng,2
"11,066,453",1
10.1186/s12887-018-1351-0,1
flavored milk,1
10.1186/s12887-018-1352-z,1
carvacrol,2
fungicidal effects,1
fungicide bifonazole,1
optically-encoded,1
2-nt dangling,1
27-nt,1
Peptide-Like Macrocycles,1
"Imidazole-4,5-dicarboxylic Acid",1
"imidazole-4,5-dicarboxylic acid",1
Lipophilic Efficiency Analysis to,1
4-methoxychalcone derivatives 1aâi,1
sulfonamide 4-metychalcone derivatives,1
pyrrolidine,2
morpholine,1
LipE,2
chalcone,6
"1,3,8-trihydroxy-6-methylanthraquinone",1
anthraquinone derivatives,2
ethyl 1-[(tert-butoxycarbonyl)amino]-2-methyl-5-(1-methyl-1H-indol-3-yl)-4-[(1-methyl-1H-indol-3-yl)carbonyl]-1H-pyrrole-3-carboxylates,1
deazaanalogues,1
Pentaherb Formula,1
Gallic Acid Pentaherb formula,1
Danpi/DP,1
"hetero Diels-Alder reactions,",1
Schiff intermediates/targets,1
Bismuth,6
bismuth,35
bismuth-based,3
dimethyl sulfoxide (DMSO),2
Chelator Quercetin Derivatives with,1
DKAs,1
7-O-substituted derivative 3i and,1
3-O-substituted derivative 4f were,1
non-antitumor,1
2-Hydroxy-4-Methoxybenzaldehyde A,1
Schiff base,7
ethyl 4-[(E)-(2-hydroxy-4-methoxyphenyl)methylene-amino]benzoate,1
[Cu(L)(NO(3))(H(2)O)(2)] (1),1
phenol oxygen,1
azomethine,1
sulfur atoms,1
chromone (4),1
Compounds 2,1
triterpenoid,3
spirostane aglycones,1
ginsenosides,2
steroid saponins,1
dioscin,1
polyphyllin,1
timosaponin,1
N3-substitued 2-vinyl-3H-quinazolin-4-ones,1
trans-11g,1
benzyl substituents at N3,1
21â102 Î¼M,1
18Î±-Glycyrrhetinic Acid,1
18Î±-glycyrrhetinic acid,1
"diethyl {4-[(5-substituted-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-methyl]-1H-1,2,3-triazol-1-yl}alkylphosphonates",1
amonafide,1
thymidine kinase-deficient,1
16d,1
"Polyinosinic-Polycytidylic Acid Quercetin (3,3â²,4â²,5,6-pentahydroxyflavone)",1
Primaquine-Cinnamic Acid Conjugates,1
primaquine,4
cinnamic acid derivatives,1
acylsemicarbazide,2
CONHNH spacer,1
acylsemicarbazide 7f,1
"7c, 7g",1
"7c,",1
7f,1
"trifluoromethyl group(s) 7i, 7j and",1
7k,1
7g,1
amide 3f,1
Î¼Î,1
CHM decoctions,1
CHM,3
Glycyrrhetinic Acid Derivatives A total,1
biocidal agents,1
micellar nanoparticles,1
Fusobacterium necrophorum,4
malic acid,1
10.1186/s12992-018-0441-y,1
omicsâtechniques,1
Lipids,10
virucidal molecules,1
thiobarbituric derivatives,1
guanine nucleotide exchange factor highly,1
xanthine nucleotides XMP/dXMP,1
acyclic nucleoside phosphonates,2
xanthine nucleobase,1
xanthine,2
adefovir,3
PMEA,6
hexadecyloxypropyl monoester derivative,1
nucleoside phosphonate with,1
CI 1.19-1.41,1
columns,1
reactive reverse transcription,1
1 Ã 10(2,2
(CT)-scan,1
conjugate,8
bafilomycin nanoparticles,1
drug-loaded,1
diphyllin nanoparticle,1
intra-assay,2
bioconjugate,1
QD580,1
TssG.,2
PPE3,3
PPE surface,1
10.1186/s13756-018-0433-y,1
Saf fimbrial,2
10.1186/s13099-018-0279-0),1
Sephacryl S-200,1
corticosteroids (n = 28; 12%,1
[OR] > 1.30),1
DNM/DNB,1
C intratracheal,1
10.1186/s12879-018-3611-x,1
reactive species,3
myeloperoxidase [,1
MPO],1
Germanyâ22-Year,1
ACH,4
PCV-3,8
quinoline compounds for,1
quinoline compounds,1
nursesâ hand,1
vanadium oxides,2
vanadium oxide,1
SYTO9 nucleic acid,1
oxide,1
Copper Alloy,2
10.1186/s12889-018-6313-9,1
MTT-assay,1
tamoxifen,7
735 112 viral,1
salicylanilide,3
niclosanide,1
oxyclozanide,1
rafoxanide,2
Piperacillin-Tazobactam,1
Amikacin,3
AM580,2
AOAA,4
PolyI,10
Phosphonylated Acyclic Guanosine Analogues,1
Nâ²-(2-Oxoindolin-3-ylidene)-2-propylpentane hydrazide-hydrazones,1
Nâ²-(2-oxoindolin-3-ylidene)-2-propylpentane hydrazide-hydrazone derivatives 4aâh,1
"compounds 3e, 3f, 4a, 4c",1
5-Fluorouracil,1
SeM) antibody titer,1
Fortyâeight horses,1
SeM antibody titers,1
SeM antibody titer,1
SeM antibody,1
barriersâand,1
[RR],3
Huo-Xiang-Zheng-Qi Formula,1
HXZQ formula,1
tween-20,1
itraconazole against type I feline coronavirus,1
itraconazole (ICZ),1
ICZ,2
10.1186/s12879-019-3671-6,1
PPE-induced,1
thioguanine,1
Compounds 18,1
glycyrrhizinic acid,7
Glycyrrhizinic acid,5
glycyrrhizinic acid-treated,1
Inorganic Complexes,1
Inorganic complexes,1
inorganic,7
tauroursodeoxycholic acid,3
TUDCA,7
DMTs,1
10.1007/s11248-018,1
10.1186/s12974-019-1397-4,1
20â100Î¼l,1
10â50,1
tail-hair,1
hypertonic saline nasal,3
chloride-ion,1
EL,3
1-2,3
nicotinic acid adenine dinucleotide phosphate (NAADP)-gated,1
linoleic acid,6
disabilityâis,1
VE(S,6
live/death,1
131/709,1
Captopril,1
intranasal (IN) routes,1
CYP450,2
microsphere,3
zero-Hopf,1
monosaccharide,2
SRB,1
ISRIB,9
guanine nucleotide exchange factor that,1
arsenite,1
carbon emissions,9
10.1186/s12879-019-3735-7,1
DnaK. Antibacterial,1
Lactic Acid Bacteria,3
non-antibiotic growth promoters,1
bacteriocins,1
diacetyl,1
phenobarbital,6
pregabalin,1
cross-linker,6
valve-type (,1
sialic-acid O-acetylation,2
sialic acid O-acetyl esterase,2
"7,9-di-O-acetyl",2
"PRV,1004",1
3708 J/L,1
(NGS)-based,1
FHVâB2eGFP,1
modifican las interacciones interespecÃ­ficas,1
transformaciÃ³n,1
con las que,1
vegetaciÃ³n dominante es un bosque lluvioso,1
cuantificamos las diferencias en composiciÃ³n,1
gremios,1
equidad,1
Single-guide,1
ILâ27,1
TNB,4
NBM,1
TNB (0.86 Â±,1
DPP4/CD26,2
PLEX,1
DIP,12
FMAG_01619,1
Fusobacterium mortiferum,2
(2) T-lymphocyte,1
airway inflammatory diseases,1
anti-parkinsonism,1
pramipexole,1
selegiline,5
HDLs,1
cholesteryl esters,1
apoC-3,1
HDL proteins,2
sterol,2
HDL-cholesterol,2
P=0.027,2
DEG,1
CH-01,3
nilotinib,2
PCP,3
trimethoprim/sulfamethoxazole for,1
OCCs,4
helioxanthin (2),1
6-methoxy-7-hydroxycoumarin (,1
behenic acid (6),1
"1,3-di-O-caffeoyl-quinic acid",1
ferulic acid,4
caffeic acid,6
stigmasterol (16),1
syringin (19),1
nitric oxide (,5
chIFN-Î»,1
Exhaled Aerosols Released,1
Nebulisation,1
albuterol sulphate,2
nebulisers,1
2â5 Âµm,1
FMCA,4
FAM,3
T4064A,1
HEX,1
FFAs,12
Enteral Feeding in Adult Critically,1
10.1186/s12909-019-1513-2,1
[iSN-aPTB],3
[non-aPTB-PD] (,1
[iSN-PD],1
[HRCT (CXR + Hypoalbuminemia)],1
[non-aPTB-PD],1
[CXR + Hypoalbuminemia],1
Nanoparticles: A Review Polysaccharides,1
PMNPs,1
Fourier-transform infrared spectroscopy,1
oxypaeoniflorin,1
paeoniflorin,1
galloylpaeoniflorin,2
benzoyloxypaeoniflorin,2
mudanpioside C,2
puromycin,8
AZA,9
eHAV,2
pNT,5
10.1186/s12879-019-3898-2,1
"(E)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(naphthalen-1-yl)prop-2-en-1-one",2
DiNap,1
chalcone flavokawain,1
aloe,1
Salmonellaâpositive,1
1âway,1
ammonia in neonatal calves,1
170.7 [148.5â219.5],1
[3.29â5.58] vs 6.78 [5.29â8.92] Î¼M,1
Î·p2 â¤,1
LSA,3
Z-FA-FMK,1
E64d,9
NFâÎºB,2
1.2â4.9],1
[RR] 1.75,1
CI 1.17 ~ 3.10,1
10.1186/s13054-019-2395-8),1
N-sulfonated derivatives of,1
lamivudine,10
baccatin III,1
psoralen (67%,1
embelin (,1
menisdaurin (64%,1
lupeol,1
rutin (,1
hesperidin,1
22L-prion,1
icaritin,11
"1,075/3,207 (33.5%",1
doctorsâ IPC,2
[mostly] observe,1
10.1186/s12889-019-6636-1,1
10.1186/s12890-019-0835-5,1
citrate synthase (,1
SOMAScan,1
Schiff base coordinated copper(II,1
Cisplatin,1
Schiff base copper,1
10.1186/s12961-019-0440-3,1
lifeâthreatening rupture,1
broad-spectrum influenza virus,1
Sialyllactose,1
AUF,3
AUF patients,1
NA functions,1
broad-spectrum HCoV,1
LCS,3
L (CatB/CatL),1
surfactin analogues,2
micelle,3
Surfactin derivatives,1
lactone bond hydrolyzation of,1
1-96,1
XCe2-,1
"organic acids,",3
extracts/compounds,1
tri-,6
endo-cleavage,1
polyethylene glycol-modified proteins/peptides,1
"2,699/8,842",1
246/393,1
20/393,1
non-purified antigen,1
"L, two-pore channel 1 and",1
WAB-Net,1
hyaluronic acid,1
FIB4,1
fatty acid-binding protein,1
Fatty acid-binding protein 1,1
Ã 10(9)/L,4
10.1186/s12877-019-1125-z,1
isoflavonoids,1
BB is,1
qTOF-MS,1
fucoidan,3
phlorotannins,15
EC70,1
Nanostructures Synthesized with,1
Particulate air,1
sulphur dioxide,3
Single-day,1
LPN,3
FOS,9
BRMs,6
Aurintricarboxylic Acid,4
encephalitisârabies,1
Galanthamine,2
tyramine,3
Glutathione,2
2-phenyl-benzotriazoles,1
paracetamol,2
EPs 7630,1
1 live-animal,1
Cho ABC,3
MLN4924,1
Heterocycle-Fused Derivatives,1
NQ,1
heterocycle-fused quinone (HetQ) derivatives,1
NQ 4,3
AQ 11,1
quinone,3
NQ 4 is,1
naked-eye,3
FcÎ±RI,1
FcÎ³RIIA,2
nebulised adrenaline:,1
nebulised adrenaline does,1
Rupintrivir,2
Piperacillin,1
bed-to-bed,1
"2,3,7,8-tetrachlorodibenzo-p-dioxin",3
TCDD,16
mVEGFR1,1
"alpha-2,6-linked sialic acids",1
Drug Administration-approved vaccines,2
tibroviruses,4
NH(4)Cl [Image: see text] ELECTRONIC,1
10.1186/s12964-019-0349-z,1
"cloudy air sacs,",1
Log(2,1
"23,418",1
reactive microglia engulf neutrophils,1
10.1007/s00401-018-1954-4,1
corticosteroid dexamethasone,3
corticosteroid levels,1
NA are,3
1.02â3.26,1
0.09â0.64,1
DCP,2
adenosine nucleotide,2
triphosphate,12
ara-ATP,1
Drug Administration- (FDA)-approved,1
regorafenib,1
eltrombopag,1
broxyquinoline,1
1 mg/kg PO q24h,1
ADPPs,1
2â118,1
DDP,2
1â27,1
LAP,3
LAP(-,1
Glucagon,1
glucagon,2
Phosphatidylinositol,1
Clostridia,2
C-indexes,1
BCH,3
mizoribine,10
embryo-infective,1
Bile AIM: Bile salt,1
bile acid canalicular export,1
guggulsterones,2
bile.,1
CMP-N-glycolylneuraminic acid hydroxylase,4
single-guide,2
NGNA,4
I/H,2
10.1186/s12889-019-6968-x,1
CI 1.23â4.58,1
sialic acid receptors Coronaviruses,1
imipenem-cilastatin,2
Imipenem-cilastatin,1
2-undecanone,7
benzo(a)pyrene-induced lung,1
interleukin-1Î²,2
NAD(P)H,1
quinone oxidoreductase 1,1
B[a]P,1
dorso-ventral,1
10.1186/s12866-019-1498-3,1
Polyamine,3
28â29,1
(4),5
convoluted membranes structures,1
Nanodiamonds,1
CBX,4
denatonium benzoate,4
Denatonium benzoate is,1
denatonium benzoate is,1
denatonium benzoate aerosol,1
omalizumab,9
Xolair,2
"corticosteroid,",2
Symbicort turbuhaler,2
diphenhydramine,2
fenoterol HBr,1
epicontacts,2
PSPs,6
ADP-ribose nucleotide,1
ARH3,1
guanidine hydrochloride,3
"Î±2,3-linked",1
1993â2000,1
OPSs,1
Metronidazole for Acute Canine Diarrhea Acute diarrhea,1
frequently-prescribed,1
amantadines,2
AN7973,3
2007â2017,1
10.1007/s12250-017-4021-8,1
Acacetin,1
acacetin,5
isoginkgetin,4
4-methoxy-TEMPO,1
NUC,2
CrI,22
IFN-Ï,2
IFN-based,5
Tigecycline,1
10.1186/s12974-019-1523-3,1
IL-4 nanoparticles,1
intranasal IL-4,1
indigo paste,1
10.1186/s12889-019-7067-8),1
sEVs,1
H/D,1
AMPPNP,1
Musk,1
antacids,1
phosphatidylserine (PS) receptor,2
xanthones,6
"benzophenones with antibacterial,",1
ethyl acetate (45 L Ea),1
hexane (45 L H) leaf extracts,1
"L Et,",2
L Ea,1
ethyl acetate is,1
"[IQR, 1.6â3.9 h] v",1
single-stranded nucleotide,1
20-wpi,1
2-wpi FcÎ³RIII,1
CoA,1
10.1186/s12879-019-4266-y,1
10.1186/s13071-019-3602-9,1
non-dengue-endemic countries,1
eckol,3
phlorofucofuroeckol A (4),1
dihydroxyphenylalanine,1
Compounds 3,2
Eckol,2
"dibenzo-1,4-dioxin",1
kynurenine,1
KYN,3
kynurenic acid,1
KYNA,3
carbenoxolone,1
U18666A,6
Sodium Arsenite,1
reactive antigens,2
25-hydroxycholesterol,6
â75/â1,1
25HC,9
Its Immunomodulatory,1
carboxylase,1
cholesterol derivatives,1
OMVs-based vaccines,1
20 IFN functional,1
violaciÃ³n,1
rhACE2,4
Fortyânine,1
20 g of immunoglobulins in,1
20 g of,1
CLRI,1
PPMOs,9
10.1186/s12974-019-1545-x,1
MBH,1
NS) isatins,1
MBH adducts,1
"1,4-diazabicyclo[2.2.2]octane",1
isatins,2
atom,1
1.00â1.01,1
10.1186/s13756-019-0574-7,1
Biguanide,2
CysHis(Xaa,1
imino nitrogens.,1
phenformin,2
phenylethyl biguanide),1
Phenformin,2
BAA,3
phenyl moieties of,1
biguanide derivatives,1
Phenformin-Zn(2+,1
nucleic acid structures,1
plecomacrolides bafilomycin,1
concanamycin,1
[mariPOC respi] ArcDia,1
ITP in association with,1
tablet or liquid preparation,1
heparin-Sepharose beads,1
FFV,1
acteoside,1
serological/molecular,1
10.1186/s12879-019-4277-8),1
2â3 reviewersâ,1
caerin 1.1,1
â2 PRF,5
Nasopharyngeal/Oropharyngeal swabs,1
Sugar-based,1
Fpr,1
mid-19(th,1
nitrous oxide in,1
nitrogen-rich organic compounds during,1
organic fertilizer causing lower nutrient losses,1
Carotenoids,1
nucleotide-,1
Corticosteroid administration,1
NAI treatment,1
double-dose,2
[1.40â5.54],1
148/454,1
28/307,1
ROS/RNS,5
antioxidant enzymes,3
coenzyme Q,1
CoQ,1
carotenoids,1
minerals,8
Se,9
"Mn,",2
pre-mixes,1
superoxide dismutase,3
CON + 0.5 g kg(â1,2
1 (4%,1
10.1186/s12877-019-1236-6,1
F-measure=0.7371/0.6698,1
anti-PD1,2
intrathecal Ab,2
ItAb,1
dynamics/patterns,1
Bafilomycin,1
cardiotonic steroid ouabain,1
PST2238,2
rostafuroxin,1
Theil-Sen regression,2
halide,1
microbicidal agents that,1
lactulose,1
cPNT,4
1 bacteriophage,1
10.1007/s12250-016-3930-2,1
BPI-3V,1
glutathione peroxidase,3
Tulathromycin,2
galloyl-HHDP-glucose,2
Water,2
Morphine,6
morphine,8
nucleic acid polymerases,2
[14/80],1
[4/27]),1
1.3â1.8],1
[OR] 2.6,1
F75,3
IFITM3/IFITM3,2
SCFP,4
CRD42019134173,1
DMI,23
"134A, 327 T, 380 L and",1
gefitinib,2
heparin binding (HB)-EGF,1
IIDs,1
10.1186/s12879-019-4400-x,1
NSR,1
VFPs,4
Y-27632,3
rTGEV-RS-SPEDV virus,2
autoimmunopathologies,1
molybdenum disulfide nanoparticles (MoS(2) NPs,1
polyethylene terephthalate,1
nanolayer,1
cysteamine,1
Closantel Sodium,2
Closantel Sodium-,1
Closantel,1
10.1186/s12879-019-4345-0,1
Drug Administration public,1
"22,694",1
10.1186/s12874-019-0819-4,1
intramuscular/intravenous,1
pcDNA-CCOL2A1,2
pcDNA-CCOL2A1 (300 Î¼g/kg,1
pcDNA-CCOL2A1 vaccine,1
1 Î¼g/ml,2
4-HD,1
[16%] were,1
[2%] died,1
[12%],1
10.1186/s12889-019-7369-x,1
Co-delivery,1
alginate nanogel,1
ALG,1
hydrogen bond,4
ALG NGPs,1
CI 1.4â9.6,1
liposomal amphotericin associated,1
caspofungin,2
posaconazole,1
Workersâ,1
1.85-Ã ,2
nivolumab,3
nivolumab-induced,1
CDCGrandRounds,1
differentâomic,1
BRL,1
BRL 39.42 [standard deviation (SD) 17.94],1
BRL 12.47 (SD 5.21,1
"BRL 19,217.25",1
Fleximer Analogues,1
EBD,3
HIS-modified ISS,1
VMC mice,1
Flu+,5
NoV+,3
anti-PCP,8
phosphatidylethanolamine,5
macrolides used,1
cephalosporins 3rd,1
Asp-211,1
fungus arrived in,1
3-hydroxyphthalic anhydride (3HP)-modified bovine beta-lactoglobulin (3HP-Î²-LG),1
nuclearâcytoplasmic,1
1.022â1.312,1
TPEN,1
zinc chelation,2
Pediococcus,1
"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide)",1
exopolysaccharides,1
EPSs 15a,1
33a,1
Non-Academic,1
C (,1
bile and duodenal-mucosal fluid,1
N-Acetylglucosamine,1
PEG chain,1
t(1/2,1
broad-spectrum anti-HIV-1,1
GEM,14
28S rRNAs,1
broad-spectrum antiviral agents against hepatitis C virus,2
furosemide,6
2-nt,2
Diammonium Glycyrrhizinate,2
lithium chloride,14
diammonium glycyrrhizinate,3
CI 1.05â1.16,1
CI 1.07â1.17,1
CI 1.04â1.07,1
CI 1.02â1.07,1
evaluation/usage,1
hydrogen peroxides,1
thiobarbituric acid reactive substances,1
TBARS,5
catalase,2
IFN-Î³-SC,1
reactive 16mer-peptides,1
(169)VFQEL K(174,1
internus,1
intravenous zanamivir,1
Intravenous (IV) zanamivir,1
NS proteins in,1
NS target proteins,1
NS degradasome,1
NSD,2
PTFE,1
NDV/AAVV-1,1
sulfated polysaccharides,2
bromotyrosine derivatives,1
rBV,9
nitrogen atom of,1
(7),4
Na),1
10.1007/s12250-019-00138-9,1
condoms,2
phorbol 12-myristate 13-acetate,5
tetrazolium salt cell,1
diacetate,1
DB-PMA,1
37w GA,1
N31,1
10.1186/s12974-019-1569-2,1
NCT02605109,1
flowcytometery,1
Tranexamic acid,1
tranexamic acid,7
Griess,1
IM,3
ethyl acetate extraction section,1
480â120 mg/kg,1
high-performance liquid,4
pseudohypericin,1
hypericin,2
toluidine,1
199.1,1
7â30,1
Drug Administration-approved oral drug nitazoxanide (,1
NTZ,26
TG),1
acetyl-coA carboxylase,1
TG contents,1
sodium bicarbonate,10
Obatoclax,4
Emetine,1
Brequinar,1
Homoharringtonine Viruses,1
obatoclax,5
emetine against herpes simplex virus type 2,1
brequinar,1
Nanoparticle-based,3
broad-spectrum microbicides,2
TBS,1
non-TBS,1
OvidSP,1
enhancedby,1
10Â·2 (,1
SDPP samples,1
1Â·4,2
bloodâborne pathogens,2
2â²-5â² oligoadenylates,1
crossâborder IDTE,1
lipopolysaccharide (LPS)/adenosine triphosphate,1
NGI-1,2
"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-",1
MPTP-,1
dopamine,31
lithium dodecyl sulfate,1
Triton X-100 and,1
Nonidet P-40,5
serum-sodium,2
Povidone Iodine With,1
PVP-I-based antiseptics,1
PVP-I mouthwashes,1
gargles,1
3162,1
âsocial networksâ,1
Cmax,6
4605/5606,1
NiV-,1
inositol requiring enzyme 1,1
10.1007/s42770-019-00065-7,1
FCF,2
2.004 (1.240â3.238),1
nitric oxide-dependent pathway Rice stripe virus,1
NO biosynthesis inhibitors revealed,1
aflatoxin,11
lidocaine,1
flunixin,1
pantoprazole,1
4-PBA,3
rhoifolin,1
pectolinarin,1
Triton X-100 played,1
sonali,3
Fulbariya,1
aminoacyl-tRNA synthetases,4
conjugated flagellin,1
pre-partum,1
FBT,1
phosphate buffered saline,8
picropodophyllin,1
10.1007/s12250-019-00148-7,1
Hexanedioic acid,1
"2,6,10,14,18,22- Tetracosahexane",1
"2,6,10",1
aromatis,1
carboxylic acids) from,1
FT-IR,2
10.1186/s12889-019-7317-9,1
silver nitrate,3
nanoconfine,1
C-8,1
D viruses,2
O-acetyl,7
(5-methoxycarbonyl)isoxazolidine,1
"1,3-dipolar cycloaddition of nucleobase-derived nitrones",1
methyl acrylate.,1
adenine moieties,1
5-bromouracil,2
5-chlorouracil fragments,1
homonucleosides,2
ÂµM.,3
Erythromycin Estolate,1
Erythromycin estolate,1
Deltacoronaviruses,2
gossypol,14
digitonin,1
conessine,1
broad-spectrum inhibitors against ZIKV,1
testing/removal,1
141/6005,1
3GPO,1
2.6â29.6,1
3.4â35.1,1
antidiarrheal agents,1
wool,1
CI 1.41â12.52,1
CI 1.55â4.26,1
M2a,3
broad-spectrum antiviral restriction factors,2
C71,2
Fractional,1
FICO(2,1
carbon dots,1
citric acid pyrolysis are,1
N-acetylglucosamine (GlcNAc)/N-acetylmuramic acid,1
colloidal aggregates,1
CFU/piece,1
femtomolar,2
Fangchinoline,1
Cepharanthine,3
bis-benzylisoquinoline alkaloids tetrandrine,1
fangchinoline,1
cepharanthine,1
Glucocorticoid add-on,1
AZD8848,5
AZD8848 60,1
2015â2017,2
Multidose intramuscular allogeneic,1
multidose,2
IL-11/STAT3,1
rituximab,9
(UPLC-ESI-Q-TOF-MS)-based,1
polyunsaturated fatty acids,3
docosapentaenoic acid,1
EPA,2
p-nitroanilide,1
amastatin,6
Tocopheryl Polyethylene Glycol Succinate,1
TPGS,2
FNA,5
GIP),1
CMF,1
0.89â0.92,1
"vinyl chloride,",1
Cardiolipin,1
artesunate-amodiaquine,1
artemether-lumefantrine,1
lumefantrine,2
162/168,1
118/168,1
cetuximab,7
Cetuximab,1
bevacizumab,3
Lopinavir/ritonavir,7
NCT02845843.,1
pyridoxal phosphate,1
reactive lymphadenopathy,1
(BSL)-2,1
peroxidase-like,1
FVHH,1
I331F (IF,2
guanosine nucleotide,2
5'-triphosphate,1
eGP,1
eGP-PA-GEM,1
C polymerases,1
FPL,8
platinum,3
Metformin,3
concentration-dependently,3
LPV,27
RTV,10
"alpha-2,3-linked sialic acids",1
Acids from Complex Samples,1
echinocandin,2
voriconazole MICs,1
NSP9-TMP9 peptide,1
carbon keto-aldononulosonic acids,1
O-acetylation,4
N-acetyl neuraminic acid,1
sialic acid O-acetyltransferases,1
shR-N1071,1
MDL28170,3
aluminum hydroxide,16
10.17269/s41997-018-0059-0,1
SN,15
Lignans,1
bicyclol,1
Droplet-Transmitted,1
glucose-free,1
NHC,3
NHC at 10,1
disulphide bond rearrangement of peptides,1
JNK-specific,3
N-ethylmaleimide,4
SM proteins,1
antibody-expression,1
Cyclodextrins,5
1-619AA,1
1-619,3
Zirconia Nanoparticles,1
ZrO(2,1
NT particles,1
iridoid glycosides,2
CI 1.2â5.5,1
CI 1.6â5.7,1
FeverPAIN,1
corticosteroid was,2
ADPr binding,1
FEV(1)/FVC%,1
FEF(25%â75,1
2.3.4.4,1
sialic acid-containing gangliosides,2
small-mode,1
FOM,3
Artemisinin derivatives,1
aminoquinolines,2
Nitazoxanide Cocrystals,1
hydroxypropyl methylcellulose,1
HPMC,1
methylcellulose,1
pre-dissolved cellulosic polymer,1
NTZ when,1
crystal growth of,1
Phlorotannins,1
lovastatin,3
IRLIIVLMPILMA tridecapeptide,1
captopril,6
fucoxanthin,1
2â²-fluoro-2â²-deoxycytidine,1
NTP affinity,1
NTP),1
Lactic Acid,2
bile salt,1
"40,035",1
flaskâshaped invaginations,1
alopecia,3
nonmedicalâgrade liquid,1
CI 41.4â48.6,1
CI 2.3â4.2,1
I507 L in spike protein receptor binding domain (RBD),1
21.55,1
Q8H for 4,1
dextran leaked,1
FAâRP,3
antibiotic deâescalation,1
Cellâbased influenza,1
cellâbased vaccines,1
VIG,7
(+ 60;+,1
carbohydrate-directed,1
proteoglycan,3
2000â2016,1
C$341,1
CIHRâs,2
10.17269/s41997-019-00247-8),1
"23,646",2
1 fungus,1
pan-caspase,4
MPTP,6
Puerarin,2
isoflavonoid,1
thymine DNA,2
thymine residues,2
Countriesâ,2
digestive/septicemic,1
10.1007/s42770-019-00170-7,1
oxyhaemoglobin,1
10.1007/s00335-020-09827-3,1
heparin binding protein (,1
[Corrigendum],1
CKDs,1
Empagliflozin,1
empagliflozin,1
disulfide bond-containing,2
rapidly-propagating,2
diaminobenzidine,1
limit-of-detection,3
sphingosine,4
dipyridamole injection,2
FBG,1
Halved,1
Vascular Epiphytic,1
epipythes,1
cholesterol-lowering foods vs,1
viscous fibers (,1
almonds (14 g/1000 kcal) (portfolio),1
15.3Â±13.6,1
cholesterol-lowering foods reduced C-reactive protein,1
2019-nCoV/SARS-CoV-2,1
mercaptopurine,4
sirolimus,6
dactinomycin,3
CQDs,1
ethylenediamine/citric acid,1
boronic acid,5
4-aminophenylboronic acid,1
N(6)-methyladenosine analogues,1
adenosine derivatives,1
phosphoramidate prodrug 3a,1
Ginkgolic acid,1
Ginkgolic acids,1
alkylphenol constituents,1
nanogels,1
nanosuspensions,2
nanoemulsions,3
8-hydroxyguanosine,1
DH82Ond pi,3
DH82Ond pi cells,1
extemporaneously,2
nucleot(s)ide analogue-resistant HBV,1
pyrrolidinyl peptide nucleic acid (acpcPNA)-induced nanoparticle,1
acpcPNA,2
citrate anion-stabilized silver nanoparticles,1
Hydroxychloroquine,22
2020;25(9,1
chelating cytosolic calcium,1
1â40 Î¼g/mL,1
dipyrithione,1
AG490,3
inter-molecular,1
OxPL,3
by-products,7
oxygen radicals,2
FOXP3(+,1
5-HT,22
adipokines,2
CI 1.09â1.53,1
doi:10.1007/s00198-016-3824-z,1
intramolecular disulfide bonds,2
NTA,2
l-carnitine,3
carnitine,1
unabsorbed l-carnitine,1
trimethylamine,1
trimethylamine-N-oxide,2
N-nitrosodimethylamine,1
doi:10.1007/s00204-014-1341-4,1
glycyrrhetic acid,8
CI 1.0â4.8,1
lenalidomide,5
Len-Dex,1
low-dose dexamethasone (,1
RRMM,1
10.1007/s00277-018-3401-y,1
anakinra,1
Neues zur Pathophysiologie,1
hydroxyl radicals,2
trigger/capture,1
ESM,2
anti-Cag12,1
CS,6
hydrocortisone,18
0â0,1
CS 7,1
polyethylene glycol monomethyl ether (PEG)-5000,1
doi:10.1007/s00253-013-4775-3,1
doi:10.1007/s00253-015-6664-4,1
doi:10.1007/s00134-010-1759-y,1
antigen-induced,1
doi:10.1007/s00109-010-0711-5,1
JanuaryâMarch 2011,1
Multipurpose,1
broad-spectrum multifunctional,1
acetylsalicylic acid,2
Lactobacillus gasseri CMUL57,1
acrylamide,4
doi:10.1007/s00253-013-5123-3,1
nucleic acids Nucleic acid,1
BacLight,1
DEAE Sepharose FF,1
doi:10.1007/s00253-011-3864-4,1
organism(s,1
10.1007/s00134-019-05906-5,1
tea tree,1
NC8-pSIP409-pgsA-S-DCpep,2
carbohydrates instead of simple sugars,1
3-hydroxyphthalic anhydride.,1
esterified beta-lactoglobulin,1
esterified lactoferrindisplayed anti-avian influenza A (H5N1),1
intragastric administration,2
PEDV-neutralizing,1
MDP,14
doi:10.1007/s00134-015-4206-2,1
doi:10.1007/s00134-016-4324-5,1
Bleomycin (BLM)-induced lung,1
intratracheal BLM (1.5U/kg),1
N-glycan fingerprint,1
ECMO network,2
doi:10.1007/s00134-011-2301-6,1
R-CHOP,12
adriamycin,1
doi:10.1007/s00277-012-1592-1,1
probable=37,1
thanatomicrobiome,1
broad-spectrum antiviral molecule for,1
POPG,1
POPC,2
tetramethylene disulfotetramine (tetramine),1
tetramine (tetramethylene disulfotetramine) is responsible for a great percentage of death and,1
Tetramine,1
tetramine poisoning,1
doi:10.1007/s00134-015-3719-z,1
DOB,2
"reactive moieties (e.g.,",1
corticosteroid treatment PURPOSE,1
corticosteroid treatment in ALI-ARDS,1
corticosteroid treatment in,2
corticosteroid treatment were,1
doi:10.1007/s00253-015-6786-8),1
methyl-beta-cyclodextrin,3
phenylalanine 109,1
"worldwide(1,2",1
diseases(6,1
[âsmokingâ OR âtobaccoâ OR ârisk factorsâ,1
Sulfated pentagalloylglucoside,1
UL36(480,1
7.25-7.35,1
CPAP,1
BiPAP modes,1
lipid-,3
Acm based solubilizing tag,1
Acm,2
"single-stranded RNA(1,2",1
ruxolitinib,4
10.1007/s10875-019-00645,1
Cyclophosphamide,5
Na transport,1
Methylprednisolone,6
glucose-facilitated Na absorption,1
Na flux,2
remyelinated,2
Ã,2
carbonate buffer,1
Fatty acid,2
palmitic acid,1
anti-microtubule,1
pontine nuclei,1
doi:10.1007/s00705-011-1056-2,1
HMA,3
"DIDS [4,4â²-disothiocyano-2,2â²-stilbenedisulphonic acid]",1
DIDS,5
gS,1
lithium chloride could,1
RBCV,5
5-amino acid,2
"28,053 nucleotides",1
doi:10.1007/s00705-017-3441-y,1
b-MAbs,2
Âµg/ml,1
doi:10.1007/s00705-011-1061-5,1
10.1007/s00705-019-04329-3,1
doi:10.1007/s00705-010-0729-6,1
4765â4782,1
nucleotides 168 to 197),1
doi:10.1007/s00705-015-2670-1,1
SQ2014,2
doi:10.1007/s00705-015-2556-2,1
Sepharose 4B,3
polyacrylamide,10
doi:10.1007/s00705-011-1110-0,1
doi:10.1007/s00705-015-2565-1,1
cytosine arabinoside,3
doi:10.1007/s00705-015-2353-y,1
10.1007/s00705-019-04186-0),1
doi:10.1007/s00705-016-2866-z,1
FeAstV,3
10.1007/s00705-019-04394-8),1
Losartan,6
enalapril,4
10.1007/s00705-019-04296-9,1
silver-methenamine,1
phosphotungstic acid,3
intraduodenal,1
doi:10.1007/s00705-015-2506-z,1
electron-microscopy,3
doi:10.1007/s00705-016-2985-6,1
doi:10.1007/s00705-013-1809-1,1
doi:10.1007/s00705-017-3570-3,1
N-acetylgalactosamine,5
Con A.,4
O-glycosidically,3
N-glycosidic carbohydrate-peptide linkages,1
doi:10.1007/s00705-014-2150-z,1
Interferon gamma inhibits transmissible gastroenteritis virus,1
doi:10.1007/s00705-013-1738-z,1
doi:10.1007/s00705-016-3088-0,1
doi:10.1007/s00705-010-0636-x,1
g/ml,21
1.24â1.26 g/ml,1
NA gene of,1
N-methyl-arginine,1
hydroxyarginine,1
colloidal gold-mediated immunoelectron,1
methylamine,3
10.1007/s00705-019-04298-7,1
DY12-2-like,1
intranasal routes of,1
10.1007/s00705-019-04230-z,1
1.5Âµg/ml,2
1.144,1
diethylaminoethyl-dextran,3
DEAE-D,5
cytocidal,9
2-deoxy-D-glucose,2
NS 1 protein,1
1.201 g/cm(3,1
PAS,2
potassium periodate,4
2-mercaptoethanol,8
ethylether,1
Tween-80,1
sodium deoxycholate,6
trichlorotrifluoroethane,1
Ã g,1
2-deoxyglucose,2
p-nitrophenylacetate,1
NP40,1
[(35)S]methionine,2
[(3)H]glucosamine,1
sodium monensin,1
10.1007/s00705-018-4037-x,1
doi:10.1007/s00705-017-3331-3,1
25â738,1
3â²UTR nucleotide,1
isobavachalcone (IBC),1
doi:10.1007/s00705-015-2614-9,1
675-nucleotide,1
224-aa-long peptide,1
SQE,6
doi:10.1007/s00705-015-2469-0,1
G100,2
"28,023 nucleotides",1
10.1007/s00705-019-04360-4,1
poylpeptide,1
7-,2
S1(N)-SCZJ3,3
doi:10.1007/s00705-017-3280-x,1
doi:10.1007/s00705-016-2983-8),1
24/174],1
[16â87],1
[36/56] vs.,1
[45/160],1
[11/24] vs.,1
[18/150],1
doi:10.1007/s00705-016-3062-x,1
NB-like strains,2
PG 78,1
chemiluminescence,2
doi:10.1007/s00430-014-0361-2,1
doi:10.1007/s00705-017-3550-7,1
reactive primer pair (,1
germacrone,4
unbound peptide,1
Beta-cyclodextrin derivatives,1
cyclodextrin derivatives,1
doi:10.1007/s00705-017-3245-0,1
CH-S,1
10(3) TCID(50,1
20â40 Âµg,1
dogâs,1
carboxymethyl cellulose,2
doi:10.1007/s00705-013-1741-4,1
Ly294002,6
405-nucleotide,1
10.1007/s00705-018-4034-0),1
10.1007/s00705-018-3967-7,1
short-wave ultraviolet light,1
U.V.,3
acid pH. Some,1
ether-,1
doi:10.1007/s00705-010-0722-0,1
10.1007/s00705-018-4020-6,1
HaeIII,1
K203-02,3
doi:10.1007/s00705-009-0323-y,1
end-tidal carbon dioxide,2
13â20,1
ascorbate,17
sodium desoxycholate,1
doi:10.1007/s00705-016-3208-x,1
tritiated uridine was,1
chlorpheniramine,1
procaine,1
polykaryoctye,1
10.1007/s00705-019-04226-9,1
ethyl-isopropyl amiloride,1
filipin III,3
genistein,12
ML-7,3
trichloroacetic acid,1
sodium dodecyl sulfate-polyacrylamide,27
L748,1
doi:10.1007/s00705-012-1500-y,1
doi:10.1007/s00705-010-0595-2,1
10.1007/s00705-018-3758-1,1
Lucifer yellow,1
"potassium cyanide,",1
DEAE-dextran,5
D/ml,1
1.18â1.20 g/cm(3,1
1.25â1.31 g/cm(3,1
10.1007/s00705-019-04384-w,1
10.1007/s00705-017-3700-y,1
nucleoside triphosphate hydrolase,1
10.1007/s00705-019-04488-3,1
NO-generating compounds,1
l-arginine,5
N-nitro-l-arginine methyl ester,1
l-NAME,1
NO inhibits,2
doi:10.1007/s00705-014-2080-9,1
doi:10.1007/s00705-015-2522-z,1
p.o,9
10.1007/s00705-018-3972-x,1
nitric oxide-mediated antiviral responses Toll-like receptors,1
doi:10.1007/s00705-016-3030-5,1
doi:10.1007/s00705-013-1901-6,1
SC.,1
N-acetylglucosamine Î²1-2 mannose,1
26â28 kilodaltons,1
sulphydryl reagent,1
kaolin,5
anti-IgG serum,1
1m magnesium chloride,1
magnesium sulphate,1
NANBH,2
393â414 nucleotide,1
Sp1âSp6,1
propidium iodide (,1
antilymphocyte serum,2
doi:10.1007/s00705-010-0848-0),1
10.1007/s00705-019-04433-4,1
N-glycosidic bonds,1
nucleotides 227,1
10.1007/s00705-019-04396-6,1
PI3K-specific,1
doi:10.1007/s00705-017-3367-4,1
[(125)I] labeled material from Pseudomonas aeruginosa,1
Triton X-114 detergent-rich,1
detergent-poor,1
xylometazoline,3
t(max,1
nicotine nasal spray,1
nicotine patch,1
[58],2
cesium chloride density gradient centrifugation,2
LAS,3
T-2 mycotoxin,4
post-excretion,1
[(3)H]-RX821002 radioligand binding.,1
Î±(2A)-,1
guanoxabenz,10
Gpp(NH)p,1
O-acetylated acids,1
gallocatechin gallate,2
doi:10.1007/s10529-011-0845-8),1
[126/154 (82 %,1
Flying-Fox,1
Nanoparticles Conjugated with,1
enteral feedings,2
ACE-inhibitors,6
apelins,1
corticosteroids in acute pharyngitis,1
MOL736,2
xanthines,1
non-xanthine type A(2A,1
[69/266 (,1
[38/69 (,1
GeRPs,2
Ruthenium Red,1
CTB,24
Alexa 488-,1
594-conjugated CTB,1
Lysotracker,1
formol-ether,1
IIaA22G1R1,1
doi:10.1007/s10529-011-0795-1,1
phenylalanyl-tRNA,1
doi:10.1007/s10753-014-9840-2,1
doi:10.1007/s10529-015-1973-3,1
272/445,1
U/ml,3
e-seminars,4
FebruaryâMay,2
JuneâOctober 2014,1
long-read,1
energy-transfer,1
FÃ¶rster,1
NIC inhibited pepsin,1
NIC bound to pepsin mainly through,1
NIC could induce changes in pepsin structure,1
1 chimpanzee-borne,1
Hoechst 33342,2
21.6â25.7 CFU/hour/plate,1
NSC122819,2
ketone,5
facility-associated,2
1.3â7.1,1
âdays,1
thiamine pyrophosphatase,1
(15)N resonance assignments,2
thalidomide,5
doi:10.1007/s00894-011-1092-6,1
MDL,9
NSC97317,2
Trimethylaurintricarboxylic acid,1
FIA,9
Drug Administration (FDA)-cleared multiplexed polymerase chain,1
21S,1
C(2677,1
FLAP,1
intrathecal,1
taurine,7
creatine,7
carnosine,11
anserine,10
Taurine,1
imino acid,1
plant-source,1
animal-source foods,1
DA rats,7
DA substrains,2
Red Crescent Movement (ICRC),1
Low-dose Interferon-Î±,1
low-dose IFN-Î±,1
Î±-galactosylceramide,2
Food Protein,1
N-hydroxysuccinimide (NHS)-activated,1
Sepharose,1
v/v,18
doi:10.1007/s10529-017-2330-5,1
N-acetylneuraminic acids,2
acyl substituents,1
Neu5Ac9Lt,1
"1,7-lactone",1
"Neu5Ac1,7L",1
neuraminic acid,3
CMP-sialic acid,3
sialylated glycans,1
aldosterone,2
methyl ester Falcipain-2 (,1
"1,4-benzodiazepine",1
doi:10.1007/s10495-015-1172-7,1
427/773,1
114/401,1
meconium,2
meconium + a protease inhibitor cocktail,1
Meconium,1
FPG,2
gallium 67,1
O-Acetylation,1
DL-Dithiothreitol,1
TrisâHCl,1
isopropyl Î²-D-l-thiogalactopyranoside,1
9-carbon negatively-charged monosaccharides commonly,1
glucocorticoids,16
Alcian blue-PAS,1
capsaicin,30
Monastral blue pigment,3
Monastral blue-labeled venules,1
http://dx.doi.org/10.1007/s00894-004-0210-0,1
2 isolates,1
[1.085â1.712]),1
adenines,8
Leu-Lys-Lys-Leu,1
Leu-Arg-Lys-Leu,1
Flavonol Kaempferol Staphylococcus aureus,1
vanadate-sensitive,1
phosphate,7
Î¼M kaempferol,1
flavonols kaempferol,1
staurosporine-induced,2
ferrocyanide/ferricyanide,1
KAA,2
lectin(s,2
CI 1.22â7.76,1
epinephrine,8
catecholamines,4
lactic acid bacteria-based,1
Î±2-6-,1
adenine,12
ÂµM. Myricetin,1
doi:10.1007/s10529-016-2261-6,1
scholarsâfor,1
pegaptanib,1
Anti-protease,1
"L, rhodesain",1
doi:10.1007/s10126-010-9349,1
terpenol,1
terpenyl glucosides in,1
10.1007/s10295-019-02184-4,1
showntwo,1
aniline naphthalene sulfonicacid,1
toreflect,1
eremomycin,2
teicoplanin aglycon,1
doi:10.1007/s10529-010-0370-1,1
hematological/biochemical variables,1
Stepwise logistic regression,1
Ã 10(9)/l,1
sialic acid-rich mucus layer,1
doi:10.1007/s10528-010-9365-9,1
sulfopropyl sepharose,1
SP-sepharose,1
unadsorbed,1
nocarriers,1
other(s,2
ibuprofen,8
1W36 PDB structures,1
phosphonic acid moieties at distal ends,1
9-O-acetyl-N-acetylneuraminic acid,2
betulonic acid ketoxime,1
diborane,1
doi:10.1007/s11262-009-0393-7,1
Apocynin,1
apocynin,7
E2 K252Q,1
doi:10.1007/s11262-009-0411-9,1
E proteins,4
doi:10.1007/s11262-016-1365-3,1
corticosteroid therapy in the,1
G nucleotide,1
Br1/87,11
taupapillomavirus,1
taupapillomavirues,1
Mab-7A,2
PG) E2,2
potatoes,1
CDR loops,3
doi:10.1007/s11095-010-0143-5,1
PNS-,1
302I,1
oligopeptide,4
doi:10.1007/s11033-012-1708-7,1
lipopolyamines,1
lipoplexes,5
polyplexes,3
non-ferrous metals),1
11/281 samples,1
malononitrile,1
S-alkylisothiouronium salts,1
(232)LGL(234,1
disease-suspected flock,1
"2,3,7,8-Tetrachlorodibenzo-p-dioxin",2
"1.16,P=0.004",1
40/222,1
100th,1
"groundglass opacities, nodules, reticulation)",1
10.1007/s11373-006-9127-1,1
CTxB,4
115â149,1
10.1007/s11427-011-4165-y,1
doi:10.1007/s11262-009-0341-6,1
arsenic trioxide,2
ATO,8
AMN107,3
doi:10.1007/s11262-013-0926-y,1
doi:10.1007/s11373-008-9235-1,1
EGTA,4
solutes drain from,1
doi:10.1007/s11262-015-1257-y,1
L protein is,1
L protein are,1
226aa-long peptide,1
doi:10.1007/s11262-015-1183-z,1
doi:10.1007/s11262-011-0574-z,1
HPD 1950â1973,1
noradrenaline,10
[(3)H]noradrenaline (,1
[(3)H]NA,2
[(3)H] NA,1
manganese or,1
Na(+)-free,1
Na(+)-dependent,3
ammonia using,1
Ammonia,2
ammonia using isobaric tag,1
10.1007/s11427-016-0202-8,1
THA001,1
Nasal Administration PURPOSE: Antigens were,1
free radical polymerization,1
tetracycline/doxycycline,1
doi:10.1007/s11262-013-0886-2,1
orf9b,1
intranasal steroids,2
topical steroids remain,1
Brefeldin-A,1
E coding region,1
broad-spectrum antiviral nitazoxanide,1
FHF,2
OK,1
NT antibody,3
10.1007/s11033-019-05230-7,1
doi:10.1007/s11262-017-1440-4,1
Acridine Orange,1
beverages,1
Ascorbic acid,1
SITS,3
dibutyryl cyclic AMP for,1
organic anions including,1
acetate,7
formate,2
malonate,1
oxalate,5
p-aminohippurate,1
pyruvate,1
succinate,1
Ascorbate,2
20â31,2
gluconate,1
"4-acetamido-4â²-isothiocyanostilbene-2,2â²-disulfonic acid",1
lactacystin,5
Brl/87,1
sodium-dependent ascorbate,1
Na(+)-dependence,1
Na(+)-ascorbate cotransport,2
ionophores gramicidin and,1
valinomycin,15
dibutyryl cyclic AMP,2
T3I,1
fungus Aspergillus,1
lipid-linked,1
83.9â97.9,1
doi:10.1007/s11262-013-0899-x,1
"27,695 nucleotides",1
proteinâligand,5
oxidant radical scavengers,1
endotoxin shock,3
high-dose corticosteroid therapy is generally,1
10.1007/s11033-018-4498-8),1
Lactobacillus plantarum Probio-38,1
itraconazole,2
inter-assay,1
single-stranded oligonucleotides,1
steam-jet aerosol collector (SJAC,1
tannic acid equivalents/g,1
DPPH radical,2
HaeIII restriction,1
NXS (Xâ P,1
doi:10.1007/s11262-011-0593-9,1
stilbene,2
stilbene intermediates used in,1
doi:10.1007/s11262-010-0512-5,1
metal chelated chromatography,1
notD-isoascorbate,1
2-deoxy-D-[(3)H(G)]glucose,1
N-acetylpenicillamine,2
N-acetylpenicillamine (,1
sulfhydryl-reducing,1
PER161,1
nalidixic acid,5
trimethoprim-sulfamethoxazole,4
Tetracycline,1
doi:10.1007/s11250-016-1152-0,1
L and W to block viral protein,1
intravenous methylprednisolone,2
[t(X;15)(p11;q11)] localized,1
doi:10.1007/s11262-017-1515-2,1
estradiol-17Î²,1
5â² part,3
doi:10.1007/s11262-013-1013-0,1
"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tet-razolium bromide",1
emodin couldnât,1
doi:10.1007/s11373-008-9278-3,1
ester-,1
amide-,1
ester-bearing linkers boosts their,1
PEIs,1
10.1007/s11427-014-4782-3,1
doi:10.1007/s11262-011-0668-7,1
CI 4.6â81.1,1
Beta-amyrin 11-oxidase,1
CYP88D6,2
beta-amyrin,1
Selenium Deficiency Influences Evolution of,1
Se),1
polyethylene glycol 6000 (PEG),1
PEG instead of 10,1
aloesaponarin I,1
chrysophanol,11
aloe-emodin,12
dihydroisocoumarin,1
homoplantaginin,1
isoorientin,1
luteolin 7-glucuronopyranoside,1
isovitexin,1
phenolic acid,1
p-coumaric acid,3
anthrone,1
aloenin,1
F41(+,1
10.1007/s12250-016-3742-4,1
26/2380,1
10.1007/s12250-015-3703-3,1
Lactic Acid Bacteria Live recombinant bacteria represent attractive antigen,1
food-grade lactic acid bacteria,1
LAB vaccines,2
1-28,1
cimiside E,3
Cimiside E,1
depolarization-induced,1
10.1007/s12250-016-3727-3,1
nsp3(513â651,1
alkaloids extract,3
Acyclovir,4
acetylenes,2
lactic acid bacterium (LAB),1
BGMF,3
7-adjusted BGMF,1
BCS,5
Sephadex G-25,1
l-Lactic Acid,1
lactic acid bacteria (LAB),8
micrococcaceae],1
l-lactic acid,1
curvatus,1
parapharyngeal/retropharyngeal,1
10.1007/s12250-016-3713-9,1
[1.0-7.0] vs 5.0 [2.0-8.0];,1
[0-6.0] vs 4.0 [1.0-7.0];,1
[1.0-8.0];,1
[6.0-28.0] in,1
[4.0-26.0] outside,1
dextran sulfate sodium,2
portosystemic shunts,1
Zinc Sulfate,1
doi:10.1007/s12033-012-9598-4,1
"1,3-diketoacid",1
aromatic substituents,1
aromatic substituent fine-tuned the,1
doi:10.1007/s12035-013-8456-0),1
sodium pentaborate pentahydrate,3
triclosan solution-treated textiles,1
monobasic,4
Quinine,2
10(2.8,2
kainic acid (KA)-lesioned hippocampus,1
KA-induced,1
wool filter,1
SIV-H1N1p-negative,1
doxcycline,1
DNP,6
[41/743,1
13â24,1
GJs,5
Cx protein,1
K+ buffering,1
bi-mode,1
colorless,3
"2â24,",1
antiparasitidal,1
reactive oxygen intermediate,1
pentachlorophenol,1
reactive oxygen and,4
nitrogen species,3
eritoran,2
EM-163,1
6-shogaol,1
tetrodotoxin,2
guanine nucleotide exchange factor 1,1
intranasal co-administration of,1
Ped,3
acidilactici 72N,1
plantarum 25F,1
doi:10.1007/s12672-013-0151-0),1
Methanol extract,2
aloe emodin,4
physcion,4
virucidal IC(50,1
water extract,1
anti-viral/anti-influenza agents,1
ribose 2â²-Oposition,1
10.1007/s12250-015-3653-9,1
creatnine,1
1.50Ã,1
intranasal administration,1
Thursday 27th,1
carbon dioxide euthanasia in 24 ferrets,1
buprenorphine analgesia,1
quinoxaline,2
CypA.,2
doi:10.1038/cr.2008.294,1
GDPs,1
juglone,6
"5-hydroxy-1,4-naphthoquinone",1
HpCGS],1
malonyl-CoA,2
HpCGS,4
HpFabD,3
crotonoyl-CoA,2
Juglone,1
O-succinyl-L-homoserine,1
Î±K(i)=7.4 Î¼mol/L,1
0â¼60,1
biomethodologies,1
LY),1
LY,2
ammonium sulphate,5
PKC-specific,1
maleimide methanesulfonate salt,1
phorbol ester-dependent PKCÎ±,1
busulfanâcyclophosphamide,1
sphingolipid-rich lipid raft microdomains,1
EDANS,1
doi:10.1038/gt.2016.55,1
trastuzumab,3
extended-release buprenorphine,3
25(OH)D],3
vitamin D supplements,1
goldâthiol,1
G-gap dipeptide composition,1
Geldanamycin,4
geldanamycin,10
enteral feeding type,1
beta-agonists,2
mycophenolate,3
VV-ECMO,1
post-ECMO,1
doi:10.1007/s00134-013-3037-2,1
BMS-790052,2
100-mg,1
"groups(1,2",1
nitric oxide synthase type 2,1
cyclohexamide,1
ORN layers,1
broad-spectrum nucleoside,1
reactive school closure could reduce,1
doi:10.1038/nature04795,1
"mortality(1,2",1
doi:10.1038/nature12005,1
10(â11)M.,1
doi:10.1038/nm.2514,1
filipin,4
high-performance liquid chromatographyâmass,1
FW,3
L(*),1
DCSIGN1-336,1
doi:10.1038/nri3694,1
10.1007/s13258-018-0686-0),1
membranous nephropathy,1
dendrimer-like,1
broad-spectrum virus-targeting drugs are,1
eicosanoids,2
phosphatidylserine â,1
doi:10.1038/nrd2973,1
micelles,9
SNEDDS,1
SMEDDS,1
"1â1,000",1
nanotubules,1
doi:10.1038/nri3488,1
âOn,1
macroD2,1
BioPharma (DOR),1
double-stranded nucleic acids,1
5-N-acetyl neuraminic acid,1
Pathogenâendoplasmic-reticulum,1
Tamiflu,6
triple-base,1
swim-related,1
transaminase,3
lipid envelope-rupturing antiviral agents,1
Its Intermediate,1
inhaled steroid,1
ACE2-Ang-(1â7)-MAS,2
dextromethorphan,3
erlÃ¤uterte,1
non-fibrous crystalline,1
doi:10.1038/mi.2008.16,1
Tilorone,4
tilorone dihydrochloride,1
ICP6-negative HSVs,1
corticosteroid therapy in patients with,1
corticosteroid causes ONFH,1
corticosteroid treatment after,1
corticosteroid treatment boosted,1
doi:10.1038/mi.2008.79,1
Polymers,3
Fluoroquinolones,3
moxifloxacin,12
gatifloxacin,5
gemifloxacin,2
concentration-time,1
Antimicrobials (,1
broad-spectrum antibacterials,2
FAAIR,1
ethacridin,1
CI [1.8â7.7],1
1 Ã 10(4,2
galactomannan (,1
intravenous corticosteroids,1
Honorar jetzt extrabudgetÃ¤r,1
Salt Lake,9
pressors,1
conjugate vaccines,3
pyrazoline derivatives,3
pyrazolines,2
Pyrazoline derivatives,1
steroidal,1
protein-selection,1
nonpeptidic inhibitors of 3CLpro,1
nelfinavir,22
gallic acid equivalent/g],1
[1.17 mg/ml,1
"2,2-azino-bis (3-ethylbenzothiazo-line-6-sulfonic acid",1
diammonium salt].,1
aliphatic alcohols and,1
sulfur compounds,1
Î¼.,1
chloroform labile,1
7 d PI,1
"2,3-oxidosqualene",3
brassinolides,1
solanine,1
triterpenoid aglycones,1
PEMS,1
AME,1
3 d,1
Arbocel RC,1
1364.8g,1
1342.9g,1
1678.1g,1
1630.5g,1
1617.1g,1
1580.4g,1
BW after 12,1
1919.4 g,1
1902.1 g,1
âConformer Librariesâ,1
Y27632,1
20 d postinoculation,1
viscosities,1
tea saponins,2
att-IB2 vaccines,1
urate,3
Conjugated linoleic acids,1
conjugated linoleic acids,1
CLA,17
cyclosporin A. Peripheral blood T lymphocytes,1
c9,2
t11-CLA,2
c12-CLA,2
CLA isomers,2
2.17â42.90],1
H5N1/H5N8/H9N2,1
GSLS,3
Furans,1
Non-ortho PCBs,1
dioxin,6
furans,2
polychlorinated biphenyls,1
PCBs,4
"1,2,3,7,8-pentachlorodibenzo-p-dioxin",1
PeCDD,1
TCDF,1
"1,2,3,7,8-pentachlorodibenzofuran (1-PeCDF)",1
"2,3,4,7,8-pentachlorodibenzofuran (4-PeCDF)",1
octachlorodibenzofuran,1
OCDF,1
PCB77,1
PCB126,1
PCB169,1
EROD,1
TEQ,2
Î¼g TCDD/kg,1
TEFs,1
dioxin-like PHAHs,1
conjugated pneumococcal polysaccharide vaccine,1
.00073,1
Polychlorinated Biphenyls (PCB 101,1
NDL-PCBs 101,1
lipopolysaccharide (LPS)-activated,1
NDL-PCB 153 or 180,1
NDL-PCBs mixtures,1
NDL-PCBs,1
1.49â33.05,1
[23 each,1
[4 (2.1%)] and,1
[2.8 (1.7%,1
L-theanine,5
"D, basal diet + 300",1
Inhaled Adrenaline Background,1
adrenaline,8
NCT00817466,1
Lopinavir/Ritonavir,8
MMF],1
interferon-Î²1b,2
MMF,5
[aHR] 2.78,1
HKU25-receptor binding domain (RBD),1
Deoxyribonucleic Acid,1
[GP],1
deoxyribonucleic acid,7
3.9â18.5],1
2.0â4.1],1
Conjugated Linoleic Acid Conjugated linoleic acid,1
fatty beef,1
esterified LA,1
L-,4
D-Lactate,1
D-lactate,3
L-lactate,2
hydrogen peroxide/peracetic acid,1
FR,1
spray-dried,2
79.8%â98.4,1
1.4â18.2],1
1.02â1.51],1
1.69â327.96],1
"442,973 air",1
N88D,1
2âamino acid,1
[IC 95],5
[1.1â5.9],1
[5.4â332]),1
2.1â63.5],1
2011â15,1
lariciresinol,9
methyl jamonate (0.5 Î¼M,1
no-IA,1
mould-active agents,2
1.7â131.3,1
sodium hypochlorite,17
[38]),1
[29]),1
[40,1
zinc chloride,4
sarin simulant,1
Moxifloxacin,1
high-dose amoxicillin-clavulanate (4 g,1
1.27â24.92,1
quimioprofilaxis con,1
Be Hazardous,1
echinacea,6
nonspreaders,1
7.5%â14.7,1
0.36â0.62,1
249â273,1
117/694],1
[31/694]) viruses,1
6/270],1
[1/270]),1
.7â1.1,1
[OR] 19.16,1
PeV,4
N371-404,1
oxygen-free,1
TACs,2
106/144 [,1
NHGPs,1
CI 0.61â0.66,1
RNA/DNA pathogens,1
0.912â0.974,1
viral-shedding,1
phorbol esters,1
trifluoperazine,1
calmidazolium,2
trifluoperazine (25 Î¼mol/liter,1
phorbol ester-induced,2
Lactobacillus casei ATCC334,1
cationic amphiphiles,1
group/s,1
Oligosaccharide structures,1
Cageside,1
HMA piglets,1
charge-neutral PMO,1
2â²-O-methyl phosphorothioate,1
24â72,2
Long-recognized agents,1
peroxidation,1
lipid peroxides,2
drugâtargetâpathway,1
BFA Brefeldin A,1
D-[6-(3)H]glucosamine,1
T(freg,1
5.00,2
technology/media,1
carotenoid,1
semi-synthetic derivatives of glycopeptide antibiotics,2
semi-synthetic derivatives,1
teicoplanin aglycone,2
teicoplanin aglycone derivatives,1
Semi-synthetic derivatives of,1
Methacrylic Acid,1
methacrylic acid,2
2008â2009 formulations,1
P10882,5
fluorescein-labelled PPMOs,1
1 parasite in 180 ÂµL,1
chIFN-Î³,3
ICSs,6
2.37â52.81],1
5.0â24.12],1
2 F4 receptor-negative,1
maltodextrins,2
NCT01254110.,1
aurintricarboxylic acid preparations,1
Paromomycin,2
paromomycin,7
Teicoplanin,4
DEAE-Sephadex column,1
cesium chloride gradient,1
PAP-Fn,10
monensin/d,1
prepartum,1
Zn,1
âopen,1
L:S),1
PPMO,11
1.06â11.91],1
FXR1P/BTF,1
DEAE-Sephacel,2
testosterone propionate,1
12.33 days(2,1
2-nonanone,1
linalool,3
LP-A,2
counter-exchange,1
ATP/ADP,1
14-virus,1
Drug Administrationâcleared,2
Phosphostim,1
Zoledronate,1
adherent-junction,1
1â5 foci/transverse,1
isopropyl hand rub,1
Nonsteroidal anti-inflammatory drug,1
meloxicam,4
MEL,1
DMBA,6
diphenylene iodonium inhibited,1
rotenone,1
reactive oxygen moiety,1
mevalonate-induced,1
fluorescein isothiocyanate labeled-Dextran and-LPS,1
Ileum inflammatory markers,1
SDBP,10
ME,6
ADFI,2
viramidine,10
adenosine-deaminase-catalysed,1
nucleoside prodrug design nan,1
Mannan oligosaccharide,1
Amotosalen,1
3 J/cm(2,1
Dil,1
Pyridine N-oxide derivatives,1
pyridine N-oxide derivatives,4
pyridine moiety,1
pyridine N-oxide derivatives varied depending the,1
pyridine N-oxide derivatives against,2
cypermethrin,4
chlorpyrifos,2
nucleic acid stains,1
methylene blue/azure II/basic fuchsin trichromeâstained,1
Fosfomycin,4
fosfomycin,2
sodium dodecylsulfate-polyacrylamide,1
Xanthine Oxidase,1
Febuxostat,1
febuxostat,1
XO,1
reuteri DSM 20016(T,1
2-hydroxyethyl disulfide,1
thiol-specific,1
CheZ,1
citrate/phosphate,1
low-pH buffers have antiviral,1
aurintricarboxylic acid OBJECTIVES,1
[OR] = 3.37),1
5.8S rRNA,1
IPP,1
18.7Â±10.4,1
SNALPs,4
L geneâspecific,1
PEI polyplexes,1
NS;,1
NS cows,5
precalving BCS,1
NS (P =,1
NS-WR cows,1
propanol,2
propyl acetate),1
vanillin,2
propionic acid,1
propyl acetate,1
canthaxanthin ( P =,1
lutein,1
Ni(2+)-NTA,1
Antihistamines,2
loratadine,1
E or N protein,1
[0.10â0.90],1
dronedarone,5
verapamil,18
47/54,1
575/766,1
Ampligen,1
LO,7
Dicarboxylate Cotransporter-3,1
NaDC,1
dihydrorhodamine 123,1
nitrogen oxide species,1
food-grade,2
enzyme-resistant,1
BW (,1
absorbed N increased linearly (P <,1
lysostaphin,3
LT(B,2
lignocellulose,4
soluble/insoluble fiber (Diet MF,1
IF pullets,1
CI 1.856â13.581,1
phospholipid membranes,2
water run-offs,1
supranutritional,1
Se is,1
Se supplementation,2
Se-containing fertilizer amendments,1
Se biofortification,1
sodium selenate,2
Selenium,6
Se-biofortified alfalfa hay,3
Se treatment of,1
Se and,1
IC50s,4
IFR,5
Nanoparticles [Image,1
"SC,",2
reversed-phase,5
mixed-mode,1
interaction/cation-exchange,1
zwitterionic lysophospholipid Sphingosine 1-Phosphate,1
Sialic Acid Receptors,1
sialic acid-containing soluble proteins,1
sialic acid-specific O-acetyltransferases,1
sialic acid-specific O-acetyltransferase,1
co-incorporated,1
2â²-deoxy-2â²-fluoro (2â²-F,1
3â²-proximal,5
5-hydroxytryptamine,1
acetylcholine,1
L-DOPA,3
DOPAC/DA,1
panitumumab,1
Vanadium,4
vanadium,14
vanadate,8
vanadium is non-toxic,1
vanadium resorbed,1
Vanadium compounds,2
vanadium species,1
vanadyl,1
oligovanadates,1
decavanadate,1
phosphate accounts,1
vanadium compounds,8
vanadiumâs,1
vanadium complex,1
BEOV,1
Chagasâ,1
2015/2016 Influenza Season,1
sinapinic acid,1
carbohydrate-containing macromolecules,2
"28â32,000 nucleotides",1
symbiose,1
animalbased,1
DX600,3
-glucose,1
antipyretics,2
Electron Cryomicroscopy of Coronavirus Particles,1
N-acetylglucosamine (,1
GlcNAc,2
N-acetylmuramic acid,1
Concanavilin A-induced aseptic inflammatory reactions,1
ReninâAngiotensinâAldosterone,1
Cyclosporine A.,1
âtissue culture infectious doseâ (,1
Fio(2,1
colloidal nanoparticle,1
Sialic acid,4
colloidal gold nanoparticle aggregation,1
Chromosome-Based Lambda Red,1
structureâfunction,3
ADP ribose 1â²-phosphatase,1
polysome,4
deoxynucleotides,2
Polyoxometalates,2
[NH(3)Pr(i)](6)[Mo(7)O(24)]â3H(2)O (PM-8),1
PM-523,3
SiMo(12,1
HDL particles,1
bile acids,9
LDL cholesterol,1
Rib,1
NS) RNA,1
L (ca 7.3,1
L polymerase),1
deaminoneuraminic acid,1
Kdn,1
SiaS,1
diSia/oligoSia/polySia,1
applicons,1
dentritotrophic,1
drug-like,3
Electron Cryomicroscopy,2
non-lipid receptors,1
Nickel Alloy,1
26â44,1
COVID-19,56
QD,3
Inorganic CdSe/ZnS QDs,2
colloidal complexes,2
Act of 1996.,2
conventionnal,2
VIT,11
VIT-negative,2
Low-dose glucocorticoids,1
lactate dehydrogenase/glucose,1
DBiTE,1
supra-physiological,2
povidone iodine ointment,1
healing/eschar,1
SB265610,1
anti-coagulant,2
EGFR-specific,1
chlorine dioxide,6
Chlorine dioxide,2
polyvinyl chlorid (PVC),1
JHM.WU,1
liposome membranes,1
IDL (Ile-Asp-Leu),1
conjugated peptides,2
conjugated peptide,1
77-fold,1
"corticosteroid therapy, anti-viral agents",1
Potassium,1
potassium-dependent dimerisation,1
ARBs,3
fungicidal against,1
anticandidal peptide,1
amphotericin B,4
Broad-Spectrum Ribonucleoside Analog,1
NHC is,2
Glycyrrhetinic Acid 3-O-Mono-Î²-d-Glucuronide Glycyrrhetinic acid 3-O-mono-Î²-d-glucuronide,1
aglycone,2
glucuronic bond in,1
pNP Î²-glucopyranosiduronic acid,1
glycyrrhetinic acid 3-O-mono-Î²-d-glucuronide,2
ion-pair,3
â«,8
K to,1
VN1203-HA2-K58I virus,1
fluorodeoxycytidine,1
2'-deoxy-2,1
2'-difluorocytidine,1
first-cycle,1
glycerol saline,1
CHR segments,1
T(m,2
bengal,1
Vitamin E,2
vitamin E.,1
nsp6-nsp7,1
21502,1
sofosbuvir,7
nucleoside phosphates,1
acidotropic,2
Carnation,1
polycationic polymers,1
squalene oil-in-water emulsion,1
LEISH-F3,1
negative/PI,2
positive/PI,2
PHEV-induced,1
"Cl, Ca,",1
amotosalen +,1
riboflavin +,1
methylene blue,7
non-inferior,1
PRN,2
Phosphatidylinositol 3-Kinase-,1
blebbistatin,2
F(SeV,3
threeâpoint,1
Oseltamivir,1
ribonucleotide triphosphates,1
7-methylguanosine cap,2
S-adenosyl methionine,3
Sialic Acid-Binding Site of Influenza A Virus N1 Neuraminidase,1
NP-40,3
N13,1
O group,1
Nonhydrophobic Residues,1
acid-like molecule poly(ADP-ribose,1
dNTP intracellular,1
Cy5-dUTP,1
sialyllactose,2
Q2161,1
G2174,1
octylglucoside,2
FPT,4
[(18)F]-labeled fluorodeoxyglucose,1
ground-glass,1
glycine 2840-alanine,1
phenylalanine 2835,1
[(35)S]methionine residues released by,1
ILâ4âinduced ILâ10,1
CD14+/âSWC3+CD11R1+,1
Lactic acid bacterial colonization,1
chloride transporters,1
hypertonic sucrose,1
FBPS-N,1
FBPS-C,2
FBPS,2
FBPS-N.,1
pâ¤0.0005,1
L genes,4
superoxide radicals,1
FFR,22
fungus Reishi,1
2-nucleotide 3Â´-overhangs,1
polyethylene glycol moiety,1
11-mercaptoundecanoic acid (11-MUA),1
2.67,1
non-hydrocarbon,1
sialic acid binding protein,1
lactose,39
(neo)glycoproteins,1
Methionine,1
convallatoxin,5
ganciclovir,12
"S-[2,3-Bispalmitoyiloxy-(2R)-Propyl]-R-Cysteinyl-Amido-Monomethoxy Polyethylene Glycol",1
Zn Superoxide Dismutase,1
Zn superoxide dismutase,1
AdoMet,4
S-adenosyl-l-homocysteine (,1
Ado-Hcy,1
m(7)GMP,1
guanylyltransfer,1
sinefungin,3
ribavirin triphosphate,4
5â² diphosphate,1
methyl beta-cyclodextrin,1
Bleo,2
DX600 peptide,1
RC-1,1
chaotropic agents),1
deuterium,2
DABK,2
4EGI-1,8
delta inulin-based,2
delta inulin-based polysaccharide adjuvants,1
A2059G,1
josamycin,2
salt bridge/hydrogen bond interactions,1
PO,7
methyl donor,3
GS10,5
Phosphatidylinositol 4-kinases,3
PI4Ks,2
(PI4P)-containing membranes,1
cobalt chloride,1
CoCl (2),2
CoCl,2
isopentenyl pyrophosphate (IPP),1
[1/118];,1
AAL-R,3
sphingosine analogs,1
LC3(+,1
[OR] 1.7,1
nebulised epinephrine (,1
BOC,1
14.18,1
intramuscular dexamethasone,1
nebulised saline,1
hCRTE6E7L2,1
betamethasone,5
512-fold,1
ADP-Ribose,3
Inorganic Nanoparticles to Achieve Immuno-potentiation,1
inorganic nanoparticle delivery,1
GFD,1
100-fold-higher receptor,1
Hydroxynaphthol blue,1
EDTA blood,2
Arm,3
Palmitate adducts,2
palmitate adducts,3
L genes.,1
surfactants,3
cholesterol ester,3
AcLDL,3
cholesterol (FC),1
cholesterol esterification,1
on-the-market,1
1.3-Ã ,1
5-N-acetyl-9-O-acetylneuraminic acid,1
ribavirin 5â²-monophosphate,1
HTAs,12
348:125-132,1
16-Kilodalton Polypeptide,1
6-Chloropurine Nucleosides Palladium-catalyzed,1
6-bromo-,1
6-chloropurine ribonucleosides,1
aryl amines are,1
nucleoside derivatives could,1
silyl,1
aryl amines and,1
deoxyadenosine,2
adenosine dimers,1
aryl amination reactions of 6-chloropurine nucleosides,1
formyl-Met-Leu-Phe (,1
fMLP,1
phorbol myristate acetate,4
Diphyllin Derivatives,1
BSG,5
intranasal (IN),1
non-enzymatic proteins,1
oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine),1
stearic,1
de-PARylation,1
hydrogen bond acceptor,1
SUD-M(527-651)],1
SUD-M(527-651,1
CI 1.12â9.17,1
terminationâreinitiation,1
Watson-Crick base-paired stem,1
Pyrrolidine Dithiocarbamate Inhibits,1
Pyrrolidine dithiocarbamate,1
N7 nitrogen,1
neomycin,8
N3 imino,1
phosphate 3â²,1
UO126,4
[(3)H]uridine,1
Nucleoporin 62,1
nucleoside reverse transcriptase,2
deoxynucleosides,1
deoxynucleoside triphosphate,1
Cys(2968)-His(2879,1
lysine 7,1
leucine 2,1
16S rRNA-based,1
Fusobacterium nucleatum,1
ephrinB3-dependent,1
lupane,1
ursane,1
oleanane,1
lanostane,1
dammarane,1
3b proteins,2
immunomodulating agents for,1
mesalazine,6
IRES-CAT,1
D3 in,1
D3 of,1
KF,2
NKG2D-blocking,1
CRAE,5
Î¼g/ml CRAE,2
aminomethylcoumarin,1
âfreeâ,1
A/L,3
cholesterol supplementations,1
TX-100,1
nsp10-Derived Peptide,1
broad-spectrum peptide,1
Poly-adenosine diphosphate-ribose polymerases,1
trans-synaptic,1
20.6â49.0,1
X XXY YYZ,1
Epac-specific inhibitor treatment or,1
Velcade,4
wheat-derived gluten,1
Nasal decongestants in monotherapy,1
pseudoephedrine,2
oxymetazoline,2
phenylpropanolamine,1
norephedrine,3
Phenylpropanolamine,1
Multiâdose,1
singleâdose nasal decongestants,1
Nonnucleoside Inhibitor of Hepatitis C Virus RNA-Dependent RNA Polymerase A,1
nonnucleoside,2
Nonpeptidic Lead Compound,1
antifungal nonpeptidic benzonaphtacenequinone antibiotic,1
"emetine, monensin sodium,",1
phenazopyridine,1
pyrvinium pamoate),1
emetine,4
broad-spectrum efficacy,1
parthenolide,1
microparticle,6
Lethal Severe Acute Respiratory Syndrome Coronavirus,1
virucidal peptides,1
Delta-1(ext)-IgG,1
2â²-deoxy,1
O(6)-allyl derivatives,1
t-BuONO,1
C-2 azido derivatives,1
C-6 azidopurine nucleosides,1
O(6)-allyl C-2 azido nucleosides,1
neat C-2 azide displayed,1
azido nucleosides with alkynes showed,1
CuCl,1
"C-2 1,2,3-triazolyl nucleosides in",1
adenosine analogues,1
C-2 triazolyl adenosine analogues,1
L and Z was,1
viromewide,1
phosphatidylserine,7
PtdSer,4
PtdSer liposomes,1
phosphatidylcholine liposomes,1
Cinanserin,2
"SQ 10,643",1
hydrochloride,2
[1.14â3.05],1
[1.02â1.82],1
kainate,8
bongkrekic acid,1
3-(4-iodophenyl)-2-mercapto-(Z)-2-propenoic acid,1
Ringer's,1
nicotinic acetylcholine receptors,2
alpha-bungarotoxin,1
2.0â9.1],1
[OR] 4.3,1
CI 1.0â2.6,1
CI 1.2â2.1,2
nucleic acid stain dye,1
Drug Administration (FDA)-cleared Prodesse,1
doi:10.1007/s11606-016-3936-3,1
oxidation-associated,1
excitatory,2
protocells,1
N-glycan side chains,2
near-random,1
dextran sodium sulfate,1
Corticosterone,4
metyrapone,2
RTKIs,2
AG879,2
SAV0325,1
1.75âÃ ,1
lipoate,1
N-nsp3,2
oropharygneal,1
INGN,10
CLQ,2
CI 1.45-6.93,1
cyclooxygenase-2-derived prostaglandin E(2,1
benzyloxycarbonyl-Val-Ala-Asp fluoromethylketone,1
IFN-Î³-signaling,1
nucleotide binding-occluded,1
Lactobacillus acidophilus derivatives,1
bicarbonate buffer,1
amantadine binding of a,1
1 m,1
carbon dioxide removal) could,1
conjugated ISG15,1
LFA,1
AlexaFluor,1
LFA membrane,1
colloidal-gold nanoparticle,1
C6orf106,6
Dpr-ome network,1
5â²L strand,1
Rom,2
coumarin,4
peptide-AMC,1
MBA,1
random-sequence peptide,1
E2/E1,2
benzodiazepine derivative,1
Asn69,1
benzodiazepine compounds,1
CpG2007,1
XGPRT,1
14A.3,2
propyl] thiourea,1
DAGs,5
laminarin,1
conjugate reserves,1
laminarin-CRT,1
Phosphorothioate Antisense Oligodeoxynucleotides The,1
AS-2,1
k(cat,4
DBT,4
sialic acid-binding,1
5-N-glycolylation,1
FKNK(1386)|SAAS,1
Cap-proximal nucleotides,1
Lipoplex Formulations,1
lipoplex,4
DOPE (dioleoyl phosphatidylethanolamine),1
thiobarbituric reactive substances),1
Lipoplex,2
cake,3
valproic acid Valproic acid,1
VPA,4
chain fatty acid,1
2001â2002,2
2003â2005 against 1Â·5,1
leupeptin,14
Amiloride Derivatives,1
Amiloride derivatives,1
5-(N-ethyl-N-isopropyl)amiloride,1
corticosteroid [WMD -39.65,1
NO.,1
[RR 1.50,1
[RR 1.29,1
taxol,1
microtubule pellet,1
microtubule binding,1
alkalizing acidic organelles Viral,1
IEM,2
polyinosinic-polycytidylic acid (poly-IC)-induced,1
microtubule,4
Kifunensine,1
PI 4-phosphate,1
Dipeptidyl Aldehydes,1
peptidyl aldehyde,1
SA-19,7
aglycoristocetin,1
aglycoristocetin derivative,1
TLI,1
PEG 1500,1
[major histocompatibility complex class I chain-related molecules A,1
RBD-,4
cholesterol or 3 U,1
tetrahydrocurcumin,1
gastrodin,1
glaucarubinone,1
ginsenoside Rg1,2
theaflavin,18
carnosic acid,2
catalpol,1
cycloastragenol,4
echinacoside,1
huperzine,1
isoliensinine,1
proanthocyanidins,1
rosmarinic acid,3
template-switching,2
acid-dependent,1
65-nt-wide 5â²-proximal,1
nitric oxide synthases,1
peroxynitrite (,1
diphenylene iodonium chloride,1
L-NAME,2
L-NIO,1
L-NIL,2
X is 6-aminohexanoic acid,1
PPMOs conjugated,1
RR3,1
17-allylamino-17-demethoxygeldanamycin,1
methylamine derivative 49 displayed,1
(+) ssRNA,1
E ion,3
low-pH,7
S-adenosylhomocysteine,1
E7(11-20,1
E7(11-20) peptide,1
3.0-Ã ,1
virusâreceptor interface,1
Cyber Intelligence,1
DM1-Ig,1
carbonyl oxygens,1
amide H(+)s four,1
(13)C=(18)O amide I,1
hydroxyl H(+,1
273/3168,1
intrachain hydrogen bonds,1
electroneutrality,1
amiloride-sensitive epithelial,1
pyridine quaternary alkaloid recently isolated from Aniba sp.,1
NSE-AT(1A,1
EMAC,3
ground-glass opacities,1
corticosteroid dose,1
rACE2,8
40pmol/min,1
1mg/kg/d,1
rACE2 (1mg/kg),1
supra-physiologic,1
hIL-1Î²:Caf1,4
dimyristoylphosphatidylcholine (,1
DMPC,3
headgroup,4
1-palmitoyl-2-hydroxyl phosphatidylcholine,1
DMPC headgroups,1
DOCA-salt,3
CD-M6PR,3
Fc-OX40L,1
cross-linkers,2
Triaryl Pyrazoline Compound Inhibits,1
Triaryl pyrazoline {,1
"[5-(4-chloro-phenyl)-3-thiophen-2-yl-4,5-dihydro-pyrazol-1-yl]-phenyl-methanone",1
neomycin phosphotransferase,1
pyrazoline,2
COPB2,1
extra-ovarially,1
h-IC,1
cotransporting polypeptide,2
zinc lozenges,1
tablets,2
disulfide bridge-mediated homo-,1
5â² phosphates,1
5â²pppRNA,1
FA RVP,3
L55,1
TI-IFN response,1
HMMA 2.5 line,1
2â²-O Me,1
aliphatic hydrocarbons,1
sialic acid binding rotavirus SA11-4F,1
ERIC,1
nsp2Î324-726,2
CP-P-GFP,2
DDSs,1
Vasoregression,1
vasoregression,1
CORT,8
1918HA/K173 viruses,1
SBP 120 â,1
high-dose intrarectal inoculation of,1
Uranine,1
soy broth,1
NA's,1
N-tosyl-l-phenylalanine chloromethyl ketone-treated trypsin,1
bafiniviruses,3
reactive cytotoxic T lymphocytes,1
1996â2006,3
FAP,2
conjugated phosphorodiamidate morpholino oligomers,1
5â² terminal-,1
OTCs,1
Sugars,2
N-trimethylammonium chloride (DOTAP)-cholesterol/plasmid DNA lipoplexes,1
equimolar DOTAP,1
3-to-1 DOTAP(+,1
5-positions,1
p40:p35,1
p40(2,2
Fuzeon,5
"282,9612 -962017276993",1
5HR,1
K),1
[hazard ratio (HR),1
Postchallenge,1
0.47â0.75,1
DOPA,1
DOTAP,1
DOPA liposomes,2
BBMV,2
non-enzymatic glycation,1
EEN,1
Ganoderic Acid DM,1
GA-DM,5
DÎ´-JÎ´-CÎ´,1
VÎ´,1
AMG487,1
caudate,1
intranasal (i.n.) immunizations,1
Drug Administration (FDA)-approved/cleared,1
bile duct inflammation,1
CI 15.7â16319.6,1
80S,4
0â0.33,1
macroautophagy/autophagy,1
TNF-Î±],1
MIP-1Î±],1
[IP-10],1
VRC 304,1
VRC 305,1
4-mg,2
NS specimens,1
z-VAD-FMK,1
CG-I,1
salt intake,1
reactive oxygen stress,1
"1,7-DAAC derivatives",1
"4,7-ACQ-based",1
AMD3100,4
Ã 10(6)/kg,2
CI 1.7â8.2,1
CI 1.7â13.5,1
PMO compounds,1
FabryâPerot,1
biotin conjugated bovine serum albumin,1
P=0.028,1
Tetracyclines,5
chlortetracycline,2
Minocycline,2
oxygen radical scavengers,1
tetracycline's,2
C37,1
pneumomediastinums,1
high-Tm,1
diC(15:0)PC,1
low-Tm unsaturated dioleoylphosphatidylcholine (,1
DOPC,3
high-Tm PC acyl-chain,1
high-Tm lipid,1
phosphatidylcholine,6
acyl-chain,2
bezafibrate-,3
medroxyprogesterone acetate-induced,2
dasatanib,1
bezafibrate,3
medroxyprogesterone acetate,3
medroxyprogesterone acetate-,1
siRNA-loaded,4
[q-score] definition,1
cyanine dyes,2
unconjugated nanoparticles,1
microtubule depolymerization,2
ERÎ±âisoform,1
ERÎ±17p internalizes,1
ethyl chloromethyl ketone,1
U(L)36,1
LV3,1
LV1,4
Phospholipids,2
oxygen-glucose,2
ionomycin,3
Sialic Acid-Binding Site,1
HealthâRelated Legal,1
cGAMP synthase,2
multivitamins,1
CA-074,5
chelating intracellular calcium,1
3â²-modified,1
3â²-proximal part,2
E in trans in Sf9 insect cells,1
"corticosteroid therapy, mechanical ventilation",1
2007â10,1
carbon nanomaterials,1
fullerenes,4
CTLA4-Ig,2
2Ã10(6,1
intravenous acyclovir,1
famciclovir,1
phorbol 12-myristate 13-acetate/ionomycin-stimulated human,1
SN) is,1
LH,6
SN in mammals,1
SN induced,1
SN activated the,1
PD-98059,1
bisindolylmaleimide,2
Intracisternal Cyclodextrin Prevents,1
unesterified cholesterol,2
2-hydroxypropyl-beta-cyclodextrin,1
intracisternal HPÎ²CD,1
poly(A)-containing proteins,3
adducts,1
finishing/store cattle,1
nitric oxide on signal transduction,1
Cys-based redox,1
dopant fraction,1
dextran sodium sulfate-induced colitis,1
G-CSF],1
Triton X-100 insoluble fraction of,1
Lucifer yellow dye,1
biotin-dependent carboxylases,1
bicarbonate,12
Mg-ADP,2
nafamostat,2
nucleotide analogue reverse transcriptase inhibitors,1
p85Î²,1
N4CT1-gag1,1
N4CT9-gag1,2
1.9-fold,2
"133,499",1
"2â²,3â²-cyclic phosphates",1
LogCRP,1
BUN],1
tissue-injurious inflammatory,1
E protein regions,1
melphalan,11
mel-flufen,10
melphalan-,1
anti-MM,2
saline [PBS],1
Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine Subunit/split,1
TPP,1
CS/TPP,1
CS/TPP nanoparticles,1
CS/TPP-HA vaccine,3
CS/TPP-HA nanoparticles,1
DSA-induced effector,1
solid-phase,4
N(7)-methylguanosine,2
cap moiety,1
imidazole,1
ascorbate peroxidase,1
5-11,1
cyanogen bromide,2
disulfide bonds formed,1
357:420-422,1
glutamic acidâleucineâarginine,1
Benzalkonium Salts,1
Benzalkonium salts,1
benzalkonium salts,1
102:10545-10550,1
FL-J6JFH/J4NS5A,1
benzothiazolium compounds,1
[1.4 Â± 0.3] Ã 10(6,1
N699,1
N-B proteins,1
transcellular,3
transcellular pores,1
GFP-PS580,1
radiolabeled isatin sulfonamide caspase-3,1
[(18)F]2 (WC-II-89),1
mesylate,2
[(18)F]fluoride,2
isatin [(18)F]2 efficiently under acidic conditions,1
isatin sulfonamide analogue [(11)C]4 (WC-98),1
[(11)C]4,2
isatin derivative radiotracers for,1
Glycosaminoglycans,4
sulfated saccharides,1
sulfate,6
chondroitin sulfate,6
Lead compounds,2
hypertonic saline nebulizers,1
ApoA1 (28.1 kDa,1
DPs,1
leptomycin,1
retinoic acid-induced gene 1,1
cell-permeating peptide,1
polyribocytidylic acid,2
disulfide oxidation,1
disulfide redox-activity,1
disulfide redox,1
glutathione S-transferase-nucleocapsid,1
chlorine,14
chlorine for 1 min,1
nicotinamide adenine dinucleotide (NAD)-dependent protein deacetylase,1
Î¼NMR,1
Z-VAD-fmk,1
purmorphamine,1
L protein in,1
Asp-129,2
L protein being,1
gB(1-750,1
gB(1-460),1
Th1-CD4(+,1
rVSV-gD vaccines,1
IPCT,1
microtubule network,4
lactophenol cotton blue,1
0.8Â±0.7cfu/cm(2,1
lipid adducts anchoring S proteins,1
LY6,1
retinoic acid inducible gene,1
NP11,1
NP111,3
NP351,4
quinoline derivative,1
Allium sativum,1
allicin,1
"L polymerase,",1
spautin-1,3
LPX,3
1mM,1
immunoplex,1
quasiâRCT,1
peroxidated lipids,1
D/3-13,2
Seco-pregnane steroids,1
seco-pregnane steroid,1
clodronate-loaded liposomes,1
Antiviral Agents The spike (S),1
teita falcons,1
LPMs,1
acidified compartments within,1
Chlorine Dioxide Gas,1
Weibull-H,1
Fungi,4
LED,1
mercury lamps,1
germicidal irradiation,1
Probes [Image: see text] Rapid,1
maraviroc,1
Interferon The type I/III interferon (IFN),1
reactive rotamer of the nucleophile determines,1
NTP 13-week,1
Income Replacement A human,1
[ExoN(â)],1
SVC,4
LMB,2
l-Hyd4C,4
tritiated l-Hyd4C,1
5â²-triphosphate derivatives,1
NHOH,1
5-diphosphate,1
19Ã ,1
nonantibacterial soap,2
NO synthase,1
EHRs,1
[1.01â2.40],1
peptidyl substrates [Rockwell NC,1
Acids Innate immune cells,1
nucleic acid species,1
Sclerosporin Derivatives,1
Fungus Cadophora malorum The marine-derived fungus Cadophora malorum,1
sclerosporin derivatives,1
acid-urea,1
HPDs],1
cardiolipin,7
Interferon Gene,1
Benzodiazepine Compound,1
acetic acid benzodiazepine (BDAA),1
benzodiazepine,3
N7-guanine methyltransferase,1
n-propanol,6
chlorhexidine (2 to 4%,1
triclosan (1 to,1
soaps,2
MERS-CoV-related,2
D-mannose,3
2H phosphoesterase proteins,1
by-products derived,1
aminoglycoside,3
kanamycin,2
Neomycin,1
18S rRNAs,1
chemoimmunotherapies,1
dicarboxylic acid compound,1
exhaled airborne,1
"[4,4,3]",1
"[4,3,3]",1
"[3,3,3]azapropellanes",1
EG3,2
TMP21/p23/p24Î´,1
VSV-hDCT,1
PMX205,2
Broad-spectrum antiviral,1
broad-spectrum anti-CoV,1
Low-dose,1
broad-spectrum fusion inhibitors,1
intranasal instillation of,1
methyl betacyclodextrin (,1
nystatin/progesterone,1
Nucleic Acid,1
reactive rubella vaccine,1
infusional,2
nitrates,1
"infusional 5-FU,",1
infusional 5-FU,2
leucovorin,1
oxaliplatin,1
CCB,5
nitrate,4
Carboxy Termini,1
"[1,3-(3)H]diisopropyl fluorophosphate",1
DPX-Survivac,1
FDA âBreakthrough Therapyâ,1
dodecylphosphocholine micelles,1
HFD feeding,1
[dNTPase),1
Diprovirins,1
reactive red baits,1
CFTR-mediated Cl(â,1
O-linked oligosaccharides,10
heparan sulfates,1
dipeptide-like,1
(R)-N-(4-(tert-butyl)phenyl)-N-(2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl)ethyl)furan-2-carboxamide,1
1537â1540],1
broad-spectrum nanomolar,1
L-mCherry,1
S-adenosyl-l-methionine,5
concanamycin A,2
DTx,2
[FARP],1
analytes,1
DFAâpositive analytes,1
XNT,2
XNT -3.26Â±0.2 vs.-1.6Â±0.2,1
NS protease containing,1
8-anilinonaphthalene-1-sulfonic acid,1
NS protease,6
NS protease is,1
Ca2 (,1
R18,6
Interferon-Î»,3
lipopolysacharide,1
sodium 128 mmol/L),1
corticosteroids.,1
CPL,8
liver-to-plasma,2
1.5-â«,1
3â² coterminal,2
D3-10,1
"[182/2,545]",1
inhaled nitric oxide,1
epoprostenol,1
Hydrogen Peroxide Facility-wide,1
VHP,21
activeâclosed VHP,1
methyl Î²-cyclodextrin,1
water vapour,4
international/national/institutional,1
vitamin K3,1
Nucleus Animal-derived RNA viruses,1
polyoxometalates,1
33/420 [,1
150/1593 [,1
37/751 [4.9%,1
34/1593 [,1
16/751 [,1
NEMO linear-ubiquitination,1
proteosome-sensitive,1
FIV-like,1
multi-FRET,1
acylated fluorescent protein,2
Lactobacillus microecological agent,1
Backbone,3
LoD],1
1 Ã 10(â2,1
LoD of 1 Ã 10(â2,1
Lipid Nanoparticles in,1
lipid nanoparticle-formulated,1
pseudouridine-modified,1
cytosine-guanine oligodeoxynucleotide 1826,1
Tyr-127,2
dockingâs,1
[HR] 5.24,1
CI 1.44â7.82,1
phosphatidylinositol 3-phosphate,1
"inorganic, polymeric or biological building",1
stepwise,1
methiothepin mesylate,1
Asn28,3
Hoechst 33258,1
hyperendemic/endemic meningococcal regions,1
"2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propranoic acid",1
GYKI-52466,3
Omalizumab,3
Anti-IgE,1
NCT00377572,1
resolvins,2
protectins,2
lipoxin,3
resolvin,2
idoxuridine,1
"acyclic nucleoside phosphonate analogues),",2
pyrophosphate analogues,2
guanosine analogues,3
"acyclic nucleoside phosphonate analogues,",1
CS-B,1
[H4(â)],1
1915â1920,1
Cytosolic,1
purine auxotroph,1
3AB,11
Gsp,6
carbonyl oxygen of,2
amide bond of,1
sulfenic acid by,1
endosulfan,4
Endosulfan,1
Ï(39,2
vitrorevealed,1
hASL(Lys3)(UUU)-mcm(5)s(2)U(34);ms(2)t(6)A(37);Ï(39,1
mcm(5)s(2)U(34,1
10/878,1
nsp2-nsp3,1
cocktail,3
"30,738 nucleotides",1
290-nucleotide,1
sialosides,2
1.33 g,1
4-O-acetyl-5-N-glycolylneuraminic acid,1
clodronate liposome depletion/suicide,1
10(6,3
â1 PRF,2
C25,1
3â² nucleotide,3
C27,3
cytidine 27,1
L2,1
ataxia-telangiectasia,2
zoniporide,1
arbidol,1
clofarabine,2
mg/m(2)/day,1
intravenous busulfan,1
NCT01188174,1
Intratracheal Routes of Inoculation Most,1
PAP-1,7
reversed-phase HPLC,1
nanomolar IC(50)s,1
repeat-dose,1
vitamin E (200 IU,1
vitamin E-supplemented,1
benzoboroxole-sulfonic acid copolymers,1
co-polymers,1
NO scavenging,1
"2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide",1
c-PTIO,1
monocrotaline pyrrole,1
LY-83583,1
fasudil,1
Tiron,1
Tempol,3
NO scavengers,1
diethylamine NONOate,1
PIs,10
2â3 WatsonâCrick,1
7-â«,1
sialic acid-binding pockets in,1
4-(2-aminoethyl)-benzenesulfonyl fluoride],1
lipid-based,1
2-aminopurine (,1
2-AP,6
VRC),1
VRC-HIVDNA009-00-VP,1
ASV,7
isopropanol,2
cysteine-coordinated metal ion-binding domain,1
FluPlex,2
10(â1,1
CEACAM1:CEACAM1,1
amiloride-sensitive sodium channel,1
DBP,1
Watson-Crick base pairing,1
ISE,4
As4 structures,1
i.t,6
CTAB (cetyltrimethylammonium bromide,1
FTA filter (Whatman,1
FTA,12
2 viruses,1
DPC,7
Gem,3
dopamine-centric,1
Benadryl,1
chlorcyclizine,2
steroids Severe acute respiratory,1
coagonist,1
subunit-selective,1
VP3-positive structures,1
DENV-EIII,2
polyinosine-polycytidylic acid,1
hypoxia/reoxygenation,1
RVSP,4
NS mutations have,1
Neuroimmunol 242:26â32,1
silybin,1
silybin derivatives,1
IFNARCD46tg mice,1
ethylmalonic encephalopathy 1,1
N-iodosuccinimide (NIS),1
4â²-ethynyl derivatives,1
adenine nucleosides,1
gagâpol,1
Aurintricarboxylic acid,3
nicotinamide adenine dinucleotide phosphateoxidative,1
[ExoN(+)] at,1
Tat-Egr-1-p300-GFAP,1
pegylated IFN,1
ribavarin,1
L-rhamnose,1
tetraethylene glycol (,1
DPPC,3
rhamnose,2
Thiol Reduction-Oxidation Protein-disulfide isomerase,1
S400-600,1
N-acetylglucosamine Crystal structures of complexes,1
N-acetylglucosamine,6
"N-acetylglucosamine,",1
1â119,3
1â284,1
chromatid,2
high-dose methylprednisolone,5
antithymocyte globulin,1
anti-IL-23p19,3
Niclosamide Antiviral agents,1
NxTAG RPP RUO,2
Met-75,1
Copper Pyrithione,1
pyrithione,3
ionophores could be,1
broad-spectrum PCR,1
[OR] 1.01,1
CI 1.36â2.03,1
high-dose Ad5-pIFN-Î³,2
NS protein seropositive,1
2.8-Ã ,1
hydrogen bond network,1
Thymopentin-loaded phospholipid-based,1
TP5,6
phospholipid-based,1
T-SOD,1
ouabain-resistant,1
ouabain-sensitive,1
vinyl sulfone inhibitor (K777),1
8b,26
8a polypeptide,1
PNP,2
transganglionic retrograde,1
choline acetyl transferase (,1
L-lactic acid,1
nano-particle formulations,1
procyanidins,3
N-ethylmaleimide [NEM],1
intermolecular disulfide linkages,1
lysolecithin injection,1
thymidine,6
LDL receptor-null,1
lysophosphatidic acid,1
HDL cholesterol,2
15-hydroxyeicosatetraenoic acid,1
HETE,1
24-hour IFN-Î»3,1
brefeldin A,2
181d+,1
F-G,1
NTZ (,1
5â² oligo(U,1
antihistamine chlorcyclizine,1
chlorcyclizine HCl,1
CCZ,2
fluorescein isothiocyanate (FITC)-conjugated anti-Cryptosporidium monoclonal,1
dec-RVKR-CMK,5
coumarin-based antihistamine-like small molecule,1
LRH},1
[HRH],1
LRH,1
Lactobacillus casei Expressing,1
Chalcone,2
chalcone derivatives,2
Sulfonamide Inhibitors of Nipah Virus Nipah virus,1
Nanosphere Inc.,1
photosensitizers (PS),1
singlet oxygen,2
5-aminolevulinic acid,1
Ammonia Disinfection,1
wt/wt,1
TCP,7
norverapamil,3
verapamil analogs,1
cGAMP) synthase (cGAS)-stimulator,1
intramolecular kissing hairpins,1
PEG 3350,1
glycine 2,1
diethylpyrocarbonate,1
nucleoporin-dependent,1
DBT-cACE2,2
11:417-422,1
inositol hexaphosphate,1
IP6,1
xylose,16
Alkaline,1
amotosalen,3
UVA light,1
PI4-phosphate lipid,1
noninhibitory nucleic acids,1
100-cm(2,1
NO bioavailability.,1
liposome association,1
lignocaine,4
tetracaine,2
lignocaine infiltration(LI,1
hydroperoxides,1
nitrotyrosine,6
MJ33,1
Nox2-derived oxidant stress associated,1
CMP-N-acetylneuraminic acid,1
CAP257 serum,1
indole-3-carbinol,1
I3C,4
[w/w],1
[w/w]),1
membranous sites,1
E by,1
TFV,7
TFV virions,1
"1,7368 Da",1
"Î±,Î²-unsaturated ethyl esters",1
SG75,1
nucleic acid analytes,1
NxTAG-RPP,7
CH2âCH3 elbow,1
Thiouracil Cross-Linking Mass,1
thiouracil cross-linking mass spectrometry,1
Muramyl Dipeptide,1
Glu-Lys,1
cis cleavage of,1
thiosemicarbazone analogues,1
"2â²,3â²-cyclic phosphate",1
R848,8
ADP/ATP,1
thymidine kinase,6
2â²-deoxyribose,1
UTP,5
Cocktails,3
ECP,3
membranous webs,1
19â23,1
Salinomycin,2
salinomycin,6
AMT,3
reactive intermediates orchestrate,1
"NO-forming RNS,",1
NO/ROS,1
Lactobacillus species play,1
isRNA,1
Tryptophan Dendrimers,1
Dendrimer 12,1
citral,6
casei upp,1
Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25,1
chelating zinc ions,1
Drug Administration-approved molecular multiplex,1
belimumab,3
vaccineswork,2
provaccine,1
adenine nucleotides,1
chloride secretory,1
nitric oxide synthase-1,1
Anti-helminth,1
cellulose ester,2
nitric oxide/reactive nitrogen species,1
OLF-1,1
4-phenylbutyrate,2
15â18,1
2-5A/RNase L,2
Isoflurane,3
ketamine,3
xylazine,4
Nonsteroidal Anti-inflammatory Drugs Potently,1
naproxen,3
lornoxicam,1
prostaglandin E(2)/prostaglandin E receptor 2 (EP2)/cAMP/protein kinase A,1
[1.05â2.86],1
"[0.33â0.92],",1
rs17036188,1
"Î±2,3-sialic acids",2
1 influenza B virus,1
pontine,2
2.79-259.75,1
9.61(1.98-46.57,1
O-acetylated sialic acids,1
difluoromethylornithine,1
DFMO,2
eflornithine,1
diethylnorspermine,1
DENSpm,1
.053â.853,1
acid-like,1
VP24-specific PMOs,1
PMO chemical,1
piperazine moieties,1
3-alanine,1
inorganic material,1
Liposomal alendronate depletes,1
otherâs,3
GA1,1
prequantified,1
RiboGreen,1
finite-time microcosm realizations,1
C5aRa,1
membranous structures,1
inositol phosphate,1
adamantane antiviral,1
Ribose 2â²-O-Methyltransferase,1
2â²-O-MTases,1
pH-independent RIS,1
epicutaneously,1
purine analogue,1
RNA-bound,1
long-chain fatty acyl-CoA,1
fatty acylations,1
2-bromopalmitate,2
2-BP,5
S-induced syncytial,1
4E1RCat,1
lipopolysaccharide (LPS)-triggered,1
DDX3X-SG,1
ribose methyltransferase,1
ITB,4
ftp://ftp.fao.org/docrep/fao/011/ajl37e/ajl37e00.pdf,1
humanâanimal,1
sulfated derivatives of,1
cholera toxin,10
salt solutions,1
D3-tsF219L,1
spherical peptide amphiphiles,1
nonpolar side chains,2
1.25-Ã ,2
IFNL4-ÎG,1
Low-Dose,1
cholesterol chelation,1
Flavirial,1
Malondialdehyde,1
1Î²,1
bleach,5
Sodium hypochlorite doses of 2.75 to 5.50 mg/liter with,1
sodium hypochlorite doses,1
â¥8.25 mg/liter,1
agglomerates,1
"3â²-(4â²-Hydroxyl-3â²,5â²-Dimethoxyphenyl)Propionic Acid",1
oxidized low-density lipoprotein,1
oxLDL,5
KME,7
HDMPPA,7
OxLDL,4
cholesterol influx-,1
Triton,2
evidencedâbased,1
NO donor,3
S-nitroso-N-acetylpenicillamine,4
camostat,13
"(23,25)trans-epoxysuccinyl-l-leucylamindo-3-methylbutane ethyl ester]",1
oligomannose,1
vertebrate-specialized,1
disulfide bond-linked envelope,1
1-8),2
6-diazo-5-oxo-l-norleucine,1
DMV,2
exposure-spatial,1
Chitosan Nanoparticles,1
intranasal route can be,1
400-fold,1
PTL,2
heparan sulfate proteoglycans,1
Alemtuzumab,3
turmeric,2
curcumin nanoformulation(s,1
nNO,5
1.8-Ã ,1
NF-ÎºB-,1
incretins,2
[2006] in,1
biotin-Lys-C5 alkyl linker-Tyr-Leu-epoxide,1
DCG-04,1
Spirooxindoles,1
Isatins [Image: see text] A,1
N-propargylated isatins,1
spiroindolones,1
N-propargylated oxindoles,1
copper-catalyzed azide-alkyne cycloaddition (CuAAC) reactions,1
Cycloheximide,1
phosphonoacetic acid,3
IFN-Î³-treatment,1
5â² triphosphates,1
3â² hydroxyls,1
5â² hydroxyl,1
"3â² monophosphoryl ends,",1
Stepwise,4
preacidified,1
L genes (,1
vLC,1
[green beads (1 Âµm,1
amiloride-sensitive epithelial sodium,3
chloride (Cl(â),1
bicarbonate ([Formula:,1
intravenous ribavirin,5
CpG-ODNs,3
IGIV,3
NA of influenza virus,1
rhIL-2,3
N-hydroxysuccinimide palmitate ester,1
interferon-ribavirin,2
lipid membranes,3
Desmosterol,1
desmosterol,7
ceramides,1
Nov. 7,1
H89,1
ODN D19,1
NPA between 9 March,1
TGB,1
D RNA,1
IFITM3-K88me1,1
âC-peptidesâ,1
Coil Peptide,1
pyrrolidine dithiocarbamate [PDTC],1
PS-341,2
9b,2
F613Y,1
Submicron-Size Bioaerosol,1
faceseal,1
Faceseal,1
faceseal leaks,1
20â800,1
C-glycoside analogs,1
ethidium bromide staining,3
hydroxyl naphthol blue,1
HNB dye,2
Hydrolyzes 4-O-Acetylated Sialic Acids Infectious salmon anemia virus,1
5-N-acetyl-4-O-acetyl neuraminic acid,1
sialic acids hydrolyzed ISAV receptors,1
isoguanine (isoG),1
Salts Block Hepatitis E Virus,1
fluorocarbon oils against,1
aristolochic acid,3
Aristolochic acid,1
BHC):,1
2002-to-March 2003,1
Ï3 Polyunsaturated Fatty Acids,1
Colitis,1
Ï3 polyunsaturated fatty acids,1
L A novel small molecule thiocarbazate,1
26681509,1
thiocarbazate displayed,1
SRPIN340,3
Sevoflurane,5
postsynaptic density 95,1
sevoflurane 2,1
sevoflurane anesthesia,5
Nutlin-3,3
eNose,5
Oligodendroglia,3
September-Octoberâ09,1
FLAI,1
2.7-â«,1
nucleoside triphosphatase,1
malachite green ATPase,1
polyinosine-polycytidylic acid [poly(I:,1
CYP72A154,1
glycyrrhizin aglycone,1
periodate,1
"(23,25)-trans-epoxysuccinyl-l-leucylamindo-3-methylbutane ethyl ester",1
HRV-induced,2
phospholipid acyl,3
oxysterols,6
n-3 polyunsaturated fatty acids,1
birdâpoultry,1
apo 3D structures of,1
antihistamine agents,1
germicidal UV light (254 nm,1
stratum corneum),1
254-nm light,1
cyclobutane pyrimidine dimers,1
germicidal lamp used as,1
germicidal UV lamps (254 nm,1
[methyl-(13)C]methionine resonances,1
reactive histidines (His 234,1
Lys 289,1
Nicotine,2
e-cigarettes,1
nicotine inhalation,1
cap guanine-N-7,1
MitoTEMPOL,1
[8] used positional,1
Carbohydrate Analysis of Nipah Virus Attachment Glycoprotein,1
carbohydrate components,1
Intravenous immunoglobulins,1
6-azauridine,4
gadolinium(III,1
[ICS-RV]),1
Hydroxynaphthol Blue Dye A,1
calcium phosphate nanoparticles Dengue virus,1
calcium phosphate nanoparticle (,1
membranous walls,1
NS is,1
Phe,1
queuosine (Q),1
Q base,1
d-amino acids,1
ms(2)io(6)A nucleoside,1
20 herbal medicine,1
NS was,1
"L, late endosomal",1
CsA.,2
NHC is more,1
NHC antiviral,1
N-monomethyl-l-arginine acetate,1
l-NMA,3
chemically-modified,2
FSmRNA,2
d(N,2
8-pCPT-cGMP,7
nucleotide moieties,1
8-(4-chlorophenylthio)-cGMP,1
cell-impermeable cGMP,1
8-CPT-cAMP,1
PIs atazanavir,2
ATV,11
darunavir,13
DRV,9
G16E,2
L33F,2
BSC,4
iron regulatory protein 1,1
liposomal,8
doi:10.1007/s12195-017-0489-4,1
conjugated covalently,1
[OR] 2.64,1
low-molecular-weight nonpeptidic,1
pyrrolidine-2,1
LPL-containing membranes,1
SRL peptide,1
SRL,2
osmolytes,1
submicromolar,2
vindesine,3
proofâofâconcept,1
3-NT,2
oxyradicals,1
HMs,5
phosphatidylinositol 3,1
VLDL,3
triglyceride-rich,1
VLDL triglyceride,1
LPL-mediated hydrolysis,1
[âflying foxesâ,1
S-adenosyl-l-methionine (SAM)-binding,2
Nanosphere,1
INF A,4
epsilonretrovirus,1
peptide-PMO conjugate,1
cis acting for viral fitness but,1
Histamine,6
IL-3,6
acceptor-type,1
immuno-pathophysiology,1
macrocycle is required for enzyme,1
single-compound,2
Bepridil,1
bepridil,2
calcium antagonists,1
RecBCD-like,1
nucleotide analogues,4
metal ion chelators,1
polycyclic aromatic polymers,1
[1;,1
Conjugated,2
unconjugated oligomers,1
epoxyeicosatrienoic,1
epoxyeicosatrienoic acid,1
LVDP,3
"14,15-epoxyeicosa-5(Z)-enoic acid",1
A71915,1
"11,12-EET",1
hippuristanol,1
trioxide-mediated,1
arsenic trioxide (ATO)-mediated,1
antiâTNF-Î±,1
nucleic acid (LNA)âbased,1
pHEPIS,2
phospholipid headgroup,1
eculizumab,4
[CRV-MS],1
1.20â1.69,1
Î-peptide-Fc,1
Bilirubin,1
cross-strand adenine,1
carboxy-,1
C1-group,1
5-formyl-tetrahydrofolate,1
Schiff's base intermediate,1
PC177,1
197-aa,4
197-aa fragment,1
16Â°C,2
Flunarizine,2
flunarizine,3
phenothiazines,3
Drug Administration each,1
Reserpine 13,1
Aescin,1
Reserpine,1
Valinomycin,3
Israel810 HA,2
pUL131,1
broad-spectrum antifungal,2
swab/medium,1
saline swabs,1
long-chain lipids,1
palmitoyl,1
302/965 [,1
3.3-â«,2
1255â62 doi:10.1016/j.devcel.2012.10.017,1
Broad-spectrum agents for flaviviral infections,1
broad-spectrum anti-flaviviral,1
glutamic acid-rich,1
Lys-756,1
phenol ether,1
sulfonamide,2
MBX2546,1
cardiotonic steroid (CTS)-binding-induced,1
cardiotonic steroids ouabain,1
bufalin,4
cardiotonic steroids,1
Nucleotides,2
5â² TRS,1
3â² TRS,1
cTRS-B,3
cTRS-B duplex,2
Propofol,5
Pentobarbital,1
niacinamide,1
(33)P,1
supine/semi,1
âcytokine synergyâ,1
connexons,1
Triton X-114 detergent,2
5â²-proximal,4
SLs,1
Carbon Dioxide,1
E induce potent humoral and,1
27.26-126.80,1
methylene carbon is,1
Chlorcyclizine Derivatives,1
chlorcyclizine derivatives,1
F-GCNt,1
non-steroidal,1
corticosteroids during acute phase,1
corticosteroids - the,1
nicotinamide adenine dinucleotide phosphate metabolism,1
vasoactive intestinal peptide,1
PGE (2),2
PGE (2)âPtger4,1
anti-EMCV,1
NA-2,4
AONs,1
zVADfmk,1
tofacitinib,1
guanine nucleotide exchange factor GBF1,5
PTFE],1
Nickel,1
heparin-agarose,1
sodium chlorate,2
F26,2
wide-spectrum inhibitors against CoV-associated diseases,1
S-e monomers,2
S-e trimers,2
early-detect,1
notoginsenoside,2
broad-spectrum antiviral small molecule,1
broad-spectrum small molecule,1
Phosphorothioate-Modified CpG,1
ODN-containing,1
guanosines,1
CP-,1
BPL,5
breakpoint,1
Trastuzumab,1
reactive m860,1
GA2,1
Byetta,1
fortified agents,1
(131)ACA(133,1
pyrimidine biosynthetic enzymes substantially,1
pyrimidine biosynthetic intermediates.,1
pyrimidine precursors,1
[11.5],1
amiloride-sensitive,1
redox-sensitive dyes,1
glutathione ester,1
reactive oxygen intermediates,2
bile duct ligated,2
seven-nucleotide,1
Busulfan,2
busulfan,6
intravenous immune globulin,1
inhaled steroids or,1
tailfindr,5
Convoluted membranes,1
actinomycin,5
Polyplexes,1
H3K(+H)4b,1
polyplex,1
broad-spectrum RBD-based subunit vaccine,1
HEAM,10
ssDNA],1
dsDNA]),1
ammonia (,1
DENV-1â4,1
ferric chloride (FeCl(3))âinjured mesenteric arterioles,1
NPA samples for 16 viruses,1
[OR] 9.67,1
[WHO-HKU],1
[WHO-Hamburg]),1
sulbactam sodium/cefoperazone sodium,1
mg/time,1
Lumizyme,1
288:555-565,1
IFNÎ±/Î² inducers,1
pâ¤0.03,1
casein-,1
CatL.,1
Methyl Donor,1
S-adenosyl-l-methionine (SAM)-dependent 2â²-O-methyltransferase,1
ribose 2â²-OH,1
N7-methylated,2
cap analogues,1
SAM/SAH,1
oxidized glycerophospholipids and,1
surfactant composition,1
6k,1
I/R.,2
Phosphatidylinositol 3-Kinase-Akt Signal,1
ubiquitin-7-amino-4-methylcoumarin,2
1 mg/kg chloroquine,1
[interleukin (IL)-6,1
sixth-generation bronchi),1
R128A,1
Triton X-114,4
5-bromouridine 5â²-triphosphate,2
miniMag,1
phosphorothioated oligodeoxynucleotides,1
"1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine",1
monodansylcadaverine,1
FoxJ1/STAT1,1
heparan sulphate,2
heparan sulfate/TLR2,1
SC and,4
IN/oral routes,1
methylpredisolone,1
thioalkylated mannose-modified dendrimer,1
doi:10.1208/s12248-014-9665-9,1
Mitoxantrone,1
E-64d,1
FU,1
Cal,1
Cal PA-XFS,1
Cal WT,4
TAGs,4
FDA TAGs,1
phosphorothioate oligodeoxynucleotides,1
PS-ONs,6
2â²-O-methylated derivatives,1
wholeâblood droplets,1
anti-C47-syn-G50,1
G50,2
C47,2
Watson-Crick edges,1
2â²â3â² cyclic phosphate termini,1
10.1007/s12250-018-0054-x,1
Hydrogen Peroxide,1
[OR] 5.0,1
CI 1.2â5.4,1
CI 1.9â4.6,1
Double-membraned Liposomes Sculpted,1
carboxanilides,1
1-benzoyl-3-arylthioureas,1
sulfonamides,2
BafA1,4
Debio-025,7
cyclosporines,2
VLP,2
Cordycepin,2
cordycepin,6
tetraethylbenzimidazolylcarbocyanine iodide,1
Aces,1
nucleoside triphosphatase (,1
5â²-[Î³-(32)P]RNA,1
429/436,1
[IQR] 68.8â87.5,1
surfactant-modified NSP,3
natural-clay-derived,1
anionic sodium dodecyl sulfate,1
cationic n-octadecanylamine hydrochloride salt,1
nonionic Triton X-100,1
surfactant-modified exfoliated nanoclay NSQc,1
sodium dodecyl sulfate,14
Phorbol ester,1
MitoSOX,1
telmisartan,1
High-salt diet (8%,1
low-salt diet (,1
STZ mice,1
triphosphates,3
cytidine analogues,1
D;,1
cholesterol-rich membrane microdomains,3
OGD,1
cocaine,9
amphetamines,1
DAT,5
cocaine analogs,1
DAT-mediated cellular,1
25âyear,1
[12%] in,1
E7(11-19/20,1
Staufen (STAU)1-mediated,1
STAU,1
1 colony-forming,1
(CFU)/mL,2
chloramphenicol acetyl transferase (,2
hydroxynapthol blue,2
Oxidized-LDL,1
1â173âresidues 233â300,1
cisternal,2
HCQ,46
prostaglandin D(2)/DP1,1
mononucleotides,1
1 Ã 10(3,1
Phosphatidylethanolamine Lipid,1
"1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE)",1
DOPE,1
DOPE species,1
domainâmuch,1
zanamvir,1
F-,1
"non-rRNA-,",1
C14,2
G12-C28,1
Â±0.4 kcalÂ·mol(â1,1
Fab-7D11,2
FLU OIA):,1
FLU OIA,2
Inhibitor Design Implications We,1
Î²-amyloidosis,1
Pyridine Nucleotide Transhydrogenase,1
conjugated proteins,1
Lactobacillus species are commensal bacteria,1
gasseri,1
PTIO,1
NO donors,1
NOC-7,1
SIN-1,1
eluents,2
detergent-based eluents,1
firstâ,1
charged-residue,1
MMC,3
L-amino acids,1
L-4F,5
lampricide,1
chocolate,1
H(C)50/A,1
H(C)50/A (H(CN)25/A),1
Struvite Stone,1
struvite uroliths,2
struvite calculi,3
struvite stones,1
struvite stone,1
Triton X-100-resistant membrane microdomain,1
methyl Î²-cyclodextrin significantly,1
Triton X-100-resistant microdomain,1
ritonavir use(1)(2)(3)(4,1
peg-interferon/ribavirin,1
HMBPP,4
[RVP] Fast v2),1
Glycogen,1
FHAVN,2
SB202190,4
1.26 (95%,1
trans protein QTL,1
hypotonic shock response (HSR),1
bismuth antiulcer,1
[1.0-7.8,1
[1.0-5.2],1
[1.0-7.5] vs.2.0,1
CI:1.14-4.99,1
2-Cyano-3-Acrylamide,1
L protein domain VI required,1
L protein sequence,1
L protein domain VI in,1
K-48,1
âcap-1â,1
5â²-(m7)G(0ppp)A(1)G(2)U(3)U(4)G(5)U(6)U(7)-3â²,1
S-adenosyl-l-homocysteine,2
adenosine 2â²-O-methylation,1
[24 mo,1
superoxide scavenger,1
tempol,5
[24Â±6,1
PK3,4
Electron Cryomicroscopy Coronavirus particles,1
7-methylguanosine nucleotide,1
endoglycosidase,2
aspartic acid,9
NF-ÎºB-Mediated Inflammation,1
I584,1
imino protons,2
viralâbacterial,1
CI 12,2
NendoUs,1
non-steroidal anti-inflammatory,6
2.06â4.69,1
"424â2,735",1
2.6â16.9,1
[soR1(1)],1
VILI,4
[nsp14-ExoN(+)],1
[nsp14-ExoN(â)] ExoN,1
5-FU): nsp12-M611F,1
5-AZC,1
ion-pair NH(+)/S(â,1
His159 imidazole,1
nucleic acid nanodevices,1
NPW,1
nonâinfluenzaâinfected,1
CI 14,1
WV15670,1
Microtubule,1
long-chain fatty-acyl-coenzyme,1
guanine nucleotide exchange factor responsible,1
zwitterionic chemical probes that,1
reuptake,1
5-60,1
stoichiometric-binding,1
Halomethyl Ketone Inhibitors Against Coronavirus Main Protease 3CL(pro,1
ketone warhead,1
11Î²-HSD (11Î²-HSD1),1
11Î²-HSD in femoral heads,1
capsazepine,1
tetra-O-galloyl-Î²-d-glucose,1
aflatoxin B(1)âalbumin,1
AF-ALB,6
"L, M",1
"2,3-butanedione monoxime",1
BDM,1
polyethylene glycol 5000 monomethyl ether,1
Doxycycline Liposomes,1
doxy,1
sulfuric acidâloading,1
doxycycline liposomes,1
Liposomes,3
sulfuric acid,1
"1,2-dipalmitoyl-sn-glycero-3-phosphocholine",1
nonliposomal,1
lipopolysaccharide (LPS)-induced acute respiratory,1
p-NF-ÎºB,1
calcium phosphate,1
FLUDV,3
[OR] 1.9,1
PSACs,1
"phosphatidylinositol 4,5-bisphosphate",1
Acids 9-O-Acetylation,1
trehalose vitrified phospholipid vesicles,1
trehalose,4
proteinâganglioside,1
"2,2-Dialkylamantadines",1
Compounds [,1
"2,2-dialkyladamantyl-1-amines",1
noradamantane alcohols,1
ALN-RSV01,8
dicarboxylates,2
solute,5
phospholipid vesicles,1
cysteate,1
malate,1
oxaloacetate,1
2-oxoglutarate,1
thiosulfate,1
mercurials,1
organic acid,2
L proteins,1
dUTP-biotin,2
ribose 2â²-O.,1
ribose 2â²-O methyltransferase,2
624-nucleotide,2
reactive electrophilic fluoromethylketone group,1
tryptose sulfite cycloserine,1
CX,1
cell-wide,2
Polyanions,1
N-sulfonated chitosan,1
sulfonate,2
normoalbuminuria (Dnormo),1
Dnormo,1
nitroxide spin,1
broad-spectrum respiratory,1
IRA,12
Kineret,1
poly(ethylene glycol) (PEG)-based,1
CD7+/CD19+,1
8-hydroxyquinoline,1
[KO],1
10(â1.3â¼â0.7,1
COPs):,1
COPs,2
lycorine derivatives,1
F76,1
[320],1
[160].,1
dCTP,2
5â² overhangs,1
DEAP,1
4b,1
Microtubule Network,1
vinblastin,1
microtubule dynamic,1
microtubule polymerization,1
N-ethyl-N-nitrosourea (ENU)-mediated,1
L1246R,1
intrachain salt,1
ÎU(S)3,1
l-leucyl-l-leucine methyl ester,1
LLME,1
Phe(P2)-induced,1
steroid-based,1
Trifluoroketone,1
"trifluoroketone [D-Î±-aminopimelyl-(1,1,1-trifluoro-3-amino)butan-2-one]",1
trifluoroketone,2
boronic acids,1
chelating agents (,1
imidazole):,1
"cationic polyethylene glycol-conjugated 3Î²-[N-(Nâ²,Nâ²-dimethylaminoethane",1
carbamoyl] cholesterolâdioleoylphosphatidyl ethanolamine,1
secukinumab,1
ixekizumab,1
S-adenosyl-l-methionine (AdoMet)-dependent RNA (nucleoside-2â²O)-methyltransferase (2â²O-MTase,1
N7-methyl guanosine cap,1
guanine N7,1
N1347A,2
N1347A virus,1
TBM,4
1 Ã 10(6,1
FI therapeutics,1
T-651,1
eventâs,1
buffer,3
15â39,1
2â² -5â² âoligoadenylate synthetase (2-5 OAS1,1
2â² -5â² âoligoadenylates,1
expertise-guided,1
intranasal imiquimod,1
imiquimod rapidly,1
NGEN,5
FLT3-L,2
10(3.6,1
vorinostat,6
Intranasal ipratropium bromide for,1
intranasal ipratropium bromide (IB,1
IM1,1
lipopolysaccharide O26,1
Tissue/serum samples,1
hydroxyurea,2
L selectin,1
allâinâone,1
Triton Xâ100,1
H-2(d,1
rtA181V,1
lamivudine-,1
cap N7 methyltransferase,1
ICI,3
peptidyl compounds,2
carboxyl-encoded microspheres,1
multicolor,1
propidium iodide in,1
10.1007/s40203-018,1
cocktail protected 100,1
FcaGHV-1,1
2013â2015 EVD,1
20Â·6,1
cross-linkingâpeptide,1
p=0.20,1
Zn fingers,1
Zn finger proteins,1
high-micromolar,1
Asunaprevir,1
Flavocoxid,1
flavocoxid,3
flavans,1
flavocoxid 250,1
double-stranded nucleic,1
NS3h slowly,1
NS3h must diffuse along the,1
Mesoporphyrin,1
ZnMP,8
Gas,2
APCP,6
vol/vol],1
vol/vol]),1
dual-donor,1
10.1007/s12250-017-3969-8,1
mannose sugars,1
reactive with microbial or autoantigens,1
dual-label,1
silicate nanoparticles,1
viral-specialized,1
asialo-GM2,1
para-nitrophenol,1
monobasic HA,2
12-hydroxyeicosatetraenoic acid,1
"(2S,3S)-transepoxysuccinyl-l-leucylamido-3-methylbutane ethyl ester",1
more-standard,1
Absorption,1
Sustained-release Buprenorphine Formulation,1
buprenorphine SR LAB,1
Nitric-oxide Synthase,1
Interferon gamma modulation,1
3D domain-swapped,1
Fenretinide,1
PEVs,2
Arsenic Trioxide Hepatitis C virus,1
dihydrosphingosine-based,2
dihydrosphingomyelin,1
dihydrosphingosine,3
tocopherol,1
dihydrosphingosine conjugate,1
5â²-guanosine cap,1
chelating cytoplasmic calcium,1
epithelium-to-mesenchyme-like,1
lithium,2
3â² nucleotides 241â185,1
H protein,1
carbon monoxide transfer factor (,1
nucleoside triphosphates,2
T-705 ribonucleoside triphosphate (RTP),1
"3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives",1
7-methyl guanosine of,1
7-methyl guanosine,1
low-dose intravaginal challenge,1
guanine N-7,1
decanoyl-Arg-Val-Lys-Arg-chloromethylketone,1
corticosterone,1
carnosine-related peptides,1
homocarnosine,4
Homocarnosine,1
Thiazolidinediones,2
P=0.774,1
carbon dioxide removal device The,1
ARDSnet,1
[14%]),1
[3â² CSI] PPMO,1
PMOs (3 mg/day,1
cGAMP into,1
PBOO,1
alvespimycin,1
L (Ctsl),1
LD(50)s,1
NGR peptide,2
liposomal surface,1
LTSLs,1
LTSL,1
morpholine ring.,1
PMO conjugated,1
nonconjugated PMO,2
P-PMO,1
VSVÎG-BHLD virions,1
4-imidazolyl quinoline,1
"quinoline derivative of flavonoid,",1
Standard-Dose Wintertime Vitamin D,1
standard-dose vitamin D supplementation,1
IU/d,1
vitamin D oral,1
high-dose vitamin D supplementation,1
NCT01419262,1
[OR] 2.32,1
PLI,2
[125/131]),1
71/131,1
Romanowsky,1
ZiehlâNeelsen stains,1
bacilli-rich granulomas,1
antiprogestins,1
mifepristone,1
ulipristal,1
reactive species in,1
enzymeâproduct,1
visible-light,1
light-absorbing contaminants,1
[OR] 9.5,1
VQQESSFVM,1
Glu4,1
CyA,5
isatinyl/indanyl nitrones,1
free radical intermediates A,1
indanone,1
bradykinin-induced,1
adamantane binding sites in,1
adamantane,3
adamantane binding of the,1
"1,2-dimyristoyl-sn-glycero-phosphocholine",1
Phosphatidylinositol 4-Kinase III Beta Is,1
clinical-stage,1
"E,",2
CoV-specific,2
"[EC(50)s], 3 to 8 Î¼M",1
FMD,2
butyrate-producing microbiota,1
short-chain fatty acid,2
butyrate-producing,2
guanosine ribonucleoside,1
guanosine cap,1
7-methyl guanosine capped,1
DSG,1
cis-adhesive,1
FRET-FLIM,1
Î±1â2-Mannose,1
TAG,1
pyridylaminated oligosaccharides,3
Mannobiose,1
mannotriose,1
mannopentaose,1
dodecapeptide,2
broad-spectrum reverse transcription,1
10.1007/s12250-018-0011-8),1
L mRNAs,1
PEG 8000,1
nanodrops,1
2003â2005,2
Adamantane Derivatives nan,1
phosphorothioate (PS) LNA ASO,1
2â²-5â²-linked oligoadenylates,1
microtubule associated protein 1 light chain 3,1
europium,1
intravenous remdesivir,1
oligomer-to-monomer,1
L peptide,1
soy,5
nonâpolitical,1
sialic acid binding proteins,1
SBPs,1
sialic acid species,1
N-glycolyl groups,1
30â100-nm intraluminal vesicles,1
VIR-576,1
flavonoid-like,1
ssDNA] phage,1
dsDNA] phage,1
5â² capped,2
5â² structures,1
polyglucosamine locus,1
capsular polysaccharide,2
L polymerase (,1
p92(pol,1
fibrinolysins,1
evidence-driven,2
polar,8
HACS,1
Triton X-100 treatment,1
Triton X-100-inactivated virus,1
cell-permeant miniature proteins,2
deoxymannojirimycin,2
5â²CS,1
CS3,1
Sat toxin,1
Corticosteroid Use,1
mock/PBS [,1
mock/DEX [,1
FR1,3
FL2,1
anti-FR1,1
liposome-associated,1
NTP binding,1
NTP recognition,1
4f,2
dipalmitoylphosphatidylcholine,2
phosphatidylglycerol,1
manganese ions,1
ribonucleotide misincorporation,1
H273R PV,2
RGU,1
Inhaled innate immune ligands,1
Chromosome 14,1
S-adenosyl-L-methionine,3
amine,2
E64c (200 Î¼M,1
E64d ester,1
practolol,1
terfenadine,1
base-stacked,1
SARS-CoV. IFN,1
CI 1Â·067â1Â·231,1
transition-state nucleotide,1
F287A,2
F164A,1
IR780,1
peptidyl fluoromethyl ketone,1
FMK,1
http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.22/issuetoc,1
reactive nitrogen oxide species,1
LCP,2
fluorochrome,1
nucleotides 166 to 129),1
CRT/E6,1
Viramidine,1
"2,3-bisphosphoglycerate",3
nucleoside kinase(s,1
deoxycytidine kinase,1
SC compartment,1
flucytosine,1
NS collected with,1
Disulfide bonding,1
disulfides,2
disulfide bonding,3
alfacon-1,1
spectinomycin,4
neamine,1
CSAX,6
BAD327,1
NAADP Receptors,1
"Ca(2+)-mobilizing messengers,",1
NAADP,4
nicotinic acid adenine nucleotide diphosphate (NAADP)-mediated,1
PAA,3
eIF2Î±,1
L upon viral,1
16Â·09,1
anti-Nogo-A,4
Dobrava-Belgrad virus,1
plerixafor,1
Isoniazid,1
HSP65- and,1
Leu221,2
tubacin,1
Tubacin,1
microtubule filaments,1
SR/RS clusters,1
Ganoderic acid A (GA-A),1
BW specimens identified 4 additional,1
endothelin-1-induced,1
systemically-applied diminazene,1
A-779,1
quencher dyes,1
quencher moiety of,1
conjugate aptamers,1
Long-Term Ventilation (,1
Long-Term Ventilation,1
Long-Term Acute Care,1
antihistamines Hyun-Sun,1
Betamethasone,1
Min-Jeong Heo,1
CPT) Angelika,1
spirulina,1
CO2-enriched,1
anti-IgE,1
A44,1
Hoon-Soo,3
steroid ointment,1
Tam,2
carboxymethyl glucan (,1
CM-glucan,1
Ga,9
Le Pham,1
"Le Pham,",1
aspergillusfumigatus,1
25-hydroxy vitamin d,1
allopurinol â,1
Jing-Nan Liu,1
Le Pham A100,1
omalizumab Ãmer Ãzbudak,1
Mo A106,1
Ara h,1
mepolizumab,1
Hye-Sook,1
polyprenol,1
Le Mignon A128,1
Budesonide,2
airborne fungi Seung-Heon,1
Cellulose,2
tiotropium bromide on,1
M-16V,1
Chan-Sun,2
A156 A,1
Inok,1
âinduced,1
airway hyperresponsiveness Jin-Young,1
Jihye Kim,1
Hye-Soo,1
Rupatadine,1
Fatty Acid Binding Protein Der p 13 Is,1
Narissara Suratannon,1
Jongkonnee,1
Diahn-Warng,2
Intralymphatic,1
Mo A234,1
Cremophor,1
A241,1
Feno,8
Drugs-Induced Liver,1
Diclofenac Ismet Bulut,1
Soo-Jong Hong,1
Pranlukast,1
Jeongho Lee,1
Airway Hyperresponsiveness in,3
Beta-Lactam,1
Fengqin Liu,1
Jong-Uk,2
Phaik,1
Chang-Jong,1
A314,1
A319,1
Vitamine D,1
Levocetirizine,1
Tablet Versus Individual,1
Tablets,1
Thistle,1
Airway Hyperresponsiveness,1
Pollen Sublingual Tablet,1
Bronchodilators,2
Non-Steroidal Anti-Inflammatory,1
A355,1
Salbutamol,1
Fluticasone Propionate,1
Vitamin,1
Adrenaline Autoinjectors,1
Inkyu Lee,1
Capsaicin,3
Methacholine,1
Mannitol,3
N-Acetylcysteine,1
Juandy Jo,1
Nonsteroidal Anti-Inflammatory Drugs,1
Methotrexate,1
Lactobacillus Gasseri PM-A0005,1
Anticholinergic Agents Mimicking Anaphylaxis Sheryl Van Nunen,1
Aminophylline,1
"Reactive Oxygen Stress Kazuhiro Sekimoto,",1
Cocoa,2
Aluminium,1
Formulations,1
Antihistamines Jasmina Golez,1
Kyung-up,1
Neutophilic Inflammation,1
A555 Two-Step,1
Nonionic Contrast Media,1
Neutrophilc Inflammation,1
A572 A Report,1
Sodium Sulfite,1
Red Maple Trials Allergen,2
Nintedanib,1
Allopurinol â,1
Glatiramer Acetate:,1
SAHA,1
Antihistamine,1
N-Acetylcysteine Ji,1
Adenosine Monophosphate,1
Cement,1
Nickel Allergy,1
Famotidine,1
Pheniramine,1
Daniela-Ioana Munteanu,1
Dalila-Ana,1
Cleo RoÅculeÈ,1
Mioara,1
fumaric acid esters Rodica Olteanu,1
Cleo RoÈculeÈ,1
"NiÈescu,",1
Sorina Claudia,1
Hristea A108 Kidney injury molecule-1,1
Ion Aurel Iliescu,1
powder paint,1
Broad-spectrum Investigational Agent GS-5734,1
intravenous (IV),2
[RP] (,1
work-restriction,2
IANCs,1
coconut,1
[NHC],1
10.1186/s12889-019-6778-1,1
2 formed,1
crystalloid,1
lactated Ringer,4
crystalloid fluids,1
Norepinephrine,2
"vasopressin,",1
Dopamine,1
iCa(2+,1
11:216-228,1
SDSâpolyacrylamide,1
ketoprofen,16
ketoprofen derivatives 4aâj,1
carbamate functionalities,1
"hydroxy derivative 2,",1
1-benzotriazole carboxylic acid chloride (1),1
benzotriazole derivatives 3a and,1
Compounds 3a,2
"1,1-diphenyl-2-picrylhydrazyl radicals",1
phosphinimine,1
zinc chloride catalyzed reaction of,1
acyl chlorides RCOCl,1
deprotected derivatives 7a,1
dibutyltin oxide,1
2-(5-substituted-1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)-N-substituted-hydrazinecarbothioamides ABSTRACT,1
-cytostatic,1
"Derivatives 4b, 5a,",2
CM-Sephadex C-50,1
POROS HS-20,1
Fusarium solani,1
copper-catalysed azide-alkyne cycloaddition reaction,1
di-propargylated azetidin-2-ones,1
N-alkylazido isatins,1
nitric oxide production A,1
monosubstituted malonic acid diesters with,1
guanidine,3
sodium ethoxide,1
thiocarbohydrazide,1
carbohydrazide derivatives,1
5-substituted isatin with thiocarbohydrazide or,1
carbohydrazide,1
mouse-skin,1
saquinavir,3
Diphenylene Iodonium Chloride (DPI),1
p<.005,3
electron microscopy(EM,1
antitubercular,3
indole derivatives ABSTRACT: A series of indole-based spirothiazolidinones,1
"polycyclic aromatic hydrocarbons,",1
CHEMS,1
reversed-phase liquid,1
glacial acetic acid,1
N(1)-(phosphonoalkyl)uracil derivatives ABSTRACT:,1
(E)-3-ethoxyacryloyl isocyanate,1
I(2)/CAN,1
OKA,1
hydrazide derivatives,1
nevirapine (IC (,1
trans-dihydronarciclasine derivatives,2
phenanthridone alkaloid analogues,1
trans-dihydronarciclasine analogues,1
phenanthridone,1
studyshows,1
citrate buffer (pH 7.0,1
thioglycolic acid,1
5Î±-Androstanolone Derivatives,1
N-containing epiandrosterone derivatives,1
phenylacetic acid chloride,1
antivirals + school closures:,1
carbon nanotags,1
hydroxy derivatives ABSTRACT:,1
four-atom,1
N/C atoms,1
(13)C NMR spectral data,1
SM is a,1
10.1007/s10344-018-1220-z,1
multicolor quantum dot (,1
multicolor QD,1
orientin,1
scutellarin,1
3â²-methoxy puerarin,1
3â²-hydroxy puerarin,1
"3,4-dimethoxybenzoic acid",1
cynaroside,1
ferric reducing,2
ethylenediaminetetraacetic acid,3
TSA,16
dual-labeled FRET,1
amines,1
Antioxidant,1
PEG (polyethylene glycol),1
part-rough,1
part-smooth,1
[(3)H]leucine,1
Isatin derivatives in reactions with,1
five-coordinate phosphorus compounds,1
cis face (cis Golgi apparatus network),1
cis compartment membrane,1
2-thio-containing pyrimidines,1
exocyclic sulfur atom,1
[3+3],1
[4+2],1
[5+1] cyclization,1
"fungicidal, herbicidal,",1
10/pack,1
10.1007/s10344-019-1326-y,1
Ethyl 5-Hydroxy-1-Methyl-2-(Trans-2-Phenylcyclopropyl)-1H-Indole-3-Carboxylate Ethyl 5-hydroxy-1-methyl-2-(trans-2-phenylcyclopropyl)-1H-indole-3-carboxylate,1
10.1007/s10344-018-1199-5,1
hAGP,3
[TRR],1
1998âearly,1
CTB-OVA epi,4
CotB-based surface,1
isopropylthio-beta-D-galactoside,1
cholera toxin B subunit,1
pMYV717,1
cellulosic filters,1
cellulose hollow fiber filters,1
glycoside,1
1 lobe in 9,1
BUN,4
CD(4)/CD(8,1
N-(4-aminobutyl)-N-ethylisoluminol (ABEI)-functionalized,1
piceatannol,1
metal oxide,1
Volatile organic compounds (VOCs),1
organic pollutants in wastewater is,1
2-nitropyridine-N-oxide,1
triple-zeta,1
2-nitropyridine-N-oxide (,1
2-NPOs,1
fluorine substituent,1
RISP,1
[2Fe-2S] redox,1
Sepharose 4FF,1
lignin,2
cutin,1
suberin,1
10.1007/s11738-019-2915-9,1
l-valine,1
phenylpropionic acid,1
isoxazole acid chloride,1
bismuth citrate,2
ethylenediamine,2
pyridine],1
pyridine moieties,1
ranitidine bismuth citrate,3
10.1007/s11426-010-4113-x,1
BDAP,1
geranyl substituents,1
chlorophyll,5
5â² -orf1a-orf1ab-s-3a-3b-e-m-6a-6b-n-3â²,1
CTB-S1D,2
Hollow-Fiber Ultrafiltration,1
hollow-fiber,1
glass wool filter,1
Thymopentin,1
corticosteroid (CS),2
glycerides,2
Pisum sativum,1
LDA,4
Isoleucyltryptophan Dipeptide,1
aromatic thiosemicarbazone derivatives were synthesized by condensation of N-(4-cyanophenyl)hydrazine carbothioamide (I),1
(7) cardiovascular diseases,1
SubLocation,1
Cy5-universal,1
"Î±-1,2",1
NA could,1
N4,1
POM,1
10.1007/s11434-010-3271-8,1
biodiesel,2
NAA,1
ICWM (,1
Glycyrrhetinic acid 3-O-mono-Î²-d-glucuronide,1
broncho-inflation,1
ICWM,1
galanthamine-type,1
FITC,2
fluorescein isothiocyanate)-conjugated goat anti-mouse IgG,1
doi:10.1007/s12039-015-0982-z,1
2-23,1
(+),1
1â2 Î¼l,1
anti-cariogenic,1
Ru,3
ESM):,1
10.1007/s12257-018-0408,1
acetonitrile-water,2
0â¼10,1
G(M1)-ganglioside,1
glucoside,1
malto-oligosaccharides,1
EGCG glucoside,1
EGCG-G1,3
maltose,3
1 326 bases long respectively,1
FEN,3
ONS,2
3â² fluorophore,1
sodium aluminosilicate) powders,1
metal ions,4
Silver/copper zeolite,1
clay mineral-based hybrids for,1
Theaflavin,1
Hexose,1
hexosamine,1
chloroquine phosphate,6
PVI,2
EKC,1
N-chlorotaurine,2
Acetazolamide,4
Nifedipine,3
glass-like,2
MK642275,1
MK642276,1
Plavix fzzranchise,1
glycyrrhizinic acid nanoparticle carriers,1
âpublic temperâ,1
inorganic metals,1
inorganic nonmetallic compounds,1
carbon atoms,3
poly-amine,1
"1,4-phenylene diisothiocyanate",1
1-(3-dimethylamino propyl)-3-ethylcarbodiimide hydrochloride,1
N-hydroxysuccinimide,1
AACA-Copolymer surface,1
10.1007/s13206-019-3404-3,1
PEGs,1
chaotropic salts,1
NaOH,3
Sodium Dodecyl sulfate,1
anionic detergent,1
vasoconstrictors,2
vasodilators,2
193-amino acid RBD,2
aurones,1
okanin glycosides,1
terpenes,10
pheophytins,1
phytosterols,1
anti-malarial,1
ionic liquids,1
Chlorogenic acid,2
[C6mim] Br aqueous,1
ionic liquid disposal,1
FLJ,2
DAIB,2
Kaempferol,3
SwissADME,1
Ellagic acid,2
propidium iodide stain,1
high-dose ribavirin,2
ZVD,1
C/L,1
benzodiazepines,1
high-polymeric double-stranded RNA,1
Hoe terecht,1
noodzaak,1
weten,1
bepaalde ziekten,1
tweede bedreiging,1
vermoeidheid,1
emergency/control,1
24(th,1
non-steroidal anti-inflammatory drugs,3
COVID-19âa,2
"low-dose steroids,",1
anti-CD20,1
Nitrogen,2
~0.35,1
IQR=256,1
2015âMay,1
Le personnel doit avoir reÃ§u,2
Travailler dans un contexte de changements continus,2
DLCO,4
SDPP diet,1
benzoic acid [BA],1
subtherapeutic antibiotic,1
PIC 1050 sows,1
acidifier,1
"fumaric,",1
lactic,1
phosphoric acid),1
NC + ZnO + acid,1
NC + DFM + RS,1
ZA,3
caprylic (C8),1
capric acids,2
C10,1
caproic acid; 6),1
caprylic acid; 7),1
capric acid,1
lauric acid; 9) 1,1
capric,2
lauric acids,1
C12,9
coconut oil,3
Commercial-based,1
caproic,1
caprylic,2
MCh,2
2SAL,2
Ã ITM interaction (P <,2
2SAL calves,1
N7-guanine,5
5â² capping,1
N7-guanine MTase,5
TWAS,1
estradiol,4
steroid hormones,4
[RVP],2
skimmed milk),1
8.00,2
skimmed milk,1
chitosan microsphere,4
chitosan microspheres,2
chitosan microsphere with,1
(+25.97Â±0.56,1
FCCS,2
High-Dose Intravenous Immunoglobulin as,1
high-dose intravenous immunoglobulin (,1
high-dose IVIg,1
methyl thiazolyl tetrazolium (MTT),1
Circular-Coupled,1
infectionâand,1
chaper,1
TCE,1
heme detoxification,1
ferroquine,4
[angiotensin-(1-12)],1
alipogene tiparvovec,1
chemical-vapor,1
chitosan derivatives,2
Low Probability Eventsâ,1
proton channel,1
amiloride derivatives,1
"[1, 2]",5
junk DNAs,1
D-ribose sugar,1
virazol,1
[66],1
ribavirin [92],1
nucleotide sugars,1
UDP-GlcNAc,1
UDP-Gal,2
GDP-fucose,1
GDP-Fuc,1
CMP-Sia,2
UDP-GlcA,1
GDP-mannose,2
GDP-Man,1
UDP-xylose,1
UDP-Xyl,1
PAPS,1
NSTs,1
bepaalde situatie,1
tree-in-bud,1
Glycans,1
heparan sulfate proteoglycan,2
algemene principes,1
vrije rand,2
fungus or interactive bacterium-fungal species,1
oorziekten Hypertrofie,1
schoolleeftijd,1
Aet,1
chemo-,1
variable-vessel vasculitis,1
zie fig.,1
â§ Tab,1
"ultraviolet germicidal irradiation,",1
germicidal chemicals,1
ultraviolet germicidal,1
Ultraviolet germicidal irradiation is,1
anti-hemorrhoid,1
free-radical scavenging enzyme,1
Se are,1
EPA (,1
childrenâs multivitamin-mineral,1
Nanoliposomes,1
Liposomes (phospholipid bilayer vesicles,1
woven,1
aminotransferases,4
dual-labeled fluorescent,1
6-carboxytetramethylrhodamine,1
quencher dye (Absolute Quencherâ¢,1
CT Computed tomography (CT),1
"[2, 3]",3
[4],13
invader-native,1
[7],6
[9],5
[10],2
Amoxicillin,5
OSHA,2
Z-Curve,1
polyethylene glycol-conjugated IFN-Î±,1
fluoroquinolone,2
zolang op gespecialiseerde hulp,1
Notaufnahme des Krankenhauses gebracht,1
voornamelijk,1
PES,2
Na 1970,1
hernieuwde sterftedaling,1
vaatziekten,3
vaccinaties,1
vaak op jonge leeftijd,1
vaak oorzaak ernstige psychische problemen,1
verhoogde bloeddruk,1
Vroegere opsporing,1
slechthorendheid,1
schrijven,1
legionellose,1
steun heeft gunstig,1
Rol genetische factoren,1
sulfur,2
Spezies,1
Fortbestehen der Spezies zu garantieren,1
Micro-CT,1
high-dose methylprednisolone (MPS).The,1
HEPE,3
macrolides [irrespective of microbial etiology],1
UV-B,13
emergence/selection,1
antibiotic agents against certain microorganisms,1
cement,1
thymidine kinase-dependent nucleotide,2
ECMO Network,1
tri,1
tetra,1
Monoterpenes,1
Electron Microscopes,1
Scientistsâ Stories,1
10(28,1
fluconazole use,1
purine analogues,1
anti-oxidants,1
Drug Administration (FDA)-,2
E monomers,1
(13)C(Î±,2
imidazole ring of histidine in proteins,2
Polycationic nanocarriers,1
infection/reservoir,2
Fomites,1
target/population,4
diagnostiek,1
[1â4].,1
[1â4],1
[6],5
recidiverende middenoorontstekingen,1
vernieuwde inzichten,1
transmucosal routes,1
fluorescent dyes conjugated with,1
chromogen,1
cephalosporin,6
vraag opgeworpen,1
managerâs,1
klachten,2
eventuele stoornissen,2
eerder,2
Na enkele dagen herhaalt,2
Provitamin D,1
7-dehydrocholesterol,1
previtamin D,1
"1,25-dihydroxyvitamin",1
CARTs,1
Lactobacillus spp,1
prebiotics like fructose oligosaccharides,1
conjugates,3
viewpointâas,1
Dat blijkt,1
glucans,1
lorazepam,1
drug-encapsulated colloidal,1
high-inspired oxygen,1
agent.(1,1
[5].,6
intraparticulate,1
fatty degeneration,1
UCNPs,2
leeftijdsgroep,1
steroidal glycoalkaloids,1
Ajmaline,1
ajmaline,1
fertilizers,3
overgrote meerderheid,2
verdere diagnostiek,2
sulfinate,1
limonoids (tetranortepenoids),1
anthranoids,1
2â3mg/mL,1
Nitric Oxide in,1
Se deficiency,2
Se dependent),1
"nicotine,",1
[161],1
[107],1
[33].,1
[149],1
beliefâimperfect,1
Nanoformulations,1
NTP hydrolysis,2
[8],1
non-transporters/non-channels,1
disaccharides,1
verwijzen,1
Saponin,1
extra-calcemic,1
bevorderen dat,1
âMethodology,1
[1â3],3
ZoÃ¶nosen Een zoÃ¶nose,1
coliforms,3
"infections,-",1
FCC requires,1
FCC,1
two/year,1
animal/animal products,1
Deze situatie,1
taaislijmziekte/cystische fibrose,1
PC6,1
PC8,1
nonbasic peptide,1
4-aminoquinolines,1
vitamin C-insufficient mice,1
high-dose vitamin C,2
luchtweginfecties bovendien,1
risicogroepen ter voorkoming,1
Flavours of Antiviral Immunity Viral diseases are a major cause,1
curry,1
sulforaphane,2
beta-hemolytic streptococci,1
environmentâand,1
NM-driven host,1
Microspheres,1
solders,1
fenugreek seeds,1
"[4, 6]",1
"[7,",1
zo kunnen nieuwe infecties,1
side-chain polar,1
isopropyl Î²-d-1-thiogalactopyranoside,2
xylenes,1
semi-volatile organic compounds (SVOCs),1
fungus responsible,1
IPR,4
soaking fungi with,1
silver,3
condensed cargo,1
ZnT,2
-12,1
laninamivir,1
[3â5],1
"[3, 8, 9]",1
opium,1
muramic acid,1
MVOC,2
cobalt,3
gallium,1
metal chelators,1
monoterpenes,2
diterpenes,1
geraniol,1
citronellol,1
immunoablation,1
Inhaled foreign body,1
vitamin D insufficiency/deficiency,1
L-type CRD,1
single-and-brief,1
Cephalanthera,1
Crepidium,1
Biomass,1
fine-particulate matter (,1
donorâs organs,1
SHOC,1
Cholera und EHEC-Infektionen,1
Zytomegalie-Virus-Infektionen,1
[7] DNA helicase III <4> [27] DNA,1
[45] Dbp9p,1
[24]) [24] DmRECQ5,1
[45] Hel E,1
"[43,54] MCM",1
"6,35",1
[43] MER3,1
"[38,65,66]) [38,65,66] NS3 NTPase/helicase <14>",1
[67]) [67] NS3,1
[63]) [63] NTPase/helicase,1
"[61]) [61,64] PDH120",1
"[49,50] RECQ5",1
[49]) [49] RECQL5b,1
[13] RSF1010,1
"[16,22] UvrD",1
[12] WRN,2
[53] helicase DnaB,1
"[61,62]) [61,62] nonstructural protein 3",1
"[38,63,65,66,67]",1
"[4]) [4,38,63,65,66,67] protein",1
[62]) [62] scHelI,1
"[1,2,4,5] SARS",1
inorganic materials,1
inorganic fibers,1
metal oxide fibers,2
chengshi yunyingshang,1
natureâs antioxidants flavonoids,1
"10,12",1
"[1,36] ATPase/RNA helicase",1
"[36,41] BMV 1a",1
[12] DDX19,1
"[12,21] DDX3",1
[12] DDX5,1
[12] DEAD,1
"[11,14] DENV",1
[41] DEXD/H-box,1
[16] EhDEAD1,1
[16] FRH,1
[7] Mtr4p,1
"12,39",1
"[27,42,44]) [1,2,4,27,35,36,39",1
[41] NS3 NTPase/helicase,1
[46]) [46] NS3 helicase,1
"[39]) [15,39,40,41,62] NTPase/helicase",1
"[37]) [37,39] RHA",1
"[51,57] helicase",1
[41] helicase B,1
[4] non structural protein 3 <12>,1
"[37,38]) [37,38] non-structural 3",1
[4] nucleoside triphosphatase/RNA helicase,1
[38]) [38],1
ENC-GC3S plot,1
supplemental oxygen and,1
defibrotide,1
MCM,1
(18)F-FDG,1
[2] paved,1
Chemical Risks Food Security,1
[5] and,1
Nucleic acid,1
TADs,3
metal oxides,2
Psymberin,1
psymberin,1
mycalamides,1
"[25, 26].",1
immune-modulating agents,1
Na(+)-dependent GABA transporter,1
phenanthrenes,1
stilbenoids,1
anthocyanins,2
carbon tetrachloride,4
type(s,1
Glycyrrhizinic Acid,1
Glycyrrhetinic Acid Glycyrrhizin,1
aglycone glycyrrhetinic acid,1
on-setting disasters like climate,1
1â100 nm,1
[1]),1
Food Policiesâ,1
starch,6
inorganic salts,1
nitrogenous constituents,1
Lane 1973,1
"[38,68] ACE-related carboxypeptidase",1
[7] Ang converting enzyme 2,1
[7] angiotensin-converting,1
"[7] angiotensin-converting enzyme-related carboxypeptidase <9> [1,6] angiotensinase",1
[4] hACE2,1
"[36,67,74] CAS",1
immunomodulators with lipids to,1
allyl disulfide,1
allyl trisulfide,1
tomatine,2
inulin,5
methyl-specific,2
stereo-array isotope labeling (SAIL),1
"regio-selectively [(2)H, (13)C,",1
aromatic ring-flipping motions,1
GHS,4
âCoronaâ,1
international/regional,1
copper nanomaterials,1
nano-sized metals,1
zinc oxide nanoparticles,3
copper nano-antimicrobials,1
isoliquiritin,1
isoflavones,9
antidemulcent,1
AFAR,1
6-point,1
e-libraries,1
Triterpene einschlieÃlich Steroide,1
1.13â1.25,1
COVID-19-positive patients,1
zwangerschapsuitkomsten kunnen,1
COVID-19 Hydroxychloroquine,1
nonsteroidal anti-inflammatory drugs (,1
Ibuprofen,2
IO,3
re-territorialisation,1
viajeros que,1
investigara,1
JournalScan,1
COVID-19 derived,1
loracarbef,4
cefaclor,4
amoxicillin/clavulanate,2
Loracarbef,1
microsomal lauric acid hydroxylase,1
lauric acid,1
microsomal metabolites,1
microsomal protein,1
Hydrogen peroxide,1
NADPH-supported microsomes,1
"2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride",1
10-undecynoic acid,1
Phospholipid vesicles,2
"potassium ionophore,",1
70-fold,1
gramidicin,1
H+ eâ,2
gramicidin (0.14 mg/g phospholipid,1
extravesicular,1
gramicidin acts,1
methyl viologen nitrate reductase activities,1
NADH cytochrome c reductase,1
carbodine,2
cytidine Abstract Carbocyclic cytidine,1
corona],2
CTP,9
Urd,2
Cyd,2
dThd,2
dCyd,2
Cyd (10 Î¼g/mL,1
HAG,1
ribonucleotide reductase,2
HAG derivatives [RCHî»NNHC(î»NH)NHOH-tosylate],1
dihydroxy-,1
trihy-droxybenzylidene-HAG derivatives,1
HAG derivatives,1
[3H]cytidine,1
[3H]deoxycytidine nucleotides,1
acid-soluble,1
cyclopentenylcytosine,1
Cyclopentenylcytosine,1
pyrazofurin,2
Î±-methyl mannoside,1
carâyterminus tail,1
l-glutamine,2
jejunal sodium,1
Na+,18
NaC1,1
Electrolyte,2
Ca2+,42
Na2+,1
"mucosal-to-serosal,",1
serosal-to-mucosal,1
Clonidine,1
d-glucose,1
o-dianisidine,1
Imino protons,1
DA virus,5
isotonic saline,3
Folate,1
dimethylamine,1
Dimethylamine (DMA),1
EDU,10
N-[2-(2-oxo-1-imidazolindinyl)ethyl]-Nâ²-phenylurea,1
ozone-induced,1
mutagens,1
sulfhydryl reagents,5
iodoacetic acid,2
sulfhydryl reagent,1
dextran-maleimide,1
[14C]Iodoacetic acid,1
Mg2+,9
urea-polyacrylamide,1
nonionic detergent,1
RNasin,1
anti-dsRNA,1
Queuine (Q),1
apoprotein of 1363 amino acids,1
inter-chain interactions,1
nucleoside triphosphate binding motifs,1
polycyclic aromatic hydrocarbons (PAH),3
chromium,9
organic dust from municipal composts,1
Cocaine,3
accumbens synaptic,2
DA vis-Ã -vis 5-HT,1
VTA,5
SC on,1
SC cocaine,3
SC cocaine (20 mg/kg),1
vlNAcc,4
stearate,1
vlNAcc DA,1
Ibogaine,3
ibogaine,4
Trans splicing,1
trnas,1
4b late,1
SN (neutralisants),1
PI 3,1
arachidonate,3
cysteinyl-leukotrienes,1
PGs,1
PGE1,1
PGI2,1
PG analogs,1
protein-bound 125I,2
protein-bound,2
Oestrone/Oestradiol,1
oestradiol,1
[methyl-3H] thymidine,1
Con,1
lipopolysaccharide (LPS)-induction,1
reactive follicular hyperplasia,1
1â12,2
IFN-Î³ or TNF-Î± oligodendrocytes,1
phorbolmyristate acetate,1
galactocerebrosides,1
IFN-Î³ 12â24,1
IFN-Î³ for 24,2
inf + /OME-,2
nonionic detergent Î²-D-octylglucoside,1
cesium gradients,1
guanidinium salt,1
"MDL 20,610",2
"dimethyl sulfate,",1
kethoxal,1
carbodiimide,1
Thunnus albacares) pyloric caeca aminopeptidase,1
1-cyclohexyl-3-(2-morpholinoethyl)carbonyl-metho-p-toluene sulfonate,1
phenylglyoxal,1
tetranitromethane,1
Trans splicing in trypanosomes â,1
Trans splicing is,1
cis splicing or archaic remnants,1
OPA,2
Nedocromil,2
Nedocromil sodium,1
cromolyn,1
Phosphatidylcholine,1
HCFC-141b,4
ophthalmoscopy,1
dolichol,3
Tunicamycin,13
halofuginone lactate,16
Fatty acylation of proteins nan,1
sodium ions,1
non-acidic compartments,1
K+,3
coccidiostat,3
monensin poisoning are,1
monensin poisoning is vacuolization and/or swelling of,1
[26],1
Fluosol-DA,1
-DA 20,1
perfluorochemical,1
E polypeptides,1
E polypeptide,1
sodium dodecyl sulphate - polyacrylamide,1
1 Ã,6
OSSMe,5
hydrophobic-interaction,2
"ion-exchange, metal chelate",1
zwitterionic an non-ionic detergents,1
Column liquid,1
1 isolates,1
IDPN,4
IDPN (400 mg/kg/day,1
IDPN (200 mg/kg/day,1
tetrapeptides,1
propol,1
MDC,2
LNP-siRNA,1
reactive astrogliosis,1
fatty non-inflammatory hepatic disease,1
chiasm,1
Viridans streptococci,2
cis element consensus,2
439-amino acid long protein,2
equimolar mixtures,2
Penicillium chrysogenum,1
lactam ring of the,1
dodecasaccharides,1
dodecasaccharides are 1 x,1
lipopolysaccharide layer,1
C-9 acetylated sialosides Abstract A chemo-enzymatic,1
"[(5-acetamido-9-O-acetyl-3,5-dideoxy-d-glycero-Î±-d-galacto-2-nonulopyranosylonic acid)-(2â3)-O-(Î²-d-galactopyranosyl)-(1â3)-O-(2-acetamido-2-deoxy-Î±-d-galactopyranosyl)]-l-serine acetate (1)",1
9-O-acetylated sialic acid 3,1
reactive airway disease,3
inmunolÃ³gicas,1
[125I]RB 129),1
K d=0.9,1
[K d],1
[125I]RB 129 (=10â6 M,1
Theophylline,2
polyethylene glycol 4000,2
mannitol permeabilities,1
nonpatch,1
chloride-,1
Interferon gamma,1
non-ionic detergents decylpolyethyleneglycol-300,1
sodium dodecyl sulphate,2
metal chelate affinity,2
micellar,4
ion-exchange HPLC,1
14.1g/L in calves fed CS,1
polyethylene glycol reduced,1
nonesterified fatty acids,5
Sodium Bicarbonate on Growth and,1
propionate,2
Sodium bicarbonate,1
cottonseed meals,1
Cottonseed,1
D) 2h,1
weight/d from d 14,1
2 terminal adenine,1
nonEnglish-language,1
PdSP15,1
Multiday,1
arterial oxygen tension/inspired oxygen,1
H2O,7
lactate <3,1
cross-circulation,1
malonaldehyde,1
12.5mg/kg body weight,1
acetylated derivatives of,1
"sodium 2Î²,3Î±-dihydroxy-5Î±-cholestane 3-sulfate",1
"sodium 2Î²,3Î±-dihydroxy-5Î±-cholestane 2-sulfate (7)",1
"disodium 2Î²,3Î±-dihydroxy-5Î±-cholestane disulfate",1
sodium 3Î±-acetoxy-2Î²-hydroxy-5Î±-cholestane 2-sulfate (12),1
sodium 2Î²-acetoxy-3Î±-hydroxy-5Î±-cholestane 3-sulfate,1
sulfated steroids,1
Compounds 7,1
disulfated steroid 8,1
sneezles,1
Cap structures,1
N7-methyl,1
HAA,1
[63] Fatty acid,1
fatty acid acylated proteins,2
protein-bound fatty acids,1
sodium dodecyl sulfate (SDS)-polyacrylamide,1
[1] Purification,1
[23/117] vs,1
[3/58],1
amoxicillin-clavulanate,1
[IQR 6â15] vs 14 days [8â16],1
broad-spectrum antiviral drug against,1
Magnesium,1
Magnesium (Mg)-based biometal,1
2â5 A,1
"2â²,5â²-linked oligoadenylates",3
depot,2
sodium hypochloride,1
conjugate pad;,1
quencher dye,3
analogs,1
[44],1
"[3,5]",1
[11],1
intranasal rIFN-a2,1
[42],1
Ala-pNA,1
Calvin,1
I0724/17,2
Supramolecular peptide nanofibers,1
self-assembled peptide nanofibers,2
CaPi,2
trypsin-PBS,1
enzymatical,1
PFR,2
12.14%Â±0.90,1
Propranolol,1
timolol,1
epidemiolÃ³gico,1
Se incluyen los,1
abscesos farÃ­ngeos,1
Se incluye informaciÃ³n detallada,1
caudatin,2
cinnamic acids,2
conjugated derivatives of,1
N-alkoxy indolylacetamide,1
NNRTI,4
non-nucleoside reverse transcriptase inhibitor) (,1
methyl (1-methoxy-1H-indol-3-yl)acetamidobenzoate,1
CI - 39,1
derivatives 10f and 10i (,1
NVP,3
10f and 10i were,1
EFV,1
10i,1
neuro-mediators,1
â,1
otologicals,1
Chitosan-based mucosal,1
2.07â2.64,1
norepinephrine (,1
CA1,3
triazolobenzodiazepine,1
TBZD,2
adinazolam,4
BZD,2
diazepam,5
Adinazolam,1
externo,1
exacerbaciones,2
interferÃ³n,1
evoluciÃ³n,12
pressor amines,1
estabilizaciÃ³n,1
publicados,1
Con respecto,1
con ellas destacan estudios de etiologÃ­a viral,1
actuaciÃ³n directamente ligados,1
esputo,1
peroxydisulfate (S2O8 2â,1
S2O8 2â,4
Singlet oxygen (1 O 2,1
carbonyls (,1
NaOCl,1
2mmol/L,1
chloramine TÂ®,1
1 O 2,1
Chlorogenic acids,1
CGAs,2
9-O-acetylated gangliosides,2
indole alkaloids from,1
RP-18,1
"Indole alkaloids, indigodoles A",1
tryptanthrin,11
HPLC-ELSD,2
quinic acid derivatives,1
phenylethanoid glycosides,1
saccharides,2
non-saccharide,1
physician-modified,1
Le VRS est identifiÃ© chez,1
order(s,1
CF11 cellulose,1
FAM dye,1
thiol-group,1
FE-SEM,1
HBCM,2
Pilocarpine Hydrochloride,1
pilocarpine hy-drochloride,1
pilocarpine,2
Salagen,1
Pilocarpine,1
macrolides prescribed,1
Le travail est,1
tar/pitch,1
B(a)P,3
carbon black,1
qinghaosu,1
Qinghaosu,1
schizontocide,1
Qinghaosu derivatives revealed dose-dependent,1
Nissl,2
dihydroartemisinin,1
proteinâpeptide,1
N-Glycolylneuraminic acid from food is antigenic in man,1
Sia O-acetylation,1
vitamin B6-Derived zinc-Chelating trioxa-adamantane-triol,1
vitamin B6,1
aldehyde pyridoxal with,1
phloroglucinol,1
hydrogen chloride,3
Zn2+) chelator,1
l-arginine derivatives,2
3.8Î¼M,1
nalidixic acid calixarene-based podands,1
nalidixic ester moieties,1
nitrogen heteroatoms can,1
copper- or ruthenium-catalysed azide-alkyne cycloaddition reactions,1
"alkylating agents,",1
anthracyclins,1
antimetabolite,1
"1,2-diamino-4,5-methylenediaoxy-benzene dihydrochloride (DMB)",1
KDN,1
"Neu5,9Ac2",1
"Neu5,7Ac2,",1
"Neu5,8Ac2,",1
Neu5Gc type of sialic acids,1
tiplaxtinin,1
SERPINEe1-derived peptide,1
phosphorothioate oligonucleotides,1
alemtuzumab/total body,1
Baycol,1
cerivastatin,1
clindamycin glucose,1
cAlthough,1
cerebrospinal fluid,1
sodium hydroxide,1
bromhexine,1
cidofovir,1
4.8mg/dl,1
Sulbactam/ampicillin,1
OVX,1
bacitracin,8
mbrAB,1
benzo[b]furan,1
MU314,8
"ICI-182,780",1
mutilobal,1
patchy/ground-glass,1
tablet (,1
252/620,1
BNI,2
BNR,2
[96â99],2
[73â85],1
[84â91],1
[2.2â6.2],1
[1.0â1.2],1
[1.3â7.4],1
thresolds,1
Lactobacillus rhamnosus,3
43/134,1
Intravenous sufentanil-midazolam,1
sevoflurane anaesthesia,1
Sufentanil,1
End-tidal sevoflurane,1
sufentanil-midazolam anaesthesia,1
H2O2,15
H2O2 signal,1
creatinine phosphokinase,3
2008â10,1
VRC 306,1
VRC 310,2
nitazoxanide 600,4
nitazoxanide 300,2
CI 0Â·09â0Â·24,1
[17Â·5],1
[3Â·6%,1
intramuscular 1,1
[44%,1
[8%] with 6 mg,1
Low-molecular-weight heparin,1
low-molecular-weight heparin,3
LMWH,19
nadroparin calcium,1
aspirin 80â300,1
OTC aspirin,1
conjugated vaccines,1
Part D vaccine,1
T3s,1
1 (1199Y) amino acid positions 160â161,1
TREY,1
16JZ0605,1
CO8089L/CO8091L-like viruses,1
thymol,1
clodronate-containing liposomes,1
Intravenous immunoglobulin IVIG,1
ion-exchange chromatography,1
IEX,1
glyoxal,7
aldehyde hydrogen,1
hydrogen atom,3
recibieron tratamiento,1
cefixime,5
cefuroxime (,1
desregulaciÃ³n (congÃ©nita,1
manosa,1
Se une,1
favoreciendo su opsonizaciÃ³n,1
eliminaciÃ³n,1
incluidas las infecciones del tracto,1
Se analizaron 1.293,1
"2,4-3,8",1
con las infecciones respiratorias leves,1
con 2picos,1
asociaron con,1
vacunaciÃ³n previa,1
embarazadas probablemente disminuirÃ¡,1
2peaks,1
describir las caracterÃ­sticas clÃ­nicas,1
epidemiolÃ³gicas,2
con evidencia radiolÃ³gica,1
confirmaciÃ³n microbiolÃ³gica,1
con un mÃ¡ximo,1
julio,2
escasa elevaciÃ³n,1
Antibiotic Prophylaxis,1
II-3B) 14,1
225-Lignes directrices,1
Le personnel offrant,1
Le personnel offrant des soins,3
seven-peptide TPEQQFT,1
tricarboxylic acid cycle/terpenoid backbone,1
1-deoxy-D-xylulose-5-phosphate,1
IiPAL1,2
L-Phe,1
trans-cinnamic acid,1
chromones,1
Oxidized phospholipids in,1
OxPLs,1
propidium iodide (PI)-Annexin-V,1
taxane,2
anti-EpCAM-immunotoxin,1
Reactive Anti-IGHV1-69 Anti-idiotypic Antibody G6,1
sialic acid receptor,1
10â26,1
NRCE-HKU270],1
[IQR 3â9],1
[4Â·9],1
7Â·7],1
glutamatergic,1
Ziehl-Neelsen acid-fast,1
birth-dose,1
Epimedium-derived,1
corticosteroid methylprednisolone,1
fluorescent dyes xylenol orange,1
calcein green,1
single-pool Kt/V,1
Kt/V,1
"[37.0,",1
"[1.9, 33.1] mg/L",1
1.628-44.864,1
corticosteroid treatment,3
2019-nCoV-Induced Acute Lung,1
AVF ST-segment,1
[left ventricle,1
1-2mg/kg/day,1
parenteral glucocorticoids,1
selamectin,2
mefloquine hydrochloride,2
[6.48 Â±,1
corona virus disease 2019,5
[n= 1,1
5-8d,1
â¥14,1
601/1014,1
year(s,2
"76,936",1
https://bigd.big.ac.cn/ncov,1
[+/-,1
ground-glass opacities (GGO),2
droplet/airborne PPE,1
2019-nCoV.,7
Tryptanthrin,1
betulin,2
extract,2
mu;M,4
carbetocin,1
carboprost tromethamine,1
long-acting uterotonic agents could,1
Midazolam,1
fentanyl,4
'd like,1
"lactic acid (1.70 (1.30, 3.00) mmol/L vs. 1.20 (1.10, 1.60) mmol/L",2
ACEI/ARB,5
5.20-6.91,1
15(37.50,2
53/230,2
5/230,2
[(43.78Â±11.12),1
[(44.84Â±10.42),1
[(44.30Â±18.42) vs(36.91 Â±,1
convectional PR,1
decreased(15/29,1
corticosteroid in patients with,1
(1~2 mg.kg(-1).d(-1,1
1 (1/9),1
"chloroquine phosphate tablet,",1
powder inhaler metered dose inhaler with,1
bile duct epithelial cells,3
36.20 ~ 44.20) g/L,1
15.95 (11.34 ~ 20.83) mmol/L,1
enteral feeding tube intubation/percutaneous,1
1-10,1
topsentin,3
Î¼M topsentin,1
ethidium bromide,5
CC-1065,1
Quest-Meridien Ltd. 1985. 300 pp,1
FernstrÃ¶m,1
146â155 1992,2
iridoid carbon,1
X + 483 pp,1
Na+ +,1
palytoxin,1
162â167,1
[2] Families,1
1980â1985,1
nonactin,1
FH6,1
Co Ltd,1
Le Chesnay,1
Daptomycin,4
daptomycin,7
LY146032,1
"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",1
1400-cow dairy,1
PCC area,1
paromomycin sulfate,1
dayâ1,1
acetone-butanol,1
âfounder effectâ,1
cotinine,2
inhaled azodicarbonamide on,1
ADA/m3,3
biurea,3
1 ppm ozone,2
1 ppm ozone;,1
1 ppm ozone for,1
body-weight,4
ferrocene-,1
ferrous,1
iron-catalyzed lipid peroxidation,1
Fourteen-day,1
callose,1
spiem,1
TGE-virus-vaccinated gilts,1
atrazine,1
Thymidine kinase deletion,1
NovaGene,1
uranyl acetate,1
diethylcarbamazine,2
"diethylcarbamazine (N,",1
N-diethyl-4-methyl-1-piperazine carboxamide,1
Le traitement est symptomatique,1
Le diagnostic virologique,7
macrolides in respiratory tract infections Macrolides,1
macrolides for respiratory infections,1
HOE,1
Fatty acids,1
D locus,2
3Â·7 megarads,1
1Â·7 Mrad,1
2Â·4 Mrad,1
phytotoxin,1
halogens,1
normal/abnormal,1
benzotriazole derivatives in,1
benzotriazole complexes,1
hydrolysable,1
condensed tannins,1
Sugar moieties,1
beer haze,1
amide bonds involving carboxylic acids,1
main-group,1
main-group element,1
stilbenes,5
1000â3000,2
FDI,5
environmental-friendly,1
inorganic NPs,1
hydrogen peroxide vapor,1
H2O2 vapor),1
aHP,2
"methyl chavicol,",1
enviromment,1
bile from infected cattle,1
SN antibody,1
Pathogens,2
specied,1
NS 20904,1
NS 00717),1
glycosylâphosphatidylinositol,1
viroid-like pathogens,1
myristate,1
hydroxytryptamine,1
agentâhas,1
NTO,1
NTO vaccines,1
QA,4
tumorurveillance,1
BOD,1
High-dose corticosteroid therapy might,2
theophyllines,1
monounsaturated fatty acids,2
IFN kappa,1
cowsâ milk,1
inorganic particles,1
Actinonin,2
brush border,1
Cis,1
calcium hypochlorite,3
sodium dodecyl-sulfate,1
agents like antisense oligonucleotides,1
inorganic contaminants,3
radon,2
nitrogen oxides,6
CO2,91
formaldehyde (HCHO)âand,1
HCHO,3
"fungus, protozoan",1
nanomicelles,2
âaeromicrobiology.â Airborne,1
aeromicrobiology,1
AMB,1
aluminum-based,2
bicarbonate ion,1
Red,2
boronic acid-dependent,1
boronic acid-independent lectin,1
âChina,2
hydroxycamptothecin,1
nitrocaphane,1
bimolane,1
sobuzoxane,1
chimmitecan,1
salvicine,1
pseudolaric acid B,1
indolin-2-one compounds,1
triaminotriazine analogs related to,1
expertise).Therefore,1
penicillines,1
cephalosporines,1
"NRC, 2011)",1
bismuth compounds,2
bismuth subsalicylate,3
atazanavir,4
valganciclovir,4
Car,1
scurvy,1
Drug Administration's animal,1
parvo viruses,1
thimerosal,2
sodium azide,2
Caesium chloride,1
Fastidious Agents,1
Food Abstract A,1
bookâinforms,1
Forensicsâ,1
DUR,1
Assets,1
cytarabine,2
ziconotide,1
phytate,1
ZNT zinc transporters,1
Zinc acetate lozenges,1
Osler,2
gamma-,2
inorganic indoor contaminants are,1
compounds/semivolatile organic compounds,1
phosphate adjuvants,1
calcium phosphate adjuvants,1
Calcium phosphate,1
1919â2005,1
COPP,1
ammonium urate renal calculi,1
CMTs,1
"fungus, bacteria, viruses",1
author(s,1
Food Ingredients,1
Food-grade biopolymers,1
Feeds,1
intranasal vaccines,2
drug-delivery,3
MHF,1
FAA,13
overhaul-MRO-facilities,1
NASA,1
Steviol Glucosides,1
steviol glucosides,1
rebaudioside,1
epotoside,1
curcuminoids,2
C19,1
steviolbioside,1
steviol,1
isosteviol,1
steviol mono-glucoside,1
steviol glycosides,1
H antibodies,1
deep-chain,1
CDPs,2
magnesium molecule association,1
bioterrorian,1
"1,3-dipolar cycloaddition reactions of selected 1,3-dipoles",1
"nitrile oxides,",1
[2+2] cycloaddition,1
ISO 17025,1
Instagram Abstract Personality,1
Instagram particularly from 2015 to,1
metal oxide nanoparticles,3
inorganic pollutants and,1
NA sequencing,1
Deaminated neuraminic acid,1
silaylation,1
alkaloids (indole alkaloids,1
tropane alkaloids) Abstract Alkaloids,1
l-phenylalanine,1
l-tyrosine,1
anthranilic acid,2
l-histidine,1
l-ornithine,1
nicotinic acid,1
l-lysine,1
tropane,1
inorganic nanoparticles enzymatically,1
metal oxide nanoparticles like ZnO-NPs,1
prepartum cows,1
shikimic acid,3
"Shikimic acid (3,4,5-trihydroxy-1-cyclohexene-1-carboxylic acid",1
"carbohydrates, fatty acids",1
fecal coliform,1
nanoparticle-enhanced,1
nano-Ag,1
reactive hazard,1
reactive chemicals,4
Chemical Weapons *,1
microparticulates,1
reactive pneumocytes,1
Bile Duct Infections nan,2
intravenous fluids),2
FNDs,2
dapivirine,1
1 mLâ1,1
high-dose corticosteroids,2
â¼1986,1
1/7,3
oxathiolane nucleoside analog,1
emtricitabine,8
oxathiolane nucleoside analog-containing drug regimens,1
S-nitrosothiols,4
sulfhydryl,1
thiol moieties on,1
sulfhydryl moiety,1
NO radicals,1
ARA,9
tetracycline administration,1
Kalorama,1
wastewaters,2
water reuse,1
free-DNA in solution to,1
streptavidin-horseradish peroxide,1
analyteâreceptor reactions occurring on,1
4-(2-aminoethyl)-benzene sulfonamide ligand,1
Deconjugation,1
antipain,1
solutes,3
Xanthones,1
2-hydroxyxanthone,1
Electrolytes,1
bile formation,1
WOW,1
disinfectant-based,1
hydrogen peroxide vapour,3
H2O2 vapour),1
ammonia vapors,1
Hemolymphatic,1
ketamine HCl,1
orradiology,1
atipamezole,2
xylazine i.m,1
tiletamine/zolazepam,1
ethylene oxide sterilization,1
8hours of fasting.,1
1564â1616,1
halamine structures,2
halamines,1
exogÃ¨ne ou,1
Le diagnostic repose,1
broad-spectrum first-line antibiotic,1
NIPA,1
Le syndrome Respiratoire,1
XXIe siÃ¨cle,1
relaciÃ³n con pacientes infectados por,1
microgotas,1
basÃ¡ndose,1
realizaciÃ³n segura de las traqueotomÃ­as,1
Le syndrome respiratoire aigu sÃ©vÃ¨re coronavirus 2,1
expiremental,1
N82,1
ropivacaine,1
63.7â99.4],1
con infecciÃ³n por,1
Se realiza un estudio observacional descriptivo prospectivo,1
evolucionaron,1
CT images of 80 cases,1
zinc acetate lozenges,3
Assurer,1
addictologie ou,1
clozapine,2
con murciÃ©,1
L.N. Ornston,1
water vapor molecular diffusion,1
PCO,3
ultraviolet lamps,1
tert-butyl,1
carboxamide,2
carboxylic acid,1
hydrazone Schiff base groups,1
1H,10
13C,8
[M(L)2],1
L is a,1
Sofosbuvir,9
Tenofovir,2
guanosine derivative,1
ACEIs,1
con enfermedad pulmonar obstructiva,1
intranasal routes with,1
IPM (0Â·1 Î¼g,1
fungus was found,1
con una diseminaciÃ³n,1
thounsands,1
"silyl enol ethers,",1
pyridine N-oxides,1
steroidal sulfamate esters,1
ASTM,2
BILN-2061,1
3TC,1
transbilayer,1
fusionâfission,1
(4) paramyxovirus glycoproteins,1
oligosaccharide portions,1
2+â¼3+,2
sodium cromoglycate,1
tryptamine,2
bisindoles,1
iridoid,1
bisindole alkaloids,1
isopropyl alcohol,1
FiO2,3
nitric oxide:,1
5-20,1
itâ,1
28Â·1,1
FN-PAGE,1
COVID-19 vaccines,3
convoluted tubules,1
22nd-March 27th,1
Contents/All,1
CGE,1
L count decreased,1
"L decreased,",1
L count are,1
L are sensitive,1
"26â50, 1990â1996",2
D-peptide,1
adamantane-based M2,1
emetine against,1
Ivermectin,2
Fusarium sp. in durum wheat,1
carbamate pesticides,1
paraoxon,3
carbofuran,1
pirimiphos methyl,1
thin-films,1
IRF-1/DNA complex,1
provider-interacting network,2
Colour,1
rimantadine (100 mg/daily,1
oser le dÃ©gradÃ©,1
Arachidonic acid (AA),1
eicosapentaenoic,2
docosahexaenoic acid DHA),1
thromboxanes,1
maresins derived from AA,1
Ultraviolet germicidal irradiation:,1
alcohol hand,2
soap water â,1
cephalosporins (3GCs),1
Etomidate,1
succinylcholine,1
[60 mg/kg] prophylactic,1
elaborar,2
con una mediana,1
adrenalin,1
hypertonic saline nebulizations,1
relaciÃ³n con,2
Coronary Units (SEMICYUC),2
con los mÃºltiples riesgos inherentes,1
con importantes costes econÃ³micos,1
Se han desarrollado diferentes modelos predictivos,1
con bajo y alto riesgo de mortalidad,1
incÃ³gnitas,1
administrarles,1
con enfermedades infecciosas,1
con la infecciÃ³n por,1
cuprizone,3
lysolecithin,4
ConclusiÃ³n,1
PATOLOGIA MAMARIA,1
hÃ©morragique,1
Le diagnostic positif repose,1
recommendedwere tripterygium,1
Oxalate contents of commonly used Chinese medicinal herbs,1
oxalate contents,2
Oxalate,1
oxalate (2146 mg/100 g,1
organic acid fractions,1
PEP +,1
"3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium",1
Xuebijing,1
sodium chloride injection,2
CI 3.0-4.0,1
Lianhuaqingwen capsules,1
Le Page,6
starch based colloids,1
CalciphylaxisâA Rare Case,1
MnZn,8
juicer,1
con fibrosis,1
agudizaciones,1
V+,4
COVID-19 desarrollan,1
Con Sospecha O Con InfecciÃ³n Confirmada Por Covid-19,1
InfecciÃ³n Por Sars-Cov-2,1
condensaciÃ³n parenquimatosa,1
PDPT,1
âgel,1
molecular-weight,1
mobile-phase,1
ESI,1
glycoside oligomeric derivatives.,1
ODEs,1
Describimos su diagnÃ³stico,1
Describimos su,1
documentaciÃ³n microbiolÃ³gica,1
calibre que aparece con,1
Se recomienda,1
anti-inflammatories,1
IntroducciÃ³n,2
con frecuencia una presentaciÃ³n clÃ­nica,1
Con frecuencia su presentaciÃ³n suele ser,1
presentaciÃ³n,2
corticotherapy,1
vacunaciÃ³n anual,1
con destrucciÃ³n,1
"inflamaciÃ³n, lesiÃ³n",1
sospecha es,1
agudas traqueales,1
foco otorrinolaringolÃ³gico,1
destacamos los,1
derivaciÃ³n,1
non-steroidal anti-inflammatory agents,3
FK224,1
FK888,1
capsaicin-induced,2
neural network (ANN)-based,1
54:836-845,1
SDG,3
Se presenta una secciÃ³n dedicada,1
cromoglycate,1
bibliographiques,2
allergiques,1
ise,1
"1 VI, 1 Chlamydia psitacci",1
Le progrÃ¨s,1
[41].,1
juridiques,2
"[Hamp-Lyons,",1
water vapor,4
Infliximab,1
"26â50, 1991â1996",1
Le.,1
"ground-glass opacities,",1
Aciclovir,1
valaciclovir,1
nucleoside analogue reverse transcriptase,2
indinavir,2
low-dose ritonavir in 656 patients,1
abacavir,4
dextrans,1
etherified starches,2
pyrimethamine,1
proguanil hydrochloride,1
atovaquone,2
caffeic acid derivatives,2
1989â1990,2
Et Perspectives,1
cyclines,1
B-01 Ãvaluation,1
Pneumonies,3
Le taux de conformitÃ© avec,1
Le nombre dâantibiothÃ©rapies,1
Le modÃ¨le,1
[IC 95,1
coxiellose,1
2o une sÃ©roconversion vis-Ã -vis,1
con los sesgos,1
salvo excepciones puntuales,1
50mg/kg/day,1
inmunosuprimidos,1
con infecciones crÃ³nicas,1
ido en aumento en estos aÃ±os,1
AOM transtimpanic exudate cultures,1
cefalosporins,1
Ï 2,2
viruziden Wirksamkeit von Octenidin-Lutschtabletten,1
viruzide und,1
viruziden und antiviralen Wirksamkeit eines antiseptischen PrÃ¤parates basierend,1
Zur PrÃ¼fung,1
suc,1
fine-needle,1
meglumine antimoniate,1
corticoids,1
lÃ©,2
abdnomal echogenicity,1
voriconazole dans les infections fungiques respiratoires,1
vancomycine,1
Linezolid,2
montelukast rÃ©duit,1
tobramycine,1
tobramycin,2
VMC,1
epi/pandemics,1
anti-IL-6,2
tocilizumab,9
[2]),1
FFP2/3,1
10.30,2
IQR:56.0-70.0,1
Tocilizumab,4
Ovomucin,1
S345 What,1
titanium oxide (,1
carbodiimide hydrochloride/N-hydroxysulfosuccinimide,1
EDC/NHS,1
polyacrylic acid,1
DM 192.-,1
sFr 181 Unknown,1
basiliximab,4
NetNCSP,3
NetNCSP mines,1
sodium intake a risk factor for,1
Adefovir,3
nucleoside/nucleotide analogues,1
nucleoside derivatives,3
nitrogen heterocycles,1
coenzymes (NAD/FAD),1
cAMP/cGMP,1
N-arylacetamide moiety,1
anion-exchange chromatographies,1
Terazosin Hydrochloride Hytrin,1
Aliskiren,2
aliskiren,1
1995â2006 US,1
DEA,8
âProblematizingâ carbon,1
dâune,2
Le nourrisson de moins dâun,1
Le traitement repose,1
cristalloide solute intravenously,1
Le Havre,4
Le traitement antibiotique est rÃ©servÃ© Ã  certaines,1
Le processus diarrhÃ©ique peut durer quelques,1
Le diagnostic est clinique et doit Ãªtre Ã©voquÃ©,1
PCDFs,1
vitrified slag,1
PX-UV,1
oligoadenylates (2-5A,1
TFP,1
Volume TOC,1
19.95,1
PSTR,1
lipid fatty acyl chains,2
[25] Protein,1
sodium dodecyl sulfateâpolyacrylamide,1
fiber-bound,1
SARS-CoV-2 vaccines,1
Part II,2
Methanol,1
manganese),1
sulfates,1
Zn (360mg/d),1
Mn (200mg/d),1
inorganic (zinc sulfate,1
manganese sulfate,1
copper sulfate,1
manganese amino acid,1
"hydroxy (IntelliBond Z, IntelliBond C",1
distillers grainâbased,1
Calf Life,1
urea nitrogen,5
Draxxin,1
ethanol by-products,1
ethanol co-products,1
exo-,1
(+) RNA,1
JanuaryâMarch 2009,1
realista con que,1
Se hizo una clasificaciÃ³n,1
[IC] 95,1
NNT,1
"3,65-5,52",1
NNT de 6 (IC 95,1
hay que demorar,1
dolor torÃ¡cico por,1
I-47,1
hypertonic-saline,1
[3.17-3.38],1
[4.51-5.74] for,1
[1.83-7.92,1
respiratorios obstructivos,1
con el virus (VRShA,1
Con frecuencia,1
rehidrataciÃ³n por,1
desnutriciÃ³n,1
niÃ±o,3
gravedad siempre,1
con suero fisiolÃ³gico,1
exploraciÃ³n funcional respiratoria,1
Se debe adaptar,2
esfera adulta estÃ¡,1
comparte con,1
corticoterapia oral,1
acciÃ³n prolongada,1
Se debe,1
particulares,1
guantes,1
energy-rich,1
Descompensaciones respiratorias,1
apropiadas,1
extracelulares como intracelulares,1
Se debe evaluar de nuevo el tratamiento,1
opiniÃ³n,1
Ãºtil el lavado broncoalveolar,1
LBA,1
concebidas para reducir la,1
con las NAVM,1
infezione,1
Le polmoniti nosocomiali acquisite sotto ventilazione meccanica,1
ventilazione meccanica,1
gastrica o,1
e dal lavaggio broncoalveolare,1
ventilazione,1
eventualmente,1
e il trattamento sintomatico,1
Le tecniche di prevenzione sono molteplici e devono,1
antibiotici nella,1
selezione,1
ottenere dei tassi molto bassi,1
durata mediana,1
dieci giorni,1
receptor-utilizing,1
Disidratazione acuta,2
lattante Il lattante,1
sei mesi,1
disidratazione,3
occhi infossati,1
pressione arteriosa e,1
e con lâasma,1
e il mantenimento dei fabbisogni di acqua e di nutrienti,1
lâalterazione dellâaspetto,1
correggere il deficit di acqua in 4-6 ore,1
lâextracorporeal membrane,2
O2 e di eliminare CO2,2
e le politiche,2
prognosi dei pazienti colpiti,2
Le diagnostic positif peut,1
Le tableau clinique de lâinfection adÃ©novirale est caractÃ©risÃ© par une fiÃ¨vre Ã©levÃ©e,1
Le diagnostic virologique rapide par lâÃ©,1
chimiokines qui,1
vicriviroc,4
aplaviroc,1
Le diagnostic de pneumonie aiguÃ«,1
SICR,1
quinazolin-4(3H)-one derivatives,1
2-(2-chloroquinolin-3-yl)-5-((aryl)benzylidene)-3-(4-oxo-2-phenylquinazolin-3(4H)-yl)thiazolidin-4-ones (V)1â12,1
13C NMR spectral data,1
tebipenem pivoxil,1
TBPM-PI,2
4mg/kg b.i.d,1
6mg/kg b.i.d,1
Polyethylene sector seeks upside,1
ultrafine aerosol pollutants in,1
NO x,3
sulphate,1
Sulfur hexafluoride,3
SF6,6
DEHS,1
APCDs,1
Penicillium italicum,1
JETRO,2
environmental-sensitive,1
carbon emissions reaches 334.5,1
McIlvaine,1
potassium persulfate Abstract,1
UV/TiO2,3
UV/H2O2,2
H2O2 (1mM of,1
oxy radicals,1
1.8Ã106,1
baicalein,4
baicalein by acidic KMnO4,1
M-I,1
M-IV Anti-viral,1
OP3-5,1
PIII-1,1
hypothiocyanite,1
1 207 000 cases (1 164 000â1,1
[14%] patient,3
Francis (Frank) Allan Plummer nan,1
Tam Mak,1
CrI] 16Â·9â19Â·2,1
22Â·9â28Â·1,1
[0Â·27â0Â·38],1
[5Â·7â7Â·2],1
[0Â·4â3Â·5],1
[n=360],1
[1Â·8â11Â·1],1
[n=151]),1
high-density lipoprotein,1
lowdensity lipoprotein cholesterol,1
COVID-19 chest,2
asymmetric/nonlinear,1
A438079,1
BBG,1
alpha-adrenergic,1
contaminans,5
serosal (basolateral) plasma-membrane,1
acidotropic agents,1
undegraded,3
Clays,1
non-myelinated nociceptive AÎ´-fibers,1
myelinated fibers,1
gibberellins,1
macarpine,1
acanthoic acid,1
Parkinson's,1
oleanolic acid,2
acanthosterol sulfates,1
dihydronepetalactone,1
isodihydronepetalactone,1
iridomyrmecin,1
isoiridomyrmecin,1
neoneptalactone,1
nepetalactone,1
actinidine,1
iridoid alkaloid,1
isoneomatatabiol,1
Compartir los recursos Ãºtiles,1
NotificaciÃ³n MicrobiolÃ³gica,1
SNMC,3
vigiladas,1
inyecciÃ³n conjuntival,1
mucosa oral,1
20-25,1
coronay arterial dilatation,1
fournissant un,1
rÃ©,3
Le traitement de lâADEM est basÃ©,1
Le pronostic est gÃ©nÃ©ralement,1
High-dose intravenous steroids,2
estornudos,1
con suero salino isotÃ³nico o hipertÃ³nico,1
viaggio,3
incubazione,1
risultati,1
sospecha de infecciÃ³n broncopulmonar,1
entidades con indicaciones terapÃ©uticas,1
fÃ¡cil diagnÃ³stico,1
taquicardia,1
realizaciÃ³n de una radiografÃ­a,1
con la toxicidad celular relativa de las molÃ©culas,1
differenziazione,1
e delle forme batteriche,1
1-10Î¼ M,1
ethanesulfonic acid Schiff base anchored silver nanocomplex,1
2-aminoethanesulphonic acid,1
"3,4-dimethoxybenzaldehyde",1
1mM AgNO3,1
nanocomplex,6
XRD machines,1
LPV/RTV,3
Airway Practitioners Background,1
propionic,1
"isobutyric, valeric and",1
isovaleric acids,1
"carbohydrates, proteins,",1
cyanogenic glycosides,1
ceguera corneal,1
vitamine E chez le,1
vitamine A,1
entrent dans,1
Le terme de rhinopharyngite est,1
fermented foods,1
LMI,2
con infecciÃ³n,1
desmielinizaciÃ³n,1
anti-bacterial therapeutic agents,1
10Â²,1
hypertonic solutions,1
water intakes related to,1
Triton X-100 with,1
vasopressor octapeptide angiotensin II,1
[19],1
1.043â1.065,1
AIIR,4
Le virus,2
ESMS,1
clostridia,1
(4) vaccines,1
NDA,1
broncopneumopatia cronica,1
PGV-0,4
PGV - 0,1
overall-process,1
"3,5-dimethoxythiophenol 4",1
benzene sulfonamides Abstract A,1
benzenesulfonamide derivatives,1
para-substituted benzoyl moiety favored antimicrobial activities,1
Le questionnement,1
hÃ©patocarcinome,1
mortalityâoesogastric,1
Nasensekretion,1
Vermeiden von Aerosolen,1
beta-mimetics,1
ediciÃ³n,3
efavirenz,2
Kaletra,4
Polysaccharide-based,1
agarose/cellulose,1
arterial oxygen,1
Days 1â14,1
Thiotepa,1
HDC,2
erythropoiesis-stimulating agents,2
clavulanate,5
petroleum hydrocarbons,2
polycyclic aromatic hydrocarbons in,1
polycyclic aromatic hydrocarbons (PAHs),4
PAHs,11
1371.43 mg kgâ1,1
491.35 mg kgâ1,1
HMW PAHs,1
ILCR,1
bronchopneumopathie chronique,4
NO2,20
SO2,10
Le traitement consiste,2
departmentâA,1
glycopyrronium,6
formoterol,9
inhaled corticosteroids inhibit,1
HNE,2
Le Goff,1
syringaldehyde,1
Lignin,1
21 herbal formulae,1
3 herbal,1
2 herbal formulae,1
corticosteroid is commonly administrated to,1
corticosteroid therapy,3
fluorescent agents,1
1mg/kg/day,1
Nano-silver,1
EC50= 100 Î¼g/mL,1
prostaglandins E2,1
Andrographolide,1
identificando os vÃ­rus,1
exacerbaÃ§Ã£o,2
episÃ³dios,1
caracterÃ­sticas epidemiolÃ³gicas,1
testadas,1
epidemiologia,1
intravenous route) are,2
ponta,1
publicadas,1
Na era,1
beber e,1
cianose central,1
marbofloxacin,1
intravenous admixture,1
HSR network,2
MNAs,1
Le service de soins intensifs (rÃ©,1
Le service des soins intensifs adultes,1
Le service accueille,1
Le taux de mortalitÃ©,2
Le service est un centre de,1
HCQ blood,1
weâre,3
âCOVID-19,1
migrating-led,1
lipid-derived vaccine,1
WR1,1
nucleic acid binding proteins,1
1-6,2
whole-breast,1
anti-cytokines drugs)may,1
tetracycline (,1
sulfamethoxazole/trimethoprim,1
cefazolin,1
amoxycillin/clavulanic acid,1
aztreonam,3
13â90,1
TDF,3
MIIT,1
43â63,1
CI 1.4-16.3,1
Labor,1
1G,1
hydrogen peroxide-based fumigation,1
manganese mining,1
S1-based,1
resiniferatoxin,2
RTX,4
milk-replacer,4
Land OâLakes,2
BW gain,1
Epimedium-derived flavonoids,2
mgÂ·kgâ1Â·dayâ1,1
vessel-like structural units,1
16.7kbp,1
fixed-time,1
FindingsWe,1
20%.InterpretationDose,1
FundingNIH-MIDAS,1
scA2AR/D2Rs,1
brain-tissue,1
qucertin,3
oestrogen,1
ROS AbstractB-cell lymphoma 2,1
MUFA,1
CAu NPs,1
chiroassay,1
[ExoN(-)],3
lipid nanodiscs,1
D residues,1
FP-Ca2+,1
eIF4A-sensitive,2
ARTD12,1
2â² hydroxyl,1
ionophores,2
HPD,6
clozapine N-oxide,1
CNO,2
FluoSpheres,1
SummaryBackgroundThe 2019,1
(E-status).InterpretationThe,1
COVID-19):,1
generation-interval,1
DUBsâMERS,1
Nucleotide Analogues,3
ProTide,2
(S)-driven,1
Ritonavir,4
Lopinavir,6
Darunavir,2
PLVP,4
"59,912 air",1
geo-stratified,1
Rc,3
http://doi.org/10.3390/v11110979,1
11926-15845,1
5-40,1
late-December 2019,1
2019-nCoV. 2019-nCov,1
2019-nCoV-positive,1
HPDI,2
[44%-69%]),1
[1.77-3.00]),1
20+ cases,1
SWI,2
"2179, 633 and",1
1734.4 ug/L,1
233(81.5,1
"Hexamethylene amiloride9,10",1
palmitoleic acid,1
10â4,1
COVID-19 Diagnosis Number Prediction,1
1.26 [1.04-1.53],1
161.27-179.26,1
109.20-520.79,1
Ritonavir tablets,1
ToA,1
MSTI,1
2019-nCoVâ,1
isotonic salt solutions,1
CPPV-1,4
[1.05-2.06,1
10.4319],1
2.1270]),1
"74,675",1
"46,096",1
95%CI 1.424,1
microsphere peptide,1
NP44-52,1
cardiotonic agents (,1
digitoxin,1
[14.90],1
[14.81] years,1
subjective-to-objective,1
[aOR]:1.27,1
health/scientific,1
3.0â9.3,1
dipyridamole,3
anti-coagulation agents with,1
K+ supplements when,1
colloidal gold-immunochromatographic,1
DOI:,3
10.1016/j.cell.2020.02.052,1
190/Î¼L,1
2019-nCoV. A,2
Linkers,1
COVID-19 Patients,1
1.55 +-,1
heparin binding,1
outside-China,1
4659,1
Forehead Temperature,1
fungus and,1
Jan.19-Feb.26,1
7.92,1
10.2)days,1
2.89days,1
Corynebacterium of,1
"130,626",1
vitamin D-binding protein macrophage activating factor AbstractSodium-bile acid,1
sodium-taurocholate cotransporting polypeptide,1
Vitamin D-binding protein macrophage activating factor (,1
DBP-MAF,4
epta-peptide,1
NTS,2
"diarrhea(OR1.80,95%CI 1.06-3.03",1
P=0.033,2
NO GGO,1
corticosteroid in the,1
1-2mg/kg/d,1
5-7,1
14.00-15.26,1
Thalamus AbstractThe basal ganglia,1
"range,2-88 years;IQR,35",1
E being,1
Ccr,2
IGU,1
IGU (0.750),1
TRU,1
ConclusionsRoom,1
ECMO and,1
IQR2.00-8.00,1
onset-of-symptoms,2
CI:1.48-3.14,1
"[52438,",1
inhaled nitric oxide gas,1
nitric oxide therapy,1
SARS-CoV-2âACE2,1
non-A blood,2
"[880, 2372])",1
"[988, 11340])",1
CVL218,6
corticosteroid ciclesonide,1
lotions,1
DruLito,1
1.0 mmol/L IPTG,1
epitranscriptome,2
Alovudine,5
95%CI:0.700-0.930,1
95%CI:1.104-2.776,1
"2,015/2,986",1
COVID-19 pneumonia [4],1
12-18,1
2 407),1
LoBs,1
LoD,1
2-3,1
PCCM,1
CI 1.83 â 7.46,1
P<0.004,1
mecobalamin,1
oxyhemoglobin,1
Day-6,1
Prefusion Conformation AbstractPandemic coronavirus disease 2019 (COVID-19),1
DCA,5
CICA,1
"125,300",1
exposed/,1
NBS,1
BEO,6
starter/d,1
proprionate,1
C2:C3,1
"335,922 - 24,930,386",1
Apr 25,1
3â²-azido-3â²-deoxythymidine triphosphate,1
Tenofovir diphosphate,1
"29,798",1
[OR 2.350,1
[OR 0.158,1
CREA,3
antivirals/antibodies,1
do}.,1
amantadine + PPE,1
adamantine,1
F-1,1
CI 7,1
COVID-19 school closures,1
ribonucleoside,1
RBD-ACE2,1
fast-flow peptide,1
Covid-19,5
PAF,3
20+ people,1
"BB,",1
ciclesonide â,1
FSH,1
1.1Ã109/L,1
[6.5-19.5],1
Danoprevir,1
danoprevir,4
reduced-form,1
Boronic acid derivatives AbstractBased,1
"boronic acid derivatives, compounds with",1
boronate B(OH)2 groups,1
Boronic acids are atracted to,1
boronic acid derivatives with,1
Draw,1
E 1405,1
FEP,2
Aug. 3,1
dezocine,1
camostat mesylate,1
CNN deep neural network,1
CNN,5
DMSs,1
Fusobacterium species,1
Hydrogen Peroxide Vapor,1
1.180-1.481,1
cholesterol (HDL-C),1
(III),2
FSC-high,1
FAM/HEX/CY5/ROX,1
COVID-19+,2
tool.6,1
CI 6.0,1
ground-glass opacities (66.0%,1
reactive school closures,1
IP lesions,1
Pyrimidine Metabolism AbstractGenome-wide,1
hydroxychloroquine sulfate,2
Symptoma,1
[2-4],1
ACEIs/ARBs,1
Aldehydes,1
11a,3
11b,3
"[1,2]",1
COVID-19 Severe acute respiratory,1
CSSE,2
CHMs,1
[12.69 years];,1
chemiluminescence-immunoassay,1
[7]),1
SCE,3
peptide-bound,1
Co-60,1
saccharin,1
chloroquine/hydroxychloroquine,2
CQ/HCQ,2
acidotropic lipophilic weak bases,1
fatty acids derived from,1
caprylic acid,5
free fatty acids,2
hydroxychloroquine anti-SARS-CoV-2,1
toilet flush button being contaminated,1
1-4 Î¼m,1
SIR-ABC framework,1
FSI,6
SARS-coronavirus-2 Severe acute respiratory,1
N4-hydroxycytidine,1
N4-hydroxycytidine (NHC),1
500nM,1
"N=444,649",1
Februarys 11,1
CNNs,2
JPEG,1
CI 1.249-1.761,1
"21,2020",1
23585-23599,1
CLogP,1
Scopodulic acid,1
Dammarenolic acid,1
silibinin,1
inter/intralobular septal,1
nitrogen dioxide pollution,1
"K, growth rate",1
VPTMpre,1
lipid-derived nanoparticles,1
CCK8,1
Forman-Ricci,4
XL-Stat,1
[r=-0.38],1
siltuximab,2
[1-4],1
[5]),1
"[6, 7]",1
[12-15],1
LISS,1
[aOR],1
"CI 10,852--11,541]",1
"124,506 [95",1
water vapor pressure,1
amphotericin,1
single-stranded positive-sense,2
COVID-19 - Template,1
90.2%-91.1,1
Capacities,1
16.8%-27.9,1
demand-side,2
capacity-dependent,1
corticosteroids (n=25),1
COVID-19 CFR,1
"L, k",1
Catecholamines,1
catecholamine,5
I(t,2
NC_045512.2,1
Triphosphates,1
Tenofovir alafenamide,1
Chloroquine derivatives,1
Azithromycine,1
Opipramol,1
Quinidine,1
Omeprazol,1
2<EC50<20ÂµM.,1
remdesivir 10-fold,1
bDMARDs,2
FCs,1
non-toilet,1
door-handles,1
cobicistat,1
Crow-AMSAA,1
28th,1
Atazanavir,1
ATV/RTV,1
20-70,1
retracement,1
2.4-3.7,1
creatinine kinase-muscle/brain,1
electrolytes,10
Nitrogen Dioxide,1
CovProfile,1
Drug Administration in 1968 as,1
Guanidinium Thiocyanate (GITC)/ Triton X-100 for,1
Guanidinium thiocyanate (GITC)/ Triton X-100 Lysis,1
ethylene oxide,1
20-39,1
[2.01-3.93]),1
DrugBank ID,1
2.41-2.71,1
79/198,1
2'-5' oligoadenylate synthase,1
half-size,1
blended,2
"fluconazole,",1
fluconazole alone,1
fluconazole therapy,1
Glycogen Storage Disorder type II,1
undegraded glycogen,1
34Ã ,1
S-adenosyl methionine domain-containing protein 2,1
crescent-shaped bin-amphiphysinrvs,1
18Ã,1
SAC components,1
ADP-beryllium fluoride,1
non-templated additions,1
VES,2
Fos-tagged,1
[14-16],1
PACA,4
PBCA,5
octyl,1
POCA,2
ofCEACAM1was,1
endogenousCEACAM1resulted,1
N7-methylated caps,1
Ethidium bromide,1
843.5,1
beclometasone,1
trihexyphenidyl,1
S-propranolol,1
ELPA,7
ELPA flavonoids,1
GGG-,1
GGGG-islands,1
23.ResultsThe,1
R2=0.967,1
Catecholamine,1
electrically-evoked signals,1
nomifensine,1
reuptake blockade,1
Fe3,1
reactive nitrogen/oxygen species,1
maltose sugar,1
golgicide A,1
ABSTRACTOver,1
K+ ions,1
VSD,1
current-voltage,1
arabinose,3
carbon catabolite repression (CCR),1
indigestible material,1
cholesteryl esters.,1
HMDP,1
Trizol,3
carbon-halogen bonds),1
proximity-labeling,1
phosphatidylserine (PS) receptors,1
FLExDUX4,1
2-5AMD,1
uncoupler CCCP,1
Tungsten Oxide,1
tungsten oxide nanodots,1
hydroxyl radical species,1
N10,1
N10 facilitates heterosubtypic (,1
N10 shows,1
MTK,2
PLPC,4
biaryl-containing natural products found in plants,1
Epigallocatechin-3-gallate,1
fortify,1
GQDs,1
Gardiquimod,1
sodium arsenite ABSTRACTFollowing reovirus,1
SIGNIFICANCEAll viruses,1
Nanotubes,1
gRNAs,1
Decelerates Termination,1
ultrapure water,1
[PE(34:4)],1
Polaprezinc,1
"[1.27, 1.32])",1
"[1.22, 1.24])",1
nucleic acid nanocarriers,1
nanocarrier,1
LNPs,1
additives,1
AgNPs,1
SG-like aggregates,1
pristane,6
AbstractEnteric,1
2â-O methyl,1
IFN ligand,1
airway interferon,1
cationic nanocarriers,1
IAA,1
hydrophilic peptide,1
net-neutral charged peptides,1
SkIf,1
non-vomiters,1
n-Dodecyl Î²-D-maltoside,1
callose deposits,1
potassium chloride,1
endotoxin aerosols breath-borne VOC,1
carbon disulfide,1
Kin,2
haloperidol,5
sulfur gases,1
water columns,1
N-acetyl,1
N-glycolyl,1
N-glycolyl modifications,1
4-O-acetyl,1
48S mRNPs,1
1-24,1
Î¼M DON,1
deoxynivalenol (DON),2
alfaxalone,2
propofol,8
induction/recovery,1
vasoconstrictor assistance,1
IRRT,1
SN - 1476-5454,1
reliableresearch,1
nearfuture,1
ParasitologyCall,1
CAPE,1
Ramaphosa,1
â Ramaphosa,1
supplemental oxygen,1
salt bridge anchors,1
1.8266,1
[Commentary/Review],1
22?24 November 2019,1
ZINC15,1
[9].ER -,1
"[1,2,3]",1
[5] reported,1
1123/37 914,1
penciclovir,6
broad-spectrum antiviral drugs remdesivir,1
compounds CQ,1
SN - 1496-8975,1
[17].JO - Drugs &,1
dehydroandrographolide succinate,1
Dehydroandrographolide succinate,1
PM1,9
PM2.5,3
45â74,1
PM2.5-associated,1
10.1016/S0140-6736(20)30304-4,1
10.1126/science.abb2507,1
front-runners,2
âsocial distancingâ,1
"corticosteroid, antiviral drugs",2
"elsewhere4,5",1
UV-Platelets,1
2019-nCoV emergedâand,1
[46%â62%]),1
Act 1974,1
BMA,2
airlines.1,1
9.5-10.5,1
"28,942",1
[...],3
FIB,1
Four-Pronged,1
ground-glass opacities (,1
CT halo sign,1
Se incluye tambiÃ©,1
incubaciÃ³n,1
velocidad con que una enfermedad puede propagarse,1
lo cual podrÃ­a favorecer,1
entidades,1
AHCC,3
3-5,1
PRM,2
Disulfiram â a,1
disulfide (TOD),1
PX-12,1
disulfiram,5
FDA 70,1
thiol proteases of,1
solutions,2
teachers&rsquo,1
852.0,1
[A pathological,1
OR=1.709,1
NS + OPS,1
Formaldehyde,3
[35S]methionine,7
[3H]mannose,2
oligosaccharide side chain(s,1
Man5GlcNAc,1
fatty acyl chain,1
ether-linked,2
polyunsaturates,1
F40,2
saturated fatty acids,2
cis-polyunsaturated fatty acids,1
trans-unsaturated fatty acids,2
phase-transition,1
cis-unsaturates,1
N-acetyl-galactosamine,3
N-acetyl- galactosamine,1
ribonucleotide triphosphate,1
nonhydrolyzable GTP analogues,1
8-Br-cAMP,2
Na2CO3,1
Triton X-100 in,1
Ca++,1
thymidine autoradiography,1
"2',3'",1
O4 +,1
O4+,2
alpha chain,2
[3H]thymidine autoradiography,1
galactocerebroside,2
phorbol esters enhances adhesion of,1
phorbol ester,1
INVs,1
Phospholipid,2
DPAP A,6
Caffeine,3
caffeine-induced,1
Gm1,6
cisternal elements,1
N-acetyl- galactosamine (GalNAc)-specific,1
guanosine 5'-(3-O- thio)triphosphate,1
268:22853-22862,1
double-label,2
suramin,1
sis-TGN38 derivatives,1
20 degrees C,2
cis compartment,1
invertase-repressor,1
Ceramide,1
glucosylceramide,1
IMVs,3
1-1.5,1
20-40 d develop classic graft-versus-host disease,1
cytoxan,1
glutamic acid-rich tract spanning positions 322-333,1
[Ca2+]i,1
"20-1,000-fold",1
9-O-acetylation,1
O-acetylated,1
O-acetylated gangliosides,1
nonionic (,1
deoxycholic acid,1
Sucrose,5
chromatographies,1
C6-NBD-ceramide,1
glycosaminoglycan carbohydrate side chains,1
p-nitrophenyl-beta-D-xyloside,1
[35S]sulfate,1
brefeldin,1
O-,2
nocodazole,1
9:1495-1502,1
87.29,1
Glabridin,1
Licorice,1
"ethanol/water (30:70,",1
apolipoprotein C-1,3
neuraminidase-inhibitors,1
vasoactive neuropeptides,1
isatin binding sites are,1
isatin analogues and/or,1
short-acting nonstimulating monoclonal antibody,1
Campath-1H,1
T10B9,1
students-for,1
Fluorescein-KCl,1
facemasks A,1
NIMV,1
intravitreal dispase injection,2
b-wave,1
DNA-Vaccines,1
uridine 5â²-triphosphate-biotin,1
1.25 IU of,1
500Î¼M,1
Oxalic Acid,1
1000Âµg/mL,1
CanTravNet,2
[1.9%];,1
amoxicillin [46.3%],1
amoxicillin/clavulanate [5.3%]),1
diphenhydramine [29.1%,1
saline nasal drops [14.2%,1
corticosteroid (,2
95%CI;-1.60,1
FHV/FIV,1
oncotarget Tylophorine compounds,1
Tylophorine derivatives,1
tylophorine,8
Tylophorine,1
tylophorine compounds,4
tylophorine compounds exert,1
18-Î²-glycyrrhetinic Acid,1
GLA,8
high-dose CS,2
CDE,1
Rimantadine,1
Laninamivir,1
amantadane,1
anti-diarrheal,1
10(-3,4
nevirapine,2
demyelinatlon,2
myricanone (1),1
myricanone 5-O- -D-glucopyranoside (4),1
propyl gallate (standard antioxidant),1
TMR,1
5'-GTAAAGAAAGT-3',1
Low-MolecularâWeight Heparin,1
orthophosphate,2
allergen-induced airway hyperreactivity,1
low-molecular-weight virion,1
"Î±-1,6-linked glucose",1
Dextran derivatives,1
tryptose phosphate broth,2
sodium o-benzyl-p-chlorophenate,1
sodium lauryl sulphate,1
"topical antiseptics,",1
Lipid Raft Vacuoles,1
hexose,1
p-nitrophenyl phosphate,1
inorganic phosphate,1
arsenate,1
inorganic cations,1
IBV-ON5,1
phorbol ester-induced CD4,1
BFLA1,1
phorbol myristate acetate-,1
[3H]uridine,7
Isoflurane Anesthesia,1
Isoflurane anesthesia,1
isoflurane (4%,1
Buprenorphine,5
Bup-SR,8
1 through 4 d,1
buprenorphine HCl,3
Bup HCl,7
Nonidet P-40 at 4 degrees C,1
Nonidet P-40-disrupted virions,1
parvo antibodies,1
Scatchard,1
acridine orange,2
PI calves,5
sufficientâ,1
61-nucleotide,1
1 MLV-boosted,1
polyadenylic acid,3
swainsonine,5
endo-beta-N-acetylglucosaminidase H,1
[3H]palmitic acid,1
Filtering-Facepiece Respirators in,1
ITSA,2
âAmerithraxâ,1
223/250,1
1-7,1
saxagliptin,1
cis (GIMPc),1
serine-substituted proteins,1
Cl- fluxes,2
Net Na+,1
Cl-,1
BBM,2
QS dipeptide,1
iNOS-specific,3
SN tests used a 24,1
oligonucleotides 1,1
ribonucleic acid,3
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid)-buffered Eagle,1
ileal absorptive enterocytes,1
orthophosphoric acid,1
isopropyl alcohol [IPA]),1
NH3--whether,1
NH3 concentration,1
NH3 exposure of,1
NH3,1
Mycoplasma-induced,1
KX anesthesia,1
KX intraperitoneal anesthesia,1
KX anesthetic,1
Triton X-100 formed trimers at low pH,1
"K, N, Q",1
Hydrogen Peroxide Vaporized hydrogen peroxide,1
S-nitroso-L-acetyl penicillamine,1
aminoguanidine,1
beta-mercaptoethanol,1
1E.F9,1
10(-6,2
UV-induced,2
CTS253,1
adenylates,1
erucic acid,1
1-5NC-S21,2
1 Ã 10(1.2,2
sufS601,1
lysolecithin permeabilization,1
L-tryptophan,7
L-TRP,13
17-nucleotide signal,1
694-nucleotide,1
Disulfide Bond,1
Na(+)-dependent amino acid,3
alpha-methyl D-glucoside,1
phosphate-saline,1
CI 1.4-34.6,1
[DSS]:,1
interferon-a,1
coproantibodies,1
214:453-463,1
bromouridine triphosphate,1
lysolecithin-permeabilized,1
trehalose dimycolate,3
muramyl dipeptide adjuvants,2
N-acetylmuramyl-L-alpha-aminobutyryl-D-isoglutamine,1
Muramyl dipeptide,1
1 part of trehalose dimycolate,1
grana,1
alkali,1
oligodeoxythymidylate-cellulose,2
perorally 10(10,1
5H2.3B12.1C9,1
naphthalene degradation) plasmid in Pseudomonas putida,1
m-toluate,1
NO inhibited growth of,1
S-nitroso-N-acetyl-dl-penicillamine,1
N-monomethyl-l-arginine,1
Dichromate,1
Floatation,1
Cl difficile toxin,1
NO-scavenger carboxyphenyl-tetramethylimidazoline-oxyl-oxide,1
"175,000-apparent-molecular-weight (175K) monomer",1
CED,2
water intakes,2
halofuginone,10
dimethyl sulfoxide can,1
dimethyl sulfoxide is,1
O-glycosidic linkages are,1
IFN-Î³ +874 T/A,3
INF-Î³ +874 T/A,1
IFN-Î³ +874 T/A (rs2430561),1
Isoflurane-,1
effect.â,1
IR(6,1
miR-27a/FOXO1/Î²-catenin,1
BAS,8
128:447-449,1
polyethylene glycol precipitation,1
Nitric Oxide Synthase,1
Chocolate,1
Kirby-Bauer,1
ciproflaxin,2
nucleotides 171,1
N-acetyl-9-O-acetylneuraminic acid,5
"Neu5,9Ac2)",1
Electron micrographic features of acute murine reovirus,1
nicotinic cholinergic,1
[457 amino acids] or,1
sialic acid-containing receptors,2
Arthrobacter ureafaciens,1
Open-Top,1
intravenously 6,1
carbonyl cyanide m-chlorophenylhydrazone-sensitive vesicular,1
Disulfide bonds,1
[287 nt plus poly(A) tail] were,1
BrUTP,2
conjugated to,1
vitamin premixes,1
saline lavage,1
antimiR platformsâranging,1
5'-terminal nucleotide,1
G residue,1
12-base repeat,1
trans factors potentially,1
5-iodo-2'-deoxyuridine,1
PI calf,1
beta-interferons,1
broad-spectrum antipicornaviral,1
broad-spectrum antipicornavirus,2
pirodavir,1
virus-drug,1
pentamidine,1
[14C]GalNAc,1
alkaline borohydride,1
90A,4
"1,480-nucleotide",1
190-nucleotide,1
"3'-terminal 2,486",1
phosphate covalently,1
bottled garlic,1
Oxidized low-density lipoprotein,2
OXPAPC,6
phospholipid 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine,1
deferoxamine,5
iron chelation,2
iron chelator,1
luminol-enhanced,1
sideâemerging,1
Triolein,2
Cortisone,2
triolein,4
colloidal carbon,1
alpha-d-galactose,1
trisaccharide,1
1/l,1
DOCE,1
CUA,1
"1,244-nucleotide genome",1
nucleotides 720 to 777 of region b,1
disulfide bonds.,1
h.p.l.c,1
N-acetyl-9-mono-O-acetylneuraminic acid,1
hydroxyamino acids,1
Oligosaccharides,1
17-base,1
"monensin, agents that",1
[3H]UMP,1
acid-precipitable material,1
ribonucleoside triphosphates,1
[3H]UTP,1
elastomerics,1
radioiron,1
C-2,1
C-8 bind epitopes,1
80S elongating ribosomes,1
indium-111,1
Disulfide bonds in folding,1
SDVs,11
SYTO-59,1
"4â²,6â²-diamidino-2-phenylindoleâpropidium iodide",1
SYTO-9,2
LCMV-binding substance,1
Nitrate Supply,1
NRA,7
Nitrotyrosine,1
nitric oxide [NO]),1
nitrogen-derived oxidants,2
fumonisin B1,1
FB(1,1
Intraperitoneal Propofol,1
Fentanyl,1
medetomidine,1
intraperitoneal atipamezole 30,1
propofol (100 mg/kg,1
fentanyl (0.1 mg/kg),1
intraperitoneal anesthesia,1
intraocular lens,1
membrane-impermeant,2
cryoprotectants,1
potassium dichromate,1
cis elements for,1
Polyethylene glycol treatment of,1
RFII,1
28S rRNA,6
dexamethasone intravenously for,1
(+LR,1
3'-terminal 24,1
"alpha-2,3-linked sialic acid",1
N-Glycolylneuraminic acid,2
Potassium tartrate-glycerol,1
Cesium chloride density gradients are frequently used,1
cesium chloride,2
uncharged polar residues,1
1a-1b,2
double-stranded RNA-specific,1
sucrose cushions,1
donkey semen,1
DCPD,5
LHRHa,4
jetliners,1
18:358-364,1
perchloric acid,1
nucleotides 11488,1
nucleotides 11875,1
nucleotides 11542 and,2
UDPgalactose,1
Cys29----Ser29,1
apolipoprotein-A1 precursor,1
palm-oil biomass,1
Ficoll,1
nucleotides 10752 to,1
18A7.4,1
potassium thiocyanate,1
Luminal RER proteins,1
dithiothreitol [DTT]),1
disulfide bonds in rotavirus proteins,1
intramolecular disulfide bonds in,1
Struvite Urolithiasis in,1
Struvite urinary calculi,1
calculi,1
alkaline urine,1
struvite urinary calculi,1
leukotriene B4,1
3-1,1
D-xylose,4
spike-capsid,1
19S cap,1
"1,1'-ethylidenebis (",1
case-associated L-TRP,1
case-associated L-TRP for 6 wk,1
PP2,2
"1,300 g/ml",1
disulfide-linked dimers,1
reactive T cells,1
Arg-Arg-Ala-Arg-Arg,1
vesicular stomatitis,1
Propofol infusion-like,1
Tramadol,1
tramadol,4
decanoyl-N-methylglucamide,1
1.50-1.99,1
mof9,2
sparsomycin,3
dideoxynucleotides,1
GHG,5
term(s,1
9-O-acetylated neuraminic acid moieties on,1
F.-I.,1
sulbactam,2
ampicillin (,3
TEMP,3
SAL calves,2
SAL,1
AMP calves,2
ATTD,1
Amprolium,1
Furazolidone,1
amprolium,1
hydrogen sulfide,1
farnesyl-,1
intravenous gammaglobulin,1
AIB virus,2
AIB,1
nonion detergent Nonidet P-40,1
levamisole,2
rhodamine B dye,1
NGR peptide-based agents for tumor imaging Molecular,1
conjugated with fluorescent or radiolabeled imaging probes.,1
inorganic hypochlorite,1
hypochlorites,1
FCoV-free catteries,1
alkylating agents induce,1
dibutyryl-cAMP,1
sialic acid-bearing envelope proteins,1
L-Pro,3
CI 44.2%â70.7,1
Ammonia Levels,1
Intracage ammonia,1
ammonia exceeded 100 ppm (,1
O-tetradecanoylphorbol-13-acetate,1
sulindac,1
25-HC,5
1--14,1
carvacrol (3.5%,1
Meloxicam,2
Pokeweed Antiviral,1
Pi,3
1 death in 7 cats,1
part-time,1
N-linked oligosaccharides,1
5â²-proximal regions,1
[HveC(143t)],1
Isoprinosine,2
isoprinosine,1
FTT,1
p-nitrophenyl acetate,2
4-methylumbelliferyl acetate,1
âhinge spacer,1
sodium chloride aerosol,2
water intake,4
E2B,2
10(-4.6,1
sucrose-deuterium oxide,1
methylmercuric hydroxide gave,1
FLA,5
FMUO,1
lomustine,1
acepromazine,1
nitrogen-15,1
"11F, 30B",1
30B,2
dichloromethylene diphosphate,1
phospholipids (,1
65-nucleotide,2
ultraviolet germicidal irradiation (UVGI),4
sodium oleate,1
MP2,1
oligosaccharide side chains of E2,1
carbohydrate-free,1
cis replication signal and,1
bromodeoxyuridine,2
decoquinate,2
Carprofen,1
sustained-release buprenorphine,1
sustained-release meloxicam,1
carprofen,2
1 mL/kg SC BID,1
"CG,",1
buprenorphine formulations,1
CGâeffectively,1
C-107,1
G + 92----A,1
Ketoprofen,3
ketoprofen (10 mg/kg SC),1
nonsteroidal antiinflammatory drug,2
inorganic phosphorus,1
S-induced cell-to-cell,3
heteroduplex,1
HIV-RT,4
acid-induced,1
N-glycan chains,1
3H-labeled diisopropylfluorophosphate,1
isocoumarin derivatives,1
"3,4-dichloroisocoumarin",1
CsCL,1
semipurified virions,1
NCT00065715,1
alkamide,1
"nebulised budesonide,",2
nebulised adrenaline (,2
racemate,1
L-adrenaline,2
ephinephrine],1
S-329-343,2
violet light,1
oligodeoxyribonucleotide primer (15-mer),1
peptidyl-tRNAs,3
ribosomal A,1
eliminated[2,1
ammonia (100 parts,1
Monastral blue,1
Monastral blue-labeled postcapillary venules,1
Monastral blue-labeled vessels,1
disulfide-linked oligomers,1
Bb,2
Intravenous PGE1,1
PGE for,1
dmPGE2,5
LD50,4
capsaicin cream,2
S1n(220),1
PO],1
hydrochlorothiazide,2
1 mg/kg,1
furosemide (2 mg/kg,1
diuretic agents for,1
thiocyanate,1
phorbol ester binding site in,1
"membrane-impermeable thiol-alkylating reagent 5,5'-dithiobis(2-nitrobenzoic acid",1
cysteine-mediated thiol-disulfide,1
thiol-alkylating reagent,1
177:768-771,1
IG,2
nucleotides 1425-1430,1
nucleotides 1437-1466,1
immunoferritin,1
oxytetracycline,1
ethanol-containing,1
sialic acid derivatives revealed,1
"Neu4,5Ac(2",1
NAF,1
polyacrylamide-agarose,1
60S single-stranded,1
particle air (HEPA) filters,1
AII,2
NIOSHTIC 2.,1
Q(2583)-G(2584,1
intragastric routes,1
PI 2A1,7
PI 1A1,1
PI 2A1 sigma1,1
polysulfone membrane,1
streptavidin-,1
Fas(+,1
Nonidet P-40 cytoplasmic extracts,1
brefeldin A.,1
copper ethylenediamine tetraacetate,1
1a/ORF 1b,1
powders,1
IgY powder,1
5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside,1
1 for influenza C virus,1
reactive arthritis especially,1
uridine nucleotide,1
24S RNAs,1
nucleotides 347 to 375),1
sialic acid donor,1
sialic acid O-acetyltransferase,1
9-O-acetylated Sias mainly,1
CMP-Sia-FITC,1
fluorescein,1
[3H]galactose,2
isopropyl-beta-D-thiogalactoside,1
anti-21-,1
oligosaccharide side,1
intravenous vancomycin (IV),1
vancomycin IV,1
cesium chloride gradient (61,1
cesium chloride gradient (85%,1
sub-genome-length minus,1
ZnCl2,4
minus-strand-RNA,1
aerobes,1
U13C,1
NH4,1
Mg2,1
Co(NH3)6(3+,1
WIN 51711,4
isoleucine 478,1
arginine 481,1
SN titers were 80 to,1
SN antibody titer,1
perfusate,1
mannitol (450 mosmol/kg,1
"iodixanol density gradient,",1
iron regulatory hormone hepcidin,1
endosomotropic weak,1
[immunoblots]) antibody titers,1
chromagen,1
IOM,1
"1,3,4-thiadiazol-2-ylcyanamide",1
LY217896,8
sodium salt,5
"1,3,4-Thiadiazol-2-ylcyanamide",1
microgram/ml,2
LY217896 (9 mg/m2,1
protein-restricted,1
actinomycin D-treated,1
1â²-methyl spiro,1
maleate,1
hydrogen peroxide disinfectant for,2
5â² single-stranded,3
O-acetylsialic acid-containing receptors,1
Diisopropyl fluorophosphate (DFP),1
phorbol myristic acid-induced,1
intranasal (i.n.) routes of,1
phosphorous concentrations,1
bromo-UTP,1
sodium carbonate,1
133:428-432,1
nebulised short-acting beta(2),1
[n=143]),1
IFN-inducer polyinosinic:polycytydylic acid,1
vertebrae,1
Nitric Oxide Play,1
germicidal irradiation (UVGI) at 14 homeless,1
half-mer polysomes,1
fluorocarbon,1
glucocorticoid fluticasone,1
Bupivacaine,1
bupivacaine,3
liposomal bupivacaine,2
1 mL/kg SC every 12 h,1
"liposomal bupivacaine,",2
1 mg/kg SC local infiltration once,1
actinomycin D-treated cells,1
nitric oxide donor,2
glycerine trinitrate,1
Sodium carbonate,1
myristate or,1
EMBO J. 15:2343-2355,1
N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone,1
monoglycerides,1
long-chain saturated fatty acids,1
Medium-chain saturated,1
long-chain unsaturated fatty acids,1
Monoglycerides,1
68-nucleotide,1
Avridine,1
cholesterol-containing liposomes,1
sterol-free liposomes,1
5'-to-3',2
12Ã ,1
parenteral routes,1
[3H]thymidine,3
talc,1
celite,1
Emulsigen,1
peroxide-based,2
hypochlorite-,1
IFN induction-blocking anti-M protein monoclonal antibodies,1
Sepharose 2-B column,1
38S,1
32S,1
Iron Oxide,1
G26-24 cells,4
Capped,1
CYMV RNA,1
SN),1
alkenyl guanine analogs,2
"thiazolo[4,5-d]pyrimidine ring system.",1
alkyl,1
alkyl halide with,1
T01132,6
3-methyl-2-butenyl moieties attached to position 3 of,1
DHPG,6
oligosaccharide moieties,1
90:1716-1720,1
anti-D11,1
periodate-boro[3H]hydride,1
Intrathecal antibody synthesis,1
Intrathecal antibody synthesis against 17 common,1
luminol-dependent,1
reactive oxygen is,1
Phospholipid Semilysobisphosphatidic Acid,1
semilysobisphosphatidic acid,1
SLBPA,3
Picture,1
sucrose density-gradient,1
transepidermal water,1
TEWL,4
cryptophycin,1
tolytoxin,1
O-glycanase,1
O-linked sugars,2
purines 3' of,1
cyclosporin A-treated LEW rats,1
[35S] methionine,1
[35S] formyl-methionine,1
[3H] mannose,1
Bb vaccines,1
formaldehyde-agarose,1
[32P]UMP,2
cesium chloride gradients,1
OR=0.34,1
T-T,1
ethanolamine,1
purine rich motif,1
mAbs-induced,1
bx + cxln(x,1
brefeldin A-resistant,1
sodium dodecyl sulfate-sensitive hetero-oligomeric,1
diethylaminoethyl dextran (,1
poly-L-lysine,3
carboxymethylcellulose,3
2-beta-mercaptoethanol,1
"nucleic acid binding (""finger""-like",1
DAV-induced,1
Prednisolone,3
jejunal mucosal lactase,1
sucrose gradient-purified BoTV,1
doughnut-shaped nucleoid,1
nitroblue tetrazolium dye,1
isotonic sodium bicarbonate,1
"hydrochloric,",1
"hydrofluoric,",1
"nitric,",1
perchloric,1
sulphuric acid solutions,1
intranasal small interference RNA could,1
oligosaccharide side chains with,1
10A (36 kDa,1
10B (41 kDa,1
glycine electrolytes,1
RIA,1
nondiluted,1
K ORF,1
DEAE-5PW,1
phenyl-5PW,1
Con A)-stimulated,1
ammonium chloride-treated cells,2
FIA vaccinates,1
reactive with,1
51Cr-release,2
SC,1
AnB,1
CHRONOBIOLOGY,1
dorso-medial,1
CD-91,4
quantal,1
leaderâbody junctions,1
othet,1
"N6,2'-O-dibutyryladenosine-3',5'-cyclic monophosphate (dbcAMP)",1
dbcAMP,5
Lactose,2
CDRI 80/53,2
NSC305812,1
WR238605,2
WR242511,2
chromium-51,1
ethylene diamine tetraacetic acid,1
51Cr-EDTA,3
histamine-induced mucosal,1
110S,1
RNA6,3
3'-terminal noncoding region of,1
bicarbonate reduced growth rates,1
Aphidicolin,2
Cephalosporium aphidicola Aphidicolin,1
sodium dodecyl sulfate-hydroxyapatite,1
6-Br,1
6-halogenated analogs,1
dextran sulfate,2
sulfated polysaccharide,1
MHV-3-specific,1
ketoprofen (,1
5 mg/kg SC,1
(3)H-uridine,1
neutrophil-generated reactive oxygen species,1
BJO,1
Lead free,1
Des formes recombinantes,1
acid base balance,1
lopinavir ritonavir,1
l-sorbose,1
placebo/standard,1
situaciÃ³n mundial,1
COVIN-19,1
anti-virual eyedrops for 1,2
epidemic&mdash;COVID-19,1
NON-NCOVID-19,2
NCOVID-19,2
non-glucocorticoid,2
disease?-,2
patients&rsquo,2
atenciÃ³n,2
continÃºa con la clasificaciÃ³n,1
embarazadas,2
identificaciÃ³n oportuna,1
adotadas,1
COE-COVID-19,1
"[2,3,4]",1
doesnât,1
phosphoramide,1
allowances,1
1 time/12,2
"[12 (9, 17) d] in",1
C reactive,1
"aspartate aminotransferase,10 patients",1
alpha-interferon,1
[4 (17%)].,1
in-batch,1
11casesat,1
ofimmunosuppression,1
tenofovir alafenamide fumarate,2
FTC/TAF,2
absorbed (19 cases,1
"2020,collect",1
cefoperazone sulbactam sodium + linezolid,1
cefoperazone sulbactam sodium,1
[(43.78&plusmn;11.12) vs (39.14 &,1
[(44.84&plusmn;10.42),1
[(44.30&plusmn;18.42),1
79/201,1
15.723;all P,1
(17/38)vs,1
epidemicoutbreak,1
G +,2
didnât,1
eyedrops for,1
corona virus disease-19,1
omega;-3 fatty acids,1
easilybe,1
Xuebijing injection was,1
No.1-4,1
âI didnât,1
20 organic dairy herds,1
vasoactive amine,1
[OR] 1.00,1
CPIV-positive,1
2â²â5â² oligo adenylate (,1
fludrocortisone,1
everolimus,1
trimethoprim-sulfamethoxazole for antimicrobial prophylaxis,1
serviÃ§o hospitalar,1
rFeIFN,6
rFeIFN (1MU/kg subcutaneoulsy,1
total-,2
E on,1
vitamin D3,2
vitamins D3,2
E to,1
copper grids,1
ultraviolet germicidal irradiation disinfection,1
K d,8
Le changement de,1
parachloromercuribenzoate,3
forebrain,1
125I-sarcosine1,2
0.3mM parachloromercuribenzoate plus,1
10ÂµM losartan,1
10ÂµM PD123319,1
nucleotide triphosphate hydrolases,1
NAD+,1
fluide sÃ©,1
rGTP,1
"Dy,",1
Nd,1
Gd,2
carbonate fractions,2
N-glycosidic linkages,1
2-deoxy-glucose,1
2-deoxy-2-fluoro-glucose,1
(ED)-based,1
BT,1
rhamnosus GG,1
Lactobacillus casei Shirota,1
Lactobacillus pentosus PCA227,1
tolerans ACA-DC 4037,1
K dCsA,1
1.2Â±0.1,1
Corticosteroid Can Mask,1
ultrafine fiber,1
NFN) membranes,1
NFN membranes,2
NFN nanomaterials,1
NFN nanostructure,1
broad-spectrum recognition molecule against,1
Neopredisan 135-1Â®,1
hexose sugars,1
[2].,1
"[5],",1
SSGP network,1
lupeol synthase,1
NLVS,1
intranasal administration of,2
L-Cysteine,2
L-Cys,4
rGO/Au nanohybrid,1
straw,1
0.01â0.9,1
Oxygenated Perfluorocarbon,1
perfluorocarbon,3
Fio2,3
oxygenated perfluorocarbon,1
Eyedrop,1
"38,738 in",1
Dc3nVLPs,1
DcHEV,2
peroxyacetic acid,1
CellTiter-Glo,1
"200,000years",2
"zwittergent,",1
Chaps,1
N-lauroylsarcosine,1
Nusinersen,1
PBPK,1
chloroquine phosphate when given 500,1
CPV/FPLV-negative serum samples,1
(R)-propanediol carbonate,1
"2,6-diaminopurine",2
ester prodrug,1
beta-adrenergic drug,1
cystoplasty,1
CCM,1
thymopentin,4
Brij,2
sodium caprylate,1
maleic dialdehyde,1
758-RXXR-762,1
SPH,3
DUC2005,1
DUC2006,1
Cyanine 5,1
CCl4,4
[5] Abstract,1
dans 25 Ã  ,1
phosphate saline,1
"con 3 y 9,35",1
con 4 o mÃ¡s,1
Necesitaron oxigenoterapia,1
dÃ©,2
CI [1.02â1.098],1
CI [1.365â1.77],1
CI [1.346â1.848],1
PS3,1
Branched-chain C-cyano,1
3-keto glucoside 1 with,1
sodium cyanide,1
cyanohydrin 2,1
silylated pyrimidines and,1
vascular fluid,1
[OR] 1.73,1
[CI] 1.38â2.17,1
nuts,1
robinetin,1
lonchocarpol A.,1
P507,1
A508,1
TAI,2
"L, n=7; NL, n=4) cows",1
FEV1/FVC,3
crowders,1
dimerizations,1
reactive monoclonal antibodies against,1
phosphatidylinositol phosphate,1
P<0Â·005,3
FAA estreptocÃ³cica,8
con la consiguiente prescripciÃ³n innecesaria de antibiÃ³ticos,4
R406,1
3-amino 9-ethyl carbazole,1
45-nuceotide,1
K d of 4.93Â±0.30nM,1
Sorafenib,3
sorafenib,4
trypan blue,1
18â30,1
4-methylpyridine-N-oxide,1
4-methylpiridine-N-oxide,1
quantum chemical (DFT),1
pyridine,1
N-oxide,1
CH3 substituent in 4-MePyO,1
NS genes,2
SDS-polyacrylamide gel,4
polar amino acids,1
100Â°,1
1:7393,1
1:2060,1
AgNCs,1
L241,1
carbon nanotubes noncovalently,1
nucleotide GTP Abstract,1
cap analogs,1
GpppA,1
faÃ§ade,1
Force-Dependent,1
VPM,1
1 real-time,1
inorganic compounds,1
15N,3
"19F,",1
(4) reachable,1
SN nÃ©,1
SN testÃ©es par PEV,1
NS (0.97%,1
NS (2.6%,1
NS (11.3%,1
airborne agents,2
34â8.5 ACH,1
ATPs,1
SiO2 nanoparticles,2
nano-clusters,1
SiO2 particles,1
NR/SiO2 nanocomposites,1
Non-enterotoxigenic type A Clostridium perfringens,1
Lactic acid bacterial colonization and,1
snRNAs,1
quinoxaline derivative,2
2.2â27.1,1
TCB,7
Furosemide,1
pimobendan,1
mexiletine,1
Domain-Swapped,1
Its Mode,1
nucleic acids Abstract The,1
Zn2+,5
Co2+,2
NP-OP specimen,1
CrI] 57Â·3â65Â·6,1
CrI 47Â·4â61Â·5,1
CrI 28Â·4â34Â·2,1
NS proteins from 3 to,1
esquizofrenia,1
infecciosos durante el periodo prenatal,1
silver nanowires,1
Methylene blue,2
UV/PS,1
VUV,2
ROSs,2
humic acid,1
inorganic ions,1
HCO3 â,1
NO3 â,1
SO4 2â,1
7-deazapurine,1
alkylated 9-deazapurine derivatives of l-ascorbic or,1
imino-l-ascorbic acid,1
deazapurines,1
l-ascorbic acid,1
l-AA,1
9-deazapurine derivatives of l-ascorbic (,1
9-deazapurine derivative of l-AA (13),1
9-deazahypoxanthine derivative of l-AA (,1
9-deazapurine derivative disubstituted with,1
l-AA (3),1
2000;118:867-879,1
CoCl2,2
guanidinoethylmercaptosuccinic acid,1
o-phenanthroline,2
ethylenediamine tetraacetic acid,2
cadmium acetate,1
NiCl2,1
CdCl2,1
ceftibuten,1
clay minerals to,1
"2â²-deoxy-2â²,2â²-difluoro-5-halouridine phosphoramidate ProTides",1
phosphoramidate ProTides,1
acid-polyacrylamide,1
congo red dye,1
congo red,1
oxamniquine,1
cyclosporine A. A,1
cinnamoyl derivatives,1
sugar-vanilla,1
sugar-vanilla flavor,1
MPL+TDM adjuvants,1
diazoamino arynes,1
intramolecular N-arylation of different,1
"o-chloro-1,2,3-benzotriazenes",1
n-3 fatty acids,2
n-3 FA,3
docosahexaenoic acids,1
1185â1202,1
DPC detergent,2
25(OH)D3,1
parathormone,1
6d,5
poly-,1
8L,1
2-imino-thiazolidin-4-one derivatives on,1
ECLA,1
GIK,4
low-molecular-weight heparin in acute myocardial infarction,1
glucose-insulin-potassium,1
Reviparin,2
FT-PatternGrowth stores,1
Carbapenem,1
digoxine,1
Le rythme et,1
diuretics,3
kainic acid,1
myelinated,2
reactive astrocytes,1
neuron-depleted,1
myelinated afferent fibers,1
intrathecal synthesis,1
L genes of,1
breastfeed,2
3â²-proximal structural protein (SP),1
"E, 3b,",1
3b protein,2
Dihydromyricetin,2
health-benefiting,1
nanocapsule,1
D being,1
1Âµm,1
stilbene derivatives with,1
Stilbene derivatives have wide,1
mlâ1,1
FecalâOral,1
hyperthermies,2
catarrhe nasal,1
FLD,2
10.1007/s11427-020-1643-8,1
salmeterol xinafoate powders,1
cabin-air,1
l-fucose,2
"43,211 single nucleotide",1
lâÃ©,1
(3-noradamantyl)amines,1
polycyclic amines show,1
shikimate,1
matairesinol,1
dictamnine,1
xanthohumol,1
sinapyl alcohol,1
[OR] = 6.4),1
lactic acid dehydrogenase,1
LempelâZiv,4
supranutritional Se supplementation,1
triethylene glycol at low vapor concentrations,1
triethylene glycol (TEG)-saturated air containing 2 ppm,1
Melamine,1
melamine,4
Clenbuterol,1
iodine in milk powder,1
n-hexane extract,1
protein-research,1
[0.98â1.18],1
1.04â1.29],1
palladium,1
pyrazine-carboxamide nucleotide,1
T-1106,2
A79-10,1
Ca2+-dependant carbohydrate,1
Flavone ingredients,1
flavone,2
flavone ingredients,1
99mTcO4 - to,1
radiopharmaceutical agents,1
cationic dioleoyl-sn-glycero-3-ethylphosphocholine,1
cholesterol (ECL)-based nanoliposomes,1
siMcl1,2
PP242,1
Si-Ni-San,11
high-performance liquid chromatography,2
picryl chloride (PCl)-induced ear,1
disulfur analogues,2
oxadiazolones,1
oxadiazolone,1
oxadiazolthione,1
CH2 tautomer,1
oxadiazolone O,1
O atom,2
S-atom,1
oxadiazole rings is,1
pi-electron,2
oxadiazolthiones,1
IgIV,1
NTG piglets,1
FBDO,1
solar-driven,1
nucleic acid analogs,1
CRA complex,1
chlorhexidine consumption,1
intragastric inoculation,1
Nanosphere Verigene RV+,1
0.871â0.985,1
FluA.,1
emetine-stopped,1
VPl,1
freeze-dried,1
raphe,1
excipientsâsiRNA,1
Chitosans,2
acrylonitrile (AN),1
water/ethanol,1
NâHâ¯Ï,1
F1S1,2
2-oxonicotinonitrile based nucleoside analogues,1
Asn-Gly-Arg (NGR)-modified multifunctional nanoparticles,1
CvME,1
droplet/airborne,1
AT1R-mediated overactivity,1
thymine (T),1
fungus) when,1
seven-row,2
ribarivin,2
NPS (,1
UV254,9
UV254 doseÃrelative,1
458â531,1
aa369â390,1
[1] high-dimensional,1
realizaciÃ³n de una reacciÃ³n,1
trataba,1
con un ligero predominio,1
"E, 5a and",1
methyl piperazine moiety,1
80/84,1
1 mg/ml,1
bile acid-dependent PEC,1
bile acid-mediated PEC,1
bile acid transporters,1
sodium-taurocholate,1
neoglycoproteins,1
porphyrin,1
carbohydrate scaffolds,1
nose-to-brain,1
gas/particle,1
VCPs,1
mercury-,1
Hg2+,1
C44,1
Zn2+-centered coordination,1
Se describen las caracterÃ­sticas clÃ­nicas,2
coinfecciones fueron,1
mogamulizumab,5
2.06Â±0.12Ã10â3 sâ1,1
Soy isoflavones,1
Isoflavones,2
soy isoflavones,1
NS6-expressing plasmids,1
2.8Ã106 plaque,1
pre-farrowing doses,1
ezetimibe,1
azacitidine,1
scutellarein,4
scultellarein,1
bismuth anti-microbial,1
Bi(III,1
[EMCC]),1
Nph PCR,1
intrathecal synthesis of,1
guanine chemiluminescence,4
TBA-conjugated carboxyfluorescein,1
6-FAM,2
tetra-n-propylammonium hydroxide,1
TBA,3
ochratoxin,1
IVS,3
IVS travelersâ,1
carbol fuschin,1
Drug Administration's,1
cumene hydroperoxide,1
t-butyl hydroperoxide,1
ISAR,1
nucleoside triphosphate analogs,1
phosphoramidate prodrugs,1
hiver 2014,1
symptÃ´me,1
SB-300 (,1
SB-300,7
intravenous fluid therapies,1
24-hour,1
fMLF,3
pegylated IFN with,1
smoke-induced,1
DQwl-positive,1
DQwl-negative,1
NTZ metabolites,1
tizoxanide glucuronide,1
1Ã107 oocysts,1
NTZ in calves,1
MDL 28170,2
Xylose,1
soy flour,2
convoluted villi,1
indole alkaloids,2
Sch,1
19-epischolaricine,1
indole alkaloids against post-infectious cough (PIC),1
sulfadimidine,3
Intervet,1
Tp5,7
PBCA-Tp5-NP,6
Tp5 samples,1
3H-thymidine,1
178Â±39,1
intravenous Tp5,1
glycine betaine,3
methyl donor S-adenosyl methionine,1
choline oxidase,1
1959â2003,1
polyethylene glycol 6000,1
nucleoside triphosphate,4
inorganic pyrophosphate,1
PLGAâPEI nanoparticles,2
l-lactide-co-glycolide,5
DNA-loaded PLGAâPEI nanoparticles,1
CHR,2
IIP-2,2
polysaccharide IIP-2,1
waterpipe,1
E gene,1
Pravastatin,1
propanols,1
virucidal hand,1
"37,2Â±22,9 ans",1
Le rendement diagnostique chez,1
2-arylsulfonyl-3-ethoxy-2-en-1-ones,2
[3+3] cyclization,1
cyclosporin A analogs,1
nitric oxide-derived reactive nitrogen intermediates (RNI),1
nitric oxide against,1
1999â2004,1
con el metapneumovirus humano,1
benzoxazinone analogues,1
"compounds 1, 3, 4,",1
ED50,1
three-codon-long,1
cycloguanil,2
6mM,1
1.6mM dNTPs,1
fluoroquinolones ABSTRACT,1
quinic acid derivative,1
neo-chlorogenic acid,1
crypto-chlorogenic acid,1
quercetin hexoside,1
LCâMS/MS in multiple reactions,1
âadvanced servicesââspecialized,1
[OR] 1.49,1
1 complex radiograph requires imaging 133 and,1
endotoxin free,1
PHA nanobeads,1
UQ,2
pyrimidine cyclopentenyl C-nucleosides Abstract,1
pyrimidine C-nucleosides 1â4,1
d-ribose,1
antimotility agents are,1
Le problÃ¨me majeur,1
Le traitement est d'abord symptomatique,1
"Compounds 4, 7",1
10Î¼M,4
2â8,1
coumarin analogues,2
nanoparticle conjugate reagent,1
pentaerythritol with,1
trivalent spacer arms,1
F74,1
F77,1
estradiol benzoate,1
0.01mg/kg estradiol benzoate,1
12Â·5,1
cuidadosa historia,1
N(NH,2
2-1-1,4
inhaled agents (,1
inhaled ipratropium bromide,1
expectorants,1
codeine,1
High-dose GC,1
noradrenalin,1
X(j,2
folates,2
Centra! Nervous,1
wall-flow,1
â344,1
diclazuril,7
toltrazuril (Baycox bovisÂ®,1
diclazuril (,1
DHPMs,1
231/637,1
cubic regression splines,1
PBA,4
con infecciÃ³n vÃ­rica,1
con asma leve o moderada,1
D los,1
IL-5 fueron mayores que,1
Genistein,1
chlorinated derivatives from triclosan in,1
"2,8-DCDD",1
"2,3,7,8-TeCDD",1
nucleic acid oligomers,1
GPC,2
Heparan sulfate,1
THA,1
ASMNPs,1
water-in-oil,1
5â²-TMR-CGCATAGGGCCTCGTGATAC-3â²,1
"2,6-Bis-arylmethyloxy-5-hydroxychromones",1
5-hydroxychromone,1
isatin derivatives,1
isatin 4o,1
chlorambucil,1
280/813,1
brainâblood barrier,1
1 OS),1
CsA derivatives,3
FORL,4
(sub)gingival,1
nanosilver,2
glutamic acid 2843 (Glu2843),1
J.2.2-selected NR,1
online/mobile,1
Gluconolactone,1
Epimedium-derived flavonoid glycosides,1
gluconolactone,4
ethyl acetate was,1
ODS,1
formic acid respectively,1
icariside II in 2,1
icariside II,1
Roundup,3
semi-synthetic routes,1
sulfur heterocyclic mimics,1
flavonoid alkaloids,1
thiophenyl flavonoids,1
karanjin,1
DNA-mimicking oligodeoxynucleotide with,1
DNA-mimicking ODN,1
SAT05f,2
SAT05f could,1
OJ,1
Î²6 strand,2
immunosuppressors,1
teicoplanin pseudoaglycon-derived,1
tetraethylene glycol linker,1
teicoplanin pseudoaglycon,1
lipoglycopeptides,1
Chalcones,1
semicarbazones,3
L Abstract Cathepsin B [EC 3.4.22.1,1
chalconesemicarbazones,2
"146,700 TJ",1
broad-spectrum vaccines,2
Purine analogs,1
purine derivative,1
phenyl rings without,1
abietane ferruginol analogues,1
(+)-dehydroabietylamine,2
abietane-type diterpenoid (+)-ferruginol,1
leishmanicidal,2
anti-ulcerogenic,1
ferruginol (1),1
ferruginol analogues,2
diterpenoid ferruginol (1),1
[IND] application,1
orthoreovirus-positive,1
419E,1
hyperpolymer,1
pAlpha-CPV-VP2,1
microcrystalline polysaccharide particle engineered from,1
Inulin,2
microcrystalline particulate from,1
cCMP,1
cereal yellow dwarf virus serotype RPV,1
100Î¼g/L.,1
GST-P,5
glutathione S-transferase placental,1
Q10,2
diethylnitrosamine (DEN),1
18.396,1
Antithymocyte Globulin,2
Antithymocyte globulin (,1
mg/m2/day,1
Norkurarinol,3
flavanone,1
Thursday,1
dâinfections,1
endonuclease-induced,1
anticholesterolaemic,1
antitumour,1
chrysophanol glycoside,1
Anthraquinone derivatives,1
A38,1
dolichol pyrophosphate intermediates to asparagine residues,1
carbohydrate precursors,1
borate,1
glycopeptides,1
oligcsaccharide,1
oligosaccharide side chains different,1
Phytocompounds,1
K BHB,2
non-aqueous aprotic solvents with,1
acetonitrile (AN),1
tetra-substituted pyridine N-oxides [B],1
[BH+] form,1
"3,5-dimethyl-4-chloropyridine N-oxide",1
conjugate acids of N-oxides.,1
MBGR,1
intratracheal LPS,2
pentoxifylline,7
flunixin meglumine,2
Pentoxifylline,3
liquiritin apioside,1
saikosaponin b1,1
saikosaponin b2,1
ginsenoside Rb1,1
(6)-gingerol,1
(6)-shogaol,1
coumarin based transitional metal complexes OBJECTIVES,1
3-aryl-azo-4-hydroxy coumarin,1
cobalt complexes,2
FIVP,1
cytotoxicies,1
limonoids 1â4,1
18Î²-glycyrrhetic acid,1
18Î±-glycyrrhetic acid,1
Î±-glycyrrhetic acid,1
ethylene glycol (80/10/10),1
SPE,5
TPI,2
MTX,2
inorganic carrier materials,1
10/40,1
C45-57,1
NREGKIVGLYGNGVV,1
mizoribine (10Î¼g/ml),1
TFST,3
aglycones,6
sophorabioside,1
ononin,1
trifolirhizin,1
TFST anticomplement,1
VRC 319,6
VRC 320,5
NCT02996461,1
split-dose,1
telithromycin,4
cationic carbosilane dendrimers,1
cationic NN16,1
carbosilane dendrimers,2
oxygenâsilicon,1
CHAPS,4
"SAR/10,000",1
N-GST,1
Lysosomal,1
N76â114,1
cation-exchange,1
IFN-a2b,2
soyabean,1
23.3â43.0,1
UDA,5
TLR4/TRIF/CD36,1
non-HDL cholesterol,1
Cycloartenol triterpenoid saponins,1
"9,19-cyclolanostane triterpenoid glycosides",2
triterpenoid glycoside,1
cycloartane triterpene glycosides,4
lysobisphosphatidic acid,1
bis(monoacylglycero)phosphate,1
glycosphyngolipids,1
FEV0.5,2
"L [IQR,",2
Con A/IL-2,1
formic acid,3
manganese ferrite,1
manganese ferrite nanoparticles,1
[CON],1
23/262,1
204/258,1
inosine,3
1st-line,1
AD-based,1
DEAE Sepharose,1
methyl esterified and part of 2-hydroxyl groups,1
1.97/participant-year,1
chylomicron-associated,1
first-pass,2
carbon black nanoparticle exposure Abstract,1
162Î¼g Printex,1
carbon black nanoparticles (,2
CBNP,3
15/372,1
intranasal corticosteroids in acute rhinosinusitis,1
intranasal corticosteroids,1
INSs,7
mometasone furoate,2
beclomethasone dipropionate,1
short-text,1
104Â°F,1
M+A(-1,1
syphilisâhas,1
NA forming,1
ozone (O3),1
thiophosphonate nucleosides,1
sulfur atom,2
PMPA,1
fungus Beauveria sulfurescens,1
retinol,1
faecal pathogens,1
bisphenol A,2
bisphenol S,1
polyinosinic-cytidylic acid,1
conjugated or catching antibody.,1
inter-airport,1
FML-vaccine,3
79â95,1
ido incrementando progresivamente,1
vacunaciÃ³n frente a los rotavirus,1
nucleotide 28330,1
nucleotide 36787,1
Strazicich [2003.,1
[19 Ã  ,1
intravenous route,1
-IIE,1
CaO,1
SiO2,1
"Ba,",3
Sn,1
Ni,1
Sn),1
FeâMn oxides,3
Cu in organic-matter,1
O3,2
"NO2, 1.04 (95%",1
quercetin-3-Î²-galactoside,2
7-hydroxy,1
Le franchissement,1
reagent-grade water,1
esiRNAs,1
low/normal,1
IMS4132,1
2014âFebruary,1
110min,1
FP2,2
calcium cations,1
Ca2+-dependency membrane,1
K11777,3
Camostat,3
vinyl sulfone-based inhibitors,1
diastereo-isomeric mixtures,1
ex-SARS,1
NIC in Lyon,1
1ÂµLâ1,1
fluorescent oligomers,1
10.1007/s00134-020-05943-5,1
aurothiomalate,1
sodium aurothiomalate,3
NP-40 detergent,1
85.20,1
amphothericin B,1
biotin-11-dUTP,1
fructooligosaccharide,1
early-applied,1
mitomycin-c,1
16(12â20,1
CIs],1
hexamidine,4
HXM,1
cytidylate.,1
Mn2+,4
Procyanidins,1
butanol extract,1
butanol,1
Leguminosae,1
broad-spectrum inhibitor of enveloped viruses,1
vasoconstrictor peptide,1
vasodilator peptide,1
SDS-polyacrylamide,1
200mM,1
[3.7;,1
vecteur,1
alcohol-aversive,1
L protein),1
L protein carries,1
nitric oxide is,1
Trifluorothymidine,2
19F nuclear,1
cholesterol recognition/interaction,1
silverâsilver chloride,1
Antimicrobials,2
Ethacrynic,1
Î±-lipoic acids,1
redox-modulating agents,1
ethacrynic,1
PSL,5
1.08Â±0.09Î¼M,1
diethylaminomethyl moieties are,1
citrulline,3
AMP-PNP,1
C12E9,1
Et les virus respiratoires !,1
unsymmetrical aromatic disulfides,2
anticholinergic bronchodilators,1
1Â·44â3Â·28,1
(bio)assays,1
inorganic nanotubes,1
gadolinium oxide nanoparticles,1
Chiral zirconium quantum,1
zirconium quantum dots (Zr QDs,1
L(+)-ascorbic acid,1
vitamine D,1
eNO,1
6-halogenated purine nucleosides,1
6-chloropurine riboside,1
agarose matrix,1
dodecylphosphocholine,2
anionic phosphatidylcholine/phosphatidylglycerol vesicles,1
DPC micelles,2
F108,2
3â² terminal ORF,1
baitfish-pathogenic virus,1
8mM,1
40min,1
FIPV-challenged kittens,1
5â² regions,1
"4-substituted 3,4-dihydropyrimidinones Abstract A",1
C-4 aryl moiety bearing halogen substitution,1
RNAse-T1 fingerprint data,1
ofrece como posibles dianas terapÃ©uticas,1
3â²-nontranslated regions,1
CI 1.233â3.318,1
DimerX-based,1
broad-spectrum prophylaxis against a,1
0.40-m,1
protein/lipid,2
246/3268,1
biocontenciÃ³n que,1
ribavirina,3
CI 1.79â1.86,1
10â2,3
thin-layer,1
nephrotoxin,1
150Î¼g/kg OTA,1
N-acetyl-l-cysteine,3
CPP-1,5
imino sugars intercalate between E5 protomers,1
lipid solvents,1
Quil A,1
dimethyl dioctadecyl ammonium bromide,1
Carbopol (,1
QCDC,1
wogonin,2
ethidium bromide dye,1
flavonoidâmetal complexes,1
broad-spectrum anti-pathogenic,1
antiparkinsonian,1
cellulose fibres,3
sodium alginate matrix,1
sodium alginate,1
antibacterial fibres,1
virusâreceptor binding,2
Polycyclic peptide,1
low-molecular weight peptidic SARS-CoV 3CL protease,1
26n,1
K i,12
hydrogen bond donor,1
lectinâoligosaccharide,1
carbohydrates acting,1
con los catÃ©teres intravasculares,1
eradical,1
short-acting gonadotropin-releasing hormone,1
deslorelin,4
6-d-tryptophan-9-(N-ethyl-l-prolinamide)-10-deglycinamide,1
gonadorelin,2
FAM-labeled,2
Se describen,1
179/217,1
Zn2+-binding motif,1
11f,1
chloroxylenol,2
cetrimide/chlorhexidine,1
benzalkonium chloride-based,1
cetrimide/ chlorhexidme,1
"15mM borate,",1
"40mM phosphate,",1
15mM,1
Baicalin,3
Baicalein,1
Wogonin,2
exhaled aerosol â,1
airway lining fluid,1
FCA,21
âearlyâ corticosteroid,1
leader-specific,1
myofibroblasic FRC,1
FLUV,2
1.3â8.5,1
VDL,1
"4-aza-7,9-dideazaadenosine C-nucleoside",1
siRNA-loaded poly(D,1
L-lactide-co-glycolide,1
siRNA-containing PLGA NPs,1
ruthenium red,1
stains-all,1
45Ca,1
convoluted membrane,1
ampicillin [n =,1
1.7Ã107 oocysts/g,1
Tanreqing injection intermediates with NIR spectroscopy,1
Tanreqing injection intermediates.,1
Tanreqing injection intermediates,1
cinnamyl derivatives of substituted uracils,1
benzophenone,1
"20,230/471,482",1
Î¼g/mL ARB,1
peginterferon,1
28.2â34.2,1
clodronate-containing,1
clodronate-containing liposome,1
nucleotides 262,1
dual-chamber,2
C/S,1
nanocapsules,1
acetal/thioacetal,1
2-(cyclohexylamino)ethanesulfonic acid Abstract Anti-bacterial,1
Relenza,1
2-(cyclohexylamino)ethanesulfonic acid,1
CHES,5
Neu5Ac,1
2-aminoethanesulfonic acid,1
cyclohexyl,1
STI-571,1
broad-spectrum inhibitors of RNA viral,1
pyrazinecarboxamide derivatives,2
water-aided,3
entamophagus fungus,1
Its fruiting,1
normal-phase high-performance liquid,1
N-butyl-deoxynojirimycin,1
Huile,1
couronne scindant,1
Hexamethylene amiloride,1
Hexamethylene amiloride (HMA) â,1
MHVÎE,1
Le diagnostic des infections virales,1
Le diagnostic repose sur,1
l-lysine (L),1
carboxymethylcellulose (C),1
liposome-encapsulated,1
GMT=1195,1
educatorâpractitioners,1
"1,01-5,17",1
Ãºtil para el diagnÃ³stico,1
7155,1
115-nt untranslated 3â²,1
acyclic nucleotide analogues,2
12Î¼M,1
4Î¼M,1
4â50Î¼M,1
Cholesterol-rich lipid,1
cholesterol-rich lipid,3
CPV-2a-297A,1
monophosphate by,1
face-to-face-semi,1
Ketone,1
effect(s,1
cytoskeleton-disrupting,1
arachidonic (,1
C-20:4,1
palmitic (C-16:0) acids,1
cholesterol (,1
2.55-4.27,1
phospholipid liposomes,2
1:4580,1
E:,4
tryptone,1
"EMBO J. 8,",1
F-RNA coliphage MS2,1
"benzotriazole esters,",1
lopinavir derivatives [1],1
180â200kDa in SDS gels,1
Mandarin-language,1
nano-aerosols,4
âskinâ layer,1
iododeoxyuridine,1
chymostatin,2
Propidium monoazide (,1
ethidium bromide monoazide,2
PVDA,4
propidium monoazide,1
Glycyrrhizic acid derivatives,1
l-amino acids,1
"methyl esters,",1
d-galactose amine,1
phenylalanine,2
2.5â10Î¼g/ml,1
enteroctyes,1
intranasal zanamivir,1
MEP,3
anti-HRV agents,1
"intranasal tremacamra,",1
intranasal AG7088,1
DMBA mammary,1
azoles,2
imidazole ring is the,1
Triazoles,1
benzimidazole/benzotriazole derivatives,1
benzotriazole derivatives in biomedical research,1
cholesterol-lowering agents,1
CI 1.4,1
LCâMS/MS,5
quercetin-3-O-Î²-d-glucoside,2
dichloromethane,1
2mM aqueous ammonium acetate,1
Anticorps monoclonaux,1
102to 1016particles/swab,1
early/late,1
Bevacizumab,1
"NPA (N = 280),",1
27âAugust 2,1
nucleotides 230,1
dimethyl sulfoxide gradients.,1
sodium hypochlorite within 1 minute,1
chlorhexidine digluconate,2
Intravenous Fluid Therapy,3
lithium chloride solution based composite supported liquid membrane,1
1.14Ã10â4 kgmâ2 sâ1,1
tinned food (1.6%,1
23.5â29.7,1
Cu/Al2O3,1
cadmium intake,1
Cadmium,2
Phytomolecule icaritin,1
lactic-co-glycolic acid/tricalcium,1
P/T,3
P/T/I,2
acid vesicles,1
3mg/ml,1
Transmission-Based Precautions,1
carbonate,1
organic matter fraction,1
CDHA,1
promazine,9
Phenothiazine,2
propylamino,1
Phenazine ethosulfate,1
phenoxathiin,1
195Â±71.2Î¼M,1
1â3.3Î¼M,1
rocaglate CR-31-B,1
dioxane moiety,1
195â199-amino acid,1
F26G18,1
d-xylose,8
flaxseed,5
alpha-linolenic acid,1
cervonic (,1
myristic,2
palmitic,2
palmitoleic acids,2
eicosadienoic acid,1
flaxseed feeding,1
aluminum phosphide,1
Ginseng polysaccharides,1
nonsteroidal antiinflammatory agents,1
rokitamycin,2
eradicationâ,1
amoxycillin,1
Tube,1
1010.2â1010.9,1
CaHPO4,1
PEG precipitation,1
3H-,1
14C-labeled virus,1
tartrate,1
benzyloxycarbonyl,1
dipeptide derivatives,1
phenanthroquinolizidines,2
phenanthroindolizidines,1
tylophorine analogues,1
tylophorine compounds strongly,1
cellulose membranes,1
examinedâinfluenza,1
papaverine,6
Papaverine,1
papaverine-induced,1
Digoxin,4
quinolinic acid,1
strychnine,1
Mg++,2
Ca++/Mg++,1
ubiquinone,1
glycoconjugate,1
stealth,1
1N NaOH,1
100mM NaIO4.,1
methylene blue treatmentsâdesigned,1
Inactine (a binary ethyleneimine),1
vitamin B2)âis,1
S-59,1
Inactine,1
riboflavin,1
photoproducts,1
Protollin,3
wogonoside,1
oroxyloside,1
norwogonoside,1
oroxylin A,1
norwogonin,2
O primary viruses,1
carbapenem antibiotic,1
tetrazolium bromide (,1
ethylene diamine tetra acetic acid,1
Cu2,1
buffer pH 6.0),1
thiiranium,1
sulfur atom of Cys145,1
enzyme-bound,1
chlorine dioxide in wastewater ensures,1
4-thiazolidinones Abstract A,1
6c,2
2.1Î¼g/mL.,1
doughnut-shaped octamers,1
pyrimidine acyclic nucleoside phosphonates,1
"alkoxyalkyl esters,",1
lesÃ£o,1
ipratropium,1
L Abstract The antigen,1
L amino acid,2
neplanocin A derivatives,1
IBV-N29-160,1
Polyethylene glycol-modified bovine (PEG) ADA,1
endoglycosidases,1
interferonÎ±-2a,2
patientâs blood,1
Intravenous fluid,1
ruminal acidosis (rumen drinkers,1
ribavirin formulations,1
Z4-siRNAs,1
interchain disulfide bonds might,1
ultraviolet C,1
imine-based multicomponent reactions (MCRs) [Figure:,1
[31P] orthophosphate,1
LoA,3
â0.60,1
â7.22,1
self-assembled,1
aurintricarboxylic acidâ [Biochem.,1
IEB,4
realizaciÃ³n de inmunofluorescencia directa y/o reacciÃ³n,1
Î¼L [normal range 3500â9500 cells,1
NBT,1
l-citrulline,5
nitrite/nitrate,5
NO derivates,1
11.15Â±0.10 to 12.08Â±0.64Î¼M),1
12.67Â±0.52Î¼M,1
11.20Â±0.37Î¼M,1
4â,1
6-diamidino-2-phenylindole (DAPI),1
15Î¼g HA,1
[97.1â98.6],1
[89.9â92.8],1
[72.3â76.9],1
[71.1â79.2],1
[52.0â61.3],1
[72.9â77.5],1
[51.0â56.4],1
RT-qPCR-confirmed,1
ADM,1
L activate Ebola,1
L activate the,1
reactive hemophagocytic syndrome,1
Friedel-Crafts,1
Tryptamine derivative 17a,1
biphenyl ethyl moiety,1
PNU,1
ethyl acetateâmethanolâwater,1
trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease Abstract A,1
trifluoromethyl ketones as,1
dâanomalies scanographiques,1
amenazas,1
lucha contra,1
K D,1
400mM NaCl,1
50mM Ca2+,1
Low-dose corticosteroids may,1
N-acetyl-cysteine,1
Celastrol,8
quinone methide triterpene isolated from the root extracts,1
celastrol,15
SnMP,1
95.2â99.0,1
polyethylenglycol,1
chloroauric acid,1
HAuCl4,1
carbonyl compounds,2
reactive arthritis and,1
290-,2
sodium chloride nose spray,1
sodium saccharin,1
corticosteroids [ICS] used,1
L groups had,1
lipopolysaccharide outer core biosynthesis loci Type 3,1
polycyclic musks,1
siloxanes,1
sweeteners,1
thioridazine,1
D3D1,1
mTIM-2,1
butaphosphan,4
cyanocobalamin,5
periparturient dairy cows 1,1
Catosal,3
ketone body,1
butyrate,1
periparturient dairy cows,1
27-hydroxycholesterol,2
27HC,1
ZBG,1
â1 frameshifiting,1
fluoro-ketopyranosyl nucleosides,1
"2,3-",1
"1-(2,3-dideoxy-3-fluoro-6-O-trityl-Î²-d-glycero-hexopyranosyl-4-ulose)-N 4-benzoyl cytosine",1
"1-(3,4-dideoxy-3-fluoro-6-O-trityl-Î²-d-glycero-hexopyranosyl-2-ulose)-N 4-benzoyl cytosine",1
14a,2
silylated N 4-benzoyl cytosine,1
cytosine 6,1
"2,3-dideoxy-3-fluoro ketonucleoside 7a",1
nucleoside 12,1
carbonyl compound 13a in equilibrium with its hydrated form 13b.,1
trityl,1
13a/b,1
"3,4-dideoxy-3-fluoro-2-ketopyranonucleoside analogues",1
Primaquine derivatives,1
antimalarial agents with,1
carboxyprimaquine,1
primaquine N-derivatives,1
C11,2
corticosteroid therapy Summary Aim,1
CTx,2
corticosteroid dosage,1
high-dose corticosteroid therapy,1
cenicriviroc,1
miravirsen,1
single-tablet,1
CMX001,1
aristeromycin (1),1
one-carbon homologated,1
base-build,1
"CI [1.16, 2.53])",1
pulse-dose,1
corticosteroids therapy9,1
vitamin K-dependent coagulation factors,1
PCC Beriplex,1
Beriplex,2
AgNO3,3
cellulose fibers,2
SEM-EDS,1
anti-microbial agents,1
NO donor compounds,1
222Î¼M,1
PhCoVs,1
Ib-type cyclopeptide alkaloids,1
CTM,2
phosphoramidate ProTide approach,2
ribavirin ProTides,1
ribavirin monophosphate,1
ProTides,3
nucleoside monophosphate,1
pegylated formulations,1
H2O2 wipes significantly,1
107PFU/0.2 g,1
5-ene-4-thiazolidinone derivatives,1
5-ene derivatives of different 4-thiazolidinone subtypes,1
lead-compounds,1
corticosteroid regimens,2
corticosteroid treatment of >2 g,1
acid-extracted organic matrix,1
calcium-based solids,1
inorganic phosphates,1
3mM,1
5mM,1
2â4 L,1
early-epidemic,1
CAWS,6
intranasal fluticasone propionate treatment,1
Fluticasone propionate,1
aglycoristocetin derivatives with cyclobutenedione carrying hydrophobic chains,1
aglycoristocetin derivatives containing hydrophobic side chain-substituted cyclobutenedione,1
ODN H,2
CpG-DNA,1
nonlabeled Ps containing RNAs,1
thisin,1
V/B,1
HTV-positive fecal specimens,1
5-chlorouracil,1
TDF/FTC,1
[11Â·2],1
[12Â·9],1
5n with,1
1.95 Ã ,1
carbon dioxide),1
1bresidues,1
dihydroartemisinin-piperaquine,2
Intravenous artesunate,1
intravenous quinine,2
GRIs,1
NLs,1
ultraviolet germicidal irradiation: Experimental Abstract Increasing,1
germicidal irradiation (UVGI),4
sialylated oligosaccharides,1
1â2 IU,1
Nitazoxanide 1a,1
"5-nitrothiazole derivatives,",1
5-chloro derivatives,1
prodrug derivatives of 1b and,1
F69,2
Al(OH)3,3
CLs,1
azanucleosides,4
sulfanilamide,1
sodium dithionite,1
personales,1
con gran variabilidad,1
sospecha,1
1-53,2
PGD2,1
inositol requiring enzyme 1 (,1
dansylcadaverine,1
C-6,1
D,2
C/H,1
Zn2+-binding fingers,1
polar growth,1
tip-focused endomembrane,1
anti-retroviral/anti-mycobacterial agents,1
Benzotriazole Esters Summary,1
Benzotriazole esters have,1
benzotriazole esters that,1
benzoic acid,1
TEO,1
1 late,1
"1,582-24,596/10(6",1
sub-micromolar,2
0.59Â±0.06Î¼M,1
oxygen plasma,1
double-shift,1
educaciÃ³n,4
benzylidene hydrazides (1â20),1
nitro substituents,1
curd,1
staurosporine,1
prostaglandin E2-regulated astrocyte,1
3â-terminal 1b,1
tetrandrine,5
0.5â4,1
Tetrandrine (1â10 Î¼M,1
hexadecyloxypropyl prodrugs of acyclic nucleoside phosphonates containing guanine or,1
PEE,3
Hexadecyloxypropyl esters of acyclic nucleoside phosphonates containing guanine (G),1
hypoxanthine (Hx),1
(S)-[3-hydroxy-2-(phosphonomethoxy)propyl] [(S)-HPMP],1
ester derivatives,2
PEEG,1
diesters,1
MVAIK/RSV/F,1
Bobel-24,2
celecoxib derivative kinase inhibitor,1
AR-12,8
OSU-03012,2
Li+,1
nhuIL-2,1
hydroxycinnamic acid,1
hydroxybenzoic acid derivatives,1
flavonoid contents,1
bile among feline calicivirus,1
bile salt (deoxycholic acid sodium salt,1
Prometheus,1
compounds 2 and,4
CC50,4
482.8Î¼M,1
522.3Î¼M,1
"N2H2) en 1957, la grippe de Hong-Kong (H3N2)",1
"3-methyl-1,6,8-trihydroxyanthraquinone",1
296â400,1
LNA):,1
LNA nucleotide monomers,1
â,2
megadoses,1
Le Syndrome respiratoire aigu sÃ©vÃ¨re,1
ribavirine combinÃ©e Ã  ,1
Ultraviolet germicidal irradiation of influenza-contaminated N95 filtering facepiece respirators Background Safe,1
1 J/cm2 UVGI for approximately 1 minute,1
20â38,1
oxygen â¥,1
NCT01052480,1
W585,1
Togariridae,1
Diammonium glycyrrhizin,1
glycyrrhizinate,1
Ziehl-Neelsen staining),1
CD2âCD4âCD8â/SW6+,1
pyridine N-oxide derivatives.,1
Methylene chloride,1
methylene chloride,2
methylene chloride for 6 hr,1
74/789,1
161/1386,1
MvaI,1
FCoV-free,2
scavenge,2
[3H]-palmitic acid,1
IFNG SC,2
FQs,1
"3-acyl-2-phenylamino-1,4-dihydroquinolin-4(1H)-one derivatives",1
3mM MgCl2,1
104.0TCID50/5 Î¼l,1
34.5â81.9,1
hydroxytyrosol,4
dihydrocaffeoyl catechols with,1
dihydrocaffeoyl catechols with lipophilic properties have,1
Drug Administration-approved antihelminthic drug,1
TiO2 nanoparticles,1
ISO,1
UV-A,1
TiO2/cordierite foam,2
acetaldehyde,2
L loci,1
Intravenous Alemtuzumab,1
Fludarabine/MelphalanâBased,1
intravenous (i.v.) alemtuzumab,1
i.v,3
15mo,1
IFN-Î±2b causes,1
200mg/kg body weight,1
hydroxyapatite high-performance liquid,1
KMO,1
PIH,8
FIPV-naive,1
Forsythoside A,2
Caffeic acid,2
"3,4-dihydroxybenzenepropionic acid",1
fomivirsen,1
nucleotide/amino acid/fatty acid,1
1 4,1
organic solvents were,1
pamaquine,1
conjugated a factor Hâbinding peptide,1
CHV-1-specific,1
5-hydroxytryptamine-,1
amphetamine,1
70â75,1
JHMV-DL,2
ST-246,1
Le syndrome respiratoire aigu sÃ©vÃ¨re,2
Fok,1
aluminium salts,1
QS-21,1
QS-21 analogs,1
iodination,1
35%â40,1
INHP,1
marine-sourced fucoidan,2
Fucoidans are sulfated polysaccharides,1
ethyl dibromofluoroacetate,1
CH3CN,1
bromodifluoroacetate,1
GSPE,4
arsenic-induced,2
quinone 1 (,1
T-AOC,2
8-OHdG,1
pegylated interferon,1
1:100 sodium hypochlorite,1
NAADP-dependent Ca2+,2
nicotinic acid adenine dinucleotide phosphate (NAADP),1
NAADP-evoked Ca2+,8
IP3-evoked Ca2+,1
cADPR,1
IP3-dependent Ca2+,1
5-fluorocytosine,1
"1,2,4-triazole-3-carboxamide",1
"4-substituted-1,2,3-triazoles",1
53 DPI,1
18.76Â±15.83,1
CI 1.1â4.1,1
N-methyl amino acids,2
hydroxycarboxylic acids,1
cyclooctadepsipeptide PF1022A based on,1
nucleic acid duplex,1
âmedia panicâ,1
squalene synthase gene,1
squalene synthase 1(SQS1,1
ergosterol in,1
vesicle-based,1
chitosan oligomers microspheres with entrapping complexes of,1
1 TCID50 mlâ1,1
ARAs,1
azathioprine,3
vandetanib,1
tetrazepam,1
O2/N2,1
NAADP-mediated channel,1
TPC,1
spin-labeled phospholipids,1
glc,1
1963â2008,1
cholesterol-sequestering,1
DNJ,4
catabolisme comprenant,1
corticosteroids â¢,1
Itraconazole (ITZ),1
broad-spectrum inhibitor of enteroviruses,1
ITZ,5
OSW-1,2
nanocomplexes,2
L type (,1
fungus load as,1
LMPG micelles,2
120â1630 L,1
chloro-containing molecules,1
betulinic acid,1
Exhaled Air Dispersion Distances,1
corticosteroid (ICS) (>1000mcg beclomethasone-equivalent/day,1
conjugate pneumococcal vaccine,1
CI [0.03â0.74],1
Leukotrienes,1
lipid peroxidizing enzymes,1
lipoxygenases,1
CD4+CD25âFoxp3+,1
Î-peptide,1
cyclosporine (CSP),1
"NRC,",1
27.2Î¼g/Î¼l,1
chitosan oligosaccharide,4
chitosan oligosaccharide administrations,1
Cytosine,2
NNU/NNC ratio,1
NNC,1
NNU/NNC,1
lipooligosacchride,1
intranasal fluticasone propionate,1
high-dose fluticasone propionate (100 Î¼g,1
self-assembled peptide nanoparticles in,1
Cys145,2
Triton-X,1
poragen,1
fungicidal,1
"adopted,1,2",1
1 Î¼g/mL,1
herbs/herbal components,1
Gly-Sar,1
"L218A,",1
CYMV,1
CYMV coat,1
Q-Sepharose,2
50mM,1
d-mannose,1
Periodic Acid Schiffâs,1
158Î¼g/mL,1
AO/EB,1
FMEA,1
hÃ©matologie vÃ©tÃ©rinaire RÃ©sumÃ© Lâobjectif,1
TVOC,1
extracorporeal photochemotherapy/photopheresis,1
triazole-based macrocyclic inhibitors of,1
Ca2+-dependent phosphatase calcineurin,1
0.95Î¼M,1
queuine,2
Q-free,1
diammonium glycyrrhizic acid,2
vitamin components,1
inositol lipids,1
2-amino-5-bromo-4(3H)-pyrimidinone derivatives,1
cardenolide ouabain,1
cardenolides,2
cardenolides impart anti-transmissible gastroenteritis coronavirus (TGEV),1
Ouabain,1
cardenolide,2
COC,2
ORO,5
[5] Characterization,1
16.50,1
con expertos espaÃ±oles,1
buscando los puntos,1
Se hizo anÃ¡lisis,1
cualquier estaciÃ³n del,1
estÃ¡n fuertemente,1
con la subespecialidad pediÃ¡trica,1
aromatic side chains present,1
non-high-density lipoprotein cholesterol,1
non-HDL-C,1
LDL-lowering therapeutics,1
QâS dipeptide bonds (Q2779âS2780,1
DQ092795,1
[6Â·63],1
compounds 2â5,1
36.6Î¼M,1
compounds 4,3
beta-adrenoceptor agonist,1
fluticasone propionate/salmeterol,1
FP/SAL,2
FP 100,1
broad-spectrum antivirals like chloroquine,1
d'Ã©,1
cliniciennes dans,1
Â«douteuxÂ»,2
divergeait,1
3-adamantyl-substituted thiazolidin-4-ones Abstract A,1
thiazolidinone,1
1.0â11Î¼M,1
inosine monophosphate (IMP) dehydrogenase,1
EICAR,1
terroristsâ,2
DUB-positive (,1
2-deoxyribose,2
fluorine atoms on the 2 position,1
OR=0.33,1
excretingâ,2
INFL,2
carbon dioxide marginal abatement costs,1
furanocoumarins,1
quinines,1
Drug Administration's upper,1
vesicular stomatitis virus,1
dialdehyde starch,4
myelin sheath,1
RMP,1
PLGA NS,1
plain-PLGA NS,4
CLSM,2
CS-modified PLGA,2
CS-modified PLGA NS,1
liposomal peptides,3
F17d,1
CNF,1
CNF2/CDT-III,1
NBCZone,2
"Neu5,9Ac2 Î²2,3",1
fluorinated acyclic nucleoside phosphonates,1
5-azacytosine base moiety,1
(S)-2-[(diisopropoxyphosphoryl)methoxy)-3-fluoropropyl p-toluenesulfonate,1
5-azacytosine,2
"[1,2-a][1,3,5]triazine derivatives",1
diisopropyl bromomethanephosphonate,1
MMA,2
nucleolarâcytoplasmic,1
cuestionarios prediseÃ±ados,1
con una infecciÃ³n respiratoria,1
con la infecciÃ³n respiratoria viral,1
con la infecciÃ³n respiratoria asociada a,1
arctigenin,3
[100%,1
hydroxyguanidine derivatives Abstract A,1
hydroxyguanidine derivatives,1
1-amino-3- hydroxyguanidine tosylate,1
ceftazidime,3
trimethoprim/sulfamethoxazole (TMP/SMX),2
TMP/SMX (,1
carbon nuclear,1
13C NMR,2
aziridinyl peptide,1
FRET-substrate-based,1
tetraphenylethylene-based fluorescent oligosaccharide,1
alkyne,2
lactosyl,2
TPE-based fluorescent oligosaccharide,1
Multiple-dose,1
skimmed,1
SCBLC,2
photo-Fenton processes acting as,1
F15,1
parvo-,1
Vorinostat,1
U18666A-induced,1
PtdIns) 4-kinase,1
C18,2
antimalarial agents Abstract,1
chloroquine derivatives,1
ferroquine derivatives,4
"thiosemicarbazone derivatives, ferrocene dual",1
VGP100,1
LPO,3
peroxide,3
GM-induced,2
oxygen free radicals,1
apo D,6
4-HNE,5
apo D.,1
[+ve] 5â²-AAATAAA â¦ G/TAGGTT-3â²,1
fluorescein-labelled,2
carbon chain,3
20pg/mL,1
4â8-year,1
nutlin-3a,1
Actinomycin D,1
C16,3
CHIR99021,1
ssRNA40,1
broad-spectrum cephalosporin,1
[VÌo2max],1
oromucosal,2
dimethyl sulfoxide.,1
lycopene,9
Lipopolysaccharides,1
lipopolysaccharides with,1
catechol,2
sodium periodate,1
sodium borate,1
"Cu(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition (CuAAC)",1
quinazolines,1
24b11,1
10/80,1
WebsiteâI,1
Intravenous azithromycin,1
Microshield Antibacterial Hand Gel,1
dulaglutide,1
hydroxyl function(s,1
hexaethyleneglycol,1
tetrabutylammonium salt,1
tosylate,1
Cidofovir [(S)-HPMPC],1
hexaethyleneglycol moiety,1
hexaethyleneglycol esters,1
"(5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl ester",1
-dependency,1
10â20min,1
glycosyaated,1
O-linked oligosaccharide side chains,1
aOR=0.82,1
CBFV,2
PPC,2
"29,802",1
anthraquinone emodin,1
anthraquinones acid,1
238â265Î¼M,1
LPG,2
gamacoronaviruses,1
4.9â14.9,1
1204Y,1
pristimerin,1
21.7Î¼M,1
DP2392-E10,4
Ðº,3
Lipid droplets,1
Rhodamine,1
cold/sinus,1
high-dose intravenous ribavirin,1
âobserved,1
Fluorescein dye,1
hÃ¡ poucos estudos,1
virais causadores,1
Sephacryl S-1000 size-exclusion,1
Indigowood root extract,1
L-glutamine (0.520g/kg),1
L-glutamine,1
liposome-encapsulation,3
topical steroidal or non-steroidal anti-inflammatory agents,1
parasympatholytic agents for,1
19â20,2
NIR spectroscopy Abstract,1
NIR spectroscopy,1
chitosan nanofibers,1
chitosan N-[(2-hydroxyl-3-trimethylammonium,1
propyl] chitosan,1
supercritical-CO2 fluid,1
SFE,3
luteolin-7-O-glucoside,1
guanine-N-7,2
ribose 2'-O methyltransferases Abstract Non-segmented negative-sense RNA viruses,1
ribose 2'-O,1
2'-O) methyltransferases,1
F1691,1
L protein abolished,1
2'-O,1
2'-O methylations,1
Gabexate,1
glass fiber filters,1
E or,1
L are lysosomal cysteine,1
L regulate cell,1
L in recycling processes during axon outgrowth,1
2â²-hydroxyacetophenones,1
sinigrin,1
217Î¼M,1
752Î¼M,1
beta-sitosterol,1
1210Î¼M,1
366Î¼M,1
supplemental oxygen requirement,1
CQS,2
3CLSP/nsp4,1
cis cleavage is,1
thiol proteases,1
6MP,4
6TG,4
Dlco,7
antibioticsâ,1
Xiao-Yao-Wan tablets,1
Saikosaponins,1
SSa,1
SSd,1
tylvalosin,6
2-amido aziridinyl peptides Abstract,1
2-amido aziridinyl peptides,1
aziridine deprotection,1
cyano,1
palladium complex 1b,1
[10.0-13.8];,1
5â² flap strand,1
5â² DNA,1
phosphatidylserine receptors,1
toluidine blue O,1
feed-based vaccines,1
3-hydroxyl,1
POMs,7
inorganic drug,1
nonsteroidal anti-inflammatory agents among,1
bicarbonates (12 mmol/L,1
Lactic acidosis is,1
bicarbonates,1
lactates,1
lactic acidosis during ASA,1
29âOctober 5,1
alternate-day,2
lactated Ringer's,1
[1.5] years,1
zinc sulfate,2
Poly-ICLC,1
kaolin-pectin,1
indole derivatives as antiviral agents with,1
indole antiviral agents,1
indole compounds (including natural products),1
40mM,1
40mM LiCI,1
inosiplex,1
L protein of,1
[4%] patients,1
[2%] patients,2
[1%] patient,1
MuLBSTA,2
[PPG]),1
[APG],1
70/161 [,1
Le hRSV infecte,1
1999â2003,2
188â202,1
1-(2â²-hydroxy-5â²-methoxybenzylidene)amino-3-hydroxyguanidine tosylate,1
LK11,1
metal chelating,1
substrate/product,1
phosphorothioate analogues,1
2H familyâduring,1
pHS,1
phenolic acid constituents against,1
phenolic acid constituents,1
coumaric acid,1
"1H-1,2,3-triazole tethered isatin-ferrocene conjugates",2
conjugates 5f,1
electron-withdrawing halogen substituent at C-5 position of isatin ring,1
imidazole ring,1
consensus-prediction,1
âCa2+-binding siteâ âD-X-[DNS]-[ILVFYW]-[DEN]-G-[GP]-XX-DEâ,1
[125I]RB 129 Abstract,1
substantia nigra,1
ventromedial nuclei,1
raphe nucleus,1
pontine nucleus,1
[125I]RB 129,1
nitric oxide synthase-2,2
[NIV],1
imidocarb dipropionate (6 mg/kg body,1
doxycycline monohydrate (5 mg/kg body,1
cyclosporin A-analog,1
streptodepsipeptide,1
HGS,3
5-fluorouracil/oxaliplatin,1
epidermal-to-mesenchymal,1
Bax/Bcl2,1
20nM.,1
splashes/sprays of body fluids,1
24/289,1
non-glucose,1
1.7â14.7,1
albuterol,2
operation-level,2
lipopolysaccharide (LPS)-binding protein (,1
drug/radiotherapy-resistance,1
1 Î¼g/ml actinomycin D,2
oligo(dT)-cellulose,2
Ã 106,4
ionised serum calcium,1
calcium soaps,2
thorium,1
pyridine monocarboxylate-N-oxides,1
N-oxides,1
actinides,2
pyridine monocarboxylates,1
picolinic acid-N-oxide,1
nicotinic acid-N-oxide,1
isonicotinic acid-N-oxide,1
chelate,1
di-O-tryptophanylphenylalanine curcumin,1
"conjugates 2, 3, 4, 6 and",1
"conjugates 2, 3, 6,",1
cholic acid,1
sinapic acid,1
riboflavin/UV-A,1
neuramide,3
NS) inhibitor by being smaller (,1
organic solvents.,1
NS inhibitor by,1
HPGPC,1
hydrolysate,1
1-phenyl-3-methyl-5-pyrazolone (PMP),1
galacturonic acid,1
anti-M,1
anti-M and P IgG,1
FMO,1
mercury,4
HgCl2,2
â1,1
CI [1.02â16.02],1
FWR,4
psittacose,3
4-thiazolidinone,1
thiazolidine,1
fluorescently,1
21/1238,1
45/2747,1
10â15,1
glycyrrhetic acid polyglycosides based,1
Glycyrrhetic acid polyglycosides,1
sulfite (4),1
Sulfite 4,1
(1â2)-linked polysaccharide skeletons,1
TfOH,1
CH2Cl2,1
synthetic/artificial microorganisms,1
retinyl-palmitate,3
lactulose/mannitol,1
d-,1
(R)-epichlorohydrin,1
d-thymine nucleoside,1
d-2,2
l-thymine nucleoside,1
l-2,4
ddI,1
intra-mitochondrial proteinase-susceptible,1
intra-mitochondrial structures,1
commune faisant intervenir lâenvironnement,1
Con la finalidad,1
Con estas modificaciones,1
uranine,1
5â² 350 nucleotides folds,1
PCP-domain,1
LTB],1
taxchinin A,1
taxchinin A (1),1
brevifoliol (2),1
"Î±,Î²-unsaturated ketone",1
SA/2381/88,1
species-derived,1
antifungal peptide,6
"rs4986790*TLR4, rs1898830*TLR2",1
ribavirin 3,1
theaflavin digallate,1
theaflavin polyphenols,1
bile and bile acids,1
bile and bile acids in gastrointestinal tract,1
carbon constituents,6
dibenzofurans (,1
1.47ng-TEQ/g,1
ck/CH/LSD/111219,2
PDZ-peptide,1
6.83-fold,1
DPP-VIII,1
Cl 5.2â7.7,1
45.3â64.7,1
2.80â44.78],1
lincosamides,2
streptogramins,2
trimethoprim,1
nonidet P40,1
"11,569,796",1
phenylisoserine derivatives for,1
Thick Air,1
2-Mercaptoethanol,1
organosulfurs,4
sulfhydryl compoundsâ2-mercaptoethanol,1
2-ME,8
l-cysteine,1
70mM,1
corticosteroid drugs.,1
high-dose corticosteroid,1
2.98Ã ,1
pathogÃ¨nes dans,1
PSL RÃ©sumÃ©,1
L generator (,1
2-amidinopropane,1
free radical,1
tocopherol (P <,1
"peroxyl radical [2,2-azobis (",1
2-amidinopropane) dihydrochloride,1
AAPH,1
hydroxybutylguanine derivatives Abstract A,1
valine side chains,1
nucleoside triphosphate molecule,1
VSP,1
Le rhume,1
Fc-9E2 serum,1
GVI-PMV1,1
pyrroles,1
methoxyfluoroquinolones,1
methoxyfluoroquinolone,1
water-in-oil emulsified S1,1
hydrogen peroxide vapor),1
corona discharge-generated,2
carbon-fiber,1
conjugated (,1
Ciprofloxacin,1
Deoxynivalenol (DON),1
vomitoxin,1
fresco tras concentraciÃ³n o,1
F26G15,1
"nitrous oxide,",1
nitrogen oxide emissions,1
PELC,1
deleciÃ³n,2
low-dose JJA VIT,1
benzyl alcohol,1
Epinephrine,2
"18Î±,Î²-glycyrrhetic acid monoglucuronide",1
hetero-30-OH-GL,2
anisodamine,5
triethylamine,1
"formic acid) (60:40,",1
anisodamine N-oxide,2
hydroxyanisodamine N-oxide,1
glucuronide conjugated N-demethylanisodamine,1
sulfate conjugated,1
"glucuronide conjugated anisodamine,",1
sulfate conjugated hydroxyanisodamine,1
AH187,1
nucleic acid based molecular,1
fusidic acid,1
chito-oligosaccharide,1
OH and IC were,1
dolastatin,1
ecteinascidin-743,1
kahalalide F,1
aplidine,1
marine-product,1
broad-spectrum defense substances,1
substances like antibodies,1
ligand-conjugated,1
folate,3
POMxp,3
often-experienced,1
8.981,1
24.240,1
acid-suppressant,1
10â11 nucleotides [AAAGGR(G)GAAG,1
purine base],1
1.2nM,1
CaCl2,1
diltiazem hydrochloride,2
SN antibodies to,2
Budesonide/Formoterol,2
NSEC Strategy,1
1.5 g,1
RTKI,1
tyrphostin,1
YSV,1
FAD,3
palvizumab,1
Le diagnostic microbiologique,1
Virbac - BS,1
vaccination-calving,1
PI â¥,1
10Î¼m aerosols,1
Newbury1-like viruses,1
acetaminophen/kg body weight,1
abomasal luminal,1
E5564,1
antioxidants like NAC,1
diagnÃ³stico,1
contemplan,1
viral-reduction,1
predispone,1
esterified l-Alanine,1
d-Alanine,1
diastereoisomeric mixtures are routinely,1
ddA,1
d4T,1
2019-nCoV outbreakâearly,1
diatomaceous earth,3
sodium acetate,1
sodium phosphate with 100 mM sodium chloride,1
K+ currents,1
"acetic acid in water (75:25,",1
reactive NO oxidation intermediates play a,1
Nucleoside analogues,2
3.275Ã10â3 nucleotide,1
isoxazolidine analogues,1
"1,3-dipolar cycloadditions with",1
vinylphosphonate,1
"trans 3,5-disubstituted isoxazolidines (d.e.",1
"3,4-disubstituted isoxazolidines",1
mixed-type simple reversible slow-binding,1
gCâ39,1
Se analizaron aspirados nasofarÃ­ngeos,1
Se incluyeron,1
Se observaron infecciones virales,1
broad-spectrum application,1
3-fluoro-6-thio-glucopyranosyl nucleosides,1
potassium thioacetate,1
analogs 7a-c,1
5-fluorouracil derivative 7c and,1
low-lactose,2
volatile fatty acid,1
rumen wall,1
13.2cm/seconds,1
corticosteroid dosage-type,1
corticosteroid group,1
corticosteroid dosages,1
corticosteroid with,1
E2 monomers,1
Saturated,1
glucocorticosteroid,1
15N-labeled peptide,1
sugar-modified nucleoside analogues,1
4â²,1
dimethyl sulfoxide,1
nucleotides 24075,1
140/278,1
"1Ã103,",1
1Ã106 oocysts,1
log-dose,2
19-cyclolanostane glycosides,1
19-cyclolanostane triterpenoid glycosides,2
19-Cyclolanostane triterpenoid glycosides,1
0.4fM.,1
bis-adducts with,1
7-chloroquinoline,1
"conjugates 7a,",1
7c,1
[log10,1
1.19Î¼M,1
conjugated ubiquitin-like molecules,1
Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase,1
furan rings,1
"SAÎ±2,3Gal binding",1
corticosteroid related osteonecrosis,1
âbronchiolitis obliterans,1
uric acid deposits,1
"H, N,",1
16Â·8â42Â·9,1
0Â·6,1
18Â·42,1
MgSO4,2
4mM MgSO4,1
DG XII-funded,1
carbonyl carbon of,1
hydrogen bonds,3
"trans-Î±,Î²-unsaturated ethyl ester (Michael acceptor",1
broad-spectrum of antimicrobial,1
12359â12369],1
"29,000d",1
nonionic detergent Nonidet P-40,1
[3H]and [14C]valine,1
neuroevolution-based,1
FEMA,1
shuk,1
gwarosa,1
thiol-based redox,1
Interferon-alpha,1
anti-Ig,3
SC fluid,2
hypertonic saline (4 mL/kg,1
2 L);,1
2 L),1
directly-,1
Hydrogen peroxide vapor is,1
GSMP,1
Mn2+-dependent endoribonuclease,1
benzothiazolyl,1
thiazolyl ketone-containing peptidic compounds,1
Ã 150,1
ACN,2
trifluoroacetic acid (TFA),1
TFA,1
11-nucleotide,4
[Simons AF,1
trans-proteolytic,1
C2383,1
15mM MÎ²CD,1
A162 (47/1012 amino acid,1
single-stranded loops,1
2nt,1
20nt (loop 2),1
proglycopolypeptide,1
[3H]serine,1
[3H]valine,1
[3H]leucine-labelled IBV-Beaudette membrane,1
continus pÃ©diatriques pendant 3 mois dâhiver,1
narrow-spectrum agents,1
Land,1
iron lung,2
intravenous methylprednisolone 500,1
ribavirin 1Â·2 g,1
Le,1
allyl-modified glucose,1
styrene monomers,1
allyl-Î±-d-glucopyranose leaded,1
FIPV-Î7,1
Le diagnostic des pneumopathies communautaires,1
Le diagnostic clinique de PAC a,1
12-deoxyphorbol 13-phenylacetate 20-acetate,1
phenolic acids (neochlorogenic acid,1
"3,5-dicaffeoylquinic acid",2
"3,4-dicaffeoylquinic acid",2
ethyl acetate/n-hexane,1
1.7Î¼m,1
acetonitrile/methanol,1
neochlorogenic acid,1
1.9â250ngmlâ1,1
pu-erh tea,1
tea polyphenols,2
L are essential,1
L proteins to,1
low-dose TBI),1
12357â12366,1
glycosaminoglycan structures,1
(R-Ahx-R)4 AhxB,1
bigâ20,1
ammonium compounds,1
Marbofloxacin,1
16â44 pi,1
octapeptide,2
CPP-delivery,1
ONs,2
charge-neutral ON,1
mevinolin,1
filipin complex,2
Myeloperoxidase,3
amylmetacresol,1
"2,4-dichlorobenzyl alcohol",1
hexylresorcinol lozenge,2
sodium crown complex Abstract Background Oxygen exists,1
cytosine nucleosides,1
sodium crown complex,1
cytosine nucleoside hydrochloride complexes,1
spermine,4
dihydrogen peroxide,1
selenite,1
sperminium phosphate/cyclooctaoxygen sodium,2
H2O2 contents and antioxidative enzyme,1
0mM,1
mixed-type,2
HEA calves,2
pyridinyl imidazole inhibitors SB 203580,1
SC 409,1
pyridinyl imidazole inhibitors.,1
buthionine sulfoximine,1
BSO,2
MK-571,1
Verapamil,1
morula,1
falsos negativos,1
con una alta frecuencia de fracaso,1
2001;37:720-727,1
C)-induced JakâStat,1
Cy5-,1
nano-silver,5
Chromatography-Mass,1
FCoV-endemic,1
con una variaciÃ³n,1
nucleoside phosphonates derived from 2-(phosphonomethoxy)propanoic acid,2
HPMP,1
2â²-carboxy-PME (CPME) derivatives,1
Ag+,6
conjugated drug,1
polyphosphates,1
3different Fluorescent,1
anxiolytics,2
abordant notamment la diversitÃ©,1
hypermodified base in,1
Carbohydrates,1
nonamannoside,1
COMMUNITY-ACQUIRED,1
virus-controlled,1
200Î¼M,1
epi-thieno analogues,2
alkaloids (â)-Cryptopleurine,1
enantiopure (S)-2-aminoadipic acid,1
nitrogen atom source,1
N-thienylmethyl-6-oxopipecolinic acids,1
enamidones,1
Landrance/Duroc hybrid,1
polycyclic aromatic hydrocarbons in different types of,1
198.92 mg kgâ1,1
three-ringed PAHs),1
MM-PAH,2
four-ringed PAHs,1
six-ringed PAHs,1
OR=3.34,1
cis acting RNA,1
BRACO-19,1
G-quadruplex-ligand,1
"3,3-di(indolyl)indolin-2-ones",1
band-sedimentation,1
FCoV-I.,1
acid-induced acute lung,1
Le diagnostic a reposÃ© jusquâici,1
DPH,1
2019-nCoVâa 61-year-old,1
â9.4Â±1.1,1
"SP600125 [anthra(1,9-cd)pyrazol-6(2H)-one 1,9-pyrazoloanthrone]",1
Sialic Acids in Molecular,1
5i,4
5k,1
5l,1
scPTZ,1
2H5M2e-2H7M2e-H5FP-H7FP,1
2H5M2e-H5FP-2H7M2e-H7FP,1
2007â8,1
Le danger actuel dâune,1
WEB,1
O349,1
NS gene for,1
nucleic acids with,1
5-benzyloxygramine,2
2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents,1
2-Aminopyrimidine based 4-aminoquinolines,1
"heme,",1
methanol solvents,1
century-wide,1
[3%] of 38,1
[12%]),1
FebruaryâMarch,1
fatty acid methyl ester,1
fatty acid methyl esters (FAMEs),1
polyunsaturated FAMEs and,1
exonâintron,1
conjugated OVAâsHsp,1
aluminium brick,1
macrolides with,1
histamine A,1
PD20,1
bisulfite adduct,1
NT 1523 to 1624 in the,1
NT 3340,3
Polyols,1
Glycerol,2
Ethylene glycol,2
ThT,2
polyols,2
operatorsâ,1
imidazole nucleoside/nucleotide analogues,1
"imidazole 4,5-positions",1
sugar phosphonate,1
imidazole 1-position,1
NHS/EDC,1
2â3Î¼m,1
4B3,1
[(Ni x,1
Ni and,2
Mn.,1
Mn3+,1
Mn4+ cations,1
spinel,1
ammonium chloride late,1
3H-leucine,1
intravenous antibody,1
francesella,1
con A,1
danthron,1
carcinogen-DNA adduct,1
smartphoneâs,1
Cd2+,1
clenbuterol,1
Leukotoxin,1
solute transporters,1
iron binding proteins,1
"[(4S)-tert-butyl 4-amino-6,6,6-trifluoro-5-hydroxyhexanoate",1
oxazolidinone 7,1
"silyl ether 8 [(4S,5S)-benzyl 4-(2-(tert-butoxycarbonyl)ethyl)-5-(trifluoromethyl)-5-(trimethylsilyloxy)oxazolidine-3-carboxylate",1
3 DPI,1
Le statut vaccinal,1
externalâwere,1
10â1 TCID50 mlâ1,1
lâinformation,1
clinician-collected nasal,1
"NS only,",1
NS was 96,1
NS (25.1),1
Nitric oxide synthase Type II,1
nitric oxide in acute versus persistent virus infection Abstract Intranasal inoculation with mouse hepatitis virus strain JHM (MHV-JHM),1
T-2 toxin,2
T-2,4
phenylmercuric acetate,2
1-hydroxypyridine-2-thione zinc,1
cooperaciÃ³n institucional,1
twin-head,1
NP/MWCNT particles,1
nanoparticle (DNA-AuNP),1
DNA-AuNPs,1
DNA-AuNP networks,1
Oxymetazoline,1
15(S)-HETE,3
ultrafine carbon particles,1
LXA4,1
8-isoprostane,2
bicarbonate particulate,1
organismsâ,1
polycytidylic acid 6,1
nucleoside phosphonates (ANPs),1
2-(2-phosphonoethoxy)ethyl (PEE),1
Benserazide,4
benserazide,11
Wien-I,2
Dex,1
Aex,3
P5âP4â²,1
enzymeâpeptide,1
treatments/vaccines,1
bromide peptide,1
CrI 2Â·47â2Â·86,1
Phospholipid Bilayers,1
P/L,1
faecal factors,1
high-dose amoxicillin,5
His548,1
29.7â31.5,1
acetyl esterase,1
acetate ion,1
Fatty acid acylation,1
Ni Sepharose,1
intranasal instillation (i.n.) of lipopolysaccharide,1
reactive samples,1
55+,1
co-prescriptions,1
JulyâDecember 2003,1
L gene fragments,1
[2013]),1
Cefoxitin,1
[100 Â± 31,1
FEUA,2
FEUA (,1
79.7â82.8,1
NB-like viruses,2
chloropyridyl ester-derived,1
Codelivery,1
ZE3,2
[RP],1
Î²CoV,1
con enfermedades infecciosas importadas,1
"fungus, mycobacteriae",1
anti-interleukin-10 oligonucleotides,1
nitrile warhead can effectively,1
nitrile warhead inhibits 3CLpro by,1
methacholine (,1
[PD15]),1
ECA,1
Ni2+,3
lactated Ringer's solution (LRS),1
emergency/intensive,1
NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides,1
"nonsteroidal anti-inflammatory drugs ibuprofen,",1
fenoprofen,1
51.5Î¼M,1
1-(1-benzotriazolecarbonyl)-4-benzyloxysemicarbazide (7),1
lipofuscin,2
2.2Ã ,1
gold-micropatterned,1
200ngmLâ1,1
[3H]glucosamine in,1
O-linked oligosaccharide,1
O-linked oligosaccharide chain,1
phorbol esters by,1
chlorogenic acid (1),1
rutin (2),1
scopoletin,1
acaciin,1
scoparone (9),1
aristolactam (14),1
"flavonoids (2, 3, 6,",1
ultrafine aerosols,1
dâHÃ©patologie,1
20 derniÃ¨res annÃ©,1
climatiques,1
Se han descrito brotes epidÃ©micos,1
con frecuencia con enfermedad gastrointestinal en reciÃ©,1
Se necesitan,1
fructooligosaccharides,1
2009â2010,2
tomentin A,1
tomentin B,1
tomentin C,1
tomentin D,1
tomentin E,1
geranyl,1
1 detected 1,1
adenine arabinoside,1
viridans streptococci,2
Eikenella corrodens,1
escin derivatives,1
escin derivatives 1â7,1
20Î¼M,1
escin,1
"inhaled steroids,",1
enkephalinsâ,1
sodium dodecyl sulphate polyacrylamide,1
DEVD-CHO peptide,1
vL126A,2
Heterocycle-Fused Acridines,1
10Î¼g,1
intravenous steroids,1
FFM-2,1
kappa=0.648,1
CET,4
Drug Administration in 2012.,1
Lipoteichoic acid,1
diethyl {2-[N-(pivaloyloxymethyl)-N-(p-toluenesulfonyl)amino]ethoxymethyl}phosphonate,1
"1, 2, 3, 7, 14",1
NBU,2
broad-spectrum antiviral adenosine nucleoside,1
monophosphate nucleotide,1
382-amino acid,1
"43,426",1
CyDs derivatives,1
CyD oligomers,1
CyD,1
Three-Domain Molecular Architecture in Solution and,1
bismuth Bismuth,1
4-oxo-,1
dihydrofuropyridinones,1
IFL,1
dicarboxylate,1
tractus olfactorius,1
[RR] 1.33,1
HCWE,3
HCWE powder,1
colloidal sediments,1
diethylenetriamino-pentaacetic acid,1
quercetrin,1
Cinanserin hydrochloride,2
Sodium dodecyl sulfate-polyacrylamide,1
18S rRNA gene,1
18S rRNA gene analysis,1
Benzotriazole Esters as Mechanism-Based Inactivators of,1
benzotriazole esters was,1
benzotriazole ester surrogates,1
broad-spectrum peptidyl inhibitors,1
neutralidad emocional y estabilidad,1
comentan,1
1.6â2.5 in 12â23-month-olds,1
dinitrophenol conjugated keyhole limpet hemocyanin,1
1-[Ï-(phenoxy)alkyl]uracil derivatives,2
broad-spectrum antivirals Abstract Viral,1
20 1-day-old commercially derived turkey poults,1
deltamethrin,3
Deltamethrin,1
phosphonoamidate analogs,1
nitrogen reagents,1
phosphonoamidate thymine analogue 19,1
pyrimidine (E)-but-2-enyl phosphonoamidate,1
5Â´,1
3Â´,1
nucleoside-analogue,1
nucleoside sugars,1
Ara-C,2
"3,803,996",1
N-methyl meglumine antimoniate,2
CLIK148,3
corticosteroid therapy (14 out,1
metal-free cross-coupling of furan ring with,1
menthofuran,1
furan ring can,1
2-ethynyl derivatives,1
acetylene derivatives with,1
chlorine disinfectants Objective A,1
chlorine disinfectants,2
sodium dichloroisocyanurate,1
NaDCC,2
Chlorine disinfectants,1
â¥4.50,1
195-amino acid protein,1
GL derivatives,1
ammonium salt,1
semi-synthetic scFv,1
non-aqueous,1
2013-May,1
cryo-TEM,1
soxhlet,1
tectoridin,6
iristectorin B,5
iristectorin A,6
tectorigenin,2
iristectorigenin A,1
F2-isoprostane,1
7-ketocholesterol,3
4-hydroxynonenal,1
intraocular fluids,1
DMAEM,1
HEMA,2
ethylene glycol dimethacrylate,1
EGDMA,1
1 death (2.5%,1
DPIs 1 to,1
DPIs 9,1
epic3,2
Saquinavir,1
Amprenavir,1
"NeuAcÎ±2,3Gal residues",1
G26-24,1
CBO,5
peptone,1
Four-hundred-one,1
(WHO)-coordinated network,1
ChIFN-Î³,3
FebruaryâMarch 2010,2
5-8,1
CRCV,2
1 filter,1
S4R,1
â¥32 +,1
galacto-oligosaccharide,1
polydextrose,1
microcrystalline cellulose,1
energies,1
thiol disulfide interchange,1
anti-L3T4,1
DEAE-Sepharose,1
THC,1
digoxigenin,1
methyl donor molecule that,1
Bb is frequently,1
alcian blue-positive,1
bio-available inhibitor for the,1
analogues,1
d 7,1
"China,2",1
cellulosic material,1
cellulosic matter,1
DTG,1
LVB,11
O-acetylated neuraminic acids,1
high-performance thin-layer,1
HPTLC,2
neuraminic acids,1
acetate esters,1
NanS-p-His derivatives,1
Vitamins C,1
"intranasal instillation 7,",1
vanadium antidiabetic,1
vanadium complexes,1
Belimumab,1
"1098,000kWh (",1
Micafungin,3
FK463,2
micafungin,4
83/225,1
organic acids (22.63%,1
site-derived,1
aluminum (alum)-based,1
thiol) proteinases,1
nonsteroidal anti-inflammatory agents,2
colloid oncotic,1
gastroprotectants,1
pecan shell fiber,2
Ag-NPs,7
flavanol,1
TEAC,2
equivalent/100 g dry weight (DW),1
gallic acid equivalent/100 g DW,1
franÃ§ais des,1
Le profil des EI rapportÃ©,1
Le suivi de,1
2â²-Î²-d-arabinouridine,1
AraU,3
phosphate prodrugs,1
AraU monophosphate prodrugs,1
AraU phosphoramidates,1
AraU monophosphate,1
phosphoramidates,1
AraU l-alanine aminoacyl phosphate derivative,1
araU monophosphate,1
âgold standardâ,1
con fibrosis quÃ­stica,1
con diferencia,1
phosphoinositide,1
phosphatidylinositol 4-kinases,3
phosphatidylinositol 4-kinase,1
13-mer peptide,1
Cu-doped TiO2,1
Cu dopant,1
propidium iodide labeling,1
Le diagnostic Ã©tiologique,1
"Le traitement, calquÃ©",1
"corticosteroid treatment,",1
reactive metabolites of drugs is,1
reactive metabolites/intermediates through,1
reactive metabolites following herbal bioactivation covalently bind,1
reactive cyclic nitrenium ion,1
pulegone,2
teucrin A,1
p-cresol,1
furan ring of the diterpenoids in germander,1
reactive epoxide which,1
reactive intermediates capable of irreversibly inhibiting,1
bergamottin,1
furanocoumarin,1
oleuropein,1
intranasal interferons,1
Q891(1b)-S892(1b)dipeptide,1
"nucleotides 16,929 to",1
heteropolymeric proteinaceous appendages,1
sialic acid receptors Abstract A,1
submicromolar EC50,1
10Î¼m droplets,1
cyclosporine A.,1
14Â·68,1
ethyl acetate (E),1
ethyl acetate extracts,1
FT2,4
pCI-N.,1
sulfur (SVI)-Containing,1
Sulfur (SVI)-based,1
sulfonamides based compounds,1
Sulfur (SVI) based drugs against the,1
1/60,1
immunopcroxidasc,1
"H, N and",1
IN-applied substances oxytocin,1
IN-applied,1
22HW ash,1
Na with,1
"Sb,",1
"Sn,",1
Sr,1
Sn are,1
TCLP,1
sVLPs,2
supera el 1.000.000/mm3,1
Se presenta,1
7.283.000/mm3,1
(+) RNA virus,1
antivenins,1
phospholipid bilayers,1
DMPC phospholipid bilayers,1
dec-RVKR-cmk,3
proS cleavage,1
isoxazolidine,2
phosphonate substructures Abstract Cycloadditions of N-substituted C-(diethoxyphosphoryl)nitrones,1
"N-allylated quinazoline-2,4-diones functionalized at N3 with",1
benzyl,1
isoxazolidine phosphonates,1
86:14,1
87:13,1
isoxazolidine phosphonates cis-15/trans-15,1
benzyl substituents,1
"quinazoline-2,4-dione",1
(4) stress-sensing,1
PanCoV,1
28-amino acid peptide,1
Force-5,1
dihydroxychromone derivatives,1
dihydroxychromone,1
niosomes,1
pyrophosphate ions,1
thymidine analogues,1
100â9000,1
cyclosporine A-derivatives,1
CsD,1
meningies,1
demyelinating-type lesions,1
reactive CNS environment,1
Striatal neural precursors,1
double-stranded RNAâinduced,1
ultraviolet-A,1
ultraviolet-B,4
ultraviolet-C,1
anatomopathologie,1
VBRB,3
rhodamine B,1
150Â°,1
bismuth subsalicylate tablets,1
ornithine,3
20â25 nucleotide,1
histamine-mediated,1
TJ-2013-92,1
TJ-2013-94,1
TJ-2013-100,1
Bile Duct Stone,1
bile duct stones,3
monophosphate,1
pH6,1
LRV,1
cytoprotectors,1
9-carbon monosaccharide,1
O-acetylated derivatives,1
neuraminic acid derivatives,1
polysialic acids,1
traditionally/popularly,1
terpenoid glycosides,1
MbCD,1
phospholipids headgroup,1
cholesterol supplementation,2
293-gag-pol,1
IFN-Î³ treatmentin,1
extract peptide,1
singlet,1
non-ionic detergents,1
cholesterol-depleted TGEV,1
biflavonoids (9â12),1
biflavones,1
biflavone,1
Non-UV germicidal activity,1
Ag/TiO2,1
germicidal material,1
FEC,1
Diversos estudios han comprobado,1
Se han encontrado fenÃ³menos,1
propan-1-ol,2
butan-1.3-diol,1
20â26,1
non-HA-MERS,1
CI [1.80â48.65],1
nucleotides 10928 and,1
nucleotide 10912,1
NAI resistance in H7N9 viruses,1
MjSyn,1
antimycobacterial agents Abstract A,1
acyl-hydrazone,1
4a-d,1
5a-d,2
Pao 2,1
contineous,1
tablet form,1
vesicle fluid,1
Deoxyribonucleic acid,1
3-indoxyl,2
isoxazolidine nucleotide analogues,2
carbon atom,1
"1,3-dipolar cycloaddition of",1
Compounds 15fâj,1
"87,818",1
"103,251",1
Intravenous Immunoglobulins:,1
IVIG Preparations,1
E could assemble readily,1
DOI,3
DOI vaccines,1
Zinc pyrithione,1
"Iodine, iodophors,",1
iodine,1
intrathecal humoral,1
Lactobacillus acidophilus S-layer,1
corticosteroid.,1
PCLS,1
"1:80,000",1
NH(2)-_L-Cys-A-Y-Cys-Cys-N_-COOH,1
Â»,3
van't Hoff,1
(PEEP);epithelial sodium,1
oxygen species (ROS);myosin light chain (MLC);pneumolysin (PLY);listeriolysin (LLO);interleukin (IL);bronchoalveolar lavage fluids (BALF);Bacillus,1
CUAG,1
corticosteroid therapy should,1
pamidronate,1
CRISPR/Cas9-technology,1
NS]),1
sodium hyaluronate,1
1 240 espÃ¨ces,1
aurintricarboxylic acid (ATA),1
4â13,1
antigen-conjugated lactic acid,1
LAB displaying divalent antigens,1
reactive disclosure,1
nsp7/8,1
25mM NaCl,1
ammonia and,1
guanosine 5â²-triphosphate (GTP)-binding protein rab2,1
describimos,1
Indole alkaloid marine natural products:,1
indole alkaloids are,1
indole alkaloids of marine origin,1
"Ca-releasing,",1
atypicalis,1
7/8,1
rAOM,1
pyridoxal,2
cefpirome,1
ticarcillin/clavulanic acid,1
carbapenems (,1
polynucleotide polymerases,1
nonsteroidal anti-inflammatory drug,1
Aldehyde,1
pentapeptide aldehydes,1
aldehyde Cm-FF-H,1
liposome-encapsulated ribavirin,1
liposomal ribavirin,1
1-[(3â²-hydroxy-6â²-methyl-2â²-pyridyl)methylene]amino-3-hydroxyguanidine tosylate,1
zwitterionic DPC,1
tachykinins,1
Ni2+-affinity,1
"166â180, 356â375",1
quinone components,1
aloe anthraquinones,1
O-glycosyl,1
5-6),1
derivatives 5 and 7,1
Intranasal fluticasone propionate,1
fluticasone (100 Î¼g,1
"[4-(2-chloro-4a,10a-dihydro-phenoxazin-10-yl)-butyl]-diethyl-amine hydrochloride",1
nickel column,1
RNA-bound fluorescent,1
wet-type,1
NEFA,1
inositol phosphates,1
La3+,1
calyculin,1
colloidal nanomaterials,2
LFD RPA,4
adulteration,2
Difluoromethylornithine,1
regional/tertiary referral centres.,1
equal-dose,1
Gentian,1
124.8Î¼g/ml,1
35S-methionine,1
regeneration-to-process air,1
cap 1,1
cap 1 structures,1
diltiazem,1
endoribonuclease-U,3
melanin deposition,1
droplets/aerosols,1
liposomal peptides derived,2
bisphenyl lignans,1
tricyclic lignans,1
cyclolignans,1
corticosteroid therapy in severe acute respiratory,1
corticosteroid in confirmed critical SARS,1
1:44.7,1
1:40.6,1
atenciÃ³n primaria distribuidos,1
con resultados positivos para alguno,1
VGB],1
calcularon las,1
VGB,1
indican que entre las manifestaciones clÃ­nicas,1
"[IVA],",1
120/286 [,1
freeze-fracture,1
BSA-gold,1
i.p S-peptide,1
co-trimoxazole in WG localized,1
steroids [HR 1.49,1
100/ÂµL [HR 1.81 (1.12 â,1
steroids [HR 1.59,1
N-acetyl-9-O-acetylneuraminic acid-containing receptors,1
7h,1
Aromatic N-oxide bridged,1
pyridine N-oxide,1
"2,2â²-BPNO=2,2â²-bipyridyl-N",1
[Cu(NicoNO)2Â·2H2O] n,1
nicotinate N-oxide,1
luteoloside,1
carbocyclic nucleosides 5â²-homocarbovir,1
cyclopropylamine analogs using facially selective Pd-mediated allylations Abstract Carbocyclic nucleosides (â)-5â²-homocarbovir,1
acylnitroso-derived hetero DielsâAlder cycloadduct,1
enantiopure aminocyclopentenol,1
"Pd(0)-mediated decarboxylative allylations of allyl 2,2,2-trifluoroethyl malonates were",1
cyclopropylamine analogs,1
(â)-5â²-homoabacavir,1
surface-trafficking,1
Salubrinal,1
DEAE-52,1
sulfuric radical and,1
uronic acid,1
perfluorooctanoic acid,1
non-peptidyl small-molecule,1
S3I-201,1
26/205,1
direct-acting agents,1
600U,1
benzophenone thiosemicarbazone analogs,1
â¼15mg/L,1
1998â9,1
[[1],1
"[2],",1
[3]],1
reactive oxygen (,1
nitrogen (NO),1
"1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC)",1
CHOL,4
BAM,2
50Î¼M,2
IFN-Î³ increased MHC class I,1
ICS,1
cis elements in controlling MHC class I,1
"[Hanlon L, Argyle D, Bain D",1
phosphoramidate prodrugs of,1
carbasugar analogues of,1
2-deoxyribose-1-phosphate,2
phosphoramidate ProTide,1
extrahelical nucleotide,1
imino proton solvent,1
1.1â2.4,1
by-products based,1
CMg,3
Cephalotaxine,1
mutagen,1
ORF1b/ORF2,1
"23,409 calves",1
chromium oxide,1
V920,2
V920 vaccine,1
intramuscular (IM),1
R g > 1,1
onset-to-visit,1
odd-eye,1
Donor-free blood,1
ESAs,1
hydrogen peroxide-based,1
broad-spectrum substitutes,1
H2O2 (AHP)-based disinfectant described,1
fungicidal in 5 minutes,1
3â² terminals,2
[RR] 1.70,1
con el anÃ¡lisis,1
CT-DNA,2
"[(phen)2Ru(bpibH2)Co(phen)2]5+ {phen=1,10-phenanthroline",1
"MTT {3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide",1
137.5Â±79.8,1
Stepwise multiple regression,1
imidic peptide bonds in oligopeptides,1
3â²-C-ethynyl-Î²-d-ribofuranose purine nucleoside,1
purine nucleobases,1
purine nucleosides,1
7-deaza 7-chloro-6-amino-purin-9-yl,1
nucleobase motifs,1
acyclonucleotide analogues,2
diethyl azidomethyl-,1
SFN,2
neofunctionalism,3
5-sulfonyl isatin derivatives,1
isatin derivatives as possible SARS-CoV 3CLpro,1
[BMIM][BF4] doped,1
catalyst solvents,1
city-entry,1
BBN,3
cytosine phosphate guanosine (,1
Tetrabutylammonium fluoride-assisted rapid,1
purine ring,1
N9-alkylated purine scaffolds,1
N9-alkylated purine,1
tetrabutylammonium fluoride,1
TBAF,1
epoxide,1
"Î±,Î²-unsaturated esters",1
"ketomethylene isosteres,",1
"tripeptide Î±,Î²-unsaturated esters",1
Phe-Phe dipeptide inhibitors 18aâe,1
"Phe-Phe dipeptide Î±,Î²-unsaturated ester",1
Aryl diketoacids (ADK),1
Zn2+ ion binding sites in,1
Phosphate,1
fluorescein isothiocyanate (FITC)-labelled intracellular fIFN-Î³.,1
Epimeric methylsulfinyladenosine derivatives,1
nucleoside derivatives (1â4),1
methylsulfinyladenosine derivatives,1
ethylidene linkers (10câ10p),1
nitric oxide synthase 2,1
aliphatic-substituted derivatives 8l and,1
ribose 2â²O,1
N7 methyl,1
high-potency,1
CBNPs,1
162Î¼g CBNPs,1
"1, 2, 3, 4,",1
aluminum coupons,1
5-1,1
l-lactate,1
ethidium bromide staining of,1
5â²-fluoro-5â²-deoxycarbocyclic nucleoside analogs,1
guanidine-hydrochloride,1
guanidine-HCl,2
6-azauridine (34.6),1
glucorhamnoside rutin,1
tamarixetin,2
SC immunized mice,2
SC and IC immunized mice,1
2mg/kg hydrocortisone i.p,1
250mg/kg curcumin,1
nitric oxide synthetase,1
alkaloids 1â10,1
lycorenine,1
virginiamycin,1
2 g purified immunoglobulins (,1
fluorescent stain,1
CDP,7
entryâ,1
3.52Î¼M,1
ampicillin (40.3%,1
"macrolides,",1
[193-fold (145â200)] for,1
COL+ (n =10,1
COL+ calves,1
Methylene blue covalently,1
â0.2864Î¼AÎ¼Mâ1,1
800nM,1
LC3-I/II,1
thienamycin,1
ketone inactivator and,1
chloromethyl ketone bound,1
IDX-184,1
[12],1
diphytanoyl phosphatidylserine,1
DPhPC) lipids,1
ROs,1
NF-ÎºB element,1
Sephadex,1
Magnesium Sulfate,1
magnesium sulfate,3
magnesium recipients,1
disulfide bond formation,1
CTB pentamers,1
transmucosal carrier molecule and,1
polyphosphate chain,1
adenosine moiety,1
sulfate ions,1
CI 10.6â11.0,1
1â50,1
274L (major capsid protein,1
intravenous (IV) ribavirin,1
monosaccharide compositions,1
monosaccharide compositional analysis plus polysaccharide structural characterization,1
N-dimethylaniline,1
LiClO4,1
"3,4,5-trimethoxycinnamic acid",1
TMCA,2
"3,4,5-trimethoxycinnamic acid) ester",1
TMCA ester,2
amide analogues,2
enzymeâinhibitor adduct,1
His102,1
N-Cbz,1
1â5 Î¼m,1
Le recours Ã  ,1
Le choix de la,1
zero-commission,1
hepatocyte-targeted,1
N-[14C]ethylmaleimide,1
[125I]iodosulfanilic acid,1
"clubbed 1,3,4-oxadiazoles Abstract A",1
"clubbed 1,3,4-oxadiazole derivatives (5aâl)",1
compounds 5c,1
phenyl ring remarkably enhanced,1
sugar cane leaves,1
maleic anhydride,1
Conjugated polyelectrolytes,1
N-triethyl-3-((4-methylthiophen-3-yl)oxy)propan-1-aminium bromide],1
RGB,1
1-555810255-4,1
calcium-sensitive dye fluo-3,1
L-type calcium,1
blockers,1
ground-glass opacification (53 [,1
[53%,1
adefovir dipivoxil,2
IFN-Î³ +874 T/A SNP,1
cocktail formulations,1
K d =105nM,1
OxDC,2
Edans,1
Î²-CD derivatives,1
sugar antennae,1
N-acetylglucosamine identified 11,1
acetylglucosamine,1
Diferentes aspectos relacionados con,1
rHuG-CSF,8
rHuG-CSF rapidly,1
parenteral natural human interferon alpha,1
Alferon N InjectionÂ,1
vitamin D deficiency (,1
N1-alkylated uracil derivatives,1
2-benzoylphenoxy)alkyl substituents,1
K103N/Y181C,1
DPI 7,1
DPI 14,1
0.8Ã109/L,1
3'-terminal 1314 nucleotides of,1
CI 1.2â8.4,1
anti-2019-nCoV,1
phenyl acetate,1
TBBL,2
Z-IETD-FMK,1
carbon dioxide emissions,1
fibrate gemfibrozil,1
tufted,1
Telithromycin,1
con otros procesos mÃ¡s,1
Le diagnostic de grippe mettant,1
3 ânot,1
Red haptens,1
SFA,1
micro-molar,1
compounds 16b,1
Biopotency,1
biopotency,3
goitrin,3
carbon dioxide emissions efficiency,1
reactive mesothelia,1
GS-327073,4
nucleoside polymerase,1
helix-driven,1
Act 1947,1
THI,3
imine,2
Schiff base ligands,1
semicarbazide,1
Imine ligandâcontaining,1
metal chalcogenide nanoparticles,1
mono-detection,1
cepharanthine hydrochloride,1
Cepharanthine hydrochloride,1
pH. NHR,1
4â14 laboratories,1
trichimeric,1
muramyl dipeptide),1
Î³-IFN-independent,1
photoantimicrobials,1
PGA,2
wing-web puncture with,1
oxazine,1
(Z)-5,1
phosphonate reagents,1
butadiene derivatives (12),1
Compounds 12f,1
12j,1
E2 (17Î²-estradiol),1
Aloe-emodin,4
immune-modulators,2
immune-modulators (corticosteroids),1
immune-modulators with antiviral agents,1
AdoHcy,1
Q1067H,1
25-hydroxycholesterol (,1
Î²-propio lactone,1
aluminium phosphate (3%,1
20Â·23,1
stilbenoid analogs,1
copper-mediated,1
RB5,1
cystatin-C,1
Se obtienen,1
con una sensibilidad,1
fÃ¡cil ejecuciÃ³n,1
hydrophilic oxygen,1
1-12.5,1
5-25,1
Nutlin,1
16.9Ã10â2 events/person-min,1
dimethyl suberimidate was,1
1 colony,1
1CFU/ml,1
Mefloquine,1
CI â0.6,1
intravenous (IV,1
SHC014,1
siRNA-containing liposomes,1
R8-liposomes,3
siRNA-loaded R8-liposomes,1
pyrithiobac derivatives,1
pyrithiobac,1
workâlife,2
employee-centric,1
25â50,1
10-point,1
intranasal (IN) vaccines,1
17.1kDa,1
homobifunctional imidoesters,1
homobifunctional imidoesters (HIs),1
chitosan polyplexes,2
chitosans,1
Fluorogenic RTâPCR,1
dual-labeled fluorogenic probes,1
pulmonary-associated,1
Arenaviral,1
colloidal gold immunoelectron microscopy,1
Quercetin solid lipid microparticles,1
Quercetin microparticles,1
o/w,1
tristearin,1
micronised quercetin,1
N-methyl-d-ribopyranuronamide,2
thymine nucleobases,1
[Table 1],1
[p=0.002],1
heteroatom annulation of,1
arabinosyl pyrimidinone derivatives were obtained by X-ray structure analysis,1
pyrimidinone,1
7.9Î¼M,1
polycyclic amines initially,1
"amine,",1
carbamoyl,1
phenyl,1
100â170Î¼M,1
Le risque infectieux est liÃ©,1
ICAs,1
glycyrrhizin acid derivatives,1
PNC,3
cis Golgi apparatus,1
BetaCoV/Korea/KCDC03/2020,1
subnanomolar,1
combinatoires oÃ¹ lâutilisation,1
chrysoeriol,7
diosmetin,7
entacapone,3
co-giving entacapone,1
self-detoxifying material Abstract,1
Nanohybrid membranes,2
PVA/PEI,2
reactive nanoparticulates (,1
2-chloroethyl-ethyl sulfide,1
CEES,4
clodronate liposome,1
endoglycosidases H,1
anti-M mAbs,1
antiâMCP-1,1
DPI 13 for,1
droplets â,1
"257,564",1
1MGxxxS6,1
2-hydroxymyristic acid,1
1.0Ã106,1
1997â2005,1
fortification,1
7â13,1
DOPS,4
Circularization,1
Steroid,1
sVLP,1
tablet formulation,1
200-mg,1
AUC0-t,3
[1.1] years,1
2033.6 (564.9),1
1992.0 (483.3) ng/mL/h,1
200-mg capsule,1
IMDM 5,1
under-aisle,1
IFN-Î± SC,1
47.2Î¼M,1
750.7 (SEM=202.9)mg/kg,1
40g/day,1
HCO3 (,1
amoxicillin 1 g,1
1000mg/day,1
niflumic acid,1
tolfenamic acid,1
Parenteral antimicrobial drugs,1
sulphonamides,1
florfenicol,2
bisbenzylisoquinoline alkaloids,2
Hoechst 33324,1
"F1,593",1
concentration-range,1
anti-glycating,1
"-IIE,",2
cell-association,1
2020-nMan Infectious diseases have,1
pentacyclic triterpenoids,1
Sivelestat sodium hydrate as,1
alkenyl acyclic nucleoside phosphonate prodrugs Abstract,1
phosphonoamidate prodrugs,1
nucleoside phosphonate (ANPs),1
allyl phosphonoamidates,1
alkenyl functionalised thymine and,1
uracil nucleobases,1
aryloxy moiety,1
uracil ProTides,1
copper phenanthroline complexes,1
copper phenanthroline-based,1
metal-ligand,1
emissions,1
carbon levies,1
inositol,1
nucleic acid vaccines,1
Drug Administration in,1
co-solvent mixtures,1
methanol (1)+water,1
n-propanol (1)+water,1
"1,4-dioxane (1)+water",1
"1,4-dioxane (Î´x 1,3",1
Î±-aminoisobutyric acid,1
Fathead Minnow Nidovirus,1
COL+ (n =9,1
COL+,1
5â² edge,1
Hypervitaminosis D,1
hypervitaminosis D,1
Nivolumab,1
dimethylsulfoxide,1
con potencial beneficio,1
High-dose TMP/SMX is first choice,1
ligand oxide,1
picoline N-oxide>pyridine N-oxide>triphenylphosphine oxide,1
electron-donating substituents in the,1
â4.10,1
electron-withdrawing substituents (Ï +,1
oxo(salen)chromium(V)+-LO,1
electron-donating substituents.,1
N-substituted naphthalimide acrylamides,1
Compounds cis-,1
voyageurs,1
unsaturated acyclic C-5 pyrimidine nucleoside analogues Abstract A,1
C-5 alkynyl pyrimidine nucleoside analogues,1
pyrimidine ring were,1
E-isomers,1
"compounds 3, 4 and",1
nonionic polymer hydroxyethyl cellulose,1
diphosphate salt,1
0.3â30,1
7-deazaguanosine (,1
Le virome humain RÃ©sumÃ© Le virome humain est une reprÃ©,1
Ã 2.0,1
L and N gene,1
D (Shizuoka strain),1
PEG),1
saturated fatty acyl,1
n=2 [20%],1
"2,3,5,4â²-tetrahydroxystilbene-2-O-Î²-d-glucopyranoside",1
Emodin-8-O-Î²-d-glucopyranoside,1
Physcion-8-O-Î²-d-glucopyranoside,1
4-aminoquinoline derivatives Abstract A,1
4-aminoquinoline derivatives,1
mono/dialkyl amines,1
10Î¼g/ml purified N antigen,1
WIN 54954,1
tritium Abstract Valuable antiviral compound WIN 54954,1
Tetracycline compounds,1
non-antimicrobial organ,1
reactive oxygen species scavengers,1
HMA joint,1
5.2â32.8,1
27â28,1
3-chloropyridine moieties,1
3-chloropyridine,1
benzene rings,1
wide-spectrum,1
"iso-d-2â²,3â²-dideoxy-3â²-fluorothianucleoside derivatives",1
"iso-d-2â²,3â²-dideoxythianucleoside derivatives 1â4",1
cytosine analogue,1
intranasal mupirocin,1
carbohydrates and,1
10â104,1
BAU,2
cBAU tube,1
particle growth by,1
"benzoimidazo[1,2-c]quinazolines",1
ethidium bromide displacement,1
17/330,1
penicillin nonsusceptibility,1
TMP/SMX,4
high-dose amoxicillin/clavulanate (4 g/250,1
high-dose amoxicillin (4 g/day,1
cefpodoxime proxetil,4
cefuroxime axetil,5
cefdinir,6
high-dose amoxicillin/clavulanate,3
high-dose amoxicillin (90 mg/kg,1
cefprozil,1
"parenteral, 1 to",1
Rifampin,3
Cefpodoxime proxetil,1
penicillin rash,1
Clindamycin,1
parenteral,1
developmentâA skin-care cream,1
4-amino-quinoline,1
261.3Â±14.5Î¼M,1
gp3-Î2,1
cholera,1
Con A-immobilized,1
Con A-PAB,1
Ionic liquid based ultrasonic assisted extraction of isoflavones from,1
1-alkyl-3-methylimidazolium ionic liquids,1
1H-NMR,1
colloid oncotic pressure,1
oliogosaccharide,1
ipratropium bromide,2
broad-spectrum (,1
dâavril,1
ConclusiÃ³n Casi,1
oxytocin i.m,2
OXY,1
1-[Ï-(4-bromophenoxy)alkyl]uracil derivatives â,1
retinyl ester,1
Guanidinium Chloride Abstract Chemical denaturant,1
guanidinium chloride,3
MIG],1
"Hoechst 33,342",1
exhaled particulate matter in airborne,1
563â85],1
xanthatin,2
lactone xanthatin,1
xanthatin (2),1
TP-5,2
Chiesi,1
azaspiro dihydrotriazines,2
azaspiro dihydrotriazine scaffolds,1
Paclitaxel,1
â¢ Emphasise,1
immunobiotic lactic acid,1
Cl.,4
FLLIYLGRT,1
ceftiofur,1
tilmicosin,4
tulathromycin in 12 isolates,1
serviceâ,1
Ribavarin,1
IPR respecto,1
con menor proporciÃ³n,1
ninguno,1
high-dose pseudochallenge,1
StructureâFunction,1
DmCPD1Bs,1
10.0â11.9log10,1
5.8log10,1
2.7log10,1
EAdo,4
ECyd,1
-adenosine (,1
51Î¼M,1
dextran sulfate sodium (DSS)-,1
dinitrobenzene sulfonic acid (DNBS)-induced colitis,1
DNBS-induced colitis in,1
hyssop,1
nucleotides 1121â1136,1
Amastatin,1
1.5â20 Î¼M,1
phosphoryl inhibitors of angiotensin converting enzyme,1
rentiapril,1
zofenoprilat,1
IÎºBÎ±DN,2
middle-dose,1
Negative-pressure,1
p-chloromercuribenzoic acid,1
methyl methanethiosulfonate,1
Triton X-100 1,4
reactive airway disease; 200 (66%,1
reactive airway disease (p=0Â·0004),1
reactive airway disease required,1
corticosteroid stress response,1
corticosteroid response provokes symptoms,1
corticosteroid treatment is delayed until inflammatory cytokine,1
0.5â5 mg/mL,1
catechin monohydrate,1
5â² tree,1
44Â·6,1
siRNA-loaded calcium phosphate nanoparticles,1
calcium phosphate core,1
CaP/PLGA,1
phosphatidylserine (PS) molecule,1
protoporphyrin IX,2
G-90,1
PIH 24â72,1
nucleotide acids,5
[40.5;107],1
Shirota,1
LcS,1
tryptophan fluorescence,1
cake layer,1
cake/gel layer,1
GPAP,2
"1:960,000",1
Nitrile oxides,1
virologues,1
NCTC 1469),1
PAPM,1
Cl. perfringens,1
âcustard-likeâ faeces,1
Vts,1
caffeine citrate,2
intravenous 25 mg/kg caffeine citrate,1
[14C]leucine,2
mannosylphosphoryl dolichol,1
compounds 4-[1-(4-Nitrobenzoyl)-1H-benzoimidazol-2-yl]-benzenesulfonic acid,1
LUMO,1
1-20,1
3-hydroxyphthalic anhydride,1
3-HP,1
[3H]proline,2
interferon-activated,1
pHLSV-7A,1
NEM,1
inhaled steroids,1
MEPs,1
rt-PA,6
dieldrin,6
Dieldrin,1
Superoxide anion,1
bleomycin (BLM)-induced lung,1
Hyp,2
RPF,1
glucan phosphate,1
"4-hydroxy-2,2,6,6-tetramethyl-1-piperidinyloxy",1
tempol (24 mg/kg,1
MassTag-PCR,2
nucleotides 4243,1
Gly673âGly674dipeptide,1
trimethoprim/sulfamethoxazole (68.7%,1
parenteral nutrition-associated cholestasis,1
enteral feeding,1
High-dose oral erythromycin,1
CTB monomers,1
Tween 20,1
viral-entry inhibitors,1
"sialic acid Î±2,3-linked",1
carbonyl iron treatment,1
2015â [Volume 6,1
superoxide anion radicals,1
ferrous ions,1
linoleic peroxidation,1
butylated hydroxytoluene,1
ferrous ion chelating activity,1
linoleic acid peroxidation,1
beta-blockers (,1
microbiologistes jouent un rÃ´le,1
FSPs,1
salt precipitations,1
cefoperazone/sulbactam,1
cuprous oxide (,1
Cu2O,3
CuO,1
silver sulfide,1
copper chloride,1
CuCl2,1
copper ions,1
pokeweed mitogen,1
lipophilic ester derivatives of,1
peroxyl radical,1
ORAC,1
oxygen radical absorbance,1
embelin,1
omega-3 PUFA,1
LB-,1
E with,1
lactam bridge) to,1
intravitreal injection of,1
âholisticâ,1
20mgmLâ1,2
NC8-pSIP409-pgsA'-S-DCpep,3
Thiamine,1
thiamine,6
Thiamine (,1
vitamin B1,1
V+ piglets,1
0.07â0.29],1
IFNa,2
Tauroursodeoxycholic acid,1
nitric oxideâbased,1
comparativos para evaluar este tipo,1
230-member peptidomimetic library against HKU4-CoV 3CLpro,1
cystathionine Î²-synthase,1
CBS-derived hydrogen sulfide,1
methylene blue assay,1
GYY4137,2
â¼60Î¼M,1
â¼40Î¼M,1
â¼30Î¼M,1
â¼3Î¼M,2
CBS-induced AzMC,1
AzMC,1
â¼300Î¼M,1
H2S-generating enzymes CSE,1
3-MST,1
Schiff base-like adducts,1
anemia/bone marrow aplasia,1
Cl 2Â·6â4Â·0,1
peptide-aldehyde derivatives,2
6â12years,1
Streamline 25 column (ID=25,1
Streamline chelating adsorbent immobilized,1
Ni2+-loaded Streamline chelating adsorbent for,1
Hypericin (HY),1
Isosporoid oocysts,1
0.4mg/ml,1
E-64D,1
nucleotides 1441,1
nanoLCâMS/MS,1
AS1517499,1
40â100,1
ncpBVDV2a 1373,1
Hemos realizado un estudio prospectivo,1
oxigenoterapia,1
Intravenous Ribavirin Human metapneumovirus,1
2o,1
compounds 2i and,1
"Se,",1
CI 0.50â0.77,1
aminosilane-modified silicate,1
Ormosil,1
XPS,1
2-chloroethylethylsulfide,1
3-indoxyl phosphate,1
indigo carmine,1
1Ã105 purified G.,1
C2-symmetric nitrogen-containing camphor derivatives,1
aliphatic linkers,1
deitiforin,1
Na+-dependent dicarboxylate cotransporter,2
NAD+/NADH,2
"2017âMay 16, 2018",1
Phosphatidylserine receptors,1
phosphatidylserine (,1
PtdSer receptors,2
Phytoestrogenic molecule desmethylicaritin,1
desmethylicaritin,7
Bromodeoxyuridine,1
manganese (IV) oxide,1
21-25(th,1
focuseson,1
methylene blue/narrow bandwidth light,1
Peracetic acid,1
methylene blue (MB)/light,1
100â110,1
30â35kDa,1
"1,2005",1
nitric oxide reduces,1
gNO,10
80ppm,1
NO-donor compounds,1
160ppm gNO,1
provocan,1
Con el objetivo de estudiar,1
polyhydroxyalkaloids,1
DMDP,1
con frecuencia no elevan,1
alta letalidad,1
expuestos,1
prevenciÃ³n con vacunaciÃ³n,1
corticosteroid in adult rabbits,1
contrÃ´les virologiques,1
sulphur dioxide emissions,1
Melphalan,1
fertiliser nitrogen (N),1
fertiliser N application,1
nonsteroidal inhibitor of prostaglandin synthetase,1
phenylbutazone,1
oxyphenylbutazone,1
phenacetin,1
Le MHV3,1
Le mutant qui tue le,1
column-retained,1
pyridoxine,2
ortho-pyridinone methide,1
4â²-O-substituted pyridoxine derivatives,1
261â270,1
C(E2,1
NASA];,1
2016â2040):,1
HRV/ENT,1
[3H]uridine-labÃ¨lled virus,1
PLO,1
protamine sulfate,1
2014â2018,1
chitosan (CHIT),1
genipin,1
GTMAC,1
1â31,1
6-TG,8
NSC23766,1
post-ribosomal,1
phenols,1
BF2*,2
BF2,2
Ni2+ NTA,1
IL-10-secretion,1
TiO2 Millennium,1
2-Deoxy-d-glucose,2
2-DG,4
glucose/mannose,1
NO),1
exantema,1
2017/18,1
â14.0,1
2019-nCoV lung,1
kasugamycin,2
TTA,7
PTU,1
ZnSO4,3
by-products (DBPs),1
1000m3/d,1
Ethyl dibromofluoroacetate,1
pH 7 and,1
Protollin Formulated,1
2019-nCoVââA desperate,1
cither,1
Drotrecogin,1
lignins,1
propiolic acid ethyl ester derived lithium reagent,1
lactone 6,1
lactone ring opening afford the acid 2a,1
amine 3,1
lipopolysaccharide-induced acute lung,1
PCMX,1
nucleic acid sensors,1
258/258,1
Phe-substituted,1
tritium-labeled sodium borohydride revealed,1
[3H] [14C] ratios,1
[35S]methionine were dark-adapted for 2 hr,1
Galactose,1
Pu in,1
Fe3O4@silica/poly(N-isopropylacrylamide,1
Fe3O4@SiO2/poly(N-isopropylacrylamide,2
H3PMo12O40 nano-drug,1
Powder,1
"calycosin, 4â²-O-Î²-glucopyranosyl-5-O-methylvisamminol (",1
cimifugin,3
B12 /B12,1
"1,25(OH)2D",1
fibrilles puis,1
Fine-Gray competing risk regression,1
CI 0.56â0.98,1
CI 1.16â1.95,1
clostridia species,1
2019-nCoV. El 30 de enero de 2020 la OrganizaciÃ³n,1
vaccine-loaded hydroxypropyl methylcellulose phthalate microspheres,2
HPMCP,3
gin,1
aminophylline,1
sialic acid derivatives,1
9-hydroxy,1
cytosine arabinoside-,1
l-Arginine,2
semi-essential amino acid,1
Con-A,1
1134g,1
3H-palmitic acid,1
T&A,1
â¥7days,1
heteropolytungstate,1
[K4(H2O)8Cl][K4(H2O)4PTi2W10O40]Â·NH2OH 1,1
2.66Î¼M,1
filterable agents,1
6-diazo-5-oxo-l-norleucine (DON),1
CPP-PNA,1
SPO2,1
Methylprednisolone acetate treatment,1
vasopeptidase,1
D3-22,1
pathogÃ¨nes,1
hydrogen peroxide disinfectant Summary A,1
H2O2) disinfectant,1
H2O2 dry fumigation system,1
8-cineole,1
organic acids and,1
intravenous immunoglobulins Abstract,1
IVIGs,1
XAV939âon,1
XAV939,3
6-mercaptopurine,1
nitrogen oxide,1
BHT,8
LPS injection,1
risperidone,1
olanzapine,1
quetiapine,1
ziprasidone,1
amisulpride,1
IL-1Î² [,1
DAPI,1
"1,3-oxazin derivatives",1
size-resolved,1
PFA,1
dUPT nick endâlabeling,2
thyroxine,1
Aryl methylene ketones,1
fluorinated methylene ketones as reversible inhibitors for severe acute respiratory,1
di-fluoro ketones,1
oxa analogues,1
13Î¼M,1
Full-day,1
anti-F-mAbs,1
alcian blue,1
nickel-agarose,1
Polyprenyl,1
[19]),1
M-11,1
I-S2-15,1
2-amino trizole.,1
A-a,1
short-chain fatty acids,1
1-deoxymannojirimycin,1
dMM,2
polyethylene glycol-induced,1
IF/RT-PCR,1
ammonium camphor derivatives,1
camphor derivatives,1
nitrogen atoms,1
C-geranyl substituent,1
"corticosteroid resistance,",1
MPEG LA,1
spina bifida,1
1200â800cmâ 1,1
NPC-based,1
Heat-clearing,1
immunostimulating agents and,1
lysomotropic basic compounds,1
0â30,1
arcuate renal arteries,1
LFP,3
DPC micelle,1
2.01â4.63,1
CRFK/FIV,1
FL4,1
intratracheal route protected monkeys,1
endovenosa,1
con especial Ã©,1
reduced-dose,1
full-dose,1
SL0101,1
19e siÃ¨cle et,1
20e siÃ¨cle,1
agro-industrial wastes,1
38-residues cytoplasmic,1
N-H Chua Abstract,1
acyclonucleosides,1
seco-nucleosides,1
PVC carpet,1
PCDD/F,2
under-ventilated fires,1
"polycyclic aromatic hydrocarbons, chlorinated dibenzo-dioxins and",1
halogenated dioxins,1
[N =44],1
[N =17]),1
"L and Q,",1
JulyâNovember 2010,1
isofucosterol,1
clionasterol,1
oblimersen sodium,1
phosphorothioate oligodeoxynucleotide,1
G3139,2
Ox,1
Neutrophil-derived,1
Con A-binding,1
exoproteases,1
21/179,1
18/179,1
28-amino-acid carboxy-terminal,1
cobalamin,1
MCX,1
ML-9,2
C18 reversed-phase column,1
I.D.,1
1â2500ngmlâ1,1
ÃTIOLOGY,1
âHospital,1
MIBE,3
nonarchaeal microbes,1
indigoticoside A,2
ethyl acetateân-butanolâwater (,1
v/v/v,1
clemastanin B,2
(CCL)-2,1
NSC87511,2
NSC343256,1
Audio-Visual,1
1.76â20.90,1
17-allylaminogeldanamycin,1
aryltriazene derivatives Abstract Twelve aminoarylazocompounds (AâC),1
12Î¼M (18),1
broad-spectrum antiviral agents for multiple coronavirus,1
Nanostructures as analytical tools,1
Le vaccin est un mÃ©dicament qui,1
hydroxyl radical footprintings of,1
16S RNA,1
quinone methide triterpene,1
especialistas,1
tetraethyl orthosilicate,1
variable(s,1
Non-AOM,1
AOM pathogens,1
SNARF-1 pH-sensitive,1
ADD200,1
Long-acting formulations with,1
reactive astrocytesâImplications,1
reactive astrocytosis is,1
corticosteroid administration: Impact on,1
MDI-spacer,10
inhaled corticosteroids (,1
2004âMay,1
"1,3,5-triazinylphosphonic acids Abstract Polysubstituted pyrimidinylphosphonic",1
"1,3,5-triazinylphosphonic acids",1
halopyrimidines,1
Le diagnostic prÃ©coce,1
CpG2006,2
antibiotic hexachlorophene,1
phenylboronic acid agarose,1
m-aminophenyleboronic acid agarose,1
aminophenyleboronic acid,1
vicinal diols,1
1.9Ã105 genome,1
Inhaled anti-infective chemotherapy,1
IFNÎ±2a 3MIU,1
amantadine 200,1
2â² O-methyl,1
carbohydrate coordination loops,1
G5P[13]I5,1
iopromide,4
peroxydisulfate,4
potassium peroxydisulfate,1
K2S2O8,1
sulphate radical,1
sulfate radicals,1
1â2Mâ2 sâ1,1
S2O8 2â.,1
sulfate radical,1
[16%]),1
oligosaccharide structures,1
unadsorbed material,1
(+)-Catechin,1
(+)-catechin,6
Lovastatin,1
CTB-FITC,1
acid-Schiff,1
IL-17Aâdominant pulmonary,1
lipoprotein-derived cholesterol,1
iso-propanol,1
"mecetronium etilsulphate; Sterillium Rub,",1
"Sterillium Virugard,",1
laurylamine,1
Kohrsolin FF,1
didecyldimonium chloride,1
Dismozon pur,1
magnesium monoperphthalate,1
"[Korsolex basic,",1
element(s,2
natureâchemical,1
inorganic toxin agents,1
LYS341,1
NAG,1
liposomal peptide,2
CHCP,5
Bouin,2
losmapimod,4
calix[4]arene derivatives,1
calixarenes,1
10â3 molLâ1 solutions,1
virucidal (antiseptic) molecule,1
pre-aerosolization,1
zVAD-fmk,1
LysoTracker Red,1
ABVD,1
acid-dependent virus,1
3bÎ124-154,2
â¤ 2,1
[r] =,1
FIO2,1
YW002,1
MF59-YW002,2
afzelin,1
Vanadium being,1
Fenton's type reactions,1
VCs,1
D757N,1
PrevenciÃ³n del sÃ­ndrome respiratorio agudo,1
15Î¼g,2
15Î¼g VLP vaccine,1
GMRs,1
CEPA,1
organic solvent extracts,1
sodium butyrate,1
sodium butyrate-treated,1
department(s,2
lactide co-glycolide,1
pDNA vaccine,1
nitric oxide synthase type II,2
14.0Î¼M,1
diastereomers,1
1.92log10,1
nano-carriers,1
amine-modified-PVAâPLGA/siRNA nanoparticles could,1
